Quarterlytics / Technology / Software - Application / Inpixon

Inpixon

inpx · NASDAQ Technology
Claim this profile
Ticker inpx
Exchange NASDAQ
Sector Technology
Industry Software - Application
Employees 51-200
← All annual reports
FY2018 Annual Report · Inpixon
Sign in to download
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2018

OR 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to _______________

Commission File Number 001-36404

INPIXON
(Exact name of registrant as specified in its charter)

Nevada
(State or other jurisdiction of
incorporation or organization)

88-0434915
(I.R.S. Employer
Identification No.)

2479 E. Bayshore Road
Suite 195
Palo Alto, CA 94303
(Address of principal executive offices)
(Zip Code)

(408) 702-2167
(Registrant’s telephone number, including area code) 

Securities registered pursuant to Section 12(b) of the Act: 

Title of each class
Common Stock, par value $0.001

Name of each exchange on
which each is registered
The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:

None
(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒ 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ☒ No ☐  

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of
registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐ 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
Non-accelerated filer

☐ 
☐

Accelerated filer
Smaller reporting company
Emerging growth company

☐ 
☒ 
☒ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☒  

Indicate by check mark whether the issuer is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒  

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the
average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter.  

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, based on the closing price of a share of the registrant’s common stock on
June 30, 2018 as reported by the Nasdaq Capital Market on such date, was $6,482,407.  

As of March 26, 2019, there were 6,973,522 shares of the registrant’s common stock outstanding.  

DOCUMENTS INCORPORATED BY REFERENCE

None.

 
 
 
 
 
 
  
 
 
  
 
 
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION CONTAINED IN THIS REPORT

INPIXON

TABLE OF CONTENTS

ITEM 1: BUSINESS

ITEM 1A: RISK FACTORS

ITEM 1B: UNRESOLVED STAFF COMMENTS

ITEM 2: PROPERTIES

ITEM 3: LEGAL PROCEEDINGS

ITEM 4: MINE SAFETY DISCLOSURES

PART I

PART II

ITEM 5: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

ITEM 6: SELECTED FINANCIAL DATA.

ITEM 7: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 7A: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 8: FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

ITEM 9: CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

ITEM 9A: CONTROLS AND PROCEDURES

ITEM 9B: OTHER INFORMATION

ITEM 10: DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

ITEM 11: EXECUTIVE COMPENSATION

PART III

ITEM 12: SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

ITEM 13: CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

ITEM 14: PRINCIPAL ACCOUNTING FEES AND SERVICES

ITEM 15: EXHIBITS, FINANCIAL STATEMENT SCHEDULES

ITEM 16: FORM 10-K SUMMARY

SIGNATURE

PART IV

i

ii

1

8

32

32

33

33

34

34

35

53

F-1

54

54

54

55

61

68

69

71

72

72

73

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION
CONTAINED IN THIS REPORT

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements give our current
expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. You can find many (but not all) of these
statements by looking for words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “would,” “should,” “could,” “may,” or
other similar expressions in this report. In particular, these include statements relating to future actions; prospective products, applications, customers and technologies; future performance
or results of anticipated products; and projected expenses and financial results. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results
to differ materially from our historical experience and our present expectations or projections. Factors that could cause actual results to differ from those discussed in the forward-looking
statements include, but are not limited to:

●

●

●

●

●

●

●

●

●

●

●

●

●

our limited cash and our history of losses;

our ability to achieve profitability;

our limited operating history with recent acquisitions;

emerging competition and rapidly advancing technology in our industry that may outpace our technology;

customer demand for the products and services we develop;

the impact of competitive or alternative products, technologies and pricing;

our ability to manufacture any products we develop;

general economic conditions and events and the impact they may have on us and our potential customers;

our ability to obtain adequate financing in the future;

our ability to continue as a going concern;

our success at managing the risks involved in the foregoing items;

strategic transactions which may include acquisitions, mergers, dispositions or investments; and

other factors discussed in this report.

The forward-looking statements are based upon management’s beliefs and assumptions and are made as of the date of this report. We undertake no obligation to publicly update or

revise any forward-looking statements included in this report. You should not place undue reliance on these forward-looking statements.

Unless  otherwise  stated  or  the  context  otherwise  requires,  the  terms  “Inpixon”  “we,”  “us,”  “our”  and  the  “Company”  refer  collectively  to  Inpixon  and,  where  appropriate,  its

subsidiaries.

Note Regarding Reverse Stock Split and Spin-off of Sysorex

The Company effected reverse splits of its outstanding common stock, par value $0.001, at a ratio of 1-for-15, effective as of March 1, 2017, 1-for-30, effective as of February 6,
2018, and 1-for-40, effective as of November 2, 2018 (collectively, the “Reverse Splits”), for the purpose of complying with Nasdaq Listing Rule 5550(a)(2). We have reflected the Reverse
Splits herein, unless otherwise indicated.

On August 31, 2018, the Company completed the spin-off (the “Spin-off”) of its value added reseller (“VAR”) business from its indoor positioning analytics business by way of a
distribution of all the shares of common stock of the Company’s wholly-owned subsidiary, Sysorex, Inc. (“Sysorex”), to the Company’s stockholders of record and certain warrant holders.
See “Part I—Item 1A. Risk Factors” included elsewhere in this Annual Report on Form 10-K for additional information. This Annual Report on Form 10-K presents our business and
results of operations as of and for the periods indicated, giving effect to the Spin-off, with the historical financial results of Sysorex reflected as discontinued operations.

ii

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 ITEM 1: BUSINESS

Introduction

 PART I

Inpixon is a technology company that helps to secure, digitize and optimize any premises with Indoor Positioning Analytics, sometimes referred to in this annual report as “IPA,”
for businesses and governments in the connected world. Inpixon Indoor Positioning Analytics is based on new sensor technology that finds all accessible cellular, Wi-Fi, Bluetooth and
RFID  signals  anonymously.  Paired  with  a  high-performance,  data  analytics  platform,  this  technology  delivers  visibility,  security  and  business  intelligence  on  any  commercial  or
government premises worldwide.

Inpixon Indoor Positioning Analytics offer:

● New sensors with proprietary technology that can find all accessible cellular, Wi-Fi, Bluetooth and RF signals. Utilizing various  radio signal technologies ensures precision
device  positioning  accurately  down  to  arm’s  length.  This  enables  highly detailed  understanding  of  customer  journey  and  dwell  time  in  retail  scenarios,  detection  and
identification of authorized and unauthorized devices, and prevention of rogue devices through alert notification based on rules when unknown devices are detected in restricted
areas.

● Data science analytics with lightning fast data mining using an in-memory database that uses a dynamic blend of RAM and NAND along with specially optimized algorithms
that both minimize data movement and maximize system performance. This enables the system to deliver reports with valuable insights to the user as well as to integrate with
common third party visualization, charting, graphing and dashboard systems.

●

Insights that deliver visibility and business intelligence about detailed customer journey and flow analysis of in-stores and storefronts allowing businesses to better understand
customer preferences, measure campaign effectiveness, uncover revenue opportunities and deliver an exceptional shopping experience.

Inpixon Indoor Positioning Analytics can assist all types of establishments, including brands, retailers, shopping malls and shopping centers, hotels and resorts, gaming operators,
airports, healthcare facilities, office buildings and government agencies, by providing greater security, gaining better business intelligence, increasing consumer confidence and reducing
risk while being compliant with applicable “Personal Identifiable Information” regulations.

IPA Product Development

Inpixon is a company in the information and technology industry and therefore keeping up with the technological advancements within the industry are critical to our long-term
success and growth. As a result, our senior management must continuously work to ensure that they remain informed and prepared to quickly adapt and leverage new technologies within
our product and service offering as such technologies become available. In connection with that goal, our product roadmap development plans include the use of blockchain technology to
maintain  and  propagate  device  reputation,  artificial  intelligence  for  amassing  anonymous  device  information,  integrating  video  image  analytics  for  additional  attributes,  ultra-wideband
technology  for  asset  tracking  and  a  voice-assisted  analytics  interface.  (See  additional  information  regarding  our  product  development  plans  under  the  heading  “Our  Products  and
Services”).

1

 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate Strategy

Management’s corporate strategy is to continue to build and develop Inpixon as a technology company that provides turnkey solutions from the collection of data to delivering
insights from that data to our customers with a focus on securing, digitizing and optimizing premises with IPA for businesses and governments. In connection with such strategy and in
order  to  facilitate  our  long-term  growth,  we  have  acquired  certain  companies,  technologies  and  intellectual  property  (“IP”)  that  complement  such  goals  and  will  continue  to  consider
completing additional strategic acquisitions as long as our financial condition permits. Currently, we are evaluating several complimentary technology companies that can add technology,
differentiation,  customers  and/or  revenue.  We  are  primarily  looking  for  accretive  opportunities  that  have  business  value  and  operational  synergies.  We  believe  these  complimentary
technologies will allow us to provide a comprehensive Indoor Positioning Platform, or one-stop shop to our customers. For example, we are evaluating a few Mobile App/SDK platforms to
help our customers with a code base to build or add locational context into their apps. We are also looking at various Wi-Fi-based positioning products to offer a no hardware solution at
large locations leveraging existing access-point infrastructure. While these Wi-Fi solutions may not be as precise or comprehensive as our solution, we believe they can provide an entry-
point solution that we can use to cross-sell our other product offerings. In addition, we are considering several Mapping interfaces that can provide a dynamic user-interface for outdoor and
indoor positioning with layers for different users like consumers, marketing teams, IT, etc. We are also considering the possibility of adding GPS capabilities to our arsenal to enhance our
Security Dome solution to areas beyond the indoors to include some outdoor areas as well. Allowing us to carry the blue dot seamlessly from the outside to the inside.

We believe that acquiring complementary products and/or IP will add value to the Company. Candidates with proven technologies that complement our overall strategy may come
from anywhere in the world, so long as there are strategic and financial reasons to make the acquisition. If we make any acquisitions in the future, we expect that we may pay for such
acquisitions using our equity securities, cash and debt financing in combinations appropriate for each acquisition.

Industry Overview

We believe that more and more enterprises are realizing the importance of employing Information Technology in their operations. The technology growth story has long focused
on the consumer, but as enterprises in every industry sector look to technology to facilitate and transform their own operations, the opportunities for technology companies have broadened
considerably. The following information illustrates the ways in which various IT markets are expected to grow.

According to third-party market research, the indoor location market is forecasted to grow from $7.11 billion in 2017 to $40.99 billion by 2022, at a compound annual growth rate,

or CAGR, of 42%. (Source: http://www.marketsandmarkets.com/PressReleases/indoor-location.asp)

The  location-based  services  (“LBS”)  and  real-time  location  systems  (“RTLS”)  market  has  grown  considerably  over  the  past  few  years  and  is  expected  to  grow  further  with
increasing use of smartphone and social media based advertisements and greater adoption of these technologies in various industry applications. In addition, third-party market research
indicates that the overall market is expected to grow from $22.18 billion in 2018 to $68.85 billion by 2023, at a CAGR of 25.4%. (Source: https://www.marketsandmarkets.com/Market-
Reports/location-based-service-market-%2096994431.html?gclid=CKz8gKml69ICFQx6fgodTkoBNQ)

The size of the cyber security market is estimated to grow from USD 137.63 Billion in 2017 to USD 248.26 Billion by 2023, at a CAGR of 10.2% during the forecast period.

(Source: http://www.marketsandmarkets.com/Market-Reports/cyber-security-market-505.html?gclid=COSEpv-Ho9MCFYVgfgodYmAJXw)

Corporate Structure

We  have  two  operating  subsidiaries:  (i)  Inpixon  Canada  Corp.  (100%  ownership)  based  in  Coquitlam,  British  Columbia;  and  (ii)  Sysorex  India  (82.5%  ownership)  based  in

Hyderabad, India.

Although the subsidiaries are separate legal entities, the Company is currently structured by function and organized to operate in an integrated fashion as one business.

Our Products and Services

We provide the following products and services that may be used by any number of businesses and government agencies.

●

Inpixon Security (formerly AirPatrol ZoneDefense) – This is a mobile security and detection product that locates devices operating within a monitored area, determines their
compliance with network security policies for that zone, and if the device is not compliant, can trigger policy modification of device apps and/or features either directly or via
third party mobile device, application and network management tools.

2

 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
●

Inpixon Intelligence (formerly AirPatrol ZoneAware)  – This is a commercial product for enabling location and/or context-based marketing services and information delivery
to mobile devices based on zones as small as 10 feet or as large as a square mile. The monitored areas may include a building, a campus, a mall, and outdoor regions like a
downtown.  Unlike  other  mobile  locationing technologies,  Inpixon  technologies  use  passive  sensors  that  work  over  both  cellular  and  Wi-Fi  networks  and  offer  device
locationing and  zone-based  app  and  information  delivery  accurate  to  within  10  feet.  Additionally,  unlike  geo-fencing  systems,  Inpixon  technologies  are  capable  of
simultaneously enabling different policies and delivering different apps or information to multiple devices within the same zone based on contexts such as the type of device,
the device user and time of day.

●

Shoom Products (eTearsheets; eInvoice, AdDelivery, ePaper) - The Shoom products are Cloud based applications and analytics  for the media and publishing industry. These
products also generate critical data analytics for the customers.

 IPA Product Enhancements

Inpixon is a company in the information and technology industry and therefore keeping up with the technological advancements within the industry are critical to our long-term
success and growth. As a result, our senior management must continuously work to ensure that they remain informed and prepared to quickly adapt and leverage new technologies within
our product and service offering as such technologies become available. In connection with that goal, our product roadmap development plans include the use of blockchain technology to
maintain and propagate device reputation, enforcing security policies and attaining compliance, artificial intelligence for amassing anonymous device information, integrating video image
analytics for additional attributes, ultra-wideband technology for asset tracking and a voice-assisted analytics interface.

Blockchain Technology for Device Reputation

Our IPA platform locates, monitors and analyzes the path of all cellular, Wi-Fi, and Bluetooth devices, regardless of make, manufacturer or device type, allowing not just the
ability to identify and prevent unwanted mobile devices, but also the ability to track and analyze device traffic within an indoor location. The addition of “device reputation” to our IPA
platform has been an important component of our anticipated product enhancements. “Device reputation” refers to information regarding the particular history of a device, such as when a
device enters a certain location, where within that location the device has travelled, the types of activities for which the device was previously used, including, but not limited to, whether
the device is linked to prior fraudulent activities, and information concerning accounts that the device might be linked to.

We  intend  to  use  “blockchain  technology”  in  order  to  propagate  device  reputation  profiles.  “Blockchain  technology”  refers  to  a  type  of  decentralized  “distributed  ledger”  or
database that can be used to securely record, store, share and synchronize data or information across multiple networks in various locations. The lack of a centralized location to store
information concerning a single device reputation profile results in a more secure repository for data and makes hacking or accessing that information for fraudulent purposes extremely
difficult. Accessing and falsifying or otherwise using information that is stored across a network of multiple servers in different locations for fraudulent purposes would require breaching
not just one server but the majority of the servers on which the information is stored making it significantly more difficult, if not impossible, to breach, thus creating a higher level of
security. We intend to leverage open source blockchain technology available to us without cost, by re-engineering such technology from a transaction-based schema to a behavior-based
schema in order to create a private proprietary code-base specifically for use within our IPA platform, to serve as a repository of “device reputation” collected in connection with our IPA
platform’s analytics capabilities. The collected data regarding device behavior will be secured through conventional methods of encrypted storage allowing for tamper proof audit trails with
respect  to  device  activity  and  behavior.  While  we  may  decide  to  hire  1-3  additional  employees  during  2018  with  greater  expertise  with  blockchain  technology,  the  addition  of  these
employees is not critical to our business plans insofar as the intent is to use open source technology and consult with third parties and/or provide training for its employees on an as needed
basis. We have an initial development of this technology within our IPA platform, but have not yet incorporated such technology into our platform. We believe we can quickly incorporate
this technology upon request by our customers.

3

 
 
 
  
 
 
 
 
 
 
 
Artificial Intelligence

        In 2019, we intend to expand our use of artificial intelligence (AI) and machine learning to anonymously capture device identity, build a repository of device profiles and
fingerprints, and offer intelligent solutions, which will continue to be refined over time, for enterprise security and marketing customers. Following this enhancement, Inpixon’s IPA AI
engine will be able to assist in providing predictive, more accurate, bidirectional information to secure the indoors. Inpixon’s IPA AI engine will interface with disparate customer site data
sources and the platform’s locationing data. The AI engine will apply heuristic analytical algorithms to data that is accumulated over time, identifying new patterns in device and customer
behavior, and deliver this information to customers and users via IPA and/or an application program interface (API) in real time. For the security domain, IPA’s AI analytics will be able to
identify  device  behavior  patterns  on  networks  that  are  associated  with  existing  blacklisted  devices,  analyze  device  behavior  and,  after  pattern  matching,  predictively  alert  users  to  a
potentially risky device and quarantine eminent threats.  Inpixon uses proto- AI techniques at almost all major layers of its technology stack including identifying devices anonymously.
The IPA AI engine will start identifying patterns of MAC Address changes based on incremental changes in the metadata of incoming device probe packets and device velocity patterns to
de-randomize  MAC  addresses,  which  will  enable  it  to  accurately  predict  device  counts  and  identify  devices  whose  MAC  addresses  are  constantly  changing.    By  applying  the  same
technology to the retail and marketing dimension, IPA’s AI engine will give managers the ability to accurately predict and quantify variance in crowd movement patterns, footfalls, and
revenue for store relocations and marketing campaigns, providing Inpixon customers with the opportunity to monetize this intelligence in correlation with big data like dwell time, weather
patterns, and demographics. We intend to continue to add AI and machine learning enhancements to our platform as we expand our customer base and add new big data partners to our
ecosystem.
 Voice-Assisted Analytics Interface

  We  also  intend  to  use  enterprise  voice-user  interface  (VUI)  technology  to  support  our  network  of  retail  and  marketing  customers  in  making  better  decisions  with  deeper
intelligence.  The  VUI  technology  in  our  IPA  platform  will  perform  as  a  digital  assistant  for  marketers,  allowing  them  to  make  quick,  hands-free  decisions  based  on  vetted,  predictive
information provided with simple voice/speech commands while also providing a complete audit trail. While the use of platforms such as Siri, Alexa, and Google Assistant have made
VUIs  modern  household  names,  Inpixon’s  IPA  VUI  is  uniquely  built  for  the  enterprise  marketing  space  digital  assistant  with  no  monitor,  no  keyboard,  no  mouse  and  only  an  audio
input/output device that functions just like a search engine, listening for keywords. While the technology itself is not revolutionary, it will modernize meetings and brainstorm sessions by
speeding  up  intelligence  gathering,  with  nearly  instantaneous  access  to  company  information  and  big  data,  it  will  be  able  to  predict  outcomes  based  on  past  information,  and  make
suggestions to keep business moving efficiently and effectively. At the same time, Inpixon’s IPA VUI will maintain a written log of all queries, seamlessly reporting all statistics back to
meeting attendees through an automated email. 
 IPA Pod

The Inpixon IPA Pod is a new addition to the Inpixon line of Radio Frequency sensors. The IPA Pod lowers the entry-level barriers to radio detection based Indoor Positioning for
our clients for Visitor Analytics in retail by delivering Wi-Fi and/or BT/BLE only based device locationing and tracking capabilities. The IPA Pod is a relatively inexpensive first step for
most retail customers, which delivers a significant amount of value at a fraction of the cost when compared to the full IPA Sensor and other competitive solutions. It is designed to be a
plug-and-play device that forms a self-calibrating array of IPA Pods that calibrates itself periodically to deal with ever changing RF environments and continuously deliver high positional
accuracy. It is designed to plug into existing electrical outlets and/or be deployed using Power-over-Ethernet drops and can backhaul data over wire or wirelessly. The IPA Pod can be
deployed in various densities in a given 3D space to match a wide array of customer use cases needing various levels of positional accuracy from the zone-level to room-level to aisle-level.

4

 
 
 
 
 
 
Asset Tracking

In 2019, we will continue to build the Inpixon IPA suite of solutions and enhance our existing tag tracking solutions. Using combinations of RFID, Dash7 and UWB frequencies
we will leverage our hardware sensors as listeners for tracking assets including employees, visitors and physical assets. With capability for accuracy  less  than  0.5  meters,  this  solution
continues to drive our capabilities in precise indoor location. Advancements in battery technology and wearables allow us to integrate and/or design new tag solutions for high value assets.

Research and Development Expenses

Our future plans include significant investments in research and development and related product opportunities. Our management believes that we must continue to dedicate a
significant amount of resources to research and development efforts to maintain a competitive position. Research and development expenses for the years ended December 31, 2018 and
2017 totaled approximately $2.4 million and $1.7 million, respectively.

Sales and Marketing

We utilize direct sales and marketing through approximately 5 sales representatives, who are compensated with a base salary and, in certain instances, may participate in incentive
plans such as commissions or bonuses. We utilize webinars, conferences, tradeshows and other direct and indirect marketing activities to generate demand for our products and services. We
also  have  relationships  with  channel  partners  to  directly  engage  with  customers  and  to  perform  the  installation  services.  We  train  our  partners  and  we  have  our  own  channel/partner
managers to support and augment partners as needed. We are in the process of expanding our channel partners in both security and intelligence markets.

Our Inpixon products are primarily sold on a license (up-front one-time fee) or software-as-a-service (SaaS) model. In our licensing model, we also typically charge an annual
maintenance fee. The SaaS model is typically for a 2-3 year contract and includes maintenance upgrades. The SaaS model generates a recurring revenue stream. Our Shoom product is on a
monthly subscription model based on 2-3 year contracts.

Customers

The Company’s customers include shopping malls, airports, government agencies, local publications, among others. Our top three customers accounted for approximately 49%
and 26% of our gross revenue during the years ended December 31, 2018 and 2017, respectively. One customer accounted for 33% of our gross revenue in 2018. From time to time one or
two customers can represent a significant portion of our revenue as a result of one-time projects.

Competition

Our  products  compete  with  Wi-Fi  based  detection  companies  such  as Aruba,  Cisco,  Euclid Analytics,  Mist  Networks, Aislelabs  and  other  smaller  companies.  However,  these
companies  primarily  offer  only  Wi-Fi  and/or  Blue-tooth  detection  and  therefore  we  believe  they  cannot  achieve  the  accuracy  and  comprehensive  detection  that  Inpixon  can  achieve.
Inpixon has partnered with or replaced some of these companies because it offers Wi-Fi, cellular, RFID and Bluetooth and has a location accuracy of approximately 10-feet. Mobile device
management companies like AirWatch, Mobile Iron and Good Technology have also integrated with Inpixon instead of developing competing products. MerlinOne and PressTeligence
compete with the functionality of our Shoom products, but typically provide information only for the specific customer and not for the customer’s competitors or for the industry.

Intellectual Property

The Company owns U.S. trademark registrations for the following six marks: Inpixon, IPA, Indoor Positioning Analytics, Security Dome, Shoom, and ZoneDefense. Each of these
registrations is in the first 10-year registration term and the Company intends to renew each registration for additional 10-year renewal terms, as available. The Company also has pending
applications for the following three additional marks:  Inpixon and ZoneDefense, both of which cover goods that are different from the goods and services covered in the Company’s issued
trademark  registrations  for  the  same  marks,  and  ZoneAware.  The  Company  has  seven  pending  applications  and  eight  registered  patents  in  various  countries  and  regions,  including  the
United States, Mexico, Australia, and the European Patent Organization region, relating to Inpixon products. The awarded patents were issued in 2014, 2017, 2018, and 2019 and will
expire in the years 2028, 2031, 2032, and 2033.

5

 
 
 
 
 
 
 
 
   
 
 
 
  
 
 
Government Regulation

In  general,  we  are  subject  to  numerous  federal,  state  and  foreign  legal  requirements  on  matters  as  diverse  as  data  privacy  and  protection,  employment  and  labor  relations,

immigration, taxation, anticorruption, import/export controls, trade restrictions, internal and disclosure control obligations, securities regulation and anti-competition.

Violations of one or more of these diverse legal requirements in the conduct of our business could result in significant fines and other damages, criminal sanctions against us or
our officers, prohibitions on doing business and damage to our reputation. Violations of these regulations or contractual obligations related to regulatory compliance in connection with the
performance of customer contracts could also result in liability for significant monetary damages, fines and/or criminal prosecution, unfavorable publicity and other reputational damage,
restrictions on our ability to compete for certain work and allegations by our customers that we have not performed our contractual obligations. To date, compliance with these regulations
has not been financially burdensome.

Employees

As  of  March  20,  2019,  we  have  69  employees  including  1  part-time  employee.  This  includes  4  officers,  8  sales  personnel,  2  marketing  personnel,  49  technical/engineering

personnel and 6 finance and administration personnel.

Emerging Growth Company

As a company with less than $1.07 billion in revenue during our most recently completed fiscal year, we qualify as an “emerging growth company” as defined in Section 2(a) of
the  Securities Act,  as  modified  by  the  Jumpstart  Our  Business  Startups Act  of  2012,  or  the  JOBS Act. As  an  emerging  growth  company,  we  may  take  advantage  of  specified  reduced
disclosure and other requirements that are otherwise applicable, in general, to public companies that are not emerging growth companies. These provisions include:

● Reduced disclosure about our executive compensation arrangements;

● No non-binding shareholder advisory votes on executive compensation or golden parachute arrangements;

●

Exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting; and

Reduced disclosure of financial information in this report, limited to two years of audited financial information and two years of selected financial information.

As a smaller reporting company, each of the foregoing exemptions is currently available to us. We will cease to be an emerging growth company on December 31, 2019, or,

immediately, if we issue more than $1.0 billion of non-convertible debt over a three-year-period.

The JOBS Act permits an emerging growth company to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public
companies. We have chosen to “opt out” of this provision. Therefore, we are subject to the same new or revised accounting standards as other public companies that are not emerging
growth companies.

6

 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate History

The Company was formed in Nevada in April 1999.

On July 29, 2011, we acquired all of the stock of the U.S. Federal government business of the Company, which included the business of Sysorex, and 50.2% of the stock of the

operating unit of the Company engaged in Saudi Arabian government contracts, Sysorex Arabia, LLC. 

On March 20, 2013, we completed the acquisition of the assets of Lilien LLC, including all the outstanding capital stock of Lilien Systems. In conjunction with our name change

to Inpixon, effective as of March 1, 2017, Lilien Systems was renamed Inpixon USA, which later became the predecessor to Sysorex.

Effective August  31,  2013,  we  acquired  100%  of  the  stock  of  Shoom,  Inc.  (“Shoom”).  Shoom,  which  was  merged  into  the  predecessor  of  Sysorex  in  January  2016,  which

provided us with Cloud based data analytics and enterprise solutions to the media, publishing and entertainment industries.

Effective April 18, 2014, we acquired 100% of the stock of AirPatrol Corporation. AirPatrol, which was merged into the predecessor of Sysorex in January 2016. That business
developed indoor device locationing, monitoring and management technologies for mobile devices operating on Wi-Fi, cellular and wideband RF networks. Through AirPatrol, we acquired
two product lines, ZoneDefense (now rebranded “Inpixon Security”) and ZoneAware (now rebranded “Inpixon Intelligence”). These products and technologies deliver solutions to address
an exploding global location-based mobile security and services (“LBS”) and real-time location systems (“RTLS”) market estimated to be more than $17.4 billion in 2017 and to grow to
$68.5 
96994431.html?
gclid=CKz8gKml69ICFQx6fgodTkoBNQ).  Inpixon  Intelligence  (formerly  known  as AirPatrol  for  Retail  or  Zone Aware)  also  serves  as  a  location-based  services,  sales  and  marketing
system. The security platform connects to third party apps on a user’s mobile device that provide functions such as location-based offers, discounts and suggestive selling, VIP service
functions (for hotels, resorts, casinos, etc.), and location-based information delivery such as mobile-based guided tours of historic sites, points of interest and museums, shopping center
maps, building floor plans and so on. These products require no app installation for anonymous collection of behavioral data such as traffic flow, entry and exit patterns, length of stay and
other business intelligence and analytics functions.

(Source:http://www.marketsandmarkets.com/Market-Reports/location-based-service-market- 

growing 

billion 

25.4% 

2023, 

by 

at 

On April  24,  2015,  we  completed  the  acquisition  of  substantially  all  of  the  assets  of  LightMiner  Systems,  Inc.  (“LightMiner”),  which  was  in  the  business  of  developing  and
commercializing in-memory Structured Query Language databases. The assets acquired from LightMiner included an in-memory, real-time, data analysis system designed to perform very
large, highly complex and extremely difficult calculations using off-the-shelf hardware and memory. The system supports both traditional SQL-based business intelligence and analytics
applications as well as a host of integrated statistical, machine learning and artificial intelligence algorithms allowing it to provide supercomputer-like performance at competitive prices.

On December 4, 2015 and effective January 1, 2016, our board of directors (the “Board”) approved the following reorganization transactions: (1) statutory mergers of AirPatrol
and  Shoom  with  and  into  Lilien,  pursuant  to  which  Lilien  was  the  surviving  corporation  and  changed  its  name  to  “Sysorex  USA”,  which  later  became  Sysorex;  and  (2)  a  short-form
statutory merger of the Company with a newly-formed wholly-owned Nevada corporation, pursuant to which the Company changed its name to “Sysorex Global”. Immediately prior to the
consummation of these mergers, the Company carried out (i) an assignment from AirPatrol to the Company of all shares of capital stock of AirPatrol Research, pursuant to which AirPatrol
Research became a direct subsidiary of the Company; (ii) the amendment of AirPatrol Research’s Notice of Articles to change its name to “Sysorex Canada Corp.”; (iii) the dissolution and
winding  up  of  Sysorex  Federal,  in  which  Sysorex  Federal  assigned  and  transferred  all  of  its  assets,  including  all  outstanding  shares  of  capital  stock  of  Sysorex  Government,  to  the
Company,  and  the  Company  assumed  Sysorex  Federal’s  debts  and  liabilities;  (iv)  an  assignment  from  the  Company  to  Lilien  of  all  outstanding  shares  of  capital  stock  of  Sysorex
Government, pursuant to which Sysorex Government became a direct subsidiary of Lilien. 

On  November  21,  2016,  we  completed  the  acquisition  of  the  business  and  certain  assets  of  Integrio  Technologies,  LLC  (“Integrio”  or  “Integrio  Technologies”)  and  Emtech
Federal, LLC (“Emtech Federal”). Integrio, together with Emtech Federal, was an IT integration and engineering company that provided solutions for network performance, secure wireless
infrastructure, software application lifecycle support, and physical cyber security for federal, state and local government agencies.

7

 
 
 
 
 
 
 
 
 
 
 
On  February  27,  2017,  we  entered  into  an Agreement  and  Plan  of  Merger  with  Inpixon,  our  wholly-owned  Nevada  subsidiary  formed  solely  for  the  purpose  of  changing  our
corporate  name  from  Sysorex  Global  to  Inpixon. As  part  of  the  name  change,  each  of  our  then-existing  subsidiaries  also  amended  their  corporate  charters  to  change  their  names  from
Sysorex USA, Sysorex Government Services, Inc. and Sysorex Canada Corp. to Inpixon USA, Inpixon Federal, Inc. and Inpixon Canada, Inc., respectively, effective as of March 1, 2017.
In addition, effective March 1, 2017, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to effect a 1-for-15
reverse stock split of the Company’s common stock.

Effective as of December 31, 2017, the Company acquired approximately 82.5% of the outstanding equity securities of Sysorex India Limited (“Sysorex India”) from Sysorex
Consulting, Inc. (“SCI”) pursuant to that certain Stock Purchase Agreement dated as of December 31, 2017 by and among the Company, SCI and Sysorex India, for aggregate consideration
for the assignment by the Company of $666,000 of outstanding receivables.

On January 18, 2018, the Company sold its 50.2% interest in Sysorex Arabia to SCI in consideration for SCI’s assumption of 50.2% of the assets and liabilities of Sysorex Arabia,

totaling approximately $11,400 and $1,031,000, respectively.

On February 2, 2018, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to increase the total number
of authorized shares of common stock from 50,000,000 to 250,000,000, as approved by the Company’s stockholders at a special meeting held on February 2, 2018 and effective upon filing
(the “Authorized Share Amendment”).

On February 2, 2018, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to effect a 1-for-30 reverse

stock split of the Company’s issued and outstanding shares of common stock, effective as of February 6, 2018.

On August 31, 2018, the Company completed the Spin-off of Sysorex to separate its VAR business from its indoor positioning analytics business.

On October 31, 2018, the Company received stockholder approval for, and subsequently effected, a reverse split of its outstanding common stock, par value $0.001, at a ratio of

1-for-40, effective as of November 2, 2018, for the purpose of complying with Nasdaq Listing Rule 5550(a)(2).

Corporate Information

Our principal executive offices are located at 2479 E. Bayshore Road, Suite 195, Palo Alto, CA 94303, and our telephone number is (408) 702-2167. Our subsidiaries maintain
offices in Coquitlam, British Columbia and Hyderabad, India. Our Internet website is www.inpixon.com. The information on, or that can be accessed through, our website is not part of this
report, and you should not rely on any such information in making any investment decision relating to our common stock.

 ITEM 1A: RISK FACTORS

We are subject to various risks that may materially harm our business, prospects, financial condition and results of operations. An investment in our common stock is speculative
and involves a high degree of risk. In evaluating an investment in shares of our common stock, you should carefully consider the risks described below, together with the other information
included in this report.

If any of the events described in the following risk factors actually occurs, or if additional risks and uncertainties later materialize, that are not presently known to us or that we
currently deem immaterial, then our business, prospects, results of operations and financial condition could be materially adversely affected. In that event, the trading price of our common
stock could decline, and investors in our common stock may lose all or part of their investment in our shares. The risks discussed below include forward-looking statements, and our actual
results may differ substantially from those discussed in these forward-looking statements.

8

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risks Related to Our Operations

We have completed five acquisitions since 2013, including Lilien, Shoom, AirPatrol, LightMiner and Integrio, and completed the Spin-off our VAR business in August 2018, which
included  the  businesses  acquired  from  Lilien  and  Integrio,  which  may  make  it  difficult  for  potential  investors  to  evaluate  our  future  business.  Furthermore,  due  to  the  risks  and
uncertainties related to the acquisition of new businesses, any such acquisition does not guarantee that we will be able to attain profitability.

Between March 2013 and November 2016, we completed five acquisitions and, in August 2018, we completed the Spin-off of our VAR business, which included the businesses
acquired  from  Lilien  and  Integrio.  Our  limited  operating  history  after  such  acquisitions  and  divestiture  makes  it  difficult  for  potential  investors  to  evaluate  our  business  or  prospective
operations or the merits of an investment in our securities. With respect to the Spin-off, the risks inherent in such divestiture are described below under “Risks Related to the Spin-off.” With
respect to acquisitions, we are subject to the risks inherent in the financing, expenditures, complications and delays characteristic of a newly combined business. These risks are described
below under the risk factor titled “Any future acquisitions that we may make could disrupt our business, cause dilution to our stockholders and harm our business, financial condition or
operating results.” In addition, while the former affiliates of four of these businesses have indemnified the Company from any undisclosed liabilities, there may not be adequate resources
to  cover  such  indemnity.  Furthermore,  there  are  risks  that  the  vendors,  suppliers  and  customers  of  these  acquired  entities  may  not  renew  their  relationships  for  which  there  is  no
indemnification. Accordingly, our business and success faces risks from uncertainties inherent to developing companies in a competitive environment. There can be no assurance that our
efforts will be successful or that we will ultimately be able to attain profitability.

We may not be able to successfully integrate the business and operations of entities that we have acquired or may acquire in the future into our ongoing business operations, which
may  result  in  our  inability  to  fully  realize  the  intended  benefits  of  these  acquisitions,  or  may  disrupt  our  current  operations,  which  could  have  a  material  adverse  effect  on  our
business, financial position and/or results of operations.

We continue to integrate the operations of AirPatrol, LightMiner and Shoom and this process involves complex operational, technological and personnel-related challenges, which

are time-consuming and expensive and may disrupt our ongoing business operations. Furthermore, integration involves a number of risks, including, but not limited to:

●

●

●

●

●

●

●

●

●

difficulties or complications in combining the companies’ operations;

differences in controls, procedures and policies, regulatory standards and business cultures among the combined companies;

the diversion of management’s attention from our ongoing core business operations;

increased exposure to certain governmental regulations and compliance requirements;

the potential loss of key personnel;

the potential loss of key customers or suppliers who choose not to do business with the combined business;

difficulties or  delays  in  consolidating  the  acquired  companies’  technology  platforms,  including  implementing  systems  designed  to  continue  to  ensure  that  the  Company
maintains effective disclosure controls and procedures and internal control over financial reporting for the combined company and enable the Company to continue to comply
with U.S. GAAP and applicable U.S. securities laws and regulations;

unanticipated costs and other assumed contingent liabilities;

difficulty comparing financial reports due to differing financial and/or internal reporting systems;

9

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
● making any  necessary  modifications  to  internal  financial  control  standards  to  comply  with  the  Sarbanes-Oxley  Act  of  2002  and  the  rules  and  regulations  promulgated

thereunder; and/or

●

possible tax costs or inefficiencies associated with integrating the operations of the combined company.

These factors could cause us to not fully realize the anticipated financial and/or strategic benefits of the acquisitions and the recent reorganization, which could have a material

adverse effect on our business, financial condition and/or results of operations.

Even if we are able to successfully operate the acquired businesses,  we  may  not  be  able  to  realize  the  revenue  and  other  synergies  and  growth  that  we  anticipated  from  these
acquisitions in the time frame that we currently expect, and the costs of achieving these benefits may be higher than what we currently expect, because of a number of risks, including, but
not limited to:

●

●

●

the possibility that the acquisition may not further our business strategy as we expected;

the possibility that we may not be able to expand the reach and customer base for the acquired companies current and future products as expected; and

the possibility that the carrying amounts of goodwill and other purchased intangible assets may not be recoverable.

As a result of these risks, the acquisitions and integration may not contribute to our earnings as expected, we may not achieve expected revenue synergies or our return on invested

capital targets when expected, or at all, and we may not achieve the other anticipated strategic and financial benefits of the acquisitions and the reorganization.

The risks arising with respect to the historic business and operations of our recent acquisition targets may be different from what we anticipate, which could significantly increase the
costs and decrease the benefits of the acquisition and materially and adversely affect our operations going forward.

Although  we  performed  significant  financial,  legal,  technological  and  business  due  diligence  with  respect  to  our  recent  acquisition  targets,  we  may  not  have  appreciated,
understood  or  fully  anticipated  the  extent  of  the  risks  associated  with  the  acquisitions.  We  have  secured  indemnification  for  certain  matters  from  the  former  equity  holders  of  Lilien,
Shoom, AirPatrol and Integrio in order to mitigate the consequences of breaches of representations, warranties and covenants under the merger agreements and the risks associated with
historic  operations,  including  those  with  respect  to  compliance  with  laws,  accuracy  of  financial  statements,  financial  reporting  controls  and  procedures,  tax  matters  and  undisclosed
liabilities,  and  certain  matters  known  to  us.  We  believe  that  the  indemnification  provisions  of  the  merger  agreements,  together  with  any  applicable  holdback  escrows  (in  the  case  of
AirPatrol, Shoom and LightMiner) and insurance policies that we have in place will limit the economic consequences of the issues we have identified in our due diligence to acceptable
levels. Notwithstanding our exercise of due diligence and risk mitigation strategies, the risks of the acquisition and the costs associated with these risks may be greater than we anticipate.
We may not be able to contain or control the costs associated with unanticipated risks or liabilities, which could materially and adversely affect our business, liquidity, capital resources or
results of operations.

A  significant  portion  of  the  purchase  price  for  our  acquisition  of  Shoom,  AirPatrol  and  LightMiner  is  allocated  to  goodwill  and  intangible  assets  that  are  subject  to  periodic
impairment evaluations. An impairment loss could have a material adverse impact on our financial condition and results of operations.

The  Company  acquired  $1.2  million  of  goodwill  and  $2.8  million  of  intangible  assets  relating  to  our  acquisition  of  Shoom,  $7.4  million  of  goodwill  and  $13.3  million  of
intangible assets relating to our acquisition of AirPatrol and $3.5 million of intangible assets relating to our acquisition of LightMiner. As required by current accounting standards, we
review intangible assets for impairment either annually or whenever changes in circumstances indicate that the carrying value may not be recoverable. The risk of impairment to goodwill is
higher during the early years following an acquisition. This is because the fair values of these assets align very closely with what we paid to acquire the reporting units to which these assets
are assigned. As a result, the difference between the carrying value of the reporting unit and its fair value (typically referred to as “headroom”) is smaller at the time of acquisition. Until
this headroom grows over time, due to business growth or lower carrying value of the reporting unit, a relatively small decrease in reporting unit fair value can trigger impairment charges.
When impairment charges are triggered, they tend to be material due to the size of the assets involved. Our business would be adversely affected, and impairment of goodwill could be
triggered, if any of the following were to occur: higher attrition rates than planned as a result of the competitive environment or our inability to provide products and services that are
competitive in the marketplace, lower-than-planned adoption rates by customers, higher-than-expected expense levels to provide services to clients, and changes in our business model that
may impact one or more of these variables. During the years ended December 31, 2018 and 2017, we recorded an impairment charge for goodwill in the amount of $636,000 and $587,000,
respectively.

10

 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our acquisitions may expose us to additional liabilities, and insurance and indemnification coverage may not fully protect us from these liabilities. 

Upon completion of acquisitions, we may be exposed to unknown or contingent liabilities associated with the acquired entity, and if these liabilities exceed our estimates, our

results of operations and financial condition may be materially and negatively affected.

Our ability to successfully execute our business plan may require additional debt or equity financing, which may otherwise not be available on reasonable terms or at all.

According to our business plan, we may need additional debt or equity financing. Future financings through equity offerings by us will be dilutive to existing stockholders. In
addition,  the  terms  of  securities  we  may  issue  in  future  capital  transactions  may  be  more  favorable  to  new  investors  than  our  current  investors.  Newly  issued  securities  may  include
preferences,  superior  voting  rights,  and  the  issuance  of  warrants  or  other  derivative  securities.  We  may  also  issue  incentive  awards  under  our  equity  incentive  plans,  which  may  have
additional dilutive effects. We may also be required to recognize non-cash expenses in connection with certain securities we may issue in the future such as convertible notes and warrants,
which would adversely impact our financial condition and results of operations. Our ability to obtain needed financing may be impaired by factors, including the condition of the economy
and capital markets, both generally and specifically in our industry, and the fact that we are not profitable, which could affect the availability or cost of future financing. If the amount of
capital we are able to raise from financing activities, together with our revenues from operations, is not sufficient to satisfy our capital needs, we may need to reduce our operations by, for
example, selling certain assets or business segments.

Failure to manage or protect growth may be detrimental to our business because our infrastructure may not be adequate for expansion.

Our  recent  acquisitions  required  a  substantial  expansion  of  the  Company’s  systems,  workforce  and  facilities  and  we  anticipate  that  we  may  need  to  consummate  additional
acquisitions  in  connection  with  the  expansion  of  our  IPA  business  after  the  Spin-off.  We  may  fail  to  adequately  manage  our  anticipated  future  growth.  The  substantial  growth  in  our
operations as a result of our acquisitions has, and is expected to continue to, place a significant strain on our administrative, financial and operational resources, and increase demands on
our management and on our operational and administrative systems, controls and other resources. There can be no assurance that our systems, procedures and controls will be adequate to
support our operations as they expand. We cannot assure you that our existing personnel, systems, procedures or controls will be adequate to support our operations in the future or that we
will be able to successfully implement appropriate measures consistent with our growth strategy. As part of this growth, we may have to implement new operational and financial systems,
procedures and controls to expand, train and manage our employee base, and maintain close coordination among our staff. We cannot guarantee that we will be able to do so, or that if we
are able to do so, we will be able to effectively integrate them into our existing staff and systems.

To the extent we acquire other businesses, we will also need to integrate and assimilate new operations, technologies and personnel. The integration of new personnel will continue
to result in some disruption to ongoing operations. The ability to effectively manage growth in a rapidly evolving market requires effective planning and management processes. We will
need to continue to improve operational, financial and managerial controls, reporting systems and procedures, and will need to continue to expand, train and manage our work force. There
can be no assurance that the Company would be able to accomplish such an expansion on a timely basis. If the Company is unable to effect any required expansion and is unable to perform
its contracts on a timely and satisfactory basis, its reputation and eligibility to secure additional contracts in the future could be damaged. The failure to perform could also result in contract
terminations and significant liability. Any such result would adversely affect the Company’s business and financial condition.

11

 
 
 
 
 
 
 
 
 
Our financial status raises doubt about our ability to continue as a going concern.

Our  cash  and  cash  equivalents  were  approximately  $1  million  at  December  31,  2018,  compared  with  approximately  $141,000  at  December  31,  2017.  We  continue  to  incur
significant  operating  losses,  and  management  expects  that  significant  on-going  operating  expenditures  will  be  necessary  to  successfully  implement  our  business  plan  and  develop  and
market  our  products.  These  circumstances  raise  substantial  doubt  about  our  ability  to  continue  as  a  going  concern  within  one  year  after  the  date  that  the  financial  statements  included
elsewhere in this Annual Report on Form 10-K are issued. Implementation of our plans and our ability to continue as a going concern will depend upon our ability to market our technology
and raise additional capital.

Management believes that we have access to capital resources through possible public or private equity offerings, exchange offers, debt financings, corporate collaborations or
other means. In addition, we continue to explore opportunities to strategically monetize our technology and our services, although there can be no assurance that we will be successful with
such plans. We have historically been able to raise capital through equity offerings, although no assurance can be provided that we will continue to be successful in the future. If we are
unable to raise sufficient capital through 2019 or otherwise, we will not be able to pay our obligations as they become due.

We will need to increase the size of our organization, and we may experience difficulties in managing growth, which could hurt our financial performance.

In addition to employees hired in connection with our recent acquisitions and any other companies, which we may acquire in the future, we anticipate that we will need to expand
our employee infrastructure for managerial, operational, financial and other resources at the parent company level. Future growth will impose significant added responsibilities on members
of  management,  including  the  need  to  identify,  recruit,  maintain  and  integrate  additional  employees.  Our  future  financial  performance  and  our  ability  to  commercialize  our  product
candidates and to compete effectively will depend, in part, on our ability to manage any future growth effectively.

In order to manage our future growth, we will need to continue to improve our management, operational and financial controls and our reporting systems and procedures. All of
these measures will require significant expenditures and will demand the attention of management. If we do not continue to enhance our management personnel and our operational and
financial systems and controls in response to growth in our business, we could experience operating inefficiencies that could impair our competitive position and could increase our costs
more than we had planned. If we are unable to manage growth effectively, our business, financial condition and operating results could be adversely affected.

We have a history of operating losses and working capital deficiency and there is no assurance that we will be able to achieve profitability or raise additional financing.

We have a history of operating losses and working capital deficiency. We have incurred net losses of approximately $24.6 million and $35.0 million for the fiscal years ended
2018 and 2017, respectively, which include the net losses of the entities we spun-off on August 31, 2018 of $4.8 million and $17.0 million for the years ended December 31, 2018 and
2017, respectively. We had a working capital deficiency of approximately $3.9 million and $32.8 million as of December 31, 2018 and December 31, 2017, respectively. The continuation
of our Company is dependent upon attaining and maintaining profitable operations and raising additional capital as needed, but there can be no assurance that we will be able to raise any
further financing.

12

 
 
 
 
 
 
 
 
 
 
Our ability to generate positive cash flow from operations is dependent upon sustaining certain cost reductions and generating sufficient revenues. In that regard, our revenues
have declined by 4.6% for the year ended December 31, 2018, as compared to the same periods for the prior fiscal year as a result of lower revenues from our Shoom product line. Our
management is evaluating options and strategic transactions and continuing to market and promote our new products and technologies, however, there is no guarantee that these efforts will
be successful or that we will be able to achieve or sustain profitability. We have funded our operations primarily with proceeds from public and private offerings of our common stock and
secured and unsecured debt instruments. Our history of operating losses and cash uses, our projections of the level of cash that will be required for our operations to reach profitability, and
the terms of the financing transactions that we completed in the past, may impair our ability to raise capital on terms that we consider reasonable and at the levels that we will require over
the coming months. We cannot provide any assurances that we will be able to secure additional funding from public or private offerings or debt financings on terms acceptable to us, if at
all. If we are unable to obtain the requisite amount of financing needed to fund our planned operations, it would have a material adverse effect on our business and ability to continue as a
going concern, and we may have to curtail, or even to cease, certain operations. If additional funds are raised through the issuance of equity securities or convertible debt securities, it will
be dilutive to our stockholders and could result in a decrease in our stock price.

The reorganization transactions we carried out in 2015 and subsequent name changes may cause us to be in a technical breach of certain third-party agreements.

In  2015,  we  carried  out  a  series  of  reorganization  transactions  to  streamline  the  organizational  structure  within  the  Company  and  both  its  direct  and  indirect  subsidiaries.  In
addition, we have changed our corporate name and the names of our subsidiaries. Although these transactions occurred solely within the Company and its subsidiaries, there still may have
been  an  obligation  to  either  provide  notice  and/or  seek  consent  from  certain  third  parties  pursuant  to  the  contracts  we  have  with  these  parties.  We  have  reviewed  and  addressed  these
requirements; however, our failure to comply with any of these notice or consent requirements may have left us in a technical breach, thus possibly subjecting us to potential liabilities or
an early termination under the applicable contracts. As of the date of this filing, there are no known breaches.

Our business depends on experienced and skilled personnel, and if we are unable to attract and integrate skilled personnel, it will be more difficult for us to manage our business and
complete contracts.

The success of our business depends on the skill of our personnel. Accordingly, it is critical that we maintain, and continue to build, a highly experienced management team and
specialized workforce, including those who create software programs and sales professionals. Competition for personnel, particularly those with expertise in government consulting and a
security clearance, is high, and identifying candidates with the appropriate qualifications can be costly and difficult. We may not be able to hire the necessary personnel to implement our
business strategy given our anticipated hiring needs, or we may need to provide higher compensation or more training to our personnel than we currently anticipate. In addition, our ability
to recruit, hire and indirectly deploy former employees of the U.S. Government is subject to complex laws and regulations, which may serve as an impediment to our ability to attract such
former employees.

Our business is labor intensive and our success depends on our ability to attract, retain, train and motivate highly skilled employees, including employees who may become part of
our organization in connection with our acquisitions. The increase in demand for consulting, technology integration and managed services has further increased the need for employees with
specialized  skills  or  significant  experience  in  these  areas.  Our  ability  to  expand  our  operations  will  be  highly  dependent  on  our  ability  to  attract  a  sufficient  number  of  highly  skilled
employees and to retain our employees and the employees of companies that we have acquired. We may not be successful in attracting and retaining enough employees to achieve our
desired expansion or staffing plans. Furthermore, the industry turnover rates for these types of employees are high and we may not be successful in retaining, training or motivating our
employees.  Any  inability  to  attract,  retain,  train  and  motivate  employees  could  impair  our  ability  to  adequately  manage  and  complete  existing  projects  and  to  accept  new  client
engagements. Such inability may also force us to increase our hiring of independent contractors, which may increase our costs and reduce our profitability on client engagements. We must
also devote substantial managerial and financial resources to monitoring and managing our workforce. Our future success will depend on our ability to manage the levels and related costs
of our workforce.

In  the  event  we  are  unable  to  attract,  hire  and  retain  the  requisite  personnel  and  subcontractors,  we  may  experience  delays  in  completing  contracts  in  accordance  with  project
schedules and budgets, which may have an adverse effect on our financial results, harm our reputation and cause us to curtail our pursuit of new contracts. Further, any increase in demand
for personnel may result in higher costs, causing us to exceed the budget on a contract, which in turn may have an adverse effect on our business, financial condition and operating results
and harm our relationships with our customers.

13

 
 
 
 
 
 
 
 
 
Any future acquisitions that we may make could disrupt our business, cause dilution to our stockholders and harm our business, financial condition or operating results.

If we are successful in consummating acquisitions, those acquisitions could subject us to a number of risks, including, but not limited to:

●

the purchase price we pay and/or unanticipated costs could significantly deplete our cash reserves or result in dilution to our existing stockholders;

● we may find that the acquired company or technologies do not improve our market position as planned;

● w e may  have  difficulty  integrating  the  operations  and  personnel  of  the  acquired  company,  as  the  combined  operations  will  place significant  demands  on  the  Company’s

management, technical, financial and other resources;

●

key personnel and customers of the acquired company may terminate their relationships with the acquired company as a result of the acquisition;

● we may experience additional financial and accounting challenges and complexities in areas such as tax planning and financial reporting;

● we may assume or be held liable for risks and liabilities (including environmental-related costs) as a result of our acquisitions, some of which we may not be able to discover

during our due diligence investigation or adequately adjust for in our acquisition arrangements;

●

our ongoing business and management’s attention may be disrupted or diverted by transition or integration issues and the complexity of managing geographically or culturally
diverse enterprises;

● we may incur one-time write-offs or restructuring charges in connection with the acquisition;

● we may acquire goodwill and other intangible assets that are subject to amortization or impairment tests, which could result in future charges to earnings; and

● we may not be able to realize the cost savings or other financial benefits we anticipated.

We cannot assure you that, following any acquisition, our continued business will achieve sales levels, profitability, efficiencies or synergies that justify the acquisition or that the

acquisition will result in increased earnings for us in any future period. These factors could have a material adverse effect on our business, financial condition and operating results.

Insurance and contractual protections may not always cover lost revenue, increased expenses or liquidated damages payments, which could adversely affect our financial results.

Although we maintain insurance and intend to obtain warranties from suppliers, obligate subcontractors to meet certain performance levels and attempt, where feasible, to pass
risks we cannot control to our customers, the proceeds of such insurance or the warranties, performance guarantees or risk sharing arrangements may not be adequate to cover lost revenue,
increased expenses or liquidated damages payments that may be required in the future.

14

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our obligations to our senior secured lender, Payplant LLC (“Payplant”), are secured by a security interest in substantially all of our assets, so if we default on those obligations, the
lender could foreclose on, liquidate and/or take possession of our assets. If that were to happen, we could be forced to curtail, or even to cease, our operations.

Pursuant to that certain Loan and Security Agreement, dated as of November 14, 2016, we issued a revolving secured promissory note to GemCap Lending I, LLC, dated as of
November 14, 2016 (the “Secured Promissory Note”). The Secured Promissory Note was assigned to Payplant on August 14, 2017 in accordance with the terms of the Payplant Loan and
Security Agreement, dated as of August 14, 2017 (as amended, the “Payplant Loan Agreement”). As of December 31, 2018, we had approximately $23,000 in outstanding revolving credit
loans. All amounts due under the Secured Promissory Note are secured by our assets. As a result, if we default on our obligations under the Secured Promissory Note, Payplant could
foreclose on its security interest and liquidate or take possession of some or all of these assets, which would harm our business, financial condition and results of operations and could
require us to curtail, or even to cease our operations.

Payplant has certain rights upon an event of default under their respective agreements that could harm our business, financial condition and results of operations and could require
us to curtail or cease our operations.

Payplant has certain rights upon an event of default. Such rights include an increase in the interest rate on any advances made pursuant to the Payplant Loan Agreement, the right
to accelerate the payment of any outstanding advances made pursuant to the Payplant Loan Agreement, the right to directly receive payments made by account debtors and the right to
foreclose on our assets, among other rights. The Payplant Loan Agreement includes in its definition of an event of default, among other occurrences, the failure to pay any principal when
due within two business days, the termination, winding up, liquidation or dissolution of any borrower and the filing of a tax lien by a governmental agency against any borrower.

The exercise of any of these rights upon an event of default could substantially harm our financial condition and force us to curtail, or even to cease, our operations.

If we are unable to comply with certain financial and operating restrictions required by the Payplant Loan Agreement, we may be limited in our business activities and access to credit
or may default under the Payplant Loan Agreement.

Provisions in the Payplant Loan Agreement impose restrictions or require prior approval on our ability, and the ability of certain of our subsidiaries to, among other things:

●

sell, lease, transfer, convey, or otherwise dispose of any or all of our assets or collateral, except in the ordinary course of business;

● make any loans to any person, as that term is defined in the Payplant Loan Agreement, with the exception of employee loans made in the ordinary course of business;

●

●

●

●

●

●

●

●

declare or pay cash dividends, make any distribution on, redeem, retire or otherwise acquire directly or indirectly, any of our Equity Interests, as defined in the Payplant Loan
Agreement;

guarantee the indebtedness of any Person;

compromise, settle or adjust any claims in any amount relating to any of the collateral;

incur, create or permit to exist any lien on any of our property or assets;

engage in new lines of business;

change, alter or modify, or permit any change, alteration or modification of our organizational documents in any manner that might adversely affect Payplant’s rights;

sell, assign, transfer, discount or otherwise dispose of any accounts or any promissory note payable to us, with or without recourse;

incur, create, assume, or permit to exist, any indebtedness or liability on account of either borrowed money or the deferred purchase price of property; and

● make any payments of cash or other property to any affiliate.

15

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
The  Payplant  Loan Agreement  also  contains  other  customary  covenants.  We  may  not  be  able  to  comply  with  these  covenants  in  the  future.  Our  failure  to  comply  with  these
covenants may result in the declaration of an event of default and cause us to be unable to borrow under the Payplant Loan Agreement. In addition to preventing additional borrowings
under  the  Payplant  Loan Agreement,  an  event  of  default,  if  not  cured  or  waived,  may  result  in  the  acceleration  of  the  maturity  of  indebtedness  outstanding  under  the  Payplant  Loan
Agreement, which would require us to pay all amounts outstanding. If the maturity of our indebtedness is accelerated, we may not have sufficient funds available for repayment or we may
not have the ability to borrow or obtain sufficient funds to replace the accelerated indebtedness on terms acceptable to us or at all. Our failure to repay the indebtedness would result in
Payplant foreclosing on all or a portion of our assets and force us to curtail, or even to cease, our operations.

We may be subject to damages resulting from claims that the Company or our employees have wrongfully used or disclosed alleged trade secrets of their former employers.

Upon completion of any acquisitions by the Company, we may be subject to claims that our acquired companies and their employees may have inadvertently or otherwise used or
disclosed trade secrets or other proprietary information of former employers or competitors. Litigation may be necessary to defend against these claims. We may be subject to unexpected
claims of infringement of third party intellectual property rights, either for intellectual property rights of which we are not aware, or for which we believe are invalid or narrower in scope
than the accusing party. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management. If we fail in defending
such claims, in addition to paying money claims, we may lose valuable intellectual property rights or personnel or be enjoined from selling certain products or providing certain services. A
loss of key research personnel or their work product could hamper or prevent our ability to commercialize certain products, which could severely harm our business.

Responding to governmental inquiries or an adverse finding by a governmental regulator could have a materially adverse effect on our business.

Pursuant to our operations, the Company regularly interacts with governmental regulators including, among others, the U.S. Securities and Exchange Commission (the “SEC”). In
certain instances, responding to inquiries from regulators could have a materially adverse effect on our business through, among other things, increased legal fees and the time and attention
required of the Company’s management and employees. Moreover, if a regulator were to make an adverse finding relating to the Company or its business practices it could have a material
adverse effect on our business, financial condition, results of operations and cash flows. In February 2019, Inpixon received a subpoena from the Chicago Regional Office of the SEC,
requiring  the  production  of  documents  and  information  pertaining  to  certain  of  the  Company’s  past  financing  activities  and  press  release  announcements.  Inpixon  believes  it  has  fully
complied with all relevant laws and regulations and is fully cooperating with the SEC’s investigation; however, we cannot assure you that the scope or nature of the inquiry will be limited
to the matters described above. With respect to this matter or other governmental inquiries that may arise from time to time, the Company can make no assurances with respect to the
amount of resources the Company will need to devote to such matters, final outcomes, or the impact on the Company’s business, financial condition, results of operations and cash flows.

Adverse judgments or settlements in legal proceedings could materially harm our business, financial condition, operating results and cash flows.

We  may  be  a  party  to  claims  that  arise  from  time  to  time  in  the  ordinary  course  of  our  business,  which  may  include  those  related  to,  for  example,  contracts,  sub-contracts,
protection  of  confidential  information  or  trade  secrets,  adversary  proceedings  arising  from  customer  bankruptcies,  employment  of  our  workforce  and  immigration  requirements  or
compliance with any of a wide array of state and federal statutes, rules and regulations that pertain to different aspects of our business. Additionally, we may be made a party to claims
against Sysorex that were pending at the time of the Spin-off, or future claims resulting from the Spin-off as described below under the risk factor section titled “Risks Related to the Spin-
off.” We may also be required to initiate expensive litigation or other proceedings to protect our business interests. There is a risk that we will not be successful or otherwise be able to
satisfactorily  resolve  any  such  claims  or  litigation.  In  addition,  litigation  and  other  legal  claims  are  subject  to  inherent  uncertainties.  Those  uncertainties  include,  but  are  not  limited
to,  litigation  costs  and  attorneys’  fees,  unpredictable  judicial  or  jury  decisions  and  the  differing  laws  and  judicial  proclivities  regarding  damage  awards  among  the  states  in  which  we
operate. Unexpected outcomes in such legal proceedings, or changes in management’s evaluation or predictions of the likely outcomes of such proceedings (possibly resulting in changes in
established reserves), could have a material adverse effect on our business, financial condition, results of operations and cash flows. Due to recurring losses and net capital deficiency, our
current financial status may increase our default and litigation risks and may make us more financially vulnerable in the face of threatened litigation.

16

 
 
 
 
 
 
 
 
 
The loss of our Chief Executive Officer or other key personnel may adversely affect our operations.

The Company’s success depends to a significant extent upon the operation, experience, and continued services of certain of its officers, including our CEO, as well as other key
personnel. While our CEO and key personnel are employed under employment contracts, there is no assurance we will be able to retain their services. The loss of our CEO or several of the
other key personnel could have an adverse effect on the Company. If our CEO or other executive officers were to leave we would face substantial difficulty in hiring a qualified successor
and could experience a loss in productivity while any successor obtains the necessary training and experience. Furthermore, we do not maintain “key person” life insurance on the lives of
any executive officer and their death or incapacity would have a material adverse effect on us. The competition for qualified personnel is intense, and the loss of services of certain key
personnel could adversely affect our business.

Internal  system  or  service  failures  could  disrupt  our  business  and  impair  our  ability  to  effectively  provide  our  services  and  products  to  our  customers,  which  could  damage  our
reputation and adversely affect our revenues and profitability.

Any system or service disruptions, on our hosted Cloud infrastructure or those caused by ongoing projects to improve our information technology systems and the delivery of
services,  if  not  anticipated  and  appropriately  mitigated,  could  have  a  material  adverse  effect  on  our  business  including,  among  other  things,  an  adverse  effect  on  our  ability  to  bill  our
customers for work performed on our contracts, collect the amounts that have been billed and produce accurate financial statements in a timely manner. We are also subject to systems
failures, including network, software or hardware failures, whether caused by us, third-party service providers, cyber security threats, natural disasters, power shortages, terrorist attacks or
other events, which could cause loss of data and interruptions or delays in our business, cause us to incur remediation costs, subject us to claims and damage our reputation. In addition, the
failure  or  disruption  of  our  communications  or  utilities  could  cause  us  to  interrupt  or  suspend  our  operations  or  otherwise  adversely  affect  our  business.  Our  property  and  business
interruption insurance may be inadequate to compensate us for all losses that may occur as a result of any system or operational failure or disruption and, as a result, our future results could
be adversely affected.

Customer systems failures could damage our reputation and adversely affect our revenues and profitability.

Many of the systems and networks that we develop, install and maintain for our customers on premise or host on our infrastructure involve managing and protecting personal
information and information relating to national security and other sensitive government functions. While we have programs designed to comply with relevant privacy and security laws and
restrictions,  if  a  system  or  network  that  we  develop,  install  or  maintain  were  to  fail  or  experience  a  security  breach  or  service  interruption,  whether  caused  by  us,  third-party  service
providers, cyber security threats or other events, we may experience loss of revenue, remediation costs or face claims for damages or contract termination. Any such event could cause
serious harm to our reputation and prevent us from having access to or being eligible for further work on such systems and networks. Our errors and omissions liability insurance may be
inadequate to compensate us for all of the damages that we may incur and, as a result, our future results could be adversely affected.

We  have  entered,  and  expect  to  continue  to  enter,  into  joint  venture,  teaming  and  other  arrangements,  and  these  activities  involve  risks  and  uncertainties.  A  failure  of  any  such
relationship could have material adverse results on our business and results of operations.

We have entered, and expect to continue to enter, into joint venture, teaming and other arrangements. These activities involve risks and uncertainties, including the risk of the joint
venture  or  applicable  entity  failing  to  satisfy  its  obligations,  which  may  result  in  certain  liabilities  to  us  for  guarantees  and  other  commitments,  the  challenges  in  achieving  strategic
objectives and expected benefits of the business arrangement, the risk of conflicts arising between us and our partners and the difficulty of managing and resolving such conflicts, and the
difficulty  of  managing  or  otherwise  monitoring  such  business  arrangements. A  failure  of  our  business  relationships  could  have  a  material  adverse  effect  on  our  business  and  results  of
operations.

17

 
 
 
  
 
 
 
 
 
  
Our business and operations expose us to numerous legal and regulatory requirements and any violation of these requirements could harm our business.

We  are  subject  to  numerous  federal,  state  and  foreign  legal  requirements  on  matters  as  diverse  as  data  privacy  and  protection,  employment  and  labor  relations,  immigration,
taxation, anticorruption, import/export controls, trade restrictions, internal control and disclosure control obligations, securities regulation and anti-competition. Compliance with diverse
and changing legal requirements is costly, time-consuming and requires significant resources. We are also focused on expanding our business in certain identified growth areas, such as
health  information  technology,  energy  and  environment,  which  are  highly  regulated  and  may  expose  us  to  increased  compliance  risk.  Violations  of  one  or  more  of  these  diverse  legal
requirements in the conduct of our business could result in significant fines and other damages, criminal sanctions against us or our officers, prohibitions on doing business and damage to
our reputation. Violations of these regulations or contractual obligations related to regulatory compliance in connection with the performance of customer contracts could also result in
liability for significant monetary damages, fines and/or criminal prosecution, unfavorable publicity and other reputational damage, restrictions on our ability to compete for certain work and
allegations by our customers that we have not performed our contractual obligations.

If we do not adequately protect our intellectual property rights, we may experience a loss of revenue and our operations and growth prospects may be materially harmed.

We have not registered copyrights on any of the software we have developed, and while we may register copyrights in the software if needed before bringing suit for copyright
infringement, such registration can introduce delays before suit of over three years and can constrain damages for infringement. We rely upon confidentiality agreements signed by our
employees, consultants and third parties to protect our intellectual property. We cannot assure you that we can adequately protect our intellectual property or successfully prosecute actual
or potential infringement of our intellectual property rights. In addition, we cannot assure you that others will not assert rights in, or ownership of, trademarks and other proprietary rights of
ours or that we will be able to successfully resolve these types of conflicts to our satisfaction. Our failure to protect our intellectual property rights may result in a loss of revenue and could
materially adversely affect our operations and financial condition.

In addition, any patents issued in the future may not provide us with any competitive advantages, and our patent applications may never be granted. The process of obtaining
patent protection is expensive and time-consuming, and we may not be able to prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. Even if
issued, there can be no assurance that these patents will adequately protect our intellectual property, as the legal standards relating to the validity, enforceability and scope of protection of
patent and other intellectual property rights are complex and often uncertain and are subject to change that can affect validity of patents issued under previous legal standards, particularly
with respect to the law of subject matter eligibility. Our inability to protect our property rights could adversely affect our financial condition, operating results and growth prospects.

Our  proprietary  software  is  protected  by  common  law  copyright  laws,  as  opposed  to  registration  under  copyright  statutes.  We  have  not  registered  copyrights  on  any  of  the
proprietary software we have developed. Our performance and ability to compete are dependent to a significant degree on our proprietary technology. Our proprietary software is protected
by common law copyright laws, as opposed to registration under copyright statutes. Common law protection may be narrower than that which we could obtain under registered copyrights.
As a result, we may experience difficulty in enforcing our copyrights against certain third party infringements. As part of our confidentiality-protection procedures, we generally enter into
agreements with our employees and consultants and limit access to, and distribution of, our software, documentation and other proprietary information. There can be no assurance that the
steps we have taken will prevent misappropriation of our technology or that agreements entered into for that purpose will be enforceable. The laws of other countries may afford us little or
no protection of our intellectual property. We also rely on a variety of technology that we license from third parties. There can be no assurance that these third party technology licenses
will continue to be available to us on commercially reasonable terms, if at all. The loss of or inability to maintain or obtain upgrades to any of these technology licenses could result in
delays in completing software enhancements and new development until equivalent technology could be identified, licensed or developed and integrated. Any such delays would materially
and adversely affect our business.

The growth of our business is dependent on increasing sales to our existing clients and obtaining new clients, which, if unsuccessful, could limit our financial performance.

Our ability to increase revenues from existing clients by identifying additional opportunities to sell more of our products and services and our ability to obtain new clients depends
on a number of factors, including our ability to offer high quality products and services at competitive prices, the strength of our competitors and the capabilities of our sales and marketing
departments.  If  we  are  not  able  to  continue  to  increase  sales  of  our  products  and  services  to  existing  clients  or  to  obtain  new  clients  in  the  future,  we  may  not  be  able  to  increase  our
revenues and could suffer a decrease in revenues as well.

18

 
 
 
 
 
 
 
 
 
 
Decreases, or slow growth, in the newspaper publishing industry may negatively affect our results from operation as it relates to our Cloud based applications and analytics for media
and publishing.

The newspaper industry as a whole is experiencing challenges to maintain and grow print circulation and revenues. This results from, among other factors, increased competition
from other media, particularly the growth of electronic media, and shifting preferences among some consumers to receive all or a portion of their news other than from a newspaper. The
customer base for our Cloud based applications and analytics for media and publishing is focused on the newspaper publishing industry and therefore sales from this operating sector will
be subject to the future of the newspaper industry.

Our competitiveness depends significantly on our ability to keep pace with the rapid changes in our industry. Failure by us to anticipate and meet our clients’ technological needs
could adversely affect our competitiveness and growth prospects.

We  operate  and  compete  in  an  industry  characterized  by  rapid  technological  innovation,  changing  client  needs,  evolving  industry  standards  and  frequent  introductions  of  new
products, product enhancements, services and distribution methods. Our success depends on our ability to develop expertise with these new products, product enhancements, services and
distribution  methods  and  to  implement  solutions  that  anticipate  and  respond  to  rapid  changes  in  technology,  the  industry,  and  client  needs.  The  introduction  of  new  products,  product
enhancements  and  distribution  methods  could  decrease  demand  for  current  products  or  render  them  obsolete.  Sales  of  products  and  services  can  be  dependent  on  demand  for  specific
product categories, and any change in demand for or supply of such products could have a material adverse effect on our net sales if we fail to adapt to such changes in a timely manner.

We operate in a highly competitive market and we may be required to reduce the prices for some of our products and services to remain competitive, which could adversely affect our
results of operations.

Our industry is developing rapidly and related technology trends are constantly evolving. In this environment, we face, among other things, significant price competition from our
competitors. As a result, we may be forced to reduce the prices of the products and services we sell in response to offerings made by our competitors and may not be able to maintain the
level of bargaining power that we have enjoyed in the past when negotiating the prices of our products and services.

Our profitability is dependent on the prices we are able to charge for our products and services. The prices we are able to charge for our products and services are affected by a

number of factors, including:

●

●

●

●

●

●

our clients’ perceptions of our ability to add value through our products and services;

introduction of new products or services by us or our competitors;

our competitors’ pricing policies;

our ability to charge higher prices where market demand or the value of our products or services justifies it;

procurement practices of our clients; and

general economic and political conditions.

If we are not able to maintain favorable pricing for our products and services, our results of operations could be adversely affected.

A delay in the completion of our clients’ budget processes cold delay purchases of our products and services and have an adverse effect on our business, operating results and financial
condition.

We rely on our clients to purchase products and services from us to maintain and increase our earnings, and client purchases are frequently subject to budget constraints, multiple
approvals and unplanned administrative, processing and other delays. If sales expected from a specific client are not realized when anticipated or at all, our results could fall short of public
expectations and our business, operating results and financial condition could be materially adversely affected.

Digital  threats  such  as  cyber-attacks,  data  protection  breaches,  computer  viruses  or  malware  may  disrupt  our  operations,  harm  our  operating  results  and  damage  our  reputation,
and  cyber-attacks  or  data  protection  breaches  on  our  customers’  networks,  or  in  cloud-based  services  provided  by  or  enabled  by  us,  could  result  in  liability  for  us,  damage  our
reputation or otherwise harm our business.

Despite our implementation of network security measures, the products and services we sell to customers, and our servers, data centers and the cloud-based solutions on which our
data,  and  data  of  our  customers,  suppliers  and  business  partners  are  stored,  are  vulnerable  to  cyber-attacks,  data  protection  breaches,  computer  viruses,  and  similar  disruptions  from
unauthorized tampering or human error. Any such event could compromise our networks or those of our customers, and the information stored on our networks or those of our customers
could be accessed, publicly disclosed, lost or stolen, which could subject us to liability to our customers, business partners and others, and could have a material adverse effect on our
business, operating results, and financial condition and may cause damage to our reputation. Efforts to limit the ability of malicious third parties to disrupt the operations of the Internet or
undermine our own security efforts may be costly to implement and meet with resistance, and may not be successful. Breaches of network security in our customers’ networks, or in cloud-
based  services  provided  by  or  enabled  by  us,  regardless  of  whether  the  breach  is  attributable  to  a  vulnerability  in  our  products  or  services,  could  result  in  liability  for  us,  damage  our
reputation or otherwise harm our business.

19

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Any failures or interruptions in our services or systems could damage our reputation and substantially harm our business and results of operations.

Our success depends in part on our ability to provide reliable remote services, technology integration and managed services to our clients. The operations of our Cloud based
applications and analytics are susceptible to damage or interruption from human error, fire, flood, power loss, telecommunications failure, terrorist attacks and similar events. We could
also experience failures or interruptions of our systems and services, or other problems in connection with our operations, as a result of:

●

●

●

●

●

●

damage to or failure of our computer software or hardware or our connections;

errors in the processing of data by our systems;

computer viruses or software defects;

physical or electronic break-ins, sabotage, intentional acts of vandalism and similar events;

increased capacity demands or changes in systems requirements of our clients; and

errors by our employees or third-party service providers.

Any production interruptions for any reason, such as a natural disaster, epidemic, capacity shortages, or quality problems, at one of our manufacturing partners would negatively

affect sales of product lines manufactured by that manufacturing partner and adversely affect our business and operating results.

Any interruptions in our systems or services could damage our reputation and substantially harm our business and results of operations. While we maintain disaster recovery plans
and insurance with coverage we believe to be adequate, claims may exceed insurance coverage limits, may not be covered by insurance or insurance may not continue to be available on
commercially reasonable terms.

We rely on a limited number of key customers, the importance of which may vary dramatically from year to year, and a loss of one or more of these key customers may adversely affect
our operating results.

Our  top  three  customers  accounted  for  approximately  49%  and  26%  of  our  gross  revenue  during  the  years  ended  December  31,  2018  and  2017,  respectively.  One  customer
accounted for 33% of our gross revenue in 2018; however, this customer may or may not continue to be a significant contributor to revenue in 2019. The loss of a significant amount of
business from one of our major customers would materially and adversely affect our results of operations until such time, if ever, as we are able to replace the lost business. Significant
clients or projects in any one period may not continue to be significant clients or projects in other periods. To the extent that we are dependent on any single customer, we are subject to the
risks faced by that customer to the extent that such risks impede the customer’s ability to stay in business and make timely payments to us.

We may need additional cash financing and any failure to obtain cash financing, could limit our ability to grow our business and develop or enhance our service offerings to respond
to market demand or competitive challenges.

We expect that we will need to raise funds in order to continue our operations and implement our plans to grow our business. However, if we decide to seek additional capital, we
may be unable to obtain financing on terms that are acceptable to us or at all. If we are unable to raise the required cash, our ability to grow our business and develop or enhance our service
offerings to respond to market demand or competitive challenges could be limited.

If we cannot collect our receivables or if payment is delayed, our business may be adversely affected by our inability to generate cash flow, provide working capital or continue our
business operations.

Our business depends on our ability to successfully obtain payment from our clients of the amounts they owe us for products received from us and any work performed by us. The
timely collection of our receivables allows us to generate cash flow, provide working capital and continue our business operations. Our clients may fail to pay or delay the payment of
invoices for a number of reasons, including financial difficulties resulting from macroeconomic conditions or lack of an approved budget. An extended delay or default in payment relating
to a significant account will have a material and adverse effect on the aging schedule and turnover days of our accounts receivable. If we are unable to timely collect our receivables from
our clients for any reason, our business and financial condition could be adversely affected.

If our products fail to satisfy customer demands or to achieve increased market acceptance our results of operations, financial condition and growth prospects could be materially
adversely affected.

The market acceptance of our products are critical to our continued success. Demand for our products is affected by a number of factors beyond our control, including continued
market acceptance, the timing of development and release of new products by competitors, technological change, and growth or decline in the mobile device management market. We
expect  the  proliferation  of  mobile  devices  to  lead  to  an  increase  in  the  data  security  demands  of  our  customers,  and  our  products  may  not  be  able  to  scale  and  perform  to  meet  those
demands. If we are unable to continue to meet customer demands or to achieve more widespread market acceptance of these products, our business operations, financial results and growth
prospects will be materially and adversely affected.

20

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
  
Defects, errors, or vulnerabilities in our products or services or the failure of such products or services to prevent a security breach, could harm our reputation and adversely affect our
results of operations.

Because our location based security products and services are complex, they have contained and may contain design or manufacturing defects or errors that are not detected until
after their commercial release and deployment by customers. Defects may cause such products to be vulnerable to advanced persistent threats (APTs) or security attacks, cause them to fail
to help secure information or temporarily interrupt customers’ networking traffic. Because the techniques used by hackers to access sensitive information change frequently and generally
are not recognized until launched against a target, we may be unable to anticipate these techniques and provide a solution in time to protect customers’ data. In addition, defects or errors in
our subscription updates or products could result in a failure to effectively update customers’ hardware products and thereby leave customers vulnerable to APTs or security attacks.

Any defects, errors or vulnerabilities in our products could result in:

●

Expenditure of significant financial and product development resources in efforts to analyze, correct, eliminate, or work-around errors or defects or to address and eliminate
vulnerabilities;

● Delayed or lost revenue;

●

●

●

Loss of existing or potential customers or partners;

Increased warranty claims compared with historical experience, or increased cost of servicing warranty claims, either of which would adversely affect gross margins; and

Litigation, regulatory inquiries, or investigations that may be costly and harm our reputation

Our current research and development efforts may not produce successful products or features that result in significant revenue, cost savings or other benefits in the near future. If we
do not realize significant revenue from our research and development efforts, our business and operating results could be adversely affected.

Developing products and related enhancements in our field is expensive. Investments in research and development may not result in significant design improvements, marketable
products or features or may result in products that are more expensive than anticipated. We may not achieve the cost savings or the anticipated performance improvements expected, and
we may take longer to generate revenue from products in development, or generate less revenue than expected.

Our future plans include significant investments in research and development and related product opportunities. Our management believes that we must continue to dedicate a
significant amount of resources to research and development efforts to maintain a competitive position. However, we may not receive significant revenue from these investments in the near
future, or these investments may not yield the expected benefits, either of which could adversely affect our business and operating results.

Misuse of our products could harm our reputation.

Our products, particularly our location based security and detection and context aware marketing may be misused by customers or third parties that obtain access to such products.
For example, these products could be used to protect information kept by criminals from government agencies. Such use of these products for censorship could result in negative press
coverage and negatively affect our reputation.

If  the  general  level  of  advanced  attacks  declines,  or  is  perceived  by  current  or  potential  customers  to  have  declined,  this  could  harm  our  location  based  security  and  detection
operating segment, and our financial condition, operating results and growth prospects.

Our location based security and detection-operating segment is substantially dependent upon enterprises and governments recognizing that advanced persistent threats (“APTs”)
and other security attacks are pervasive and are not effectively prevented by legacy security solutions. High visibility attacks on prominent enterprises and governments have increased
market awareness of the problem of APTs and security attacks and help to provide an impetus for enterprises and governments to devote resources to protecting against attacks, such as
testing our platform, purchasing it, and broadly deploying it within their organizations. If APTs and other security attacks were to decline, or enterprises or governments perceived that the
general level of attacks has declined, our ability to attract new customers and expand its offerings for existing customers could be materially and adversely affected, which would, in turn,
have a material adverse effect on our financial condition, results of operations and growth prospects.

21

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If our location based security and detection products do not effectively interoperate with our customers’ IT infrastructure, installations could be delayed or cancelled, which would
harm our financial condition, operating results and growth prospects.

Our products must effectively interoperate with our customers’ existing or future IT infrastructure, which often has different specifications, utilizes multiple protocol standards,
deploys products from multiple vendors, and contains multiple generations of products that have been added over time. As a result, when problems occur in a company’s infrastructure, it
may be difficult to identify the sources of these problems. If we find errors in the existing software or defects in the hardware used in our customers’ infrastructure, we may have to modify
its  software  or  hardware  so  that  our  products  will  interoperate  with  the  infrastructure  of  our  customers.  In  such  cases,  our  products  may  be  unable  to  provide  significant  performance
improvements for applications deployed in the infrastructure of our customers. These issues could cause longer installation times for our products and could cause order cancellations, either
of  which  would  adversely  affect  our  business,  results  of  operations  and  financial  condition.  In  addition,  other  customers  may  require  products  to  comply  with  certain  security  or  other
certifications and standards. If our products are late in achieving or fail to achieve compliance with these certifications and standards, or competitors sooner achieve compliance with these
certifications  and  standards,  we  may  be  disqualified  from  selling  our  products  to  such  customers,  or  may  otherwise  be  at  a  competitive  disadvantage,  either  of  which  would  harm  our
business, results of operations, and financial condition.

Our international business exposes us to geo-political and economic factors, regulatory requirements and other risks associated with doing business in foreign countries.

We provide our products and services to customers worldwide. These risks differ from and potentially may be greater than those associated with our domestic business.

Our international business is sensitive to changes in the priorities and budgets of international customers and geo-political uncertainties, which may be driven by changes in threat
environments and potentially volatile worldwide economic conditions, various regional and local economic and political factors, risks and uncertainties, as well as U.S. foreign policy. Our
international sales are subject to U.S. laws, regulations and policies, including the International Traffic in Arms Regulations and the Foreign Corrupt Practices Act (see below) and other
export laws and regulations. Due to the nature of our products, we must first obtain licenses and authorizations from various U.S. Government agencies before we are permitted to sell our
products outside of the U.S. We can give no assurance that we will continue to be successful in obtaining the necessary licenses or authorizations or that certain sales will not be prevented
or delayed. Any significant impairment of our ability to sell products outside of the U.S. could negatively affect our results of operations and financial condition.

22

 
 
 
 
 
 
 
Our  international  sales  are  also  subject  to  local  government  laws,  regulations  and  procurement  policies  and  practices,  which  may  differ  from  U.S.  Government  regulations,
including regulations relating to import-export control, investments, exchange controls and repatriation of earnings, as well as to varying currency, geo-political and economic risks. Our
international contracts may include industrial cooperation agreements requiring specific in-country purchases, manufacturing agreements or financial support obligations, known as offset
obligations, and provide for penalties if we fail to meet such requirements. Our international contracts may also be subject to termination at the customer’s convenience or for default based
on performance, and may be subject to funding risks. We also are exposed to risks associated with using foreign representatives and consultants for international sales and operations and
teaming with international subcontractors, partners and suppliers in connection with international programs. As a result of these factors, we could experience award and funding delays on
international programs and could incur losses on such programs, which could negatively affect our results of operations and financial condition.

We are also subject to a number of other risks including:

●

the absence in some jurisdictions of effective laws to protect our intellectual property rights;

● multiple and possibly overlapping and conflicting tax laws;

●

●

●

●

●

●

●

●

restrictions on movement of cash;

the burdens of complying with a variety of national and local laws;

political instability;

currency fluctuations;

longer payment cycles;

restrictions on the import and export of certain technologies;

price controls or restrictions on exchange of foreign currencies; and

trade barriers.

Our international operations are subject to special U.S. government laws and regulations, such as the Foreign Corrupt Practices Act, and regulations and procurement policies and
practices, including regulations to import-export control, which may expose us to liability or impair our ability to compete in international markets.

Our  international  operations  are  subject  to  the  U.S.  Foreign  Corrupt  Practices Act  (FCPA),  and  other  laws  that  prohibit  improper  payments  or  offers  of  payments  to  foreign
governments and their officials and political parties by U.S. and other business entities for the purpose of obtaining or retaining business. We have operations and deal with governmental
customers in countries known to experience corruption, including certain countries in the Middle East and in the future, the Far East. Our activities in these countries create the risk of
unauthorized payments or offers of payments by one of our employees, consultants or contractors that could be in violation of various laws including the FCPA, even though these parties
are not always subject to our control. We are also subject to import-export control regulations restricting the use and dissemination of information classified for national security purposes
and the export of certain products, services, and technical data, including requirements regarding any applicable licensing of our employees involved in such work.

Difficult  conditions  in  the  global  capital  markets  and  the  economy  generally  may  materially  adversely  affect  our  business  and  results  of  operations,  and  we  do  not  expect  these
conditions to improve in the near future.

Our results of operations are materially affected by conditions in the global capital markets and the economy generally, both in the U.S. and elsewhere around the world.  Weak
economic  conditions  generally,  sustained  uncertainty  about  global  economic  conditions,  or  a  prolonged  or  further  tightening  of  credit  markets  could  cause  our  customers  and  potential
customers to postpone or reduce spending on technology products or services or put downward pressure on prices, which could have an adverse effect on our business, results of operations
or cash flows.  Concerns over inflation, energy costs, geopolitical issues and the availability of credit, in the U.S. have contributed to increased volatility and diminished expectations for the
economy and the markets going forward. These factors, combined with volatile oil prices and wavering business and consumer confidence, have precipitated an economic slowdown and
uncertain global outlook. Domestic and international equity markets have been experiencing heightened volatility and turmoil. These events and the continuing market upheavals may have
an adverse effect on our business. In the event of extreme prolonged market events, such as the global economic recovery, we could incur significant losses.

Changes  in  U.S.  administrative  policy,  including  changes  to  existing  trade  agreements  and  any  resulting  changes  in  international  relations,  could  adversely  affect  our  financial
performance and supply chain economics.

As a result of changes to U.S. administrative policy, among other possible changes, there may be (i) changes to existing trade agreements; (ii) greater restrictions on free trade
generally; and (iii) significant increases in tariffs on goods imported into the United States, particularly those manufactured in China. China is currently a leading global source of hardware
products, including the hardware products that we use. In September 2018, the Office of the U.S. Trade Representative announced that the current U.S. administration would impose a 10%
tariff on approximately $200 billion worth of imports from China into the United States, effective September 24, 2018. Such tariff is subject to increase if the United States and China are
unable to reach a trade deal.

23

 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
It remains unclear what the U.S. administration or foreign governments, including China, will or will not do with respect to tariffs, or other international trade agreements and
policies. A trade war, other governmental action related to tariffs or international trade agreements, changes in U.S. social, political, regulatory and economic conditions or in laws and
policies governing foreign trade, manufacturing, development and investment in the territories and countries where we currently do business or any resulting negative sentiments towards
the United States could adversely affect our supply chain economics, consolidated revenue, earnings and cash flow.

The Company intends to use open source blockchain technology in its IPA platform.  This technology has been scrutinized by regulatory agencies and therefore we may be impacted
by unfavorable regulatory action in one or more jurisdictions.

The Company intends to use open source blockchain technology as a secure repository for “device reputation” acquired by its IPA platform. Blockchain technologies have been
the  subject  of  scrutiny  by  various  regulatory  bodies  around  the  world.  The  Company  could  be  impacted  by  one  or  more  regulatory  inquiries  or  actions,  including  but  not  limited  to
restrictions on the use of blockchain technology, which could impede or limit the use of this technology within our product offerings.

We intend to use and leverage open source technology in our IPA platform which may create risks of security weaknesses.

Some parts of our technology may be based on open-source technology, including the blockchain technology that we intend to use in our IPA platform, There is a risk that the
development team, or other third parties may intentionally or unintentionally introduce weaknesses or bugs into the core infrastructure elements of our technology solutions interfering with
the use of such technology or causing loss to the Company.

The use of new and untested technologies, including blockchain technology, may result in risks that we may not be able to currently anticipate.

Blockchain technology is a relatively new and untested technology. In addition to the risks set forth here, there are risks with the use of this technology that the Company cannot

anticipate. Risks may further materialize as unanticipated combinations or variations from the risks set forth here.

We may not be able to develop new products or enhance our product to keep pace with our industry’s rapidly changing technology and customer requirements.

The  industry  in  which  we  operate  is  characterized  by  rapid  technological  changes,  new  product  introductions,  enhancements,  and  evolving  industry  standards.  Our  business
prospects  depend  on  our  ability  to  develop  new  products  and  applications  for  our  technology  in  new  markets  that  develop  as  a  result  of  technological  and  scientific  advances,  while
improving performance and cost-effectiveness. New technologies, techniques or products could emerge that might offer better combinations of price and performance than the blockchain
technology  solutions  that  are  being  developed  by  the  Company.  It  is  important  that  we  anticipate  changes  in  technology  and  market  demand.  If  we  do  not  successfully  innovate  and
introduce new technology into our anticipated technology solutions or effectively manage the transitions of our technology to new product offerings, our business, financial condition and
results of operations could be harmed.

Domestic and foreign government regulation and enforcement of data practices and data tracking technologies is expansive, broadly defined and rapidly evolving. Such regulation
could  directly  restrict  portions  of  our  business  or  indirectly  affect  our  business  by  constraining  our  customers’  use  of  our  technology  and  services  or  limiting  the  growth  of  our
markets.

Federal, state, municipal and/or foreign governments and agencies have adopted and could in the future adopt, modify, apply or enforce laws, policies, and regulations covering
user privacy, data security, technologies that are used to collect, store and/or process data, and/or the collection, use, processing, transfer, storage and/or disclosure of data associated with
individuals. The categories of data regulated under these laws vary widely, are often broadly defined, and subject to new applications or interpretation by regulators. The uncertainty and
inconsistency among these laws, coupled with a lack of guidance as to how these laws will be applied to current and emerging indoor positioning analytics technologies, creates a risk that
regulators, lawmakers or other third parties, such as potential plaintiffs, may assert claims, pursue investigations or audits, or engage in civil or criminal enforcement. These actions could
limit the market for our services and technologies or impose burdensome requirements on our services and/or customers’ use of our services, thereby rendering our business unprofitable.

Some features of our services may trigger the data protection requirements of certain foreign jurisdictions, such as the EU General Data Protection Regulation (the “GDPR”), and
the EU ePrivacy Directive. In addition, our services may be subject to regulation under current or future laws or regulations. For instance, the EU ePrivacy Directive is soon to be replaced
in  its  entirety  by  the  ePrivacy  Regulation,  which  will  bring  with  it  an  updated  set  of  rules  relevant  to  many  aspects  of  our  business.  If  our  treatment  of  data,  privacy  practices  or  data
security measures fail to comply with these current or future laws and regulations in any of the jurisdictions in which we collect and/or process information, we may be subject to litigation,
regulatory investigations, civil or criminal enforcement, financial penalties, audits or other liabilities in such jurisdictions, or our customers may terminate their relationships with us. In
addition, data protection laws, such as the GDPR, foreign court judgments or regulatory actions could affect our ability to transfer, process and/or receive transnational data that is critical to
our operations, including data relating to users, clients, or partners outside the United States. For instance, the GDPR restricts transfers of personal data outside of the European Economic
Area, including to the United States, subject to certain requirements. Such data protection laws, judgments or actions could affect the manner in which we provide our services or adversely
affect our financial results if foreign clients and partners are not able to lawfully transfer data to us.

24

 
 
 
 
 
 
 
 
 
 
 
 
 
  
This area of the law is currently under intense government scrutiny and many governments, including the U.S. government, are considering a variety of proposed regulations that
would restrict or impact the conditions under which data obtained from individuals could be collected, processed, stored, transferred, sold or shared with third parties. In addition, regulators
such as the Federal Trade Commission and the California Attorney General are continually proposing new regulations and interpreting and applying existing regulations in new ways. For
example, in June 2018, California passed the California Consumer Privacy Act (the “CCPA”), which provides new data privacy rights for consumers and new informational, disclosure and
operational requirements for companies, effective January 2020. Fines for non-compliance may be up to $7,500 per violation. The burdens imposed by the GDPR and CCPA, and changes
to  existing  laws  or  new  laws  regulating  the  solicitation,  collection,  processing,  or  sharing  of  personal  and  consumer  information,  and  consumer  protection  could  affect  our  customers’
utilization of our services and technology and could potentially reduce demand, or impose restrictions that make it more difficult or expensive for us to provide our services.

In addition, ongoing legal challenges in Europe to the mechanisms allowing companies to transfer personal data from the European Economic Area to the United States could
result in further limitations on the ability to transfer data across borders, particularly if governments are unable or unwilling to reach new or maintain existing agreements that support cross-
border  data  transfers,  such  as  the  EU-U.S.  and  Swiss-U.S.  Privacy  Shield  frameworks  and  the  European  Commission’s  Model  Contractual  Clauses,  each  of  which  are  currently  under
particular scrutiny. Additionally, certain countries have passed or are considering passing laws requiring local data residency. The costs of compliance with, and other burdens imposed
by, privacy laws, regulations and standards may limit the use and adoption of our services, reduce overall demand for our services, make it more difficult to meet expectations from or
commitments to customers, lead to significant fines, penalties or liabilities for noncompliance, impact our reputation, or slow the pace at which we close sales transactions, any of which
could harm our business.

Furthermore,  the  uncertain  and  shifting  regulatory  environment  and  trust  climate  may  cause  concerns  regarding  data  privacy  and  may  cause  our  customers  or  our  customers’
customers to resist providing the data necessary to allow our customers to use our services effectively. Even the perception that the privacy of personal information is not satisfactorily
protected or does not meet regulatory requirements could inhibit sales of our products or services and could limit adoption of our cloud-based solutions.

If our customers fail to abide by applicable privacy laws or to provide adequate notice and/or obtain consent from end users, we could be subject to litigation or enforcement action or
reduced demand for our services.

Our customers utilize our services and technologies to track connected devices anonymously and we must rely on our customers to implement and administer notice and choice
mechanisms required under applicable laws. If we or our customers fail to abide by these laws, it could result in litigation or regulatory or enforcement action against our customers or
against us directly.

Any actual or perceived failure by us to comply with our privacy policy or legal or regulatory requirements in one or multiple jurisdictions could result in proceedings, actions or
penalties against us.

Any failure or perceived failure by us to comply with federal, state or foreign laws or regulations, industry standards, contractual obligations or other legal obligations, or any actual
or suspected security incident, whether or not resulting in unauthorized access to, or acquisition, release or transfer of personal data or other data, may result in governmental enforcement
actions and prosecutions, private litigation, fines and penalties or adverse publicity and could cause our customers to lose trust in us, which could have an adverse effect on our reputation
and business. Any inability to adequately address privacy and security concerns, even if unfounded, or comply with applicable laws, regulations, policies, industry standards, contractual
obligations or other legal obligations could result in additional cost and liability to us, damage our reputation, inhibit sales and adversely affect our business.

Evolving and changing definitions of what constitutes “Personal Information” and “Personal Data” within the EU, the United States and elsewhere, may limit or inhibit our ability to
operate or expand our business, including limiting technology alliance partners that may involve the sharing of data.

If  we  are  perceived  to  cause,  or are  otherwise  unfavorably  associated  with,  violations  of  privacy  or  data  security  requirements,  it  may  subject  us  or  our  customers  to  public
criticism, financial penalties and potential legal liability. Existing and potential privacy laws and regulations concerning privacy and data security and increasing sensitivity of consumers to
unauthorized  processing  of  personal  data  may  create  negative  public  reactions  to  technologies,  products  and  services  such  as  ours.  Public  concerns  regarding  personal  data
processing, privacy and security may cause some of our customers’ end users to be less likely to visit their websites or otherwise interact with them. If enough end users choose not to visit
our customers’ websites or otherwise interact with them, our customers could stop using our platform. This, in turn, may reduce the value of our service, and slow or eliminate the growth
of our business, or cause our business to contract.

25

 
 
 
 
 
 
 
 
 
 
 
Around  the  world,  there  are  numerous  lawsuits  in  process  against  various  technology  companies  that  process  personal  information  and  personal  data.  If  those  lawsuits  are
successful, it could increase the likelihood that our company may be exposed to liability for our own policies and practices concerning the processing of personal data and could hurt our
business. Furthermore, the costs of compliance with, and other burdens imposed by laws, regulations and policies concerning privacy and data security that are applicable to the businesses
of  our  customers  may  limit  the  use  and  adoption  of  our  technologies  and  reduce  overall  demand  for  it.  Privacy  concerns,  whether  or  not  valid,  may  inhibit  market  adoption  of  our
technologies. Additionally, concerns about security or privacy may result in the adoption of new legislation that restricts the implementation of technologies like ours or require us to make
modifications to our existing services and technology, which could significantly limit the adoption and deployment of our technologies or result in significant expense.

We incurred significant transaction and transaction-related costs in connection with the Spin-off.

Risks Related to the Spin-off

We incurred significant costs in connection with the Spin-off, including legal, accounting, consulting, financial advisory, and related fees. Although we expect the Spin-off to

benefit both us and Sysorex as independent public companies, we cannot assure you these benefits will be achieved in the near term, or at all.

The Spin-off could give rise to disputes or other unfavorable effects, which could have a material adverse effect on our business, financial position and results of operations.

Disputes with third parties could arise out of the Spin-off, and we could experience unfavorable reactions to the Spin-off from employees, investors, or other interested parties.
These disputes and reactions of third parties could have a material adverse effect on our business, financial position, and results of operations. In addition, following the Spin-off, disputes
between us and Sysorex could arise in connection with any of the Spin-off related agreements.

We agreed to indemnify Sysorex for certain liabilities.

Pursuant to the terms of that certain Separation and Distribution Agreement, dated August 7, 2018, as amended, the Company agreed to indemnify Sysorex for certain liabilities.
Although no such liabilities are currently anticipated, if we have to indemnify Sysorex for unanticipated liabilities, the cost of such indemnification obligations may have a material and
adverse effect on our financial performance.

A court could deem the Spin-off to be a fraudulent conveyance and void the transaction or impose substantial liabilities upon us.

If  a  third  party  challenged  the  transaction,  a  court  could  deem  the  Spin-off  or  certain  internal  restructuring  transactions  undertaken  in  connection  with  the  Spin-off  to  be  a
fraudulent conveyance or transfer. Fraudulent conveyances or transfers are defined to include transfers made or obligations incurred with the actual intent to hinder, delay or defraud current
or future creditors or transfers made or obligations incurred for less than reasonably equivalent value when the debtor was insolvent, or that rendered the debtor insolvent, inadequately
capitalized or unable to pay its debts as they become due. In such circumstances, a court could void the transactions or impose substantial liabilities upon us, which could adversely affect
our financial condition and our results of operations. Among other things, the court could require our stockholders to return to us some or all of the shares of Sysorex common stock issued
in the Spin-off or require us to fund liabilities of Sysorex for the benefit of creditors.

The Company has entered into a loan arrangement with Sysorex and there can be no guarantee Sysorex will be able to repay any amounts borrowed.

As described further within “Part I—Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” below, the Company and Sysorex entered
into a note purchase agreement pursuant to which the Company agreed to loan Sysorex up to an aggregate principal amount of $3,000,000.00, which was later increased to $5,000,000.00.
Although we believe Sysorex will be able to repay any amounts borrowed when due, there can be no guarantee this will be the case nor that the collateral Sysorex provided pursuant to the
loan arrangement would be sufficient to cover any borrowed amounts in the event of a default. If Sysorex were to default, it could have an adverse material impact on the Company’s
financial condition and cash flows.

The Company currently generates less revenue as a result of the Spin-off.

As  described  further  within  “Part  I—Item  7.  Management’s  Discussion  and  Analysis  of  Financial  Condition  and  Results  of  Operations”  below,  the  Company  generates
significantly less revenue as a result of the Spin-off. Although we believe that the Spin-off has positioned the Company for future revenue growth, there can be no guarantee that such
growth will be realized or achieved.

26

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risks Related to Our Securities

We are eligible to be treated as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, and we cannot be certain if the reduced disclosure
requirements applicable to emerging growth companies will make our common stock less attractive to investors.

We are an “emerging growth company”, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. For as long as we continue to be an emerging growth
company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including (1)
not  being  required  to  comply  with  the  auditor  attestation  requirements  of  Section  404  of  the  Sarbanes-Oxley Act  of  2002,  which  we  refer  to  as  the  Sarbanes-Oxley Act,  (2)  reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements and (3) exemptions from the requirements of holding a nonbinding advisory vote on
executive compensation and stockholder approval of any golden parachute payments not previously approved. In addition, as an emerging growth company, we are only required to provide
two years of audited financial statements and two years of selected financial data in this annual report. We will cease to be an emerging growth company on December 31, 2019, or, if we
issue more than $1.0 billion in non-convertible debt during any three-year period before that time, we would cease to be an emerging growth company immediately. Even after we no longer
qualify as an emerging growth company, we may still qualify as a “smaller reporting company” which would allow us to take advantage of many of the same exemptions from disclosure
requirements,  including  not  being  required  to  comply  with  the  auditor  attestation  requirements  of  Section  404  of  the  Sarbanes-Oxley Act  and  reduced  disclosure  obligations  regarding
executive compensation in our periodic reports and proxy statements. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If
some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.

Our independent registered public accounting firm will not be required to formally attest to the effectiveness of our internal control over financial reporting until the later of our
second annual report or the first annual report required to be filed with the Commission following the date we are no longer an “emerging growth company” as defined in the JOBS Act. We
cannot assure you that there will not be material weaknesses or significant deficiencies in our internal controls in the future.

Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We
irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we are subject to the same new or revised accounting standards as
other public companies that are not emerging growth companies.

We do not intend to pay cash dividends to our stockholders, so it is unlikely that stockholders will receive any return on their investment in our Company prior to selling stock in the
Company.

We have never paid any dividends to our common stockholders as a public company. We currently intend to retain any future earnings for funding growth and, therefore, do not
expect to pay any cash dividends in the foreseeable future. If we determine that we will pay cash dividends to the holders of our common stock, we cannot assure that such cash dividends
will be paid on a timely basis. The success of your investment in the Company will likely depend entirely upon any future appreciation. As a result, you will not receive any return on your
investment prior to selling your shares in our Company and, for the other reasons discussed in this “Risk Factors” section, you may not receive any return on your investment even when
you sell your shares in our Company.

27

 
 
 
 
 
 
  
 
 
Some provisions of our Articles of Incorporation and bylaws may deter takeover attempts, which may inhibit a takeover that stockholders consider favorable and limit the opportunity
of our stockholders to sell their shares at a favorable price.

Under our Articles of Incorporation, our Board may issue additional shares of common or preferred stock. Our Board has the ability to authorize “blank check” preferred stock
without future shareholder approval. This makes it possible for our Board to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to
acquire us by means of a merger, tender offer, proxy contest or otherwise, including a transaction in which our stockholders would receive a premium over the market price for their shares
and/or any other transaction that might otherwise be deemed to be in their best interests, and thereby protects the continuity of our management and limits an investor’s opportunity to
profit by their investment in the Company. Specifically, if in the due exercise of its fiduciary obligations, the Board were to determine that a takeover proposal was not in our best interest,
shares could be issued by our Board without stockholder approval in one or more transactions that might prevent or render more difficult or costly the completion of the takeover by:

●

●

●

diluting the voting or other rights of the proposed acquirer or insurgent stockholder group,

putting a substantial voting bloc in institutional or other hands that might undertake to support the incumbent Board, or

effecting an acquisition that might complicate or preclude the takeover.

Nevada Anti-Takeover Law may discourage acquirers and eliminate a potentially beneficial sale for our stockholders.

We are subject to the provisions of Section 78.438 of the Nevada Revised Statutes concerning corporate takeovers. This section prevents many Nevada corporations from engaging
in a business combination with any interested stockholder, under specified circumstances. For these purposes, a business combination includes a merger or sale of more than 5% of our
assets,  and  an  interested  stockholder  includes  a  stockholder  who  owns  10%  or  more  of  our  outstanding  voting  stock,  as  well  as  affiliates  and  associates  of  these  persons.  Under  these
provisions, this type of business combination is prohibited for three years following the date that the stockholder became an interested stockholder unless:

●

●

●

the transaction in which the stockholder became an interested stockholder is approved by the Board prior to the date the interested stockholder attained that status;

on consummation of the transaction that resulted in the stockholder’s becoming an interested stockholder, the interested  stockholder owned at least 90% of the voting stock of
the corporation outstanding at the time the transaction was commenced, excluding those shares owned by persons who are directors and also officers; or

on or subsequent to that date, the business combination is approved by the Board and authorized at an annual or special meeting of stockholders by the affirmative vote of at
least a majority of the outstanding voting stock that is not owned by the interested stockholder.

This statute could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us.

Our indemnification of our officers and directors may cause us to use corporate resources to the detriment of our stockholders.

Our Articles of Incorporation eliminate the personal liability of our directors for monetary damages arising from a breach of their fiduciary duty as directors to the fullest extent
permitted by Nevada law. This limitation does not affect the availability of equitable remedies, such as injunctive relief or rescission. Our Articles of Incorporation require us to indemnify
our directors and officers to the fullest extent permitted by Nevada law, including in circumstances in which indemnification is otherwise discretionary under Nevada law.

28

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Under Nevada law, we may indemnify our directors or officers or other persons who were, are or are threatened to be made a named defendant or respondent in a proceeding

because the person is or was our director, officer, employee or agent, if we determine that the person:

●

conducted himself or herself in good faith, reasonably believed, in the case of conduct in his or her official capacity as our director or officer, that his or her conduct was in our
best interests, and, in all other cases, that his or her conduct was at least not opposed to our best interests; and

●

in the case of any criminal proceeding, had no reasonable cause to believe that his or her conduct was unlawful.

These persons may be indemnified against expenses, including attorneys’ fees, judgments, fines, including excise taxes, and amounts paid in settlement, actually and reasonably
incurred by the person in connection with the proceeding. If the person is found liable to the corporation, no indemnification will be made unless the court in which the action was brought
determines that the person is fairly and reasonably entitled to indemnity in an amount that the court will establish.

Insofar  as  indemnification  for  liabilities  under  the  Securities Act  may  be  permitted  to  directors,  officers  or  persons  controlling  us  under  the  above  provisions,  we  have  been

informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

The obligations associated with being a public company require significant resources and management attention, which may divert from our business operations.

We are subject to the reporting requirements of the Exchange Act and the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”). The Exchange Act requires that we file annual,
quarterly and current reports, proxy statements, and other information. The Sarbanes-Oxley Act requires, among other things, that we establish and maintain effective internal controls and
procedures for financial reporting. Our principal executive officer and principal financial officer are required to certify that our disclosure controls and procedures are effective in ensuring
that material information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the SEC’s rules and forms. As a result, we incur significant legal, accounting and other expenses. Furthermore, the need to establish the corporate infrastructure demanded of a
public  company  may  divert  management’s  attention  from  implementing  our  growth  strategy,  which  could  prevent  us  from  improving  our  business,  results  of  operations  and  financial
condition. We have made, and will continue to make, if necessary, changes to our internal controls and procedures for financial reporting and accounting systems to meet our reporting
obligations as a public company. However, the measures we take may not be sufficient to satisfy our obligations as a public company. In addition, we cannot predict or estimate the amount
of additional costs we may incur in order to comply with these requirements. We anticipate that these costs could materially increase our selling, general and administrative expenses.

Section  404  of  the  Sarbanes-Oxley Act  requires  annual  management  assessments  of  the  effectiveness  of  our  internal  control  over  financial  reporting.  In  connection  with  the
implementation of the necessary procedures and practices related to internal control over financial reporting, we may identify deficiencies. Additionally, in the event we are no longer a
smaller reporting company, as defined under the Exchange Act, and we are unable to comply with the internal controls requirements of the Sarbanes-Oxley Act of 2002, then we may not be
able to obtain the independent registered public accountants’ certifications required by that act, which may preclude us from keeping our filings with the SEC current, and interfere with the
ability of investors to trade our securities and our shares to continue to be listed on The Nasdaq Capital Market.

If we fail to establish and maintain an effective system of internal controls, we may not be able to report our financial results accurately or prevent fraud. Any inability to report and
file our financial results accurately and timely could harm our reputation and adversely affect the trading price of our common stock.

Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide reliable financial reports or prevent fraud, we may not
be  able  to  manage  our  business  as  effectively  as  we  would  if  an  effective  control  environment  existed,  and  our  business  and  reputation  with  investors  may  be  harmed.  With  each
prospective  acquisition  we  may  make  we  will  conduct  whatever  due  diligence  is  necessary  or  prudent  to  assure  us  that  the  acquisition  target  can  comply  with  the  internal  controls
requirements  of  the  Sarbanes-Oxley Act.  Notwithstanding  our  diligence,  certain  internal  controls  deficiencies  may  not  be  detected. As  a  result,  any  internal  control  deficiencies  may
adversely affect our financial condition, results of operations and access to capital. We have not performed an in-depth analysis to determine if historical undiscovered failures of internal
controls exist, and may in the future discover areas of our internal controls that need improvement.

29

 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Public company compliance may make it more difficult to attract and retain officers and directors.

The Sarbanes-Oxley Act and rules implemented by the SEC have required changes in corporate governance practices of public companies. As a public company, these rules and
regulations increase our compliance costs and make certain activities more time consuming and costly. As a public company, these rules and regulations may make it more difficult and
expensive for us to maintain our director and officer liability insurance and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the
same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified persons to serve on our Board or as executive officers, and to maintain insurance at
reasonable rates, or at all.

Our stock price may be volatile.

The market price of our common stock is likely to be highly volatile and could fluctuate widely in price in response to various factors, many of which are beyond our control,

including the following:

●

●

●

●

●

●

●

●

●

●

●

●

●

●

●

●

our ability to execute our business plan and complete prospective acquisitions;

changes in our industry;

competitive pricing pressures;

our ability to obtain working capital financing;

additions or departures of key personnel;

limited “public float” in the hands of a small number of persons whose sales or lack of sales could result in positive or negative pricing pressure on the market price for our
common stock;

sales of our common stock (particularly following effectiveness of this registration statement);

operating results that fall below expectations;

regulatory developments;

economic and other external factors;

period-to-period fluctuations in our financial results;

our inability to develop or acquire new or needed technologies;

the public’s response to press releases or other public announcements by us or third parties, including filings with the SEC;

changes in financial estimates or ratings by any securities analysts who follow our common stock, our failure to meet these estimates or failure of those analysts to initiate or
maintain coverage of our common stock;

the development and sustainability of an active trading market for our common stock; and

any future sales of our common stock by our officers, directors and significant stockholders.

30

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In  addition,  the  securities  markets  have  from  time  to  time  experienced  significant  price  and  volume  fluctuations  that  are  unrelated  to  the  operating  performance  of  particular

companies. These market fluctuations may also materially and adversely affect the market price of our common stock.

Our shares of common stock are thinly traded, the price may not reflect our value, and there can be no assurance that there will be an active market for our shares of common stock
either now or in the future.

Our shares of common stock are thinly traded, our common stock is held by a small number of holders, and the price may not reflect our actual or perceived value. There can be
no assurance that there will be an active market for our shares of common stock either now or in the future. The market liquidity will be dependent on the perception of our operating
business, among other things. We will take certain steps including utilizing investor awareness campaigns, investor relations firms, press releases, road shows and conferences to increase
awareness of our business. Any steps that we might take to bring us to the awareness of investors may require that we compensate consultants with cash and/or stock. There can be no
assurance that there will be any awareness generated or the results of any efforts will result in any impact on our trading volume. Consequently, investors may not be able to liquidate their
investment or liquidate it at a price that reflects the value of the business, and trading may be at a depressed price relative to the performance of the Company due to, among other things,
the availability of sellers of our shares. If an active market should develop, the price may be highly volatile. Because there is currently a relatively low per-share price for our common
stock, many brokerage firms or clearing firms are not willing to effect transactions in the securities or accept our shares for deposit in an account. Many lending institutions will not permit
the use of low-priced shares of common stock as collateral for any loans.

Offers or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline.

If our stockholders sell substantial amounts of our common stock in the public market upon the expiration of any statutory holding period under Rule 144, or shares issued upon
the exercise of outstanding options or warrants, it could create a circumstance commonly referred to as an “overhang” and, in anticipation of which, the market price of our common stock
could fall. The existence of an overhang, whether or not sales have occurred or are occurring, also could make more difficult our ability to raise additional financing through the sale of
equity or equity-related securities in the future at a time and price that we deem reasonable or appropriate.

In general, a non-affiliated person who has held restricted shares for a period of six months, under Rule 144, may sell into the market our common stock all of their shares, subject
to the Company being current in its periodic reports filed with the SEC. As of March 20, 2019, approximately 6,772,545 shares of common stock of the 6,973,522 shares of common stock
outstanding were free trading.

Sales of substantial amounts of our common stock in the public market, or the perception that these sales could occur, could adversely affect the price of our common stock and

could impair our ability to raise capital through the sale of additional shares.

In addition, as of March 20, 2019, there were 202 shares issuable upon conversion of 1 share of Series 4 Convertible Preferred Stock, 596,397 shares of common stock issuable
upon  conversion  of  1,986  shares  of  Series  5  Convertible  Preferred  Stock,  5,371,452  shares  subject  to  outstanding  warrants,  2,772,421  shares  subject  to  outstanding  options  under  the
Company’s equity incentive plans, 39 shares subject to options not under such plans, 1,100 shares of common stock reserved for issuance to investor relations firms, an additional 158,212
shares reserved for future issuance under the Company’s Amended and Restated 2011 Employee Stock Incentive Plan and up to an additional 2,544,167 shares of common stock which
may be issued under the Company’s 2018 Employee Stock Incentive Plan that will become, or have already become, eligible for sale in the public market to the extent permitted by any
applicable vesting requirements, lock-up agreements, if any, Rule 144 under the Securities Act or in connection with their registration under the Securities Act.

Our common stock may be delisted from the Nasdaq Capital Market if we cannot satisfy Nasdaq’s continued listing requirements in the future.

If we fail to maintain compliance with the continued listing requirements of the Nasdaq Capital Market, our common stock may be delisted and the price of our common stock

and our ability to access the capital markets could be negatively affected.

31

 
 
 
 
 
 
 
 
 
 
 
 
Our common stock currently trades on the Nasdaq Capital Market under the symbol “INPX.” This market has continued listing standards that we must comply with in order to
maintain  the  listing  of  our  common  stock.  The  continued  listing  standards  include,  among  others,  a  minimum  bid  price  requirement  of  $1.00  per  share  and  any  of:  (i)  a  minimum
stockholders’  equity  of  $2.5  million;  (ii)  a  market  value  of  listed  securities  of  at  least  $35.0  million;  or  (iii)  net  income  from  continuing  operations  of  $500,000  in  the  most  recently
completed fiscal year or in the two of the last three fiscal years. Our results of operations and fluctuating stock price directly affect our ability to satisfy these continued listing standards. In
the event we are unable to maintain these continued listing standards, our common stock may be subject to delisting from the Nasdaq Capital Market. 

Without a Nasdaq listing, stockholders may have a difficult time getting a quote for the sale or purchase of our stock, the sale or purchase of our stock would likely be made more
difficult and the trading volume and liquidity of our stock could decline. Delisting from Nasdaq could also result in negative publicity and could also make it more difficult for us to raise
additional capital. Further, if we were delisted, we would also incur additional costs under state blue sky laws in connection with any sales of our securities. These requirements could
severely limit the market liquidity of our common stock and the ability of our stockholders to sell our common stock in the secondary market. If Nasdaq delisted our common stock, our
common  stock  may  be  eligible  to  trade  on  an  over-the-counter  quotation  system,  such  as  the  OTCQB  market,  where  an  investor  may  find  it  more  difficult  to  sell  our  stock  or  obtain
accurate  quotations  as  to  the  market  value  of  our  common  stock.  We  cannot  assure  you  that  our  common  stock,  if  delisted  from  Nasdaq,  will  be  listed  on  another  national  securities
exchange or quoted on an over-the counter quotation system.

There may be future sales or other dilution of our equity, which may adversely affect the market price of our common stock.

We are generally not restricted from issuing additional common stock, including any securities that are convertible into or exchangeable for, or that represent the right to receive,
common stock. The market price of our common stock could decline as a result of sales of common stock or securities that are convertible into or exchangeable for, or that represent the
right to receive common stock or the perception that such sales could occur.

If securities or industry analysts do not publish research or reports about our business, or if they change their recommendations regarding our stock adversely, our stock price and
trading volume could decline.

The  trading  market  for  our  common  stock  relies  in  part  on  the  research  and  reports  that  equity  research  analysts  publish  about  us  and  our  business.  We  do  not  control  these
analysts.  The  price  of  our  common  stock  could  decline  if  one  or  more  equity  research  analysts  downgrade  our  common  stock  or  if  they  issue  other  unfavorable  commentary  or  cease
publishing reports about us or our business.

 ITEM 1B: UNRESOLVED STAFF COMMENTS

As a smaller reporting company, we are not required to provide this information.

 ITEM 2: PROPERTIES

The Company’s executive offices consist of approximately 4,377 square feet and are located at 2479 E. Bayshore Road, Suite 195, Palo Alto, CA 94303. In October 2014, the
Company entered into a 64-month lease for the facility, which expires on January 31, 2020. The current monthly base rent is $16,020 (subject to increases of 3% per year) plus the pro rata
share of the operating costs, which approximates $8,985 per month.

The Company also has an office located at 6345 Balboa Boulevard, Suite 140, Encino, CA 91316, which is approximately 3,169 square feet under a lease that expires on July 31,
2021. The monthly base rent is $6,684, which is increasing to $6,859 on August 1, 2019. In addition, the Company pays the landlord a pro rata share of operating costs, which is currently
$276.30 per month.

Inpixon Canada Inc. has an office of approximately 6,656 square feet that is located at 2963 Glen Drive, Suites 405 and 400, Coquitlam, BC V3P 2B7. The monthly rent under the
lease is comprised of a base rent of approximately $12,757 CAD plus the pro rata share of the operating costs, which approximates $5,776 CAD per month. Effective March 1, 2019 the pro
rata share of the operating costs increases to approximately $7,424 CAD per month. The lease expires on September 30, 2021 with a five-year option to extend.

32

 
 
 
 
 
 
 
 
 
 
 
 
  
 
Sysorex  India  Limited  has  an  office  of  approximately  6,896  square  feet  located  at  Unit  6  E&F  in  Vaishnavi’s  Cynosure,  Plot  No.  35,  6th  Floor,  Gachibowli  Village,
SerilingampallyMandal Ranga Reddy dist., Hyderabad - 500032 Telangana State. The lease is for a period of 5 years commencing on March 1, 2019 with a lock-in period of 2 years and an
option to renew thereafter. The lease rent is approximately $7,034 per month, which increases by 5% per year.

We believe that each of our properties is suitable and adequate for the operations conducted therein.

 ITEM 3: LEGAL PROCEEDINGS

Atlas Technology Group, LLC

On February 20, 2019, in connection with the satisfaction of an award in an aggregate amount of $1,156,840.25 plus pre-judgment interest equal to an aggregate of $59,955.28
(the “Award”) granted to Atlas Technology Group, LLC (“Atlas”) following arbitration proceedings arising out of an engagement agreement, dated September 8, 2016, by and between
Atlas and the Company (including its subsidiaries) (the “Engagement Agreement”), the Company, Sysorex and Atlas entered into a settlement agreement (the “Settlement Agreement”)
pursuant to which Atlas agreed to (a) reduce the Award by $275,000 resulting in a “Net Award” of $941,795.53 and (b) accept an aggregate of 749,440 shares of freely-tradable common
stock of the Company (the “Settlement Shares”) in satisfaction of the Award which was determined by dividing 120% of the Net Award by $1.508, which was the “minimum price,” as
defined under Nasdaq Listing Rule 5635(d).

Pursuant to the Settlement Agreement, after the Company issued and delivered the Settlement Shares to Atlas, the Award was deemed satisfied in full and the parties were deemed
to have released each other from any claims arising out of the Engagement Agreement. The Settlement Shares were issued to Atlas pursuant to the Company’s registration statement on
Form S-3, as amended (SEC File No. 333-223960), which was declared effective by the Securities and Exchange Commission on June 5, 2018.

In connection with Sysorex’s spin-off from the Company, the Company and Sysorex each agreed pursuant to the terms and conditions of that certain Separation and Distribution
Agreement, dated August 7, 2018, as amended, 50% of the costs and liabilities related to the arbitration action arising from the Engagement Agreement would be shared by each party
following the spin-off.  As a result, Sysorex indemnified the Company for half of the total amount paid by the Company to satisfy the Award.

There are no other material pending legal proceedings as defined by Item 103 of Regulation S-K, to which we are a party or of which any of our property is the subject, other than

ordinary routine litigation incidental to the Company’s business.

There are no proceedings in which any of the directors, officers or affiliates of the Company, or any registered or beneficial holder of more than 5% of the Company’s voting

securities, is an adverse party or has a material interest adverse to that of the Company.

 ITEM 4: MINE SAFETY DISCLOSURES

Not applicable.

33

 
 
 
 
 
 
 
 
 
 
 
 
 
 ITEM 5: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stock currently trades under the symbol “INPX” on the Nasdaq Capital Market and traded under the symbol “SYRX” prior to the March 1, 2017 name change. The

following table sets forth the high and low sales prices on Nasdaq during the years ended December 31, 2018 and 2017. All prices reflect the Reverse Splits.

 PART II

Period
Year Ended December 31, 2018
October 1, 2018 through December 31, 2018
July 1, 2018 through September 30, 2018
April 1, 2018 through June 30, 2018
January 1, 2018 through March 31, 2018

Year Ended December 31, 2017
October 1, 2017 through December 31, 2017
July 1, 2017 through September 30, 2017
April 1, 2017 through June 30, 2017
January 1, 2017 through March 31, 2017

Holders of Record

High

Low

20.40 
11.12 
50.7338 
455.8946 

  $
  $
  $
  $

2.62 
4.327 
5.0314 
43.1866 

767.2465 
1,227.6699 
5,799.3219 
5,849.3489 

  $
  $
  $
  $

254.7424 
239.0176 
817.6918 
3,122.0731 

  $
  $
  $
  $

  $
  $
  $
  $

According to our transfer agent, as of March 20, 2019, we had approximately 520 shareholders of record of our common stock. This number does not include an indeterminate
number of shareholders whose shares are held by brokers in street name. Our stock transfer agent is Computershare Trust Company, N.A., Meidinger Tower, 462 S. 4th Street, Louisville,
KY 40202.

Dividends

We  have  not  declared  or  paid  any  cash  dividends  on  our  common  stock,  and  we  currently  intend  to  retain  future  earnings,  if  any,  to  finance  the  expansion  of  our  business,
therefore, we do not expect to pay any cash dividends in the foreseeable future. The decision whether to pay cash dividends on our common stock will be made by our Board, in their
discretion, and will depend on our financial condition, results of operations, capital requirements and other factors that our Board considers significant. Holders of Series 4 Convertible
Preferred Stock and Series 5 Convertible Preferred Stock will not be entitled to receive any dividends, unless and until specifically declared by our Board.

Securities Authorized for Issuance under Equity Compensation Plans

For information required by this item with respect to our equity compensation plans, please see Item 11 of this report.

Recent Sales of Unregistered Equity Securities

Except as disclosed below, since the beginning of our fiscal year ended December 31, 2018, we have not sold any equity securities that were not registered under the Securities

Act that were not previously reported in a quarterly report on Form 10-Q or in a current report on Form 8-K.

Issuance of Conversion Shares upon Conversions of August 9, 2016 Debenture

On February 5, 2018, the holder of an 8% Original Issue Discount Senior Convertible Debenture, issued on August 8, 2016 (the “Debenture”), delivered a conversion notice to the
Company pursuant to which it converted $300,000 of principal of the Debenture into 1,254 shares of the Company’s common stock. Such shares of common stock were issued on February
6, 2018.

On February 7, 2018, the holder of the Debenture delivered a conversion notice to the Company pursuant to which it converted $400,000 of principal of the Debenture into 2,982

shares of the Company’s common stock.

On February 9, 2018, the holder of the Debenture delivered a final conversion notice to the Company pursuant to which it converted $317,000 of principal of the Debenture into

2,645 shares of the Company’s common stock, which paid the Debenture in full.

The issuances and sales of the shares of common stock above were not registered under the Securities Act, in reliance on an exemption from registration under Section 4(a)(2) of
the Securities Act, based on the fact that the investor was an “accredited investor,” as such term is defined in Rule 501 of Regulation D, and the transactions did not involve any public
offering.

Issuance of Shares of Common Stock to Consultant

On October 8, 2018, the Company issued 37,500 shares of common stock to a consultant for services. The Company recorded an expense of approximately $465,000 for the fair

value of those shares. 

The shares of common stock above were not registered under the Securities Act in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act, based on the fact
that the transaction did not involve any public offering. 

 ITEM 6: SELECTED FINANCIAL DATA.

As a smaller reporting company, we are not required to provide this information.

34

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ITEM 7: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the audited financial statements and related notes
included elsewhere in this Annual Report on Form 10-K. In addition to historical information, this discussion and analysis here and throughout this Form 10-K contains forward-looking
statements  that  involve  risks,  uncertainties  and  assumptions.  Our  actual  results  may  differ  materially  from  those  anticipated  in  these  forward-looking  statements,  due  to  a  number  of
factors, including but not limited to, risks described in the section entitled “Risk Factors.”

Except where indicated, all share and per share data in this section, as well as the consolidated financial statements, reflect the 1-for-15 reverse split of the Company’s outstanding
common  stock  effected  on  March  1,  2017,  the  1-for-30  reverse  split  of  the  Company’s  outstanding  common  stock  effected  on  February  6,  2018,  and  the  1-for-40  reverse  split  of  the
Company’s outstanding common stock effected on November 2, 2018 (collectively, the “Reverse Splits”). We have reflected the Reverse Splits herein, unless otherwise indicated.

Overview of Our Business

We provide a number of different technology products and services to private and public sector customers. Effective January 1, 2017, the Company changed the way it analyzes
and assesses divisional performance of the Company. The Company re-aligned its operating segments along those division business lines and operated in two segments, namely Indoor
Positioning Analytics and Infrastructure. The Infrastructure business was part of the Spin-off of Sysorex and is no longer part of our reporting. Our Indoor Positioning Analytics (“IPA”)
products secure, digitize and optimize the interior of any premises with indoor positioning and data analytics that provide rich positional information, similar to a global positioning system,
and browser-like intelligence for the indoors. In addition, we offer digital tear-sheets with optional invoice integration, digital ad delivery, and an e-edition designed for reader engagement
for the media, publishing and entertainment industry.

Revenues were flat in 2018 because of an increase in our IPA product revenues, which was offset by a decrease in our Shoom services revenue. We expect to continue to grow our
IPA product line in 2019. The IPA product line does have long sales cycles, which are a result from customer-related issues such as budget and procurement processes but also because of
the early stages of indoor-positioning technology and the learning curve required for customers to implement such solutions. Customers also engage in a pilot program first which prolongs
sales cycles and is typical of most emerging technology adoption curves. We anticipate sales cycles to improve in 2019 as our customer base moves from early adopters to mainstream
customers. The sales cycle is also improving with the increased presence and awareness of beacon and Wi-Fi locationing technologies in the market. IPA sales can be licensed-based with
government customers but commercial customers typically prefer a SaaS or subscription model. Our other digital solutions are also delivered on a SaaS model and allow us to generate
industry analytics that complement our indoor-positioning solutions.

We experienced a net loss of $24.6 million for the year ended December 31, 2018 and a net loss of $35.0 million for the year ended December 31, 2017. We cannot assure that we
will ever earn revenues sufficient to support our operations, or that we will ever be profitable. In order to continue our operations, we have supplemented the revenues we earned with
proceeds from the sale of our equity and debt securities and proceeds from loans and bank credit lines. Furthermore, except for our Payplant facility, we have no committed source of
financing and we cannot assure that we will be able to raise money as and when we need it to continue our operations. If we cannot raise funds as and when we need them, we may be
required to scale back our business operations by reducing expenditures for employees, consultants, business development and marketing efforts, selling assets or one or more products in
our business, or otherwise severely curtailing our operations.

35

 
 
 
 
   
 
 
 
 
Recent Events

Reverse Stock Splits

During 2018 and 2017, the Company has effected three reverse stock splits: (1) a 1-for-15 reverse split of the Company’s outstanding common stock effected on March 1, 2017;
(2)  a  1-for-30  reverse  split  of  the  Company’s  outstanding  common  stock  effected  on  February  6,  2018;  and  (3)  a  1-for-40  reverse  split  of  the  Company’s  outstanding  common  stock
effected on November 2, 2018.

January 2018 Capital Raise

On January 5, 2018, the Company entered into a securities purchase agreement (the “January 2018 SPA”) with certain investors pursuant to which the Company agreed to sell, in a
registered direct offering, an aggregate of 14,996 shares (the “January 2018 Shares”) of the Company’s common stock at a purchase price of $212.40 per share for aggregate gross proceeds
of approximately $3.2 million. After deducting placement agent fees and other expenses, the net proceeds from the offering was approximately $2.8 million. Concurrently with the sale of
the January 2018 Shares, pursuant to the January 2018 SPA the Company also sold warrants to purchase up to 14,996 shares of common stock (the “January 2018 Warrants”). This offering
closed on January 8, 2018.

The January 2018 Warrants became exercisable on February 2, 2018 (the “January 2018 Warrant Initial Exercise Date”), at an exercise price per share equal to $264.00, subject to
certain adjustments pursuant to the terms of the January 2018 Warrants (the “January 2018 Warrant Exercise Price”), and will expire on the fifth anniversary of the January 2018 Warrant
Initial Exercise Date. As a result of a Dilutive Issuance (as defined in the January 2018 Warrants) as of February 20, 2018, the January 2018 Warrant Exercise Price was adjusted to the
floor price of $120.00 per share pursuant to the January 2018 Warrants.

February 2018 Public Offering

On February 20, 2018, the Company completed a public offering for approximately $18 million in securities, consisting of (i) an aggregate of 83,149 Class A units, at a price to
the public of $94.00 per Class A unit, each consisting of one share of common stock, and a five-year warrant to purchase one share of common stock, and (ii) 10,184.9752 Class B units, at
a price to the public of $1,000 per Class B unit, each consisting of one share of the Company’s newly designated Series 3 convertible preferred stock, par value $0.001 per share (“Series 3
Preferred”),  with  a  stated  value  of  $1,000  and  initially  convertible  into  approximately  11  shares  of  common  stock  at  a  conversion  price  of  $94.00  per  share  for  up  to  an  aggregate  of
108,351  shares  of  common  stock  and  warrants  exercisable  for  the  number  of  shares  of  common  stock  into  which  the  shares  of  Series  3  Preferred  is  initially  convertible.  The  warrants
(“February 2018 Warrant”) were immediately exercisable at an exercise price of $140.00 per share (subject to adjustment).

The  Company  received  approximately  $18  million  in  gross  proceeds  from  this  offering,  including  the  satisfaction  of  approximately  $1  million  in  amounts  payable  to  service
providers. After  satisfying  the  amounts  due  to  service  providers  and  deducting  placement  agent  fees,  the  net  cash  proceeds  from  this  offering  was  approximately  $15.4  million.  The
Company used the net proceeds from the transactions for working capital and general corporate purposes, including research and development and sales and marketing.

The shares of Series 3 Preferred issued in this offering have all been converted into common stock. As a result of the April 2018 offering described below as of April 24, 2018, the
exercise price of the February 2018 Warrants was adjusted to the floor price of $25.36 per share and the number of shares of common stock underlying the February 2018 Warrants was
increased to an aggregate of 1,057,178 shares of common stock.

April 2018 Public Offering

On April 24, 2018, the Company completed a public offering consisting of 10,115 units at a price to the public of $1,000 per unit, each consisting of (i) one share of our newly
designated Series 4 convertible preferred stock, par value $0.001 per share (the “Series 4 Preferred”), with a stated value of $1,000 and initially convertible into approximately 54 shares of
common  stock,  at  a  conversion  price  of  $18.40  per  share  (subject  to  adjustment)  and  (ii)  one  warrant  to  purchase  such  number  of  shares  of  common  stock  as  each  share  of  Series  4
Preferred is initially convertible into. The warrants are immediately exercisable at an exercise price of $26.80 per share (subject to adjustment).

36

 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Series 4 Preferred contain an anti-dilution protection feature, to adjust the conversion price if shares of common stock are sold or issued for a consideration per share less than
the  conversion  price  then  in  effect  (subject  to  certain  exemptions),  provided,  that  the  conversion  price  will  not  be  less  than  $4.96.  In  addition,  on  the  60th  day  following  the  original
issuance date of the Series 4 Preferred, the conversion price was reduced, and only reduced, to the lesser of (x) the then conversion price, as may be adjusted, and (y) 80% of the VWAP (as
defined in the certificate of designation filed for the Series 4 Preferred) on the trading day immediately prior to the 60th day, provided that the conversion price will not be less than $4.96.
On  June  25,  2018,  in  accordance  with  the  terms  of  such  price  reset  provision,  the  conversion  price  of  the  Series  4  Preferred  was  adjusted  to  $7.12,  which  was  subsequent  adjusted  on
January 15, 2019 in connection with the rights offering to $4.96. In addition, in connection with the rights offering, on January 15, 2019, the exercise price of the warrants issued in the
April offering were also reduced to the floor price of $4.96 and the number of shares issuable upon exercise of such warrants was increased to 2,769,000 shares of common stock.

The Company received approximately $10.1 million in gross proceeds from this offering, before deducting placement agent fees and offering expenses payable by the Company.
After deducting placement agent fees and expenses, the net proceeds from this offering were approximately $9.2 million. The Company intends to use the net proceeds from this offering
for working capital, general corporate purposes (including research and development, sales and marketing and the satisfaction of outstanding amounts payable to our vendors in connection
with  trade  payables). Additionally,  the  Company  may  use  a  portion  of  the  net  proceeds  of  this  offering  to  finance  acquisitions  of,  or  investments  in,  competitive  and  complementary
businesses, products or services as a part of our growth strategy. However, the Company does not have any current commitments with respect to any such acquisitions or investments.

Spin-off of Sysorex, Inc. and its wholly owned subsidiary, Sysorex Government Services, Inc.

On August  31,  2018,  the  Company  completed  the  spin-off  (the  “Spin-off”)  of  its  value  added  reseller  business  from  its  indoor  positioning  analytics  business  by  way  of  a
distribution of all the shares of common stock of the Company’s wholly-owned subsidiary, Sysorex, to the Company’s stockholders of record as of August 21, 2018 (the “Record Date”)
and certain warrant holders. The distribution occurred by way of a pro rata stock distribution to such common stock, preferred stock and warrant holders, each of whom received one share
of Sysorex’s common stock for every 3 shares of the Company’s common stock (without taking into effect the Reverse Split effected on November 2, 2018) held on the Record Date or
such number of shares of common stock issuable upon complete conversion of the preferred stock or exercise of the warrants.

October 2018 and December 2018 Note Purchase Agreements and Promissory Notes

On October 12, 2018 the Company entered into a note purchase agreement with an institutional investor (the “Holder”), pursuant to which the Company agreed to issue and sell to
the Holder an unsecured promissory note (the “October 2018 Note”) in an aggregate principal amount of $2.52 million (the “Initial Principal Amount”), which is payable on or before the
date that is 12 months from the issuance date. The Initial Principal Amount includes an original issue discount of $500,000.00 and $20,000.00 that the Company agreed to pay to the Holder
to cover the Holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the October 2018 Note, the Holder paid an aggregate purchase price
of  $2.0  million.  Interest  on  the  October  2018  Note  accrues  at  a  rate  of  10%  per  annum  and  is  payable  on  the  maturity  date  or  otherwise  in  accordance  with  the  October  2018  Note.
Beginning on the date that is 6 months from the issuance date and at the intervals indicated below until the October 2018 Note is paid in full, the Holder shall have the right to redeem up to
an aggregate of 1/3 of the initial principal balance of the October 2018 Note each month (each monthly exercise, a “Monthly Redemption Amount”) by providing written notice (each, a
“Monthly Redemption Notice”) delivered to the Company; provided, however, that if the Holder does not exercise any Monthly Redemption Amount in its corresponding month then such
Monthly  Redemption Amount  shall  be  available  for  the  Holder  to  redeem  in  any  future  month  in  addition  to  such  future  month’s  Monthly  Redemption Amount.  Upon  receipt  of  any
Monthly Redemption Notice, the Company shall pay the applicable Monthly Redemption Amount in cash to the Holder within 5 business days of the Company’s receipt of such Monthly
Redemption Notice.

On December 21, 2018, the Company entered into a note purchase agreement with an institutional investor (the “Holder”), pursuant to which the Company agreed to issue and sell
to the Holder an unsecured promissory note (the “December 2018 Note”) in an aggregate principal amount of $1.895 million (the “Initial Principal Amount”), which is payable on or before
the date that is 10 months from the issuance date. The Initial Principal Amount includes an original issue discount of $375,000 and $20,000 that the Company agreed to pay to the Holder to
cover the Holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the December 2018 Note, the Holder paid an aggregate purchase price
of $1.5 million. Interest on the December 2018 Note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the December 2018 Note. The
Company may pay all or any portion of the amount owed earlier than it is due; provided, that in the event the Company elects to prepay all or any portion of the outstanding balance, it shall
pay to the Holder 115% of the portion of the outstanding balance the Company elects to prepay. Beginning on the date that is 6 months from the issuance date and at the intervals indicated
below until the December 2018 Note is paid in full, the Holder shall have the right to redeem up to an aggregate of 1/3 of the initial principal balance of the December 2018 Note each
month (each monthly exercise, a “Monthly Redemption Amount”) by providing written notice (each, a “Monthly Redemption Notice”) delivered to the Company; provided, however, that
if the Holder does not exercise any Monthly Redemption Amount in its corresponding month then such Monthly Redemption Amount shall be available for the Holder to redeem in any
future  month  in  addition  to  such  future  month’s  Monthly  Redemption  Amount.  Upon  receipt  of  any  Monthly  Redemption  Notice,  the  Company  shall  pay  the  applicable  Monthly
Redemption Amount in cash to the Holder within 5 business days of the Company’s receipt of such Monthly Redemption Notice.

37

 
 
 
 
 
 
 
 
 
On February 9, 2019, the note purchase agreements were each amended to delete the phrase “by cancellation or exchange of the Note, in whole or in part”. The Company also
agreed to pay the Note Holder’s fees and other expenses in an aggregate amount of $80,000.00 (the “Fee”) in connection with the preparation of the amendment by adding $40,000.00 of
the Fee to the outstanding balance of each of the notes issued pursuant to the note purchase agreements.

Sysorex Loan Transaction

On December 31, 2018, the Company and Sysorex entered into a note purchase agreement pursuant to which the Company agreed to purchase from Sysorex at a purchase price
equal to the Loan Amount (as defined below), a secured promissory note (the “Secured Note”) for up to an aggregate principal amount of 3.0 million (the “Principal Amount”), including
any amounts advanced through the date of the Secured Note (the “Prior Advances”), to be borrowed and disbursed in increments (such borrowed amount, together with the Prior Advances,
collectively referred to as the “Loan Amount”), with interest to accrue at a rate of ten percent (10%) per annum on all such Loan Amounts, beginning as of the date of disbursement with
respect to any portion of such Loan Amount. In addition, Sysorex agreed to pay $20,000 to the Company to cover the Company’s legal fees, accounting costs, due diligence, monitoring and
other transaction costs incurred in connection with the purchase and sale of the Secured Note (the “Transaction Expense Amount”), all of which amount is included in the Principal Amount.
The initial Loan Amount, therefore, includes any amounts disbursed to Sysorex and the Transaction Expense Amount.

Sysorex may borrow repay and borrow under the Secured Note, as needed, for a total outstanding balance, exclusive of any unpaid accrued interest, not to exceed the Principal

Amount at any one time.

All outstanding principal amounts and accrued unpaid interest owing under the Secured Note shall become immediately due and payable on the earlier to occur of (i) the twenty-
four (24) month anniversary of the date the Secured Note is issued (the “Maturity Date”), (ii) at such date when declared due and payable by the Company upon the occurrence of an Event
of Default (as defined in the Secured Note), or (iii) at any such earlier date as set forth in the Secured Note. All accrued unpaid interest shall be payable in cash.

Pursuant to the terms of the Secured Note, Sysorex granted the Company, subject to any and all Payplant Liens (as defined in the Secured Note) and Permitted Liens (as defined in
the Secured Note), a continuing first priority security interest in all assets of Sysorex whether owned as of the date of the Secured Note or subsequently acquired, including all proceeds
therefrom (collectively, the “Collateral”) to secure the payment of the Secured Note and all other loans and advances (including all renewals, modifications and extensions thereof) and all
obligations of any and every kind and nature of Sysorex to the Company, whether arising prior to, under or after the date of the Secured Note, however incurred or evidenced, plus all
interest, reasonable costs, reasonable expenses and reasonable attorneys’ fees, which may be made or incurred by the Company in the disbursement, administration, and collection of such
amounts, and in the protection, maintenance, and liquidation of the Collateral.

On February 4, 2019, the documents were amended to increase the maximum Principal Amount that may be outstanding at any time under the Secured Note from $3.0 million to

$5.0 million.

Convertible Note Exchange

On  January  29,  2019,  the  Company  and  the  holder  (the  “Note  Holder”)  of  that  certain  outstanding  convertible  promissory  note,  issued  on  November  17,  2017  (as  amended,
supplemented or otherwise modified, the “Original Note”), with an outstanding balance of $383,768.07 (the “Remaining Balance”), entered into an exchange agreement (the “Exchange
Agreement”), pursuant to which the Company and the Note Holder agreed to (i) partition a new convertible promissory note in the form of the Original Note (the “Partitioned Note”) in the
original principal amount equal to the Remaining Balance (the “Exchange Amount”) and then cause the Remaining Balance to be reduced by the Exchange Amount; and (ii) exchange the
Partitioned  Note  for  the  delivery  of  172,869  shares  (each,  an  “Exchange  Share”  and  collectively,  the  “Exchange  Shares”)  of  the  Company’s  common  stock  at  an  effective  price  per
Exchange Share equal to $2.22 (the “Exchange”). The Exchange was completed on January 29, 2019. Following such partition of the Original Note, the Original Note was deemed paid in
full, was automatically deemed canceled, and shall not be reissued.

38

 
 
 
 
 
 
 
 
 
 
 
Rights Offering

On  January  15,  2019,  the  Company  closed  its  rights  offering  (the  “Rights  Offering”)  for  aggregate  gross  proceeds  to  the  Company  of  $12.0  million  and  net  proceeds  of

approximately $10.77 million after deducting expenses relating to dealer-manager fees and expenses.

The Company sold an aggregate of 12,000 units consisting of one share of Series 5 Convertible Preferred Stock with a stated value of $1,000 (and immediately convertible into
shares of common stock at a conversion price of $3.33 per share) and 300 warrants to purchase common stock with an exercise price of $3.33 per share. The warrants are exercisable for 5
years after the date of issuance. The Series 5 Convertible Preferred Stock and the warrants comprising the units immediately separated upon the closing of the Rights Offering.

Atlas Technology Settlement

On February 20, 2019, the Company, Sysorex and Atlas Technology Group, LLC (“Atlas”) entered into a settlement agreement (the “Settlement Agreement”) in connection with
the satisfaction of an arbitration award in an aggregate amount of $1,156,840.25 plus pre-judgment interest equal to an aggregate of $59,955.28 (the “Award”) granted to Atlas following
arbitration proceedings arising out of an engagement agreement, dated September 8, 2016, by and between Atlas and the Company as well as its subsidiaries, including the predecessor to
Sysorex (the “Engagement Agreement”).

Pursuant to the Settlement Agreement, Atlas agreed to (a) reduce the Award by $275,000 resulting in a net award of $941,795.53 (the “Net Award”) and (b) accept an aggregate of
749,440 shares of freely-tradable common stock of the Company (the “Settlement Shares”), in satisfaction of the Award, which was determined by dividing 120% of the Net Award by
$1.508, which was the “minimum price,” as defined under Nasdaq Listing Rule 5635(d). The closing occurred on February 21, 2019.

The Award is deemed satisfied in full and the parties have released each other from any claims arising out of the Engagement Agreement. In connection with the Spin-off, the
Company and Sysorex each agreed pursuant to the terms and conditions of that certain Separation and Distribution Agreement, dated August 7, 2018, as amended, that 50% of the costs and
liabilities related to the arbitration action arising from the Engagement Agreement would be shared by each party following the Spin-off. As a result, Sysorex is obligated to indemnify the
Company for half of the total amount paid by the Company to satisfy the Award.

In the event that the total net proceeds received by Atlas or its designees from the sale of the Settlement Shares (exclusive of brokerage fees) exceeds the amount of the Net Award,
Atlas agreed to deliver an amount equal to the difference between the sale proceeds and the Net Award to the legal counsel for the Company and Sysorex to be applied against fees incurred
in connection with the arbitration and the Settlement Agreement.

JOBS Act

Pursuant to Section 107 of the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards until such time as those standards apply to private
companies. We have irrevocably elected to opt out of this exemption from new or revised accounting standards and, therefore, are subject to the same new or revised accounting standards
as other public companies that are not emerging growth companies.

39

 
 
 
 
 
 
 
 
 
 
 
 
Critical Accounting Policies and Estimates

Our  consolidated  financial  statements  are  prepared  in  accordance  with  U.S.  Generally Accepted Accounting  Principles  (“GAAP”).  In  connection  with  the  preparation  of  our
consolidated  financial  statements,  we  are  required  to  make  assumptions  and  estimates  about  future  events,  and  apply  judgments  that  affect  the  reported  amounts  of  assets,  liabilities,
revenue, expenses and the related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be
relevant at the time our consolidated financial statements are prepared. On a regular basis, we review the accounting policies, assumptions, estimates  and  judgments  to  ensure  that  our
consolidated financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results
could differ from our assumptions and estimates, and such differences could be material.

Our significant accounting policies are discussed in Note 2 of the audited consolidated financial statements for the years ended December 31, 2018 and 2017 which are included
elsewhere in this 10-K. We believe that the following accounting estimates are the most critical to aid in fully understanding and evaluating our reported financial results, and they require
our most difficult, subjective or complex judgments, resulting from the need to make estimates about the effect of matters that are inherently uncertain. There have been no changes to
estimates during the periods presented in the filing. Historically changes in management estimates have not been material.

Revenue Recognition

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-08, “Revenue from Contracts with Customers -
Principal versus Agent Considerations”, in April 2016, the FASB issued ASU No. 2016-10, “Revenue from Contracts with Customers (Topic 606) - Identifying Performance Obligations
and  Licensing”  and  in  May  9,  2016,  the  FASB  issued ASU  No.  2016-12,  “Revenue  from  Contracts  with  Customers  (Topic  606)”,  or ASU  2016-12.  This  update  provides  clarifying
guidance regarding the application of ASU No. 2014-09 - Revenue From Contracts with Customers (Topic 606), (“ASU 2014-09”) which is not yet effective. These new standards provide
for a single, principles-based model for revenue recognition that replaces the existing revenue recognition guidance. In July 2015, the FASB deferred the effective date of ASU 2014-09
until  annual  and  interim  periods  beginning  on  or  after  December  15,  2017  and  has  replaced  most  existing  revenue  recognition  guidance  under  GAAP. ASU  2016-12  may  be  applied
retrospectively to historical periods presented or as a cumulative-effect adjustment as of the date of adoption. We have adopted ASU 2016-12 using a modified retrospective approach and
will be applied prospectively in our financial statements from January 1, 2018 forward. Revenues under ASU 2016-12 are required to be recognized either at a “point in time” or “over
time”,  depending  on  the  facts  and  circumstances  of  the  arrangement,  and  will  be  evaluated  using  a  five-step  model.  The  adoption  of  Topic  606  did  not  have  a  material  impact  on  our
consolidated financial statements, neither at initial implementation nor will it have a material impact on an ongoing basis.

Software As A Service Revenue Recognition

With respect to sales of our maintenance, consulting and other service agreements including our digital advertising and electronic services, customers pay fixed monthly fees in
exchange for the Company’s service. The Company’s performance obligation is satisfied over time as the digital advertising and electronic services are provided continuously throughout
the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous access to its service.

Professional Services Revenue Recognition

The  Company’s  professional  services  include  fixed  fee  and  time  and  materials  contracts.  Fixed  fees  are  paid  monthly,  in  phases,  or  upon  acceptance  of  deliverables.  The
Company’s time and materials contracts are paid weekly or monthly based on hours worked. Revenue on time and material contracts is recognized based on a fixed hourly rate as direct
labor hours are expended. Materials, or other specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize
revenue  for  the  right  to  invoice  because  the  Company’s  right  to  consideration  corresponds  directly  with  the  value  to  the  customer  of  the  performance  completed  to  date.  For  fixed  fee
contracts including maintenance service provided by in house personnel, the Company recognizes revenue evenly over the service period using a time-based measure because the Company
is providing continuous service. Because the Company’s contracts have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a)
to not disclose information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the years ended December 31, 2018 and
2017, the Company did not incur any such losses. These amounts are based on known and estimated factors.

Contract Balances

The timing of our revenue recognition may differ from the timing of payment by our customers. We record a receivable when revenue is recognized prior to payment and we have
an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, we record deferred revenue until the performance obligations are satisfied.
The Company had deferred revenue of approximately $235,000 as of December 31, 2018 related to cash received in advance for product maintenance services provided by the Company’s
technical staff. The Company expects to satisfy its remaining performance obligations for these maintenance services and recognize the deferred revenue and related contract costs over the
next twelve months.

40

 
 
 
 
 
 
 
 
 
 
  
 
 
Long-lived Assets

We account for our long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”
(“ASC 360”), which requires that long-lived assets be evaluated whenever events or changes in circumstances indicate that the carrying amount may not be recoverable or the useful life
has changed. Some of the events or changes in circumstances that would trigger an impairment test include, but are not limited to:

●

●

●

●

significant under-performance relative to expected and/or historical results (negative comparable sales growth or operating cash flows for two consecutive years);

significant negative industry or economic trends;

knowledge of transactions involving the sale of similar property at amounts below our carrying value; or

our expectation to dispose of long-lived assets before the end of their estimated useful lives, even though the assets do not meet the criteria to be classified as “held for sale.”

Long-lived assets are grouped for recognition and measurement of impairment at the lowest level for which identifiable cash flows are largely independent of the cash flows of
other assets. The impairment test for long-lived assets requires us to assess the recoverability of our long-lived assets by comparing their net carrying value to the sum of undiscounted
estimated future cash flows directly associated with and arising from our use and eventual disposition of the assets. If the net carrying value of a group of long-lived assets exceeds the sum
of related undiscounted estimated future cash flows, we would be required to record an impairment charge equal to the excess, if any, of net carrying value over fair value. 

When assessing the recoverability of our long-lived assets, which include property and equipment and finite-lived intangible assets, we make assumptions regarding estimated
future cash flows and other factors. Some of these assumptions involve a high degree of judgment and also bear a significant impact on the assessment conclusions. Included among these
assumptions are estimating undiscounted future cash flows, including the projection of comparable sales, operating expenses, capital requirements for maintaining property and equipment
and residual value of asset groups. We formulate estimates from historical experience and assumptions of future performance, based on business plans and forecasts, recent economic and
business trends, and competitive conditions. In the event that our estimates or related assumptions change in the future, we may be required to record an impairment charge. Based on our
evaluation we did not record a charge for impairment for the years ended December 31, 2018 and 2017. 

The  benefits  to  be  derived  from  our  acquired  intangibles,  will  take  additional  financial  resources  to  continue  the  development  of  our  technology.  Management  believes  our
technology has significant long-term profit potential, and to date, management continues to allocate existing resources to the develop products and services to seek returns on its investment.
We continue to seek additional resources, through both capital raising efforts and meeting with industry experts, as part of our continued efforts. Although there can be no assurance that
these efforts will be successful, we intend to allocate financial and personnel resources when deemed possible and/or necessary. If we choose to abandon these efforts, or if we determine
that such funding is not available, the related development of our technology (resulting in our lack of ability to expand our business), may be subject to significant impairment.

41

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As described previously, we continue to experience weakness in market conditions, a depressed stock price, and challenges in executing our business plans. The Company will

continue to monitor these uncertainties in future periods, to determine the impact.

We evaluate the remaining useful lives of long-lived assets and identifiable intangible assets whenever events or circumstances indicate that a revision to the remaining period of
amortization is warranted. Such events or circumstances may include (but are not limited to): the effects of obsolescence, demand, competition, and/or other economic factors including the
stability of the industry in which we operate, known technological advances, legislative actions, or changes in the regulatory environment. If the estimated remaining useful lives change,
the remaining carrying amount of the long-lived assets and identifiable intangible assets would be amortized prospectively over that revised remaining useful life. We have determined that
there were no events or circumstances during the years ended December 31, 2018 and 2017, which would indicate a revision to the remaining amortization period related to any of our
long-lived assets. Accordingly, we believe that the current estimated useful lives of long-lived assets reflect the period over which they are expected to contribute to future cash flows and
are therefore deemed appropriate.

Goodwill and Indefinite-lived Assets

We have recorded goodwill and other indefinite-lived assets in connection with our acquisition of Shoom. Goodwill, which represents the excess of acquisition cost over the fair
value of the net tangible and intangible assets of the acquired company, is not amortized. Indefinite-lived intangible assets are stated at fair value as of the date acquired in  a  business
combination. The recoverability of goodwill is evaluated at least annually and when events or changes in circumstances indicate that the carrying amount may not be recoverable.

 We analyze goodwill first to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a
basis for determining whether it is necessary to perform a detailed goodwill impairment test as required. The more-likely-than-not threshold is defined as having a likelihood of more than
50%.

 Events and circumstances for an entity to consider in conducting the qualitative assessment are:

● Macroeconomic conditions  such  as  a  deterioration  in  general  economic  conditions,  limitations  on  accessing  capital,  fluctuations  in  foreign exchange  rates,  or  other

developments in equity and credit markets.

●

Industry and market considerations such as a deterioration in the environment in which an entity operates, an increased competitive environment, a decline in market-dependent
multiples  or  metrics  (considered  in  both  absolute  terms  and  relative  to  peers), a  change  in  the  market  for  an  entity’s  products  or  services,  or  a  regulatory  or  political
development.

● Cost factors such as increases in raw materials, labor, or other costs that have a negative effect on earnings and cash flows.

● Overall financial  performance  such  as  negative  or  declining  cash  flows  or  a  decline  in  actual  or  planned  revenue  or  earnings  compared with  actual  and  projected  results  of

relevant prior periods.

● Other relevant entity-specific events such as changes in management, key personnel, strategy, or customers, contemplation of bankruptcy, or litigation.

42

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
●

Events affecting a reporting unit such as a change in the composition or carrying amount of its net assets, a more-likely-than-not expectation of selling or disposing of all, or a
portion,  of  a  reporting  unit,  the  testing  for  recoverability  of  a  significant asset  group  within  a  reporting  unit,  or  recognition  of  a  goodwill  impairment  loss  in  the  financial
statements of a subsidiary that is a component of a reporting unit.

●

If applicable, a sustained decrease in share price (considered in both absolute terms and relative to peers).

Acquired In-Process Research and Development (“IPR&D”)

In accordance with authoritative guidance, we recognize IPR&D at fair value as of the acquisition date, and subsequently account for it as an indefinite-lived intangible asset until
completion  or  abandonment  of  the  associated  research  and  development  efforts.  Once  an  IPR&D  project  has  been  completed,  the  useful  life  of  the  IPR&D  asset  is  determined  and
amortized accordingly. If the IPR&D asset is abandoned, the remaining carrying value is written off. During fiscal year 2014, we acquired IPR&D through the acquisition of AirPatrol and
in 2015 through the acquisition of the assets of LightMiner. Our IPR&D is comprised of AirPatrol and LightMiner technology, which was valued on the date of the acquisition. It will take
additional financial resources to continue development of these technologies.

 We continue to seek additional resources, through both capital raising efforts and meeting with industry experts, for further development of the AirPatrol technology. Through
December 31, 2018, we have made some progress with raising capital since these acquisitions, building our pipeline and getting industry acknowledgment. We are being recognized by
leading industry analysts in their report on leading indoor positioning companies and also was awarded the IoT Security Excellence award by TMC. However, management is focused on
growing revenue from these products and continues to actively and aggressively pursue efforts to recognize the value of the AirPatrol and LightMiner technologies. Although there can be
no assurance that these efforts will be successful, we intend to allocate financial and personnel resources when deemed possible and/or necessary. If we choose to abandon these efforts, or
if we determine that such funding is not available, the related IPR&D will be subject to significant impairment.

Impairment of Long-Lived Assets Subject to Amortization

We amortize intangible assets with finite lives over their estimated useful lives and review them for impairment whenever an impairment indicator exists. We continually monitor
events and changes in circumstances that could indicate carrying amounts of our long-lived assets, including our intangible assets, may not be recoverable. When such events or changes in
circumstances occur, we assess recoverability by determining whether the carrying value of such assets will be recovered through the undiscounted expected future cash flows. If the future
undiscounted cash flows are less than the carrying amount of these assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. We
did  not  recognize  any  intangible  asset  impairment  charges  for  the  year  ended  December  31,  2018.  See  “Acquired  In-Process  Research  and  Development  (“IPR&D”)”  for  further
information.

Deferred Income Taxes

In accordance with ASC 740 “Income Taxes” (“ASC 740”), management routinely evaluates the likelihood of the realization of its income tax benefits and the recognition of its
deferred tax assets. In evaluating the need for any valuation allowance, management will assess whether it is more likely than not that some portion, or all, of the deferred tax asset may not
be  realized.  Ultimately,  the  realization  of  deferred  tax  assets  is  dependent  upon  the  generation  of  future  taxable  income  during  those  periods  in  which  temporary  differences  become
deductible and/or tax credits and tax loss carry-forwards can be utilized. In performing its analyses, management considers both positive and negative evidence including historical financial
performance, previous earnings patterns, future earnings forecasts, tax planning strategies, economic and business trends and the potential realization of net operating loss carry-forwards
within a reasonable timeframe. To this end, management considered (i) that we have had historical losses in the prior years and cannot anticipate generating a sufficient level of future
profits in order to realize the benefits of our deferred tax asset; (ii) tax planning strategies; and (iii) the adequacy of future income as of and for the year ended December 31, 2018, based
upon certain economic conditions and historical losses through December 31, 2018. After consideration of these factors, management deemed it appropriate to establish a full valuation
allowance. 

A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax filings that do not meet these recognition and measurement standards. As
of December 31, 2018 and 2017, no liability for unrecognized tax benefits was required to be reported. The guidance also discusses the classification of related interest and penalties on
income taxes. The Company’s policy is to record interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during the
years ended December 31, 2018 and 2017.

43

 
 
 
  
 
  
 
 
 
 
 
 
 
 
  
Allowance for Doubtful Accounts

We maintain our reserves for credit losses at a level believed by management to be adequate to absorb potential losses inherent in the respective balances. We assign an internal
credit quality rating to all new customers and update these ratings regularly, but no less than annually. Management’s determination of the adequacy of the reserve for credit losses for our
accounts and notes receivable is based on the age of the receivable balance, the customer’s credit quality rating, an evaluation of historical credit losses, current economic conditions, and
other relevant factors.

As of December 31, 2018 and December 31, 2017, reserves for credit losses included a reserve for doubtful accounts of approximately $464,000 and $1.1 million, respectively,

due to the aging of the items greater than 120 days outstanding and other potential non-collections.

Business Combinations

We account for business combinations using the acquisition method of accounting, and accordingly, the assets and liabilities of the acquired business are recorded at their fair
values at the date of acquisition. The excess of the purchase price over the estimated fair value is recorded as goodwill. Any changes in the estimated fair values of the net assets recorded
for  acquisitions  prior  to  the  finalization  of  more  detailed  analysis,  but  not  to  exceed  one  year  from  the  date  of  acquisition,  will  change  the  amount  of  the  purchase  price  allocable  to
goodwill. Any subsequent changes to any purchase price allocations that are material to our consolidated financial results will be adjusted. All acquisition costs are expensed as incurred
and in-process research and development costs are recorded at fair value as an indefinite-lived intangible asset and assessed for impairment thereafter until completion, at which point the
asset is amortized over its expected useful life. Separately recognized transactions associated with business combinations are generally expensed subsequent to the acquisition date. The
application of business combination and impairment accounting requires the use of significant estimates and assumptions.

Upon acquisition, the accounts and results of operations are consolidated as of and subsequent to the acquisition date and are included in our Consolidated Financial Statements

from the acquisition date.

Stock-Based Compensation

We account for equity instruments issued to non-employees in accordance with accounting guidance, which requires that such equity instruments are recorded at their fair value on

the measurement date, which is typically the date the services are performed.

We account for equity instruments issued to employees in accordance with accounting guidance that requires that awards are recorded at their fair value on the date of grant and
are  amortized  over  the  vesting  period  of  the  award.  We  recognize  compensation  costs  over  the  requisite  service  period  of  the  award,  which  is  generally  the  vesting  term  of  the  equity
instrument issued.

The Black-Scholes option valuation model is used to estimate the fair value of the options or the equivalent security granted. The model includes subjective input assumptions that
can materially affect the fair value estimates. The model was developed for use in estimating the fair value of traded options or warrants. The expected volatility is estimated based on the
average of historical volatilities for industry peers. 

44

 
 
 
 
 
 
 
 
 
 
 
 
The principal assumptions used in applying the Black-Scholes model along with the results from the model were as follows:

Risk-free interest rate
Expected life of option grants
Expected volatility of underlying stock
Dividends assumption

For the Years Ended
December 31,

2018

2.79-3.01%   
 5-6 years 
45.64-46.18%   
  $

-- 

2017

2.27%

7 years 

47.34%

-- 

  $

During the years ended December 31, 2018 and 2017, the Company recorded a charge of $1.5 million, for the amortization of employee stock options.

Results of Operations

Year Ended December 31, 2018 compared to the Year Ended December 31, 2017

The following table sets forth selected consolidated financial data as a percentage of our revenue and the percentage of period-over-period change:

(in thousands, except percentages)

Product revenues
Services revenues
Cost of revenues - Products
Cost of revenues - Services
Gross profit
Operating expenses
Loss from operations
Net loss
Net loss attributable to stockholders

Revenues

Years ended

December 31, 2018

December 31, 2017

Amount

% of
Revenues

Amount

% of
Revenues

%
Change

  $
  $
  $
  $
  $
  $
  $
  $
  $

1,135     
2,621     
490     
586     
2,680     
21,082     
(18.402)    
(24,561)    
(44,624)    

30%   $
70%   $
13%   $
16%   $
71%   $
561%   $
(490)%  $
(654)%  $
(1,188)%  $

535     
3,400     
494     
738     
2,703     
17,733     
(15,030)    
(35,030)    
(35,769)    

14%    
86%    
13%    
19%    
69%    
451%    
(382)%   
(890)%   
(909)%   

112%
(23)%
(1)%
(21)%
(1)%
19%
22%
(30)%
25%

Revenues  for  the  year  ended  December  31,  2018  were  $3.8  million  compared  to  $3.9  million  for  the  comparable  period  in  the  prior  year  for  a  decrease  of  $0.1  million,  or
approximately  2.6%.  Revenues  between  the  two  comparable  periods  are  relatively  flat  due  to  an  increase  in  our  IPA  product  revenues,  which  was  offset  by  a  decrease  in  our  Shoom
services revenue.

Our revenues for the year ended December 31, 2018 include our IPA and other product lines that remain following the Spin-off. Such revenues do not include the revenues of our
historical  value  added  reseller  business,  as  such  business  was  part  of  the  Spin-off  of  Sysorex. Accordingly,  the  revenues  for  the  year  ended  December  31,  2018  represent  a  decline  of
approximately 90% from the total historical revenues reported for the year ended December 31, 2017, which included the aggregate revenues of our IPA business and the value added
reseller business.

Cost of Revenues

Cost of revenues for the year ended December 31, 2018 were $1.1 million compared to $1.2 million for the comparable period in the prior year. This decrease of $0.1 million, or

approximately 8.3%, was primarily attributable the nominally lower revenue with higher gross margins during the year ended December 31, 2018.

The gross profit margin for the year ended December 31, 2018 was 71% compared to 69% for the year ended December 31, 2017. This slight increase in margin is primarily due

to the sales mix of products and services sold during the year ended December 31, 2018.

Operating Expenses

Operating  expenses  for  the  year  ended  December  31,  2018  were  $21.1  million  and  $17.7  million  for  the  comparable  period  ended  December  31,  2017.  This  increase  of  $3.4
million  is  primarily  attributable  to  higher  IT  infrastructure  costs,  compensation,  cost  of  public  offerings,  and  legal  and  professional  fees  as  well  as  a  $636,000  intangibles  impairment,
$690,000 of deconsolidation costs related to the Spin-off and a litigation settlement of $560,000.

45

 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
   
 
 
   
 
 
   
 
 
 
 
   
     
 
   
     
 
   
 
 
 
 
 
 
 
 
 
 
Loss From Operations

 \
Loss from operations for the year ended December 31, 2018 was  $18.4  million  as  compared  to  $15  million  for  the  comparable  period  in  the  prior  year.  This  increase  of  $3.4
million was primarily attributable to the higher operating expenses during the year ended December 31, 2018 as discussed in the reporting caption above. In addition, total losses reported
include losses associated with the value added reseller business prior to the spin-off of the value added reseller business in the deconsolidated operations line item.

Other Income/Expense

Other  income/expense  for  the  year  ended  December  31,  2018  was  a  loss  of  $1.4  million  compared  to  a  loss  of  $3.1  million  for  the  comparable  period  in  the  prior  year.  This
decrease in loss of $1.7 million is primarily attributable to a $643,000 decrease in interest expense due to the amortization of deferred financing costs in 2017 and lower interest on credit
facilities and notes in 2018 and forgiveness of debt and a non-cash extinguishment loss for the value of the common shares issued as repayment for the debenture in 2017.

Provision for Income Taxes

There was no provision for income taxes for the years ended December 31, 2018 and 2017 as the Company was in a net taxable loss position. Deferred tax assets resulting from
such losses are fully reserved as of December 31, 2018 and 2017 since, at present, the Company has no history of taxable income and it is more likely than not that such assets will not be
realized.

Net Gain and Net Loss Attributable To Non-Controlling Interest

Net gain attributable to non-controlling interest for the year ended December 31, 2018 was $11,000. Net loss attributable to non-controlling interest for the year ended December

31, 2017 was $17,000. This increase in gain of $28,000 was attributable to the gain from Sysorex India.

Net Loss Attributable To Stockholders of Inpixon

Net loss attributable to stockholders of Inpixon for the year ended December 31, 2018 was $24.6 million compared to $35.0 million for the comparable period in the prior year.
This decrease in loss of $10.4 million was primarily attributable to the $2 million lower other income/expenses offset by the $3.4 million increase in operating expenses during the year
ended December 31, 2018 plus the $12 million lower loss from deconsolidated operations of the Spin-off during the year ended December 31, 2018.

Non-GAAP Financial information

EBITDA

EBITDA  is  defined  as  net  income  (loss)  before  interest,  provision  for  (benefit  from)  income  taxes,  and  depreciation  and  amortization.  Adjusted  EBITDA  is  used  by  our
management as the matrix in which it manages the business. It is defined as EBITDA plus adjustments for other income or expense items, non-recurring items and non-cash stock-based
compensation.

Adjusted EBITDA for the year ended December 31, 2018 was a loss of $15.0 million compared to a loss of $12.1 million for the prior year period. 

46

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following table presents a reconciliation of net income/loss attributable to stockholders of Inpixon, which is our GAAP operating performance measure, to Adjusted EBITDA

for the year ended December 31, 2018 and 2017 (in thousands):

Net loss attributable to common stockholders
Adjustments:

Non-recurring one-time charges:

Acquisition transaction/financing costs
Costs associated with public offering
Impairment of goodwill
Write off of project expenses
Gain on earnout
Gain on the sale of Sysorex Arabia
Change in the fair value of derivative liability
Severance
Stock based compensation – acquisition costs
Provision for doubtful accounts
Gain on the sale of contracts
Gain on the settlement of obligations
Exchange of warrants for shares
Extinguishment loss for debt modification
Debt forgiveness
Settlement of litigation

Deemed dividend to preferred stockholders
Deemed dividend for triggering of warrant down round feature
Stock-based compensation - compensation and related benefits
Interest expense
Depreciation and amortization

Adjusted EBITDA

For the Years Ended
December 31,

2018

2017

  $

(44,624)   $

(35,769)

108 
327 
636 
726 
(934)  
(23)  
(48)  
15 
-   
(659)  
(601)  
(307)  
-   
-   
-   
559 
6,407 
13,645 
1,494 
2,044 
6,186 
(15,049)   $

5 
212 
8,392 
-   
(561)
-   
(555)
27 
7 
952 
-   
(430)
434 
1,523 
635 
-   
756 
-   
1,526 
3,821 
6,895 
(12,130)

  $

We rely on Adjusted EBITDA, which is a non-GAAP financial measure for the following:

●

●

To review and assess the operating performance of our Company as permitted by Accounting Standards Codification Topic 280, Segment Reporting;

To compare our current operating results with corresponding periods and with the operating results of other companies in our industry;

● As a basis for allocating resources to various projects;

● As a measure to evaluate potential economic outcomes of acquisitions, operational alternatives and strategic decisions; and

●

To evaluate internally the performance of our personnel.

We have presented Adjusted EBITDA above because we believe it conveys useful information to investors regarding our operating results. We believe it provides an additional
way for investors to view our operations, when considered with both our GAAP results and the reconciliation to net income (loss). By including this information, we can provide investors
with a more complete understanding of our business. Specifically, we present Adjusted EBITDA as supplemental disclosure because of the following:

● We believe Adjusted EBITDA is a useful tool for investors to assess the operating performance of our business without the effect  of interest, income taxes, depreciation and
amortization  and other non-cash items including stock based compensation, amortization of intangibles, change in the fair value of shares to be issued, change in the fair value
of  derivative  liability, impairment  of  goodwill  and  one  time  charges  including  gain/loss  on  the  settlement  of  obligations,  severance  costs,  provision for  doubtful  accounts,
acquisition costs and the costs associated with the public offering.

● We believe that it is useful to provide to investors with a standard operating metric used by management to evaluate our operating performance; and

● We believe that the use of Adjusted EBITDA is helpful to compare our results to other companies.

47

 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Even though we believe Adjusted EBITDA is useful for investors, it does have limitations as an analytical tool. Thus, we strongly urge investors not to consider this metric in
isolation or as a substitute for net income (loss) and the other consolidated statement of operations data prepared in accordance with GAAP. Some of these limitations include the fact that:

● Adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments;

● Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

● Adjusted EBITDA does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt;

● Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA

does not reflect any cash requirements for such replacements;

● Adjusted EBITDA does not reflect income or other taxes or the cash requirements to make any tax payments; and

● Other companies in our industry may calculate Adjusted EBITDA differently than we do, thereby potentially limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered a measure of discretionary cash available to us to invest in the growth of our business or as a measure of
performance  in  compliance  with  GAAP.  We  compensate  for  these  limitations  by  relying  primarily  on  our  GAAP  results  and  providing  Adjusted  EBITDA  only  as  supplemental
information.

Proforma Non-GAAP Net Loss per Share

Basic and diluted net loss per share for the twelve months ended December 31, 2018 was ($57.83) compared to ($5,511.40) for the prior year period. The decreased loss per share

in 2018 was attributable to the changes discussed in our results of operations.

Proforma non-GAAP net income (loss) per share is used by our Company’s management as an evaluation tool as it manages the business and is defined as net income (loss) per
basic and diluted share adjusted for non-cash items including stock based compensation, amortization of intangibles and one time charges including gain on the settlement of obligations,
severance costs, provision for doubtful accounts, change in the fair value of shares to be issued, acquisition costs and the costs associated with the public offering.

Proforma non-GAAP net loss per basic and diluted common share for the twelve months ended December 31, 2018 was ($24.18) compared to a loss of ($2,747.92) per share for

the prior year period.

48

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 The following table presents a reconciliation of net loss per basic and diluted share, which is our GAAP operating performance measure, to proforma non-GAAP net loss per

share for the periods reflected (in thousands, except per share data):

(thousands, except per share data)
Net loss attributable to common stockholders
Adjustments:

Non-recurring one-time charges:

Acquisition transaction/financing costs
Costs associated with public offering
Impairment of goodwill
Write off of project expenses
Gain on earnout
Gain on the sale of Sysorex Arabia
Change in the fair value of derivative liability
Severance
Stock based compensation – acquisition costs
Provision for doubtful accounts
Gain on the sale of contracts
Gain on the settlement of obligations
Exchange of warrants for shares
Extinguishment loss for debt modification
Debt forgiveness
Settlement of litigation

Deemed dividend to preferred stockholders
Deemed dividend for triggering of warrant down round feature
Stock-based compensation - compensation and related benefits
Amortization of intangibles
Proforma non-GAAP net loss

Proforma non-GAAP net loss per basic and diluted common share

Weighted average basic and diluted common shares outstanding

For the Years Ended
December 31,

2018

2017

  $

(44,624)   $

(35,769)

108 
327 
636 
726 
(934)  
(23)  
(48)  
15 
-   
(659)  
(601)  
(307)  
-   
-   
-   
559 
6,407 
13,645 
1,494 
4,617 
(18,662)   $
(24.18)   $

771,688 

5 
212 
8,392 
-   
(561)
-   
(555)
27 
7 
952 
-   
(430)
434 
1,523 
635 
-   
756 
-   
1,526 
5,012 
(17,834)
(2,747.92)
6,490 

  $
  $

We rely on proforma non-GAAP net loss per share, which is a non-GAAP financial measure:

●

●

To review and assess the operating performance of our Company as permitted by Accounting Standards Codification Topic 280, Segment Reporting;

To compare our current operating results with corresponding periods and with the operating results of other companies in our industry;

● As a measure to evaluate potential economic outcomes of acquisitions, operational alternatives and strategic decisions; and

●

To evaluate internally the performance of our personnel.

We have presented proforma non-GAAP net loss per share above because we believe it conveys useful information to investors regarding our operating results. We believe it
provides  an  additional  way  for  investors  to  view  our  operations,  when  considered  with  both  our  GAAP  results  and  the  reconciliation  to  net  income  (loss),  and  that  by  including  this
information we can provide investors with a more complete understanding of our business. Specifically, we present proforma non-GAAP net loss per share as supplemental disclosure
because: 

● We believe  proforma  non-GAAP  net  loss  per  share  is  a  useful  tool  for  investors  to  assess  the  operating  performance  of  our  business without  the  effect  of  non-cash  items
including stock based compensation, amortization of intangibles and one time charges including gain on the settlement of obligations, severance costs, provision for doubtful
accounts, change in the fair value of shares to be issued, acquisition costs and the costs associated with the public offering.

● We believe that it is useful to provide to investors a standard operating metric used by management to evaluate our operating performance; and

● We believe that the use of proforma non-GAAP net loss per share is helpful to compare our results to other companies.

Liquidity and Capital Resources as of December 31, 2018

Our current capital resources and operating results as of and through December 31, 2018, consist of:

1)

an overall working capital deficit of $3.9 million;

49

 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2)

cash of $1.0 million;

3)

the Payplant credit facility which we may borrow against based on eligible assets of which $23,000 is utilized; and

4)

net cash used by operating activities for the year of $26.8 million.

The breakdown of our overall working capital deficit is as follows (in thousands):

Working Capital
Cash and cash equivalents
Accounts receivable, net / accounts payable
Notes and other receivables
Prepaid licenses and maintenance contracts/deferred revenue
Short-term debt
Other
Total

Assets

Liabilities

Net

  $

  $

1,008 
1,280 
4 
-- 
-- 
1,064 
3,356 

  $

  $

--    $
1,129     
--     
234     
4,127     
1,792     
7,282    $

1,008 
151 
4 
(234)
(4,127)
(728)
(3,926)

Net cash used in operating activities during the year ended December 31, 2018 of $26.8 million consists of net loss of $24.6 million offset by non-cash adjustments of $7.0 million

less net cash changes in operating assets and liabilities of $9.2 million.

The Company’s capital resources as of December 31, 2018, availability on the Payplant facility to finance purchase orders and invoices in an amount equal to 80% of the face
value of purchase orders received and funds from higher margin business line expansion will not be sufficient to fund planned operations during the next twelve months from the date the
financial statements are issued based on current projections. In addition, the Company is pursuing possible strategic transactions. Therefore, the Company may raise such additional capital
as needed, through the issuance of equity, equity-linked or debt securities. 

Going Concern and Management Plans

Our consolidated financial statements as of December 31, 2018 have been prepared under the assumption that we will continue as a going concern for the next twelve months
from the date the financial statements are issued. Footnote 1 to the notes to our consolidated financial statements as of December 31, 2018 include language referring to our recurring and
continuing losses from operations and expressing substantial doubt in our ability to continue as a going concern without additional capital becoming available. Management’s plans and
assessment of the probability that such plans will mitigate and alleviate any substantial doubt about the Company’s ability to continue as a going concern, is dependent upon the ability to
obtain additional equity or debt financing, attain further operating efficiency, reduce expenditures, and, ultimately, to generate sufficient levels of revenue, which together represent the
principal  conditions  that  raise  substantial  doubt  about  our  ability  to  continue  as  a  going  concern.  Our  consolidated  financial  statements  as  of  December  31,  2018  do  not  include  any
adjustments that might result from the outcome of this uncertainty.

Liquidity and Capital Resources – Payplant

See the discussion above in the section titled “Loan and Security Agreement” for information concerning this loan.

As of December 31, 2018, the principal amount outstanding under the Loan Agreement was $23,000. 

50

 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liquidity and Capital Resources as of December 31, 2018 Compared With December 31, 2017

The Company’s net cash flows used in operating, investing and financing activities for the year ended December 31, 2018 and 2017 and certain balances as of the end of those

periods are as follows (in thousands):

Net cash provided by (used in) operating activities
Net cash used in investing activities
Net cash (used in) provided by financing activities
Effect of foreign exchange rate changes on cash
Net increase (decrease) in cash

Cash and cash equivalents

Working capital (deficit)

Operating Activities for the year ended December 31, 2018

For the Years Ended 
December 31,

2018

2017

(26,765)   $
(1,429)  
28,996 

(5)  

797 

  $

2,249 
(1,318)
(2,660)
(21)
(1,750)

As of
December 31,
2018

As of
December 31,
2017

1,008    $
(3,926)   $

119 
(32,822)

  $

  $

  $
  $

Net cash used in operating activities during the year ended December 31, 2018 was $26.8 million. Net cash provided by operating activities during the year ended December 31,

2017 was $2.2 million. The cash flows related to the year ended December 31, 2018 consisted of the following (in thousands):

Net loss
Non-cash income and expenses
Net change in operating assets and liabilities
Net cash used in operating activities

  $

  $

(24,561)
7,041 
(9,245)
(26,765)

The non-cash income and expense of $7.0 million consisted primarily of the following (in thousands):

$

6,186 

Depreciation and amortization expenses (including amortization of intangibles) primarily attributable to the Shoom, AirPatrol, and LightMiner and operations, which
were acquired effective August 31, 2013, April 16, 2014, and November 21, 2016, respectively and Lilien and Integrio operations through August 31, 2018, the date
of the spin-off.

  Impairment of goodwill

636 
(48)   Change in the fair value of derivative liability

  Stock-based compensation expense attributable to warrants and options issued as part of Company operations and for the AirPatrol acquisition

1,494 
(307)   Gain on settlement of obligations of vendor liabilities
703 
  Amortization of debt discount
(23)   Gain on the sale of Sysorex Arabia

$

$

$

(659)   Provision for doubtful accounts
(941)   Other
7,041 

  Total non-cash expenses

The net use of cash in the change in operating assets and liabilities aggregated $9.2 million and consisted primarily of the following (in thousands):

744 

  Decrease in accounts receivable and other receivables
(5)   Increase in prepaid licenses and maintenance contracts

681 

  Decrease in inventory and other assets

(8,445)   Decrease in accounts payable
(2,466)   Decrease in accrued liabilities and other liabilities

246 

  Increase in deferred revenue

(9,245)   Net use of cash in the changes in operating assets and liabilities

51

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Activities for the year ended December 31, 2017

Net cash provided by operating activities during the year ended December 31, 2017 was $2.3 million and consisted of the following (in thousands):

Net loss
Non-cash income and expenses
Net change in operating assets and liabilities
Net cash provided by operating activities

  $

  $

(35,030)
21,823 
15,456 
2,249 

The non-cash income and expense of $21.8 million consisted primarily of the following (in thousands):

$

6,894 

Depreciation  and  amortization  expenses  (including  amortization  of  intangibles)  primarily  attributable  to  the  Lilien,  Shoom,  AirPatrol,  LightMiner  and  Integrio
operations, which were acquired effective March 1, 2013, August 31, 2013, April 16, 2014, April 24, 2015 and November 21, 2016, respectively

  Stock-based compensation expense attributable to warrants and options issued as part of Company operations and for the AirPatrol acquisition

  Impairment of goodwill

8,392 
(555)   Change in the fair value of derivative liability
1,533 
(430)   Gain on settlement of obligations of vendor liabilities
2,110 
434 
1,523 
952 
970 
21,823 

  Amortization of debt discount
  Exchange of warrants for shares
  Extinguishment loss
  Provision for doubtful accounts
  Other
  Total non-cash expenses

The net use of cash in the change in operating assets and liabilities aggregated $15.5 million and consisted primarily of the following (in thousands):

8,706 
11,588 
959 
5,414 
1,545 

  Decrease in accounts receivable and other receivables
  Decrease in prepaid licenses and maintenance contracts
  Decrease in inventory and other assets
  Increase in accounts payable
  Increase in accrued liabilities and other liabilities

(12,756)   Decrease in deferred revenue
15,456 

  Net use of cash in the changes in operating assets and liabilities

$

$

$

Cash Flows from Investing Activities as of December 31, 2018 and 2017

Net cash flows used in investing activities during 2018 was $1.4 million compared to net cash flows used in investing activities during 2017 of $1.3 million. Cash flows related to
investing activities during the year ended December 31, 2018 include $88,000 for the purchase of property and equipment, $804,000 investment in capitalized software, $175,000 for the
investment in Athentek, and $362,000 related to the deconsolidation activity. Cash flows related to investing activities during the year ended December 31, 2017 include $101,000 for the
purchase of property and equipment and $1.3 million investment in capitalized software offset by $37,000 related to the Sysorex India acquisition.

52

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash Flows from Financing Activities as of December 31, 2018 and 2017

Net cash flows provided by financing activities during the year ended December 31, 2018 was $29.0 million. Net cash flows used in financing activities during the year ended
December  31,  2017  was  $2.7  million.  During  the  year  ended  December  31,  2018,  the  Company  received  incoming  cash  flows  of  $29.0  million  from  the  issuance  of  common  stock,
preferred stock and warrants, $1.0 million of repayments from a related party, $3.5 million from promissory notes offset by $3.2 million of advances to related party, $1.1 million of net
repayments to the credit line and $181,000 repayments of notes payable. During the year ended December 31, 2017 the Company received incoming cash flows of $6.6 million from the
issuance of common stock, preferred stock and warrants, $2.0 million from convertible promissory notes and $1.7 million of cash flows from notes offset by $2.7 million in repayments of
convertible promissory notes, $5.6 million of repayments of the credit line, $4.7 million of repayments of the debenture and $57,000 repayments of notes payable. 

Off-Balance Sheet Arrangements

We do not have any off-balance sheet guarantees, interest rate swap transactions or foreign currency contracts. We do not engage in trading activities involving non-exchange

traded contracts.

Recently Issued Accounting Standards 

For a discussion of recently issued accounting pronouncements, please see Note 2 to our financial statements, which are included in this report beginning on page F-1.

 ITEM 7A: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, we are not required to provide this information.

53

 
 
 
 
 
 
 
  
 
 
 ITEM 8: FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INPIXON

INDEX TO FINANCIAL STATEMENTS

ANNUAL FINANCIAL INFORMATION

Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets at December 31, 2018 and 2017
Consolidated Statements of Operations for the years ended December 31, 2018 and 2017
Consolidated Statements of Comprehensive Loss for the years ended December 31, 2018 and 2017
Consolidated Statements of Changes in Stockholders’ (Deficit) Equity for the years ended December 31, 2018 and 2017
Consolidated Statements of Cash Flows for the years ended December 31, 2018 and 2017
Notes to Consolidated Financial Statements

F-1

Page No.

F-2
F-3
F-5
F-6
F-7
F-8
F-9

 
 
 
 
 
 
 
 
 
  
 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of
Inpixon and Subsidiaries

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Inpixon and Subsidiaries (the “Company”) as of December 31, 2018 and 2017, the related consolidated statements of
operations,  comprehensive  loss,  changes  in  stockholders’  (deficit)  equity  and  cash  flows  for  each  of  the  two  years  in  the  period  ended  December  31,  2018,  and  the  related  notes
(collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2018 and 2017, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2018, in conformity with accounting principles generally
accepted in the United States of America.

Explanatory Paragraph – Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1, the Company
has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise
substantial  doubt  about  the  Company’s  ability  to  continue  as  a  going  concern.  Management’s  plans  in  regard  to  these  matters  are  also  described  in  Note  1.  The  consolidated  financial
statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control
over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the
effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to
those  risks.  Such  procedures  included  examining,  on  a  test  basis,  evidence  regarding  the  amounts  and  disclosures  in  the  financial  statements.  Our  audits  also  included  evaluating  the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a
reasonable basis for our opinion.

/s/ Marcum llp

Marcum llp

We have served as the Company’s auditor since 2012.

New York, NY
March 28, 2019

F-2

 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
Assets

Current Assets

Cash and cash equivalents
Accounts receivable, net
Notes and other receivables
Inventory
Assets held for sale
Current assets of deconsolidated operations
Prepaid assets and other current assets

Total Current Assets

Property and equipment, net
Software development costs, net
Intangible assets, net
Goodwill
Non-current assets of deconsolidated operations
Loan to related party
Other assets

Total Assets

INPIXON AND SUBSIDIARIES

 CONSOLIDATED BALANCE SHEETS

(In thousands, except number of shares and par value data)

The accompanying notes are an integral part of these financial statements.

F-3

December 31,

2018

2017

  $

  $

1,008 
1,280 
4 
568 
-- 
-- 
496 

3,356 

202 
1,690 
4,509 
-- 
-- 
2,204 
217 

119 
429 
13 
783 
23 
6,983 
859 

9,209 

348 
2,017 
7,566 
636 
7,558 
-- 
357 

  $

12,178 

  $

27,691 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
INPIXON AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED)

(In thousands, except number of shares and par value data)

Liabilities and Stockholders’ (Deficit) Equity

Current Liabilities

Accounts payable
Accrued liabilities
Deferred revenue
Short-term debt
Derivative liabilities
Current liabilities of deconsolidated operations
Liabilities held for sale

Total Current Liabilities

Long Term Liabilities
Long-term debt
Other liabilities
Non-current liabilities of deconsolidated operations

Total Liabilities

Stockholders’ (Deficit) Equity

Preferred stock - $0.001 par value; 5,000,000 shares authorized, consisting of Series 4 Convertible Preferred Stock - $0.001 par value; 10,185
shares authorized; 1 and 0 issued, and 1 and 0 outstanding at December 31, 2018 and 2017, respectively. Liquidation preference of $0 at
December 31, 2018 and 2017.

Common Stock - $0.001 par value; 250,000,000 shares authorized; 1,581,893 and 24,055 issued and 1,581,880 and 24,042 outstanding at

December 31, 2018 and 2017, respectively.

Additional paid-in capital
Treasury stock, at cost, 13 shares
Accumulated other comprehensive income
Accumulated deficit (excluding $2,442 reclassified to additional paid in capital in quasi-reorganization)

Stockholders’ (Deficit) Equity Attributable to Inpixon

Non-controlling Interest

Total Stockholders’ (Deficit) Equity

  $

December 31,

2018

2017

  $

1,129 
1,792 
234 
4,127 
-- 
-- 
-- 

7,282 

74 
19 
-- 

1,562 
2,206 
58 
3,058 
48 
33,040 
2,059 

42,031 

767 
73 
3,673 

7,375 

46,544 

-- 

2 
123,224 

(695)  
26 

(117,772)  

4,785 

18 

4,803 

-- 

1 
78,302 
(695)
31 
(94,486)

(16,847)

(2,006)

(18,853)

Total Liabilities and Stockholders’ (Deficit) Equity

  $

12,178 

  $

27,691 

The accompanying notes are an integral part of these financial statements.

F-4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
INPIXON AND SUBSIDIARIES

 CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

Revenues

Products
Services
Total Revenues

Cost of Revenues

Products
Services

Total Cost of Revenues

Gross Profit

Operating Expenses

Research and development
Sales and marketing
General and administrative
Acquisition related costs
Impairment of goodwill
Amortization of intangibles

Total Operating Expenses

Loss from Operations

Other Income (Expense)

Interest expense
Change in fair value of derivative liability
Gain on the sale of Sysorex Arabia
Extinguishment loss for debt modification
Other income/(expense)

Total Other Income (Expense)

Net Loss from Continuing Operations

Loss from Discontinued Operations, Net of Tax

Net Loss

Net Income/(Loss) Attributable to Non-controlling Interest

Net Loss Attributable to Stockholders of Inpixon

Deemed dividend to preferred stockholders
Deemed dividend for triggering of warrant down round feature

Net Loss Attributable to Common Stockholders

Net Loss Per Basic and Diluted Common Share

Loss from continuing operations
Loss from discontinued operations
Net Loss Per Share - Basic and Diluted

Weighted Average Shares Outstanding

Basic and Diluted

The accompanying notes are an integral part of these financial statements.

F-5

For the Years Ended
December 31,

2018

2017

  $

  $

1,135 
2,621 
3,756 

490 
586 
1,076 

2,680 

1,231 
1,726 
14,149 
108 
636 
3,232 

21,082 

535 
3,400 
3,935 

494 
738 
1,232 

2,703 

964 
2,367 
10,874 
5 
587 
2,936 

17,733 

(18,402)  

(15,030)

(1,241)  
48 
23 
-- 
(211)  

(1,381)  

(19,783)  

(4,778)  

(24,561)  

11 

(1,884)
555 
-- 
(653)
(1,069)

(3,051)

(18,081)

(16,949)

(35,030)

(17)

  $

(24,572)   $

(35,013)

(6,407)  
(13,645)  
(44,624)  

(756)
-- 
(35,769)

  $
  $
  $

(51.62)   $
(6.19)   $
(57.83)   $

(2,902.47)
(2,611.56)
(5,511.40)

771,688 

6,490 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES

 CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(In thousands)

Net Loss

Unrealized foreign exchange gain/(loss) from cumulative translation adjustments

Comprehensive Loss

The accompanying notes are an integral part of these financial statements.

F-6

For the Years Ended
December 31,

2018

2017

  $

(24,561)   $

(35,030)

(5)  

(21)

  $

(24,566)   $

(35,051)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
INPIXON AND SUBSIDIARIES

 CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

(In thousands, except per share data)

Series 1
Convertible

Series 2
Convertible

  Preferred Stock     Preferred Stock    
 Shares   Amount    Shares   Amount   

Series 3
Convertible
Preferred Stock
Shares

   Amount  

Series 4
Convertible
Preferred Stock
Shares

   Additional    

 Due from
Sysorex 

Accumulated 
Other

    Non-

   Common Stock     Paid-In     Treasury Stock    Consulting,   Comprehensive   Accumulated   Controlling   

   Amount   Shares

  Amount    Capital

   Shares   Amount 

Inc.

    Income (Loss)     Deficit

Interest

Total
Stockholders’ 
(Deficit)
Equity

Balance -
January 1, 2017   2,250   $  1,340    

--   $ 

--    

--   $ 

--   

--   $

--   

1,810  $ 

1   $  64,148    

(13) $ 

(695) $ 

(666) $ 

52   $ 

(59,474) $ 

(1,995) $ 

2,711 

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

Common shares
issued for
services
Stock options
granted to
employees for
services
Common shares
issued for
LightMiner
Acquisition
Fractional
shares issued
for stock split
Redemption of
convertible
series 1
preferred stock   (2,250)   (1,340)  
Common shares
issued in lieu of
interest
Common and
preferred shares
issued for net
cash proceeds
from a public
offering
Redemption of
convertible
series 2
preferred stock  
Common shares
issued for net
proceeds from
warrants
exercised
Reclassification
of warrants to
derivative
liabilities
Common shares
issued for
warrants
exercised
Reclassification
of warrants
from derivative
liabilities to
equity
Common shares
issued for
extinguishment
of trade
payables
Common shares
issued for
extinguishment
of debenture
liability
Investment in
Sysorex India
Settlement of
related party
receivable
Cumulative
Translation
Adjustment
Net loss

--    
--    

--    
--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--   

--    

--   

264   

--    

308    

--    

--    

--    

--    

--    

--    

308 

--    

--    

--    

--   

--    

--   

--   

--    

909    

--    

--    

--    

--    

--    

--    

909 

--    

--    

--    

--   

--    

--   

16   

--    

567    

--    

--    

--    

--    

--    

--    

--   

--    

--   

1   

(1)  

1    

--    

--    

--    

--    

--    

--    

--   

--    

--   

83   

--    

1,340    

--    

--    

--    

--    

--    

--    

--   

--    

--   

92   

--    

316    

--    

--    

--    

--    

--    

--    

--    

--    

--    

567 

--    

--    

--    

--    

-- 

-- 

--    

--    

316 

--     4,060     1,508    

--    (4,060)   (1,508)  

--    

--   

--    

--   

1,541   

--    

3,620    

--    

--    

--    

--    

--    

--    

5,128 

--    

--   

--    

--   

6,426   

--    

1,508    

--    

--    

--    

--    

--    

--    

-- 

--    

--    

--    

--   

--    

--   

4,035   

--    

1,452    

--    

--    

--    

--    

--    

--    

1,452 

--    

--    

--    

--   

--    

--   

--   

--    

(3,773)  

--    

--    

--    

--    

--    

--    

(3,773)

--    

--    

--    

--   

--    

--   

1,667   

--    

434    

--    

--    

--    

--    

--    

--    

434 

--    

--    

--    

--   

--    

--   

--   

--    

3,773    

--    

--    

--    

--    

--    

--    

3,773 

--    

--    

--    

--   

--    

--   

1,569   

--    

640    

--    

--    

--    

--    

--    

--    

640 

--    

--    

--    

--    

--    

--    

--   

--   

--    

--    

--   

6,552   

--    

3,059    

--    

--   

--   

--    

--    

--    

--    

--    

--    

30    

--    

--    

--    

--   

--    

--   

--   

--    

--    

--    

--    

636    

--    

--    

--    

--    

--    

--    

6    

3,059 

36 

--    

--    

636 

--    
--    

--    
--    

--    
--    

--   
--   

--    
--    

--   
--   

--   
--   

--    
--    

--    
--    

--    
--    

--    
--    

--    
--    

(21)  
--    

--    
(35,013)  

--    
(17)  

(21)
(35,030)

Balance -
December 31,
2017

Common shares
issued for
services
Stock options
granted to
employees for
services

--   $

--   

--   $

--   

--   $

--  

--   $

--   

24,055  $

--   $  78,302    

(13) $ 

(695) $

--    

31   $

(94,487) $

(2,006) $ 

(18,855)

--    

--    

--    

--    

--    

--   

--    

--   

37,696   

--    

545    

--    

--    

--    

--    

--    

--    

545 

--    

--    

--    

--    

--    

--   

--    

--   

--   

--    

949    

--    

--    

--    

--    

--    

--    

949 

 
 
 
 
 
 
 
 
   
   
  
   
    
   
   
    
   
 
  
 
 
   
   
 
 
  
    
    
    
    
    
   
    
   
   
    
    
    
    
    
    
    
    
 
 
 
     
     
     
     
     
    
     
    
    
     
     
     
     
     
     
     
     
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
     
     
     
     
    
     
    
    
     
     
     
     
     
     
     
     
  
 
 
 
     
     
     
     
     
    
     
    
    
     
     
     
     
     
     
     
     
  
 
 
Fractional
shares issued
for stock split
Common and
preferred shares
issued for net
cash proceeds
from a public
offering
Redemption of
convertible
series 3
preferred stock  
Redemption of
convertible
series 4
preferred stock  
Common shares
issued for
extinguishment
of debenture
liability
Common shares
issued for
extinguishment
of debt
Common shares
issued for net
proceeds from
warrants
exercised
Deconsolidation
of Sysorex as a
result of spin-
off
Sale of Sysorex
Arabia
Adoption of
accounting
standards (Note
2)
Cumulative
Translation
Adjustment
Net loss

Balance -
December 31,
2018

--    

--    

--    

--    

--    

--   

--    

--   

27,896   

--    

--    

--    

--    

--    

--    

--    

--    

-- 

--    

--    

--    

--     10,184.9752    

--    10,115.0000    

--   

98,145   

--    

27,961    

--    

--    

--    

--    

--    

--    

27,961 

--    

--    

--    

--    (10,184.9752)  

--   

--    

--    108,351   

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--   (10,114.0000)  

--   1,044,098   

1    

(1)  

--    

--    

--    

--    

--    

--    

-- 

-- 

--    

--    

--    

--    

--    

--   

--    

--   

6,881   

--    

1,457    

--    

--    

--    

--    

--    

--    

1,457 

--    

--    

--    

--    

--    

--   

--    

--    142,282   

1    

1,536    

--    

--    

--    

--    

--    

--    

1,537 

--    

--    

--    

--    

--    

--   

--    

--   

92,489   

--    

999    

--    

--    

--    

--    

--    

--    

999 

--    

--    

--    

--    

--    

--    

--    

--    

--    

--    

--   

--   

--    

--    

--   

--   

--   

--   

--    

11,476    

--    

--    

--    

--    

--    

--    

--    

--    

_-    

--    

--    

--    

11,476 

--    

2,013    

2,013 

--    

--    

--    

--    

--    

--   

--    

--   

--   

--    

--    

--    

--    

--    

--    

1,287    

--    

1,287 

--    
--    

--    
--    

--    
--    

--    
--    

--    
--    

--   
--   

--    
--    

--   
--   

--   
--   

--    
--    

--    
--    

--    
--    

--    
--    

--    
--    

(5)  
--    

--    
(24,572)  

--    
11    

(5)
(24,561)

--   $

--    

--   $

--    

--   $

--   

1.0000   $

--   1,581,893   

2   $ 123,224    

(13) $ (695) $

--   $

26   $

(117,772) $

18   $

4,803 

The accompanying notes are an integral part of these financial statements.

F-7

 
 
 
 
 
 
 
 
 
 
 
 
     
     
     
     
     
    
     
    
    
     
     
     
     
     
     
     
     
  
 
 
 
INPIXON AND SUBSIDIARIES

 CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

Cash Flows (Used In) from Operating Activities

Net loss

Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of intangible assets
Impairment of goodwill
Stock based compensation
Amortization of technology
Change in fair value of derivative liability
Amortization of debt discount
Amortization of deferred financing costs
Provision for doubtful accounts
Gain on earnout
Gain on the settlement of liabilities
Gain on the sale of Sysorex Arabia
Forgiveness of debt
Extinguishment loss for debt modification
Exchange of warrants for shares
Other

Changes in operating assets and liabilities:

Accounts receivable and other receivables
Inventory
Other current assets
Prepaid licenses and maintenance contracts
Other assets
Accounts payable
Accrued liabilities
Deferred revenue
Other liabilities
Total Adjustments

Net Cash (Used in) Provided By Operating Activities

Cash Flows Used in Investing Activities
Purchase of property and equipment
Investment in capitalized software
Investment in Pod Technology
Investment in Sysorex India
Cash spun off a result of deconsolidation
Net Cash Flows Used in Investing Activities

Cash Flows From (Used in) Financing Activities

Net repayments to credit line facility
Net proceeds from issuance of common stock, preferred stock and warrants
Repayment of notes payable
Advances to related party
Repayments from related party
Repayment of debenture
Proceeds from notes received
Net proceeds from convertible promissory notes
Repayment of convertible promissory notes

Net Cash Provided By (Used in) Financing Activities

Effect of Foreign Exchange Rate on Changes on Cash

Net Increase (decrease) in Cash, Cash Equivalents and Restricted Cash

Cash, Cash Equivalents and Restricted Cash - Beginning of period

Cash, Cash Equivalents and Restricted Cash - End of period

Supplemental Disclosure of cash flow information:
Cash paid for:

Interest
Income Taxes

Non-cash investing and financing activities

Common shares issued for extinguishment of debenture liability
Common shares issued for extinguishment of debt
Adjustment to opening retained earnings for the adoption of ASC 606
Deconsolidation of Sysorex as a result of spin-off
Common shares issued for LightMiner acquisition
Settlement of interest for shares
Common shares issued for extinguishment of trade payables

For the Years Ended
December 31,

2018

2017

  $

(24,561)   $

(35,030)

1,570 
4,616 
636 
1,494 
66 
(48)  
703 
-- 
(659)  
(934)  
(307)  
(23)  
-- 
-- 
-- 
(73)  

744 
222 
481 

(5)  
(22)  
(8,445)  
(2,412)  
246 
(54)  
(2,204)  

(26,765)  

(88)  
(804)  
(175)  
-- 
(362)  
(1,429)  

(1,119)  
28,960 

(181)  
(3,244)  
1,040 
-- 
3,540 
-- 
-- 
28,996 

(5)  

797 

351 

  $

  $
  $

  $
  $
  $
  $
  $
  $
  $

1,148 

  $

853 
-- 

  $
  $

1,457 
1,537 
1,287 
11,838 
-- 
-- 
-- 

  $
  $
  $
  $
  $
  $
  $

1,882 
5,012 
8,392 
1,533 
66 
(555)
2,110 
451 
952 
(561)
(430)
-- 
635 
1,523 
434 
379 

8,706 
270 
645 
11,588 
44 
5,414 
1,806 
(12,756)
(261)
37,279 

2,249 

(101)
(1,254)
-- 
37 
-- 
(1,318)

(5,576)
6,581 
(57)
-- 
-- 
(4,691)
1,745 
2,000 
(2,662)
(2,660)

(21)

(1,750)

2,101 

351 

1,027 
-- 

3,059 
-- 
-- 
-- 
567 
316 
640 

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
 
 
  
 
 
  
 
 
  
Reclassification of warrants from derivative liabilities to equity
Reclassification of warrants to derivative liabilities

  $
  $

-- 
-- 

  $
  $

3,773 
(3,773)

The accompanying notes are an integral part of these financial statements.

F-8

 
INPIXON AND SUBSIDIARIES
 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 1 - Organization and Nature of Business and Going Concern

Inpixon, its wholly-owned subsidiary, Inpixon Canada, Inc. (“Inpixon Canada”), and its majority-owned subsidiary Sysorex India Limited (“Sysorex India”) (unless otherwise stated or the
context otherwise requires, the terms “Inpixon” “we,” “us,” “our” and the “Company” refer collectively to Inpixon and the above subsidiaries), provides Big Data analytics and location
based products and related services. The Company is headquartered in California, and has subsidiary offices in Hyderabad, India and Vancouver, Canada.

On December 31, 2017, and as more fully described in Note 3, the Company acquired approximately 82.5% of the outstanding equity securities of Sysorex India, which is in the business
of  providing  information  technology  (“IT”)  services  including  software  application  and  development,  quality  assurance  (“QA”)  and  testing  and  graphical  user  interface  (“GUI”)
development.

On August 31, 2018, and as more fully described in Note 9, we completed the spin-off of our value-added reseller business from our indoor positioning analytics business by way of a
distribution of all the shares of common stock of our wholly-owned subsidiary, Sysorex, Inc., to our stockholders of record as of August 21, 2018 and certain warrant holders. 

Going Concern and Management’s Plans

As  of  December  31,  2018,  the  Company  has  a  working  capital  deficiency  of  approximately  $3.9  million.  For  the  year  ended  December  31,  2018,  the  Company  incurred  a  net  loss  of
approximately $24.6 million, which includes the losses generated by Sysorex, Inc. through August 31, 2018, the date the entity and its wholly owned subsidiary were spun off as more fully
described in Note 9. The aforementioned factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements
have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not
include  any  adjustments  relating  to  the  recoverability  and  classification  of  asset  amounts  or  the  classification  of  liabilities  that  might  be  necessary  should  the  Company  be  unable  to
continue as a going concern within one year after the date the financial statements are issued.

On January 5, 2018, the Company entered into a securities purchase agreement with certain investors pursuant to which it sold an aggregate of 14,996 shares of the Company’s common
stock and warrants to purchase up to 14,996 shares of common stock at a purchase price of $212.40 per share of common stock for aggregate net proceeds of approximately $2.8 million.
On February 20, 2018, the Company completed a public offering consisting of an aggregate of 83,149 Class A units, at a price to the public of $94.00 per Class A unit, and 10,184.9752
Class B units, at a price to the public of $1,000 per Class B unit for aggregate net proceeds of approximately $15.4 million. On April 24, 2018, the Company completed a public offering
consisting of 10,115 units at a price to the public of $1,000 per unit for aggregate net proceeds after expenses of approximately $9.2 million. The Company raised approximately $2 million
and $1.5 million in net proceeds from the sale of one-year promissory notes on October 12, 2018 and December 21, 2018, respectively. On January 15, 2019, the Company completed a
rights offering whereby it sold 12,000 units at a price to the public of $1,000 per unit for aggregate net proceeds of approximately $10.77 million after commissions and expenses.

F-9

 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 1 - Organization and Nature of Business and Going Concern (continued)

Going Concern and Management’s Plans (continued)

The Company expects its capital resources as of December 31, 2018, availability on the Payplant facility to finance purchase orders and invoices in an amount equal to 80% of the face
value of purchase orders received (as described in Note 11), funds from higher margin business line expansion and credit limitation improvements will not be sufficient to fund planned
operations for the next twelve months from the date the financial statements are issued.  In addition, the Company is pursuing possible strategic transactions. Therefore, the Company may
raise such additional capital as needed, through the issuance of equity, equity-linked or debt securities.  The Company’s consolidated financial statements as of December 31, 2018 have
been  prepared  under  the  assumption  that  we  will  continue  as  a  going  concern  for  the  next  twelve  months  from  the  date  the  financial  statements  are  issued.  Management’s  plans  and
assessment of the probability that such plans will mitigate and alleviate any substantial doubt about the Company’s ability to continue as a going concern, is dependent upon the ability to
attain  further  operating  efficiency,  reduce  expenditures,  and,  ultimately,  to  generate  sufficient  levels  of  revenue,  which  together  represent  the  principal  conditions  that  raise  substantial
doubt about our ability to continue as a going concern. The Company’s consolidated financial statements as of December 31, 2018 do not include any adjustments that might result from
the outcome of this uncertainty.

Note 2 - Summary of Significant Accounting Policies

Consolidations

The consolidated financial statements have been prepared using the accounting records of Inpixon, Inpixon Canada and Sysorex India. All material inter-company balances and transactions
have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“GAAP”) requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during each of the reporting periods. Actual results could differ from those estimates. The Company’s significant estimates consist of:

●

●

●

●

the valuation of stock-based compensation;

the allowance for doubtful accounts;

the valuation allowance for the deferred tax asset; and

impairment of long-lived assets and goodwill.

Business Combinations

The  Company  accounts  for  business  combinations  under  Financial Accounting  Standards  Board  (“FASB”) Accounting  Standards  Codification  (“ASC”)  805  “Business  Combinations”
using the acquisition method of accounting, and accordingly, the assets and liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the
purchase price over the estimated fair value is recorded as goodwill. All acquisition costs are expensed as incurred. Upon acquisition, the accounts and results of operations are consolidated
as of and subsequent to the acquisition date.

F-10

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 2 - Summary of Significant Accounting Policies (continued)

Cash and Cash Equivalents

Cash and cash equivalents consist of cash, checking accounts, money market accounts and temporary investments with maturities of three months or less when purchased. As of December
31, 2018 and 2017, the Company had no cash equivalents.

Restricted Cash

In connection with certain transactions, the Company may be required to deposit assets, including cash or investment shares, in escrow accounts. The assets held in escrow are subject to
various contingencies that may exist with respect to such transactions. Upon resolution of those contingencies or the expiration of the escrow period, some or all the escrow amounts may
be used and the balance released to the Company. As of December 31, 2018, the Company had $140,000 deposited in escrow as restricted cash for the Shoom acquisition, of which any
amounts not subject to claims shall be released to the pre-acquisition stockholders of Shoom, on a pro-rata basis, on each of the next (2) anniversary dates of the closing date of the Shoom
acquisition. $70,000 of that amount is current and included in Prepaid Assets and Other Current Assets and $70,000 is non-current and included in Other Assets on the consolidated balance
sheet. As of December 31, 2017, the Company had $210,000 deposited in escrow of which $70,000 was part of Prepaid Assets and Other Current Assets and the non-current portion of
$140,000 was part of Other Assets on the consolidated balance sheet.

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the balance sheets that sum to the total of the same amounts show in the statement of
cash flows.

(in thousands)
Cash and cash equivalents
Restricted cash
Restricted cash included in other assets (long term)
Total cash, cash equivalents, and restricted cash in the balance sheet

Accounts Receivable, net and Allowance for Doubtful Accounts

2018

2017

  $

  $

1,008 
70 
70 
1,148 

  $

  $

141 
70 
140 
351 

Accounts  receivables  are  stated  at  the  amount  the  Company  expects  to  collect.  The  Company  recognizes  an  allowance  for  doubtful  accounts  to  ensure  accounts  receivables  are  not
overstated due to un-collectability. Bad debt reserves are maintained for various customers based on a variety of factors, including the length of time the receivables are past due, significant
one-time  events  and  historical  experience. An  additional  reserve  for  individual  accounts  is  recorded  when  the  Company  becomes  aware  of  a  customer’s  inability  to  meet  its  financial
obligation, such as in the case of bankruptcy filings, or deterioration in such customer’s operating results or financial position. If circumstances related to a customer change, estimates of
the recoverability of receivables would be further adjusted. The Company has recorded an allowance for doubtful accounts of $0.5 million and $1.1 million as of December 31, 2018 and
2017, respectively.

Inventory

Inventory is stated at the lower of cost or net realizable value utilizing the first-in, first-out method. The Company continually analyzes its slow-moving, excess and obsolete inventories.
Based on historical and projected sales volumes and anticipated selling prices, the Company establishes reserves. If the Company does not meet its sales expectations, these reserves are
increased. Products that are determined to be obsolete are written down to net realizable value. As of December 31, 2018 and 2017, the Company deemed any such allowance nominal.

Deferred Financing Costs

Costs incurred in  conjunction  with  a  credit  facility  have  been  capitalized  and  have  been  amortized  to  interest  expense  using  the  straight-line  method,  which  approximates  the  effective
interest rate method, over the term of the credit facility and is included as a component of other assets. During the year ended December 31, 2018, the Company did not have deferred
financing  costs.  During  the  year  ended  December  31,  2017,  the  Company  incurred  $124,000  of  deferred  financing  costs  and  amortized  $451,000  of  costs. As  of  December  31,  2017,
accumulated  amortization  approximated  $465,000.  Costs  incurred  with  our  debt  financings  have  been  presented  as  a  direct  deduction  from  the  carrying  amount  of  the  debt  obligation,
consistent with debt discounts.

F-11

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 2 - Summary of Significant Accounting Policies (continued)

Property and Equipment, net

Property and equipment are recorded at cost less accumulated depreciation and amortization. The Company depreciates its property and equipment for financial reporting purposes using
the straight-line method over the estimated useful lives of the assets, which range from 3 to 7 years. Leasehold improvements are amortized over the lesser of the useful life of the asset or
the initial lease term. Expenditures for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred, and expenditures,
which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related accumulated depreciation or amortization are removed from the
accounts and any gain or loss on disposal is recognized.

Intangible Assets

Intangible assets primarily consist of developed technology, customer lists/relationships, non-compete agreements, export licenses and trade names/trademarks. They are amortized ratably
over a range of 1 to 7 years, which approximates customer attrition rate and technology obsolescence. The Company assesses the carrying value of its intangible assets for impairment each
year. Based on its assessments, the Company did not incur any impairment charges for the years ended December 31, 2018 and 2017.

Goodwill

We test goodwill for potential impairment at least annually, or more frequently if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net
assets of the reporting unit. In evaluating goodwill for impairment, we may assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%)
that  the  fair  value  of  a  reporting  unit  is  less  than  its  carrying  amount.  If  we  bypass  the  qualitative  assessment,  or  if  we  conclude  that  it  is  more  likely  than  not  that  the  fair  value  of  a
reporting unit is less than its carrying value, then we perform a quantitative impairment test by comparing the fair value of a reporting unit with its carrying amount.

We calculate the estimated fair value of a reporting unit using a weighting of the income and market approaches. For the income approach, we use internally developed discounted cash
flow models that include the following assumptions, among others: projections of revenues, expenses, and related cash flows based on assumed long-term growth rates and demand trends;
expected future investments to grow new units; and estimated discount rates. For the market approach, we use internal analyses based primarily on market comparables. We base these
assumptions on our historical data and experience, third party appraisals, industry projections, micro and macro general economic condition projections, and our expectations.

The Company performed the annual impairment test and recorded an impairment charge for goodwill of $636,000 and $587,000 during the years ended December 31, 2018 and 2017,
respectively.

Software Development Costs

The Company develops and utilizes internal software for the processing of data provided by its customers. Costs incurred in this effort are accounted for under the provisions of ASC 350-
40, Internal Use Software and ASC 985-20, Software – Cost of Software to be Sold, Leased or Marketed, whereby direct costs related to development and enhancement of internal use
software is capitalized, and costs related to maintenance are expensed as incurred. The Company capitalizes its direct internal costs of labor and associated employee benefits that qualify
as development or enhancement. These software development costs are amortized over the estimated useful life which management has determined ranges from one to five years.

F-12

 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 2 - Summary of Significant Accounting Policies (continued)

Research and Development

Research and development costs consist primarily of professional fees and compensation expense. All research and development costs are expensed as incurred.

Impairment of Long-Lived Assets

The Company assesses  the  recoverability  of  its  long-lived  assets,  including  property  and  equipment  and  intangible  assets,  when  there  are  indications  that  the  assets  might  be  impaired.
When evaluating assets for potential impairment, the Company compares the carrying value of the asset to its estimated undiscounted future cash flows. If an asset’s carrying value exceeds
such estimated cash flows (undiscounted and with interest charges), the Company records an impairment charge for the difference.

Based on its assessments, the Company did not record any impairment charges for the years ended December 31, 2018 and 2017.

Income Taxes

The Company accounts for income taxes using the asset and liability method. Accordingly, deferred tax assets and liabilities are recognized for the future tax consequences attributable to
differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax
rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a
change  in  the  tax  rate  is  recognized  in  income  or  expense  in  the  period  that  the  change  is  effective.  Income  tax  benefits  are  recognized  when  it  is  probable  that  the  deduction  will  be
sustained. A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will either expire before the Company is able to realize the benefit,
or that future deductibility is uncertain.

Non-Controlling Interest

The Company has an 82.5% equity interest in Sysorex India as of December 31, 2018. The portion of the Company’s equity/(deficiency) attributable to this third party non-controlling
interest was approximately $18,000 and ($6,000) as of December 31, 2018 and 2017, respectively.

The Company had a 50.2% equity interest in Sysorex Arabia as of December 31, 2017 and 0% equity interest at December 31, 2018. The portion of the Company’s deficiency attributable
to this third-party non-controlling interest was approximately $2.0 million as of December 31, 2017.

Deferred Rent Expense

The Company has operating leases, which contain predetermined increases and rent holidays in the rentals payable during the term of such leases. For these leases, the aggregate rental
expense over the lease term is recognized on a straight-line basis over the lease term. The difference between the expense charged to operations in any year and the amount payable under
the lease during that year is recorded as deferred rent expense on the Company’s consolidated balance sheet, which will reverse to the statement of operations over the lease term.

F-13

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 2 - Summary of Significant Accounting Policies (continued)

Foreign Currency Translation

Assets and liabilities related to the Company’s foreign operations are calculated using the Indian Rupee and Canadian Dollar and are translated at end-of-period exchange rates, while the
related  revenues  and  expenses  are  translated  at  average  exchange  rates  prevailing  during  the  period.  Translation  adjustments  are  recorded  as  a  separate  component  of  consolidated
stockholders’ equity and were losses of $5,000 and $21,000 for the years ended December 31, 2018 and 2017, respectively. Gains or losses resulting from transactions denominated in
foreign currencies are included in other income (expense) in the consolidated statements of operations. The Company engages in foreign currency denominated transactions with customers
that operate in functional currencies other than the U.S. dollar. Aggregate foreign currency net transaction losses were not material for the years ended December 31, 2018 and 2017.

Comprehensive Income (Loss)

The  Company  reports  comprehensive  income  (loss)  and  its  components  in  its  consolidated  financial  statements.  Comprehensive  loss  consists  of  net  loss,  foreign  currency  translation
adjustments and unrealized gains and losses from marketable securities, affecting stockholders’ (deficit) equity that, under GAAP, are excluded from net loss.

Revenue Recognition

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-08, “Revenue from Contracts with Customers - Principal
versus Agent  Considerations”,  in April  2016,  the  FASB  issued ASU  No.  2016-10,  “Revenue  from  Contracts  with  Customers  (Topic  606)  -  Identifying  Performance  Obligations  and
Licensing” and in May 9, 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606)”, or ASU 2016-12. This update provides clarifying guidance
regarding the application of ASU No. 2014-09 - Revenue From Contracts with Customers (Topic 606), (“ASU 2014-09”) which is not yet effective. These new standards provide for a
single, principles-based model for revenue recognition that replaces the existing revenue recognition guidance. In July 2015, the FASB deferred the effective date of ASU 2014-09 until
annual  and  interim  periods  beginning  on  or  after  December  15,  2017  and  has  replaced  most  existing  revenue  recognition  guidance  under  GAAP.  ASU  2016-12  may  be  applied
retrospectively to historical periods presented or as a cumulative-effect adjustment as of the date of adoption. We have adopted ASU 2016-12 using a modified retrospective approach and
will be applied prospectively in our financial statements from January 1, 2018 forward. Revenues under ASU 2016-12 are required to be recognized either at a “point in time” or “over
time”,  depending  on  the  facts  and  circumstances  of  the  arrangement,  and  will  be  evaluated  using  a  five-step  model.  The  adoption  of  Topic  606  did  not  have  a  material  impact  on  our
consolidated financial statements, neither at initial implementation nor will it have a material impact on an ongoing basis.

Software As A Service Revenue Recognition

With respect to sales of our maintenance, consulting and other service agreements including our digital advertising and electronic services, customers pay fixed monthly fees in exchange
for the Company’s service. The Company’s performance obligation is satisfied over time as the digital advertising and electronic services are provided continuously throughout the service
period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous access to its service.

F-14

 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 2 - Summary of Significant Accounting Policies (continued)

Revenue Recognition (continued)

Professional Services Revenue Recognition

The Company’s professional services include fixed fee and time and materials contracts. Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company’s time
and materials contracts are paid weekly or monthly based on hours worked. Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are
expended. Materials, or other specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize revenue for the
right to invoice because the Company’s right to consideration corresponds directly with the value to the customer of the performance completed to date. For fixed fee contracts including
maintenance  service  provided  by  in  house  personnel,  the  Company  recognizes  revenue  evenly  over  the  service  period  using  a  time-based  measure  because  the  Company  is  providing
continuous  service.  Because  the  Company’s  contracts  have  an  expected  duration  of  one  year  or  less,  the  Company  has  elected  the  practical  expedient  in ASC  606-10-50-14(a)  to  not
disclose information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the years ended December 31, 2018 and 2017, the
Company did not incur any such losses. These amounts are based on known and estimated factors.

Contract Balances

The timing of our revenue recognition may differ from the timing of payment by our customers. We record a receivable when revenue is recognized prior to payment and we have an
unconditional right to payment. Alternatively, when payment precedes the provision of the related services, we record deferred revenue until the performance obligations are satisfied. The
Company had deferred revenue of approximately $235,000 as of December 31, 2018 related to cash received in advance for product maintenance services provided by the Company’s
technical staff. The Company expects to satisfy its remaining performance obligations for these maintenance services and recognize the deferred revenue and related contract costs over the
next twelve months.

Shipping and Handling Costs

Shipping and handling costs are expensed as incurred as part of cost of revenues. These costs were deemed to be nominal during each of the reporting periods.

Advertising Costs

Advertising costs are expensed as incurred. Advertising costs, which are included in selling, general and administrative expenses, were deemed to be nominal during each of the reporting
periods.

Stock-Based Compensation

The Company accounts for options granted to employees by measuring the cost of services received in exchange for the award of equity instruments based upon the fair value of the award
on the date of grant. The fair value of that award is then ratably recognized as an expense over the period during which the recipient is required to provide services in exchange for that
award. 

Options and warrants granted to consultants and other non-employees are recorded at fair value as of the grant date and subsequently adjusted to fair value at the end of each reporting
period until such options and warrants vest, and the fair value of such instruments, as adjusted, is expensed over the related vesting period. 

F-15

 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 2 - Summary of Significant Accounting Policies (continued)

Stock-Based Compensation (continued)

The  Company  incurred  stock-based  compensation  charges  of  $1.5  million  for  each  of  the  years  ended  December  31,  2018  and  2017,  which  are  included  in  general  and  administrative
expenses.  The  Company  has  elected  to  recognize  forfeitures  as  they  occur,  rather  than  calculate  an  estimated  forfeiture  rate  using  a  modified  retrospective  transition  approach.  The
following table summarizes the nature of such charges for the periods then ended (in thousands):  

Compensation and related benefits
Professional and legal fees
Acquisition transaction costs
Interest expense
Totals

Net Loss Per Share

For the Years Ended
December 31,

2018

2017

  $

  $

949 
545 
-- 
-- 
1,494 

  $

  $

909 
301 
7 
316 
1,533 

The Company computes basic and diluted earnings per share by dividing net loss by the weighted average number of common shares outstanding during the period. Basic and diluted net
loss per common share were the same since the inclusion of common shares issuable pursuant to the exercise of options and warrants in the calculation of diluted net loss per common
shares would have been anti-dilutive.

The following table summarizes the number of common shares and common share equivalents excluded from the calculation of diluted net loss per common share for the years ended
December 31, 2018 and 2017:

Options
Warrants
Convertible preferred stock
Convertible note
Convertible debenture
Reserved for service providers
Totals

Preferred Stock

For the Years Ended
December 31,

2018

2017

73,043 
2,368,431 
202 
171,482 
-- 
1,100 
2,614,258 

290 
1,426 
-- 
4,668 
11,212 
395 
17,991 

The Company applies the accounting standards for distinguishing liabilities from equity under GAAP when determining the classification and measurement of its convertible preferred
stock.  Preferred  shares  subject  to  mandatory  redemption  are  classified  as  liability  instruments  and  are  measured  at  fair  value.  Conditionally  redeemable  preferred  shares  (including
preferred  shares  that  feature  redemption  rights  that  are  either  within  the  control  of  the  holder  or  subject  to  redemption  upon  the  occurrence  of  uncertain  events  not  solely  within  the
Company’s control) are classified as temporary equity. At all other times, preferred shares are classified as permanent equity.

F-16

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 2 - Summary of Significant Accounting Policies (continued)

Fair Value of Financial Instruments

Financial instruments consist of cash and cash equivalents, accounts receivable, notes receivable, accounts payable, and short-term debt. The Company determines the estimated fair value
of such financial instruments presented in these financial statements using available market information and appropriate methodologies. These financial instruments, except for short-term
debt, are stated at their respective historical carrying amounts, which approximate fair value due to their short-term nature. Short-term debt approximates market value based on similar
terms available to the Company in the market place.

Reclassification

Certain  accounts  in  the  prior  year’s  consolidated  financial  statements  have  been  reclassified  for  comparative  purposes  to  conform  to  the  presentation  in  the  current  year’s  consolidated
financial statements. These reclassifications have no effect on previously reported earnings.

Derivative Liabilities

During the year ended December 31, 2016, the Company issued a convertible debenture that included reset provisions considered to be down-round protection. In addition, the Company
issued warrants that include a fundamental transaction clause which provide for the warrant holders to be paid in cash the fair value of the warrants as computed under a Black Scholes
valuation model. The Company determined that the conversion feature and warrants are derivative instruments pursuant to ASC 815 “Derivatives and Hedging” issued by the FASB. The
accounting treatment of derivative financial instruments requires that the Company bifurcate the conversion feature and record it as a liability at fair value and the fair value of the warrants
were computed as defined in the agreement. The instruments are marked-to-market at fair value as of each balance sheet date. Any change in fair value is recorded as a change in the fair
value  of  derivative  liabilities  for  each  reporting  period.  The  fair  value  of  the  conversion  feature  was  determined  using  the  Binomial  Lattice  model.  The  Company  reassesses  the
classification  at  each  balance  sheet  date.  If  the  classification  changes  as  a  result  of  events  during  the  period,  the  contract  is  reclassified  as  of  the  date  of  the  event  that  caused  the
reclassification. As of December 31, 2018 and 2017, the fair value of the derivative liability was $0 and $48,000, respectively, and was included in the current liabilities section of the
balance sheet.

Software Development Costs

The Company develops and utilizes internal software for the processing of data provided by its customers. Costs incurred in this effort are accounted for under the provisions of ASC 350-
40, Internal Use Software and ASC 985-20, Software – Cost of Software to be Sold, Leased or Marketed, whereby direct costs related to development and enhancement of internal use
software is capitalized, and costs related to maintenance are expensed as incurred. The Company capitalizes its direct internal costs of labor and associated employee benefits that qualify
as development or enhancement. These software development costs are amortized over the estimated useful life which management has determined ranges from one to five years.

Carrying Value, Recoverability and Impairment of Long-Lived Assets

The Company has adopted Section 360-10-35 of the FASB Accounting Standards Codification for its long-lived assets. Pursuant to ASC Paragraph 360-10-35-17, an impairment loss shall
be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not
recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the
carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by which the carrying amount of a long-lived asset
(asset group) exceeds its fair value. Pursuant to ASC Paragraph 360-10-35-20 if an impairment loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost
basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment
loss is prohibited.

Pursuant to ASC Paragraph 360-10-35-21, the Company’s long-lived asset (asset group) is tested for recoverability whenever events or changes in circumstances indicate that its carrying
amount  may  not  be  recoverable.  The  Company  considers  the  following  to  be  some  examples  of  such  events  or  changes  in  circumstances  that  may  trigger  an  impairment  review:  (a)
significant decrease in the market price of a long-lived asset (asset group); (b) A significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or
in its physical condition; (c) A significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset group), including an adverse
action or assessment by a regulator; (d) An accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset
group); (e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated
with the use of a long-lived asset (asset group); and (f) A current expectation that, more likely than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly
before the end of its previously estimated useful life. The Company tests its long-lived assets for potential impairment indicators at least annually and more frequently upon the occurrence
of such events.

Pursuant to ASC Paragraphs 360-10-35-29 through 35-36, estimates of future cash flows used to test the recoverability of a long-lived asset (asset group) shall include only the future cash
flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset (asset
group). Estimates of future cash flows used to test the recoverability of a long-lived asset (asset group) shall incorporate the entity’s own assumptions about its use of the asset (asset group)
and shall consider all available evidence. The assumptions used in developing those estimates shall be reasonable in relation to the assumptions used in developing other information used
by  the  entity  for  comparable  periods,  such  as  internal  budgets  and  projections,  accruals  related  to  incentive  compensation  plans,  or  information  communicated  to  others.  However,  if
alternative courses of action to recover the carrying amount of a long-lived asset (asset group) are under consideration or if a range is estimated for the amount of possible future cash flows
associated with the likely course of action, the likelihood of those possible outcomes shall be considered. A probability-weighted approach may be useful in considering the likelihood of
those possible outcomes. Estimates of future cash flows used to test the recoverability of a long-lived asset (asset group) shall be made for the remaining useful life of the asset (asset group)
to the entity. For long-lived assets (asset groups) that have uncertainties both in timing and amount, an expected present value technique will often be the appropriate technique with which
to estimate fair value.

F-17

 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 2 - Summary of Significant Accounting Policies (continued)

Pursuant  to ASC  Paragraphs  360-10-45-4  and  360-10-45-5  an  impairment  loss  recognized  for  a  long-lived  asset  (asset  group)  to  be  held  and  used  shall  be  included  in  income  from
continuing operations before income taxes in the income statement of a business entity. If a subtotal such as income from operations is presented, it shall include the amount of that loss. A
gain or loss recognized on the sale of a long-lived asset (disposal group) that is not a component of an entity shall be included in income from continuing operations before income taxes in
the income statement of a business entity. If a subtotal such as income from operations is presented, it shall include the amounts of those gains or losses.

Based on its assessments, the Company did not record any impairment charges for the years ended December 31, 2018 and 2017.

Recently Issued and Adopted Accounting Standards

In  May  2014,  the  FASB  issued ASU  2014-09,  which  supersedes  the  revenue  recognition  requirements  in ASC  605  -  Revenue  Recognition  (“ASC  605”)  and  most  industry-specific
guidance  throughout ASC  605.  The  FASB  has  issued  numerous  updates  that  provide  clarification  on  a  number  of  specific  issues  as  well  as  requiring  additional  disclosures.  The  core
principle of Topic 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the
company expects to be entitled in exchange for those goods or services.

The Company adopted ASC 606 effective January 1, 2018 using the modified retrospective method, which was applied to all contracts at the date of initial application. We recognized the
cumulative  effect  of  initially  applying  the  new  revenue  standard  as  an  adjustment  to  the  opening  balance  of  retained  earnings.  The  comparative  information  has  not  been  restated  and
continues to be reported under the accounting standards in effect for those periods. The cumulative effect of the changes made on January 1, 2018 did not have a material effect on the post-
spin off financial statements of the Company.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842),” (“ASU 2016-02”). ASU 2016-02 requires an entity to recognize assets and liabilities arising from a lease for
both financing and operating leases. ASU 2016-02 will also require new qualitative and quantitative disclosures to help investors and other financial statement users better understand the
amount, timing, and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018. As a result of the new standard, all of our
leases greater than one year in duration will be recognized in our balance sheets as both operating lease liabilities and right-of-use assets upon adoption of the standard. We will adopt the
standard using the prospective approach. Upon adoption, we expect to record approximately $0.7 million in right-of-use assets and operating lease liabilities in our balance sheets.

In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force)”, which clarifies how
entities  should  present  restricted  cash  and  restricted  cash  equivalents  in  the  statement  of  cash  flows,  and  as  a  result,  entities  will  no  longer  present  transfers  between  cash  and  cash
equivalents  and  restricted  cash  and  restricted  cash  equivalents  in  the  statement  of  cash  flows. An  entity  with  a  material  balance  of  restricted  cash  and  restricted  cash  equivalents  must
disclose information about the nature of the restrictions. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017.
Early  adoption  is  permitted  and  the  new  guidance  must  be  applied  retroactively  to  all  periods  presented.  The  adoption  of  this  standard  did  not  have  a  material  impact  to  the  financial
statements or disclosures.

Reverse Stock Split

On March 1, 2017, the Company effectuated a 1-for-15 reverse stock split of its outstanding common stock, on February 6, 2018, the Company effectuated a 1-for-30 reverse stock split of
its outstanding common stock and on November 2, 2018, the Company effectuated a 1-for-40 reverse stock split of its outstanding common stock. The consolidated financial statements
and accompanying notes give effect to each of these reverse stock splits as if they occurred at the beginning of the first period presented.  

Subsequent Events

The Company evaluates events and/or transactions occurring after the balance sheet date and before the issue date of the consolidated financial statements to determine if any of those
events and/or transactions requires adjustment to or disclosure in the consolidated financial statements. 

F-18

 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 3 - Sysorex India Acquisition

Effective as of December 31, 2017, the Company acquired approximately 82.5% of the outstanding equity securities of Sysorex India from Sysorex Consulting, Inc. (“SCI”) pursuant to
that certain Stock Purchase Agreement, dated as of December 31, 2017, by and among the Company, SCI and Sysorex India, in exchange for the assignment by the Company of $37,000 of
outstanding receivables. 

The  Company  acquired  Sysorex  India  to  pursue  sales  and  business  development  opportunities  in  India.  In  addition,  the  Company  is  looking  to  potentially  expand  its  engineering  and
development teams in India. Sysorex India is in the business of providing IT services including software application and development, QA and testing and GUI development.

The purchase price is allocated as follows (in thousands):

Assets Acquired:
Cash
Fixed assets
Other assets
Total Assets Acquired

Liabilities Assumed:
Other current liabilities
Total Liabilities Assumed

Total Purchase Price

Note 4 - Inventory

Inventory as of December 31, 2018 and December 31, 2017 consisted of the following (in thousands):

Raw materials
Finished goods
Total Inventory

Note 5 - Property and Equipment, net

Property and equipment at December 31, 2018 and 2017 consisted of the following (in thousands):

Computer and office equipment
Furniture and fixtures
Leasehold improvements
Software
Total
Less: accumulated depreciation and amortization

Total Property and Equipment, Net

Depreciation and amortization expense were $355,000 and $660,000 for the years ended December 31, 2018 and 2017, respectively.

F-19

  $

  $

1 
14 
32 
47 

10 
10 

37 

As of December 31,

2018

2017

143 
425 
568 

  $

  $

220 
563 
783 

  $

  $

  $

As of December 31,

2018

2017

  $

1,133 
199 
16 
109 
1,457 
(1,255)  

1,001 
209 
53 
156 
1,419 
(1,071)

348 

  $

202 

  $

 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 6 - Software Development Costs

Capitalized software development costs as of December 31, 2018 and 2017 consisted of the following (in thousands):

Capitalized software development costs
Accumulated amortization
Software development costs, net

  $

  $

As of December 31,

2018

2017

5,102 
(3,412)  
1,690 

  $

  $

4,297 
(2,280)
2,017 

The weighted average remaining amortization period for the Company’s software development costs is 0.78 years.

Amortization expense for internally developed and externally marketed computer software was $1.2 million for each of the years ended December 31, 2018 and 2017.

Future amortization expense on the computer software is anticipated to be as follows (in thousands):

For the Years Ending December 31,
2019
2020
2021
Total

Note 7 - Intangible Assets

Intangible assets at December 31, 2018 and 2017 consisted of the following (in thousands):

Amount

708 
650 
332 
1,690 

  $

  $

Amortized Intangible Assets

Trade Name/Trademarks
Customer Relationships
Developed Technology
Non-compete Agreements
Pod Technology
Export License
Totals

Aggregate Amortization Expense:

Gross Carrying Amount
December 31,

2018

2017

Accumulated Amortization
December 31,

2018

2017

  $

  $

780 
2,620 
15,696 
400 
175 
13 
19,684 

  $

  $

780 
2,620 
15,696 
400 
-- 
13 
19,509 

  $

  $

(574)   $
(2,318)    
(11,856)    
(400)    
(17)    
(10)    
(15,175)   $

(424)
(2,136)
(8,976)
(400)
-- 
(7)
(11,943)

Aggregate amortization expense for the years ended December 31, 2018 and 2017 were $3.2 million and $5 million, respectively.

F-20

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 7 - Intangible Assets (continued)

Future amortization expense on intangibles assets is anticipated to be as follows (in thousands):

For the Years Ending December 31,
2019
2020
2021
2022
2023
Total

Amount

3,249 
1,173 
35 
35 
17 
4,509 

  $

The  weighted  average  remaining  amortization  periods  for  the  Company’s  trade  names/trademarks,  customer  relationships,  pod  technology,  developed  technology,  non-compete
agreements, and export license are 0.6, 0.11, 0.16, 1.14, 0, and 0 years, respectively.

Note 8 - Goodwill

The Company has recorded goodwill and other indefinite-lived assets in connection with its acquisition of Shoom. Goodwill, which represents the excess of acquisition cost over the fair
value of the net tangible and intangible assets of the acquired company, is not amortized. Indefinite-lived intangible assets are stated at fair value as of the date acquired in  a  business
combination.  The  Company’s  goodwill  balance  and  other  assets  with  indefinite  lives  were  evaluated  for  potential  impairment  during  the  years  ended  December  31,  2018  and  2017,  as
certain indications on a qualitative and quantitative basis were identified that an impairment exists as of the reporting date.

During  the  years  ended  December  31,  2018  and  2017,  the  Company  recognized  $636,000  and  $587,000  of  impairment  charges,  respectively.  The  impairment  charge  was  primarily
precipitated by the continued decline in Company’s stock price during those years, accumulated losses and the lack of required working capital to fund our continuing operations. The
Company used a market approach to determine if the carrying amounts of the Company’s reporting units exceeded the fair value of the Company.

The following table summarizes the changes in the carrying amount of Goodwill for the year ended December 31, 2018 (in thousands):

Balance as of January 1, 2017
Goodwill impairment (level 3 fair value adjustment)
Balance as of December 31, 2017
Goodwill impairment (level 3 fair value adjustment)
Balance at December 31, 2018

Note 9 - Discontinued Operations

Sale of Sysorex Arabia

Goodwill

  $

  $

1,223 
(587)
636 
(636)
-- 

As of December 31, 2015, the Company’s management decided to close its Saudi Arabia legal entity as business activities and operations have been strategically shifted according to the
business  plan  of  the  Company.  On  January  18,  2018,  the  Company  sold  its  50.2%  interest  in  Sysorex Arabia  to  SCI  in  consideration  for  SCI’s  assumption  of  50.2%  of  the  assets  and
liabilities of Sysorex Arabia, totaling approximately $11,500 and $1 million, respectively.

In accordance with ASC topic 360 “Property, Plant and Equipment”, the Company had classified the assets and liabilities as available for sale assets and liabilities as of December 31, 2017
in the accompanying consolidated financial statements.

F-21

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 9 - Discontinued Operations (continued)

The major categories of assets and liabilities held for sale in the consolidated balance sheet as of December 31, 2017:

Sysorex Arabia Assets/Liabilities (In thousands)
Assets:

Accounts receivable, net
Notes and other receivables
Other assets
Total Current Assets

Other assets
Total Assets

Liabilities:

Current Liabilities:
Accounts payable
Accrued liabilities
Deferred revenue
Due to related party
Short term debt

Total Current Liabilities

Long Term Liabilities

Total Liabilities

As of
December 31,
2017

  $

  $

  $

  $

1 
8 
14 
23 

-- 
23 

178 
918 
236 
5 
722 
2,059 

-- 

2,059 

The Company has entered into surety bonds with a financial institution in Saudi Arabia, which guaranteed performance on certain contracts.

The Company did not recognize any depreciation or amortization expense related to discontinued operations during the years ended December 31, 2018 or 2017. There were no significant
capital expenditures or non-cash operating or investing activities of discontinued operations during the periods presented. The operations of Sysorex Arabia were insignificant for the year
ended December 31, 2017. On January 18, 2018, the Company sold its 50.2% interest in Sysorex Arabia to SCI ( Abdus Salam Qureishi, the former Chairman of the Board, is the majority
stockholder of SCI and is the father in law of Nadir Ali the Company’s CEO) in consideration for SCI’s assumption of 50.2% of the assets and liabilities of Sysorex Arabia.

F-22

 
 
 
 
 
 
 
 
  
   
   
   
 
   
  
   
 
   
  
   
  
 
   
  
   
  
   
   
   
   
   
 
   
  
   
 
   
  
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 9 - Discontinued Operations (continued)

End of Service Indemnity Provision

In accordance with local labor laws, Sysorex Arabia is required to accrue benefits payable to its employees at the end of their services with Sysorex Arabia. For the years ended December
31, 2018 and 2017, no amounts were required to be accrued under this provision.

Spin-Off of Sysorex, Inc. and its wholly owned subsidiary, Sysorex Government Services, Inc.

On August 31, 2018, the Company completed the spin-off (the “Spin-off”) of its value added reseller business from its indoor positioning analytics business by way of a distribution of all
the shares of common stock of the Company’s wholly-owned subsidiary, Sysorex, Inc. (“Sysorex”), to the Company’s stockholders of record as of August 21, 2018 (the “Record Date”)
and certain warrant holders. The distribution occurred by way of a pro rata stock distribution to such common stock, preferred stock and warrant holders, each of whom received one share
of Sysorex’s common stock for every 3 shares of the Company’s common stock held on the Record Date (without taking into effect the 1-for-40 reverse stock split) or such number of
shares of common stock issuable upon complete conversion of the preferred stock or exercise of the warrants.

As a result of the Spin-off, the Company’s common stock continues trading on the Nasdaq Stock Market (“Nasdaq”), and Sysorex is an independent public company with common stock
that is quoted on the OTC Markets.

In accordance with ASC 205-20, “Discontinued Operations,” the results of Sysorex, including Inpixon’s former subsidiary, Sysorex Government Services, Inc., formerly Inpixon Federal,
Inc. (“SGS”), are reflected in Inpixon’s consolidated financial statements as discontinued operations and, therefore, are presented as assets and liabilities of discontinued operations on the
consolidated balance sheet and loss from discontinued operations on the consolidated statements of operations. Certain amounts in the prior year’s consolidated financial statements and
related footnotes thereto have been reclassified to conform with the current year presentation as a result of the Spin-off of Sysorex.

Gain on Earnout

Under the terms of the asset purchase agreement between Integrio Technologies, LLC and Emtec Federal, LLC (its wholly owned subsidiary) (collectively, the “Seller”) and the Company
and SGS, the Seller was eligible for an earnout that was included as part of the purchase consideration. During the year ended December 31, 2018, the Company determined that the Seller
was ineligible for a portion of the earnout as the Seller did not meet the terms of the earnout provisions under the agreement and therefore recorded a gain on earnout of $934,000, which is
included in the net loss from discontinued operations section of the consolidated statements of operations.

F-23

 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 9 - Discontinued Operations (continued)

The major categories of assets and liabilities of deconsolidated operations in the consolidated balance sheet as of December 31, 2017 (in thousands): 

Sysorex/SGS Assets/Liabilities (In thousands)
Assets:

Cash and cash equivalents
Accounts receivable, net
Notes and other receivables
Inventory
Prepaid licenses and maintenance contracts
Other current assets
Total Current Assets

Prepaid licenses and maintenance, non-current
Property and equipment, net
Intangible assets, net
Other assets
Total Non-Current Assets

Liabilities:

Current Liabilities:
Accounts payable
Accrued liabilities
Deferred revenue
Total Current Liabilities

Deferred revenue, non-current
Other liabilities
Acquisition liability - Integrio
Total Non-Current Liabilities

F-24

As of
December 31,
2017

  $

  $

  $

  $

  $

  $

  $

  $

22 
1,882 
171 
7 
4,638 
263 
6,983 

2,264 
172 
5,112 
10 
7,558 

24,271 
3,215 
5,554 
33,040 

2,636 
40 
997 
3,673 

 
 
 
 
 
 
 
 
  
   
   
   
   
   
 
   
  
   
   
   
 
   
  
   
  
 
   
  
   
  
   
   
 
   
  
   
   
  
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 9 - Discontinued Operations (continued)

The assets and liabilities that were divested as part of the Spin-off completed on August 31, 2018 were as follows:

Sysorex/SGS Assets/Liabilities (In thousands)
Assets:

Accounts receivable, net
Notes and other receivables
Prepaid licenses and maintenance contracts
Other current assets
Property and equipment, net
Intangible assets, net
Other assets

Total Assets
Liabilities:

Accounts payable
Accrued liabilities
Deferred revenue
Other liabilities
Acquisition liability - Integrio

Total Liabilities
Total Net Liabilities Deconsolidated as Result of Spin-off

Note 10 - Deferred Revenue

Deferred revenue as of December 31, 2018 and 2017 consisted of the following (in thousands):

Deferred Revenue, Current
Maintenance agreements
Service agreements
Total Deferred Revenue, Current

Total Deferred Revenue

The fair value of the deferred revenue approximates the services to be rendered.

F-25

  $

  $

  $

  $
  $

651 
473 
5 
146 
41 
3,728 
34 
5,078 

(15,952)
(792)
(70)
(40)
(62)
(16,916)
(11,838)

As of December 31,

2018

2017

  $

  $

  $

2 
232 
234 

234 

  $

2 
56 
58 

58 

 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 11 - Debt

Debt as of December 31, 2018 and 2017 consisted of the following (in thousands):

Short-Term Debt
Notes payable (A)
Revolving line of credit (B)
Total Short-Term Debt

Long-Term Debt
Notes payable
Senior secured convertible debenture, less debt discount of $417 (C)
Total Long-Term Debt

(A) Notes Payable

As of December 31,

2018

2017

  $

  $

  $

  $

4,104 
23 
4,127 

  $

  $

74 
-- 
74 

  $

  $

1,917 
1,141 
3,058 

175 
592 
767 

On  November  17,  2017,  the  Company  issued  a  $1.745  million  principal  face  amount  convertible  promissory  note  (the  “November  Note”)  to  an  accredited  investor  (the  “November
Noteholder”) which yielded net proceeds of $1.5 million to the Company pursuant to that certain Securities Purchase Agreement, dated as of November 17, 2017, by and between the
Company and the November Noteholder (the “November Note SPA” and together with the November Note, the “November Transaction Documents”). On January 5, 2018, the November
Transaction Documents were amended pursuant to a Waiver and First Amendment Agreement (the “Waiver and Amendment Agreement”). The November Note, as amended, bore interest
at the rate of 10% per year and was due 10 months after the date of issuance. In accordance with the Waiver and Amendment Agreement, the Conversion Price (as defined in the November
Note) was amended to be equal to 70% of the closing bid price reported by Nasdaq as of the date immediately prior to each applicable conversion, subject to a floor of $3.00 (subject to
adjustment). The approval of the issuance of the shares of common stock pursuant to the Waiver and Amendment Agreement was obtained at a meeting of stockholders held on February 2,
2018.

Redemptions may have occurred at any time after the 6-month anniversary of the date of issuance of the November Note with a minimum redemption price equal to the Conversion Price. If
the  Conversion  Price  was  less  than  the  market  price,  then  the  redemptions  must  have  been  made  in  cash.  The  November  Note  contained  standard  events  of  default  and  a  schedule  of
redemption premiums and a most favored nations provision, which allowed for adjustments upon dilutive issuances, which was subject to a floor of $3.00. 

On  May  23,  2018,  the  Company  and  the  November  Noteholder  entered  into  a  Standstill Agreement  whereby  the  November  Noteholder  agreed  to  delay  for  a  period  of  nine  months
following the Purchase Price Date its right to make redemptions under the November Note. In exchange for the agreement and for reimbursement of the fees incurred by the November
Noteholder in having the Standstill Agreement prepared, the Company paid the November Noteholder $68,000 upon execution of the agreement, which is included as a part of interest
expense in the consolidated statement of operations.

On August 30, 2018, the Company entered into a Standstill Agreement with the November Noteholder. Pursuant to the Standstill Agreement, the November Noteholder agreed that its right
to redeem all or any portion of the November Note would not commence until the date that is the earlier of (i) 12 months after the purchase price date, and (b) five trading days following
receipt  of  approval  from  Inpixon’s  stockholders,  as  may  be  required  in  accordance  with  applicable  Nasdaq  Listing  Rules,  to  amend  the  terms  of  the  November  Note  to  modify  the
Conversion  Price  and  the  Minimum  Redemption  Price,  as  those  terms  are  defined  in  the  November  Note,  on  terms  that  are  acceptable  to  the  November  Noteholder.  The  Standstill
Agreement also extended the maturity date of the November Note to December 31, 2018. Inpixon paid the November Noteholder $75,000 as consideration for the November Noteholder’s
consent to enter into the Standstill Agreement and accordingly expensed the $75,000 to interest expense on the date paid.

F-26

 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 11 - Debt (continued)

(A) Notes Payable (continued)

November Noteholder Exchange Agreement

On October 5, 2018, the Company and the November Noteholder entered into an exchange agreement (the “Exchange Agreement”). Pursuant to the Exchange Agreement, the Company
and the November Noteholder agreed to (i) partition a new convertible promissory note in the form of the November Note (the “Partitioned Note”) in the original principal amount of
$1,536,649 (the “Exchange Amount”) from the November Note and then cause the outstanding balance of the November Note to be reduced by the Exchange Amount; and (ii) exchange
the Partitioned Note for the delivery of 142,282 shares of the Company’s common stock (each, an “Exchange Share” and collectively, the “Exchange Shares”) at an effective price per
Exchange Share equal to $10.80. The Exchange Shares were issued on October 8, 2018.

On October 5, 2018, in connection with the issuance of the Exchange Shares, the exercise price of the warrants issued in the Company’s public offering on April 24, 2018 (as described in
Note  13)  was  adjusted  to  $10.80  per  share  and  increased  the  number  of  shares  of  common  stock  issuable  upon  exercise  of  such  warrants  to  1,364,169  shares  of  common  stock.  The
Company has presented a deemed dividend of $8,817,000 on the consolidated statements of operations for this price reset.

On January 29, 2019, the November Note was deemed paid in full and automatically deemed canceled as more fully described in Note 24.

October 2018 Note Purchase Agreement and Promissory Note

On October 12, 2018 the Company entered into a Note Purchase Agreement with an institutional investor (the “Holder”), pursuant to which the Company agreed to issue and sell to the
Holder an unsecured promissory note (the “Note”) in an aggregate principal amount of $2,520,000.00 (the “Initial Principal Amount”), which is payable on or before the date that is 12
months from the issuance date. The Initial Principal Amount includes an original issue discount of $500,000.00 and $20,000.00 that the Company agreed to pay to the Holder to cover the
Holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the Note, the Holder paid an aggregate purchase price of $2,000,000.00. Interest
on the Note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the Note. Beginning on the date that is 6 months from the issuance date
and at the intervals indicated below until the Note is paid in full, the Holder shall have the right to redeem up to an aggregate of 1/3 of the initial principal balance of the Note each month
(each monthly exercise, a “Monthly Redemption Amount”) by providing written notice (each, a “Monthly Redemption Notice”) delivered to the Company; provided, however, that if the
Holder does not exercise any Monthly Redemption Amount in its corresponding month then such Monthly Redemption Amount shall be available for the Holder to redeem in any future
month in addition to such future month’s Monthly Redemption Amount. Upon receipt of any Monthly Redemption Notice, the Company shall pay the applicable Monthly Redemption
Amount in cash to the Holder within 5 business days of the Company’s receipt of such Monthly Redemption Notice.

F-27

 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 11 - Debt (continued)

(A) Notes Payable (continued)

December 2018 Note Purchase Agreement and Promissory Note

On December 21, 2018 the Company entered into a note purchase agreement with an institutional investor (the “Holder”), pursuant to which the Company agreed to issue and sell to the
Holder an unsecured promissory note (the “December 2018 Note”) in an aggregate principal amount of $1,895,000 (the “Initial Principal Amount”), which is payable on or before the date
that is 10 months from the issuance date. The Initial Principal Amount includes an original issue discount of $375,000 and $20,000 that the Company agreed to pay to the Holder to cover
the Holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the December 2018 Note, the Holder paid an aggregate purchase price of
$1,500,000. Interest on the Note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the December 2018 Note. The Company may pay
all or any portion of the amount owed earlier than it is due; provided, that in the event the Company elects to prepay all or any portion of the outstanding balance, it shall pay to the Holder
115% of the portion of the outstanding balance the Company elects to prepay. Beginning on the date that is 6 months from the issuance date and at the intervals indicated below until the
December  2018  Note  is  paid  in  full,  the  Holder  shall  have  the  right  to  redeem  up  to  an  aggregate  of  1/3  of  the  initial  principal  balance  of  the  December  2018  Note  each  month  (each
monthly exercise, a “Monthly Redemption Amount”) by providing written notice (each, a “Monthly Redemption Notice”) delivered to the Company; provided, however, that if the Holder
does not exercise any Monthly Redemption Amount in its corresponding month then such Monthly Redemption Amount shall be available for the Holder to redeem in any future month in
addition to such future month’s Monthly Redemption Amount. Upon receipt of any Monthly Redemption Notice, the Company shall pay the applicable Monthly Redemption Amount in
cash to the Holder within 5 business days of the Company’s receipt of such Monthly Redemption Notice.

Amendment to Note Purchase Agreements

On February 8, 2019, the Company entered into a global amendment (the “Global Amendment”) to the Note and the December 2018 Note to delete the phrase “by cancellation or exchange
of the Note, in whole or in part” from Section 8.1 of those agreements. The Company also agreed to pay the Holder’s fees and other expenses in an aggregate amount of $80,000.00 (the
“Fee”) in connection with the preparation of the Global Amendment by adding $40,000.00 of the Fee to the outstanding balance of each of the notes.

(B) Revolving Line of Credit

Payplant Accounts Receivable Bank Line

Pursuant to the terms of that certain Commercial Loan Purchase Agreement, dated as of August 14, 2017 (the “Purchase Agreement”), Gemcap Lending I, LLC (“GemCap”) sold and
assigned to Payplant LLC, as agent for Payplant Alternatives Fund LLC (“Payplant” or “Lender”), all of its right, title and interest to that certain revolving Secured Promissory Note in an
aggregate principal amount of up to $10,000,000 (the “GemCap Note”) issued in accordance with that certain Loan and Security Agreement, dated as of November 14, 2016 (the “GemCap
Loan”), by and among GemCap and the Company and its wholly-owned subsidiaries, Sysorex and SGS for an aggregate purchase price of $1,402,770.16.

In connection with the purchase and assignment of the GemCap Loan in accordance with the Purchase Agreement, the GemCap Loan was amended and restated in accordance with the
terms  and  conditions  of  the  Payplant  Loan  and  Security Agreement,  dated  as  of August  14,  2017,  between  the  Company  and  Payplant  (the  “Loan Agreement”).  The  Loan Agreement
allows the Company to request loans from the Lender (in the manner provided therein) with a term of no greater than 360 days in amounts that are equivalent to 80% of the face value of
purchase orders received. The Lender is not obligated to make the requested loan, however, if the Lender agrees to make the requested loan, before the loan is made, the Company must
provide Lender with (i) one or more promissory notes for the amount being loaned in favor of Lender, (ii) one or more guaranties executed in favor of Lender and (iii) other documents and
evidence of the completion of such other matters as Lender may request. The principal amount of each loan shall accrue interest at a 30 day rate of 2% (the “Interest Rate”), calculated per
day on the basis of a year of 360 days and, when combined with all fees that may be characterized as interest will not exceed the maximum rate allowed by law. Upon the occurrence and
during the continuance of any event of default, interest shall accrue at a rate equal to the Interest Rate plus 0.42% per 30 days. All computations of interest shall be made on the basis of a
year of 360 days. The promissory note is subject to the interest rates described in the Loan Agreement and is secured by the assets of the Company pursuant to the Loan Agreement and will
be satisfied in accordance with the terms of the Payplant Client Agreement.

F-28

 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 11 - Debt (continued)

(B) Revolving Lines of Credit (continued)

Payplant Accounts Receivable Bank Line (continued)

On August 31, 2018, Inpixon, Sysorex, SGS, and Payplant executed Amendment 1 to Payplant Client Agreement (the “Amendment”). Pursuant to the Amendment, Sysorex and SGS are
no  longer  parties  to  the  Payplant  Client Agreement,  originally  entered  into  on August  14,  2017,  and  have  been  released  from  any  and  all  obligations  and  liabilities  arising  under  the
Payplant Client Agreement, whether such obligations and liabilities were in existence prior to or on the date of the Amendment or arise after the date of the Amendment.

(C) Senior Secured Debenture

As of January 1, 2017, the Company had outstanding an 8% Original Issue Discount Senior Convertible Debenture in the amount of $3.8 million net of a debt discount of $1.9 million. The
debenture was due on August 9, 2018 and interest was payable quarterly on February 9, May 9, August 9 and November 9, commencing on May 9, 2017, as well as the dates on which
principal payments are made, as described in the debenture in cash, or upon notice to the holder and compliance with certain equity conditions as set forth in the debenture in shares of the
Company’s common stock. The debenture was convertible any time at the option of the holder at a conversion price of $900.00 per share, subject to adjustments provided in the debenture.
Subject  to  certain  equity  conditions,  the  Company  had  the  option  to  redeem  the  debenture  before  its  maturity  by  payment  in  cash  of  120%  or  110%  (depending  on  the  timing  of  the
redemption) of the then outstanding principal amount plus accrued interest and other charges. The Company was required to redeem 25% of the initial principal amount of the debenture
plus accrued unpaid interest and other charges in November 2017, February 2018, May 2018, and August 2018.

On June 2, 2017, the Company repaid $200,000 of the debenture. On June 30, 2017, after the close of the June 2018 equity raise (see Note 13), the Company repaid $2.65 million of the
senior secured debenture.

On December 11, 2017, the Company and the holders of the Debentures, entered into an Amendment Agreement to modify the terms of the Debentures to extend the maturity date of the
Debentures  from August  9,  2018  to  January  2,  2019,  to  suspend  all  payments  of  interest  scheduled  to  be  made  on  the  Debentures  after  December  11,  2017,  all  Periodic  Redemption
Amounts on each Periodic Redemption Date (as defined in the Debenture) and any other amounts payable under the Debentures until the Maturity Date, to reduce the conversion price of
the Debentures to a fixed price of $288.00, which is based on a discount to the reported closing price of the Company’s common stock as of December 8, 2017, as may be adjusted, but not
increased and to provide the Company with a forced conversion right if the VWAP (as defined in the Debenture) equals or exceeds $360.00 (subject to adjustment for reverse and forward
stock splits, stock dividends, stock combinations and other similar transactions of the common stock that occur after the date hereof) for any 5 consecutive Trading Days, the Company
may, upon the delivery of notice to the Debenture Holders, force the Debenture Holders to convert all or part of the then outstanding principal amount of this Debenture plus, if so specified
in the forced conversion notice, accrued but unpaid interest, liquidated damages and other amounts owing to the Holders under the Debenture, so long as the Equity Conditions have been
satisfied.

On December 29, 2017, the Company entered into a Second Amendment Agreement to modify the terms of the securities purchase agreement and the Debentures to amend the conversion
price then in effect to a price equal to up to a discount of 30% of the closing price of the Company’s common stock as reported by the Nasdaq Stock Market as of the date immediately prior
to each applicable conversion date, with a floor of $3.00. During December 31, 2017, the Company calculated the effect of the conversion price amendments to the debenture and recorded
an extinguishment loss of $1.5 million, which is presented in the other income (expense) section of the statement of operations for the year ended December 31, 2017.

Debenture Amendment

On  January  5,  2018,  the  then  holder  of  that  certain  8%  Original  Issue  Discount  Note  (the  “Debenture”)  of  which  an  aggregate  principal  amount  of  $1,004,719  plus  interest  and  the
Company agreed to amend the Debenture to:

(i) cause an event of default in the event of the failure by the Company to amend its Articles of Incorporation in order to increase its authorized shares (the “Authorized Share Amendment”)
or otherwise reserve a sufficient number of shares of common stock for issuance upon conversion of the Debenture on or prior to February 15, 2018; and

(ii) require a reserve of at least 150% of the number of shares into which the Debenture is convertible upon the effectiveness of the Authorized Share Amendment.

On February 5, 2018, the holder of the Debenture delivered a conversion notice to the Company pursuant to which it converted $300,000 of principal of the Debenture into 1,254 shares of
the Company’s common stock. Such shares of common stock were issued on February 6, 2018.

On February 7, 2018, the holder of the Debenture delivered a conversion notice to the Company pursuant to which it converted $400,000 of principal of the Debenture into 2,982 shares of
the Company’s common stock.

On February 9, 2018, the holder of the Debenture delivered a final conversion notice to the Company pursuant to which it converted $317,000 of principal of the Debenture into 2,645
shares of the Company’s common stock, which satisfied the debenture in full.

The Company analyzed the conversions of the Debenture and determined there was a beneficial conversion feature, which had a value of $439,000. The Company recorded this amount as
interest expense-debt discount on the consolidated statement of operations and as an increase to additional paid in capital on the consolidated balance sheet.

F-29

 
 
 
 
             
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 12 - Capital Lease Obligations

During the year ended December 31, 2014, the Company entered into a lease arrangement for furniture with Madison Funding. The lease term was from March 2014 through February
2019. Monthly minimum lease payments were $3,000 and the lease required a security deposit of $14,000. The Company exercised the buy-out option and the lease was paid in full on
January 27, 2016.

During the year ended December 31, 2014, the Company entered into a lease arrangement for equipment with Cambridge TelCom Services, Inc. The lease term was from November 2014
through April 2019. Monthly minimum lease payments were $13,000. Cambridge TelCom and the Company agreed to terminate the lease during the year ended December 31, 2017.

Depreciation expense for leased property and equipment for the years ended December 31, 2018 and 2017 were $0 and $119,000, respectively.

Note 13 - Capital Raises

June 2017 Equity Raise

On June 30, 2017, the Company completed a registered underwritten public offering (“the Offering”) of an aggregate of (i) 1,541 Class A Units (the “Class A Units”), with each Class A
Unit consisting of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $1,575.00 (“Exercise Price”) and (ii) 4,060 Class B Units (the
“Class B Units”), with each Class B Unit consisting of one share of Series 2 Convertible Preferred Stock, par value $0.001 per share (“Series 2 Preferred”) and one warrant to purchase the
number of shares of common stock equal to the number of shares of common stock underlying the Series 2 Preferred at the Exercise Price. The net proceeds to the Company from the
transactions, after deducting the underwriter’s discounts and commissions but before paying the Company’s estimated offering expenses, and excluding the proceeds from the exercise of
the Warrants, was approximately $5.7 million. In connection with the capital raise, the Company granted in the aggregate 4,771 warrants, which consisted of 1,541 Class A warrants and
4,771  Class  B  warrants.  The  fair  value  of  the  warrants  on  the  date  of  the  issuance  was  approximately  $3.8  million.  The  Company  determined  that  the  warrants  included  certain  price
protection features and, under ASC 815 Derivatives and Hedging, the warrants were deemed to be a derivative liability and are marked to market at each reporting period. On July 1, 2017,
the Company early adopted ASU 2017-11 and accordingly has reclassified approximately $3.8 million of derivative liabilities to equity.

In  connection  with  the  Offering,  the  Company  entered  into  that  certain  waiver  and  consent  agreement,  dated  June  28,  2017,  with  those  purchasers  signatory  to  that  certain  securities
purchase  agreement,  dated  as  of  December  12,  2016.  Pursuant  to  the  terms  of  the  Waiver  and  Consent Agreement,  the  December  2016  Purchasers  agreed  to  waive  the  variable  rate
transaction prohibition contained in the December 2016 SPA, which, if not waived, prohibited the adjustment to the exercise price set forth in the Warrants. In consideration of the Waiver,
the warrants held by the December 2016 Purchasers issued in accordance with the December 2016 SPA were amended to equal the Exercise Price of the warrants issued in the Offering and
to provide for an adjustment to the Exercise Price to the extent shares of Common Stock are issued or sold for a consideration per share that is less than the exercise price then in effect;
provided, that the exercise price will not be less than $600.00 per share. The impact of this modification was deemed to be de minimis for the year ended December 31, 2017.

F-30

 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 13 - Capital Raise (continued)

June 2017 Equity Raise (continued)

Agreement with Warrant Holders

On August 9, 2017, the Company entered into a warrant exercise agreement with certain participants in the Offering pursuant to which such warrant holders agreed to exercise, for up to an
aggregate  of  917  shares  of  common  stock,  the  warrants  (the  “Warrants”)  issued  pursuant  to  that  certain  warrant  agency  agreement,  dated  as  of  June  30,  2017  (the  “Warrant Agency
Agreement”), by and between the Company and Corporate Stock Transfer, as warrant agent (the “Warrant Agent”), provided that the Company would agree to:

(a)  amend  the  Warrant Agency Agreement  to  reduce  the  exercise  price  of  the  Warrants  from  $1,590.00  per  share  to  $360.00  per  share  in  accordance  with  the  terms  and  conditions  of
Amendment No. 1 to the Warrant Agency Agreement, dated August 9, 2017 between the Company and the Warrant Agent, with the consent of Aegis Capital Corp. and the registered
holders of a majority of the outstanding Warrants. The impact of this modification was deemed to be de minimis for the year ended December 31, 2017; and

(b) issue additional warrants to the Warrant Holders, for the number of shares of common stock that will be equal to the number of exercised shares purchased by such Warrant Holder (the
“Additional Warrant Shares”), at an exercise price of $660.00 per share for warrants to purchase up to an aggregate of 917 shares of common stock. In connection with the grant of the
additional 917 warrants which have a life of 5 years, under the terms of the agreement included a fundamental transaction clause, which provided for the warrant holder to be paid in cash
upon an event as defined in the warrant agreement. The cash payment is to be computed under a Black-Scholes valuation model for the unexercised portion of the warrant. Accordingly,
under ASC 815 Derivatives and Hedging, the warrants were deemed to be a derivative liability and are marked to market at each reporting period. The fair value of the warrants on the date
of the issuance was approximately $349,000 and was recorded as a charge to the statement of operations in other income and expenses. As of December 31, 2017, the fair value of the
warrants was approximately $48,000.

January 2018 Capital Raise

On January 5, 2018, the Company entered into that certain Securities Purchase Agreement (the “January 2018 SPA”) with certain investors (the “January 2018 Investors”) pursuant to
which the Company agreed to sell an aggregate of 14,996 shares (the “January 2018 Shares”) of the Company’s common stock, at a purchase price of $212.40 per share (the “January 2018
Offering”) and warrants to purchase up to 14,996 shares (the “January 2018 Warrant Shares”) of common stock (the “January 2018 Warrants”). The aggregate gross proceeds for the sale of
the January 2018 Shares and January 2018 Warrants was approximately $3.2 million. After deducting placement agent fees and other expenses, the net proceeds from the offering was
approximately $2.8 million. The January 2018 Warrants were initially exercisable at an exercise price per share equal to $264.00, subject to certain adjustments, and will expire on the five
year anniversary of the initial exercise date. Following the February offering described below, the exercise price of the January 2018 Warrants was reduced to $120.00 per share. 

February 2018 Public Offering

On February 20, 2018, the Company completed a public offering for approximately $18 million in securities, consisting of an aggregate of 83,149 Class A units, at a price to the public of
$94.00 per Class A unit, each consisting of one share of the Company’s common stock and a five-year warrant to purchase one share of common stock at an exercise price of $140.00 per
share (“February 2018 Warrants”), and 10,184.9752 Class B units, at a price to the public of $1,000 per Class B unit, each consisting of one share of the Company’s newly designated
Series 3 convertible preferred stock (“Series 3 Preferred”) with a stated value of $1,000 and initially convertible into approximately 11 shares of our common stock at a conversion price of
$94.00 per share for up to an aggregate of 108,351 shares of common stock and February 2018 Warrants exercisable for the number of shares of common stock into which the shares of
Series 3 Preferred were initially convertible.

F-31

 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 13 - Capital Raise (continued)

February 2018 Public Offering (continued)

The Company received approximately $18 million in gross proceeds from the offering, including $1 million in amounts payable to service providers that participated in the offering, and
before placement agent fees and offering expenses payable by the Company. After satisfying the amounts due to service providers and deducting placement agent fees, the net proceeds
from the offering were approximately $15.4 million.

The embedded conversion option associated with the Series 3 Preferred shares has a beneficial conversion feature, which has a value of $1,508,000. The Company recorded this amount as
a deemed dividend on the consolidated statement of operations for these beneficial conversion features.

Following the April offering described below, the exercise price of the February 2018 Warrants was reduced to the floor price of $25.36 and the number of shares issuable upon exercise of
such warrants was increased to 1,057,178 shares of common stock.

April 2018 Public Offering

On April 24, 2018, the Company completed a public offering consisting of 10,115 units at a price to the public of $1,000 per unit, each consisting of (i) one share of our newly designated
Series 4 convertible preferred stock (the “Series 4 Preferred”) with a stated value of $1,000 and initially convertible into approximately 54 shares of common stock, at a conversion price of
$18.40 per share (subject to adjustment) and (ii) one warrant to purchase such number of shares of common stock as each share of Series 4 Preferred is convertible into. The warrants are
immediately exercisable at an initial exercise price of $26.80 per share (subject to adjustment). The Company received approximately $10.1 million in gross proceeds from this offering,
before  deducting  placement  agent  fees  and  offering  expenses  payable  by  the  Company. After  deducting  placement  agent  fees  and  expenses,  the  net  proceeds  from  this  offering  were
approximately $9.2 million.

The embedded conversion option associated with the Series 4 Preferred shares has a beneficial conversion feature, which has a value of $673,000. Additionally, the embedded conversion
option had a price reset feature, which resulted in the reduction of the conversion price from $18.40 to $7.12 on June 25, 2018, which has a value of $4,226,000. The Company recorded
$4,899,000 as a deemed dividend on the consolidated statement of operations for these beneficial conversion features.

As described above, the April offering reset the price of the February 2018 Warrants to the floor price of $25.36 and the number of shares issuable upon exercise of such warrants was
increased to 1,057,178 shares of common stock. The Company has presented a deemed dividend of $4,828,000 on the consolidated statement of operations for this price reset.

Following the rights offering described below (See Note 25), the conversion price of the Series 4 Preferred was reduced to the floor price of $4.96 and the exercise price of the warrants
issued in the April offering were also reduced to the floor price of $4.96 and the number of shares issuable upon exercise of such warrants was increased to 2,769,000 shares of common
stock.

Note 14 - Common Stock

During the three months ended March 31, 2017, the Company issued 2 shares of common stock related to the acquisition of Integrio Technologies, LLC, which were fully vested upon the
date of grant. The Company recorded an expense of $7,050 for the fair value of those shares.

During the three months ended March 31, 2017, the Company issued 3 shares of common stock for services, which were fully vested upon the date of grant. The Company recorded an
expense of approximately $14,100 for the fair value of those shares.

During  the  three  months  ended  March  31,  2017,  the  Company  issued  16  of  common  stock  for  the  settlement  of  $567,000  of  shares  held  in  escrow  related  to  the  LightMiner  asset
acquisition.

During the three months ended March 31, 2017, the Company issued 1 share of common stock for fractional shares due to the March 1, 2017 reverse stock split.

F-32

 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 14 - Common Stock (continued)

On April 19, 2017, Inpixon entered into an exchange agreement with Hillair Capital Investments L.P. (“Hillair”) in connection with an interest payment due on May 9, 2017 pursuant to the
Company’s 8% Original Issue Discount Senior Secured Convertible Debenture in the principal amount of $5,700,000. In accordance with the exchange agreement, solely in respect of the
interest payment in the amount of approximately $343,000 due on May 9, 2017, the parties agreed that $315,700 of such interest payment would be made in in the form of 92 shares of the
Company’s common stock issued at an interest conversion rate equal to $86.10 per share. The shares were issued on April 20, 2017.

On May 8, 2017, Hillair delivered a conversion notice to the Company pursuant to which it converted 2,250 shares of the Company’s Series 1 Convertible Preferred Stock into 83 shares of
the Company’s common stock. Such shares of common stock were issued on May 9, 2017.

On June 30, 2017, and as more fully described in Note 17, the Company issued 1,541 shares of common stock at $31.50 per share for proceeds of approximately $1.9 million.

During the three months ended June 30, 2017, the Company issued 44 shares of common stock for services, which were fully vested upon the date of grant. The Company recorded an
expense of approximately $144,800 for the fair value of those shares.

During the three months ended September 30, 2017, the Company issued 82 shares of common stock for services, which were fully vested upon the date of grant. The Company recorded
an expense of $87,000 for the fair value of those shares.

During the three months ended September 30, 2017, the Company issued 1,754 shares of common stock for the conversion of 2,210 of Series 2 Preferred Stock.

During  the  three  months  ended  September  30,  2017,  pursuant  to  an  exchange  agreement  the  Company  cancelled  1,850  shares  of  Series  2  Preferred  Stock  and  issued  4,672  shares  of
common stock.

During the three months ended September 30, 2017, the Company issued 2,747 shares of common stock in connection with the exercise of 109,870 warrants at $9.00 a share. 

During  the  three  months  ended  December  31,  2017,  51,514  warrants  were  exercised  in  exchange  for  1,288  of  the  Company’s  common  stock  at  $9.00  a  share.  The  Company  received
approximately $464,000 in proceeds from the warrants exercised.

On December 6, 2017, the Company entered into subscription agreements with certain service providers and vendors in connection with the issuance by the Company of an aggregate of
1,765 shares of the Company’s common stock, including 785 shares issued at closing and rights to acquire up to an additional 980 shares of common stock at a purchase price of $10.20 per
share, in satisfaction of an aggregate of $775,000 payable to the providers by the Company for services rendered. The Company did not receive any cash proceeds from the issuance and
sale of the shares. In connection with the exercise of the rights granted pursuant to the subscription agreements, on December 14, 2017, an additional 784 of the shares were issued and, on
January 5, 2018, the final 196 shares of common stock were issued.

Effective as of December 15, 2017, the Company, pursuant to certain exchange agreements, by and between the Company and the December 2016 Purchasers, agreed to issue up to an
aggregate  of  1,667  shares  of  the  Company’s  common  stock  to  the  December  2016  Purchasers,  in  exchange  for  the  termination  and  cancellation  of  the  8,333  of  the  December  2016
Warrants.  The  Company  recorded  a  charge  of  approximately  $434,000  for  the  incremental  increase  in  the  fair  value  of  66,667  shares  of  common  stock  issued  in  connection  with  the
cancellation of the 8,333 warrants to purchase common stock that were issued in December 2016 as part of its capital raise.

During December 2017, 5,725 shares of the Company’s common stock were issued to pay $1,649,000 in principal of debentures at a conversion rate equal to $7.20 per share.

F-33

 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 14 - Common Stock (continued)

During December 2017, 827 shares of the Company’s common stock were issued to pay $158,000 in principal of debentures at a conversion rate equal to $4.77 per share.

During the three months ended December 31, 2017, the Company issued 133 shares of common stock for services, which were fully vested upon the date of grant. The Company recorded
an expense of approximately $55,000 for the fair value of those shares.

On January 5, 2018, the Company issued 196 shares of common stock pursuant to a subscription agreement with a service provider at a purchase price of $408.00 per share, in satisfaction
of $80,000 payable to the provider.

On January 5, 2018, the Company entered into a securities purchase agreement with certain investors pursuant to which the Company agreed to sell an aggregate of 14,996 shares of the
Company’s common stock, at a purchase price of $212.40 per share (see Note 13).

On February 5, 2018, the holder of the Debenture delivered a conversion notice to the Company pursuant to which it converted $300,000 of principal of the Debenture into 1,254 shares of
the Company’s common stock. Such shares of common stock were issued on February 6, 2018.

On February 7, 2018, the holder of the Debenture delivered a conversion notice to the Company pursuant to which it converted $400,000 of principal of the Debenture into 2,982 shares of
the Company’s common stock.

On February 9, 2018, the holder of the Debenture delivered a final conversion notice to the Company pursuant to which it converted $317,000 of principal of the Debenture into 2,645
shares of the Company’s common stock, which paid the Debenture in full.

On February 20, 2018, the Company completed a public offering including an aggregate of 83,149 Class A units, at a price to the public of $94.00 per Class A unit, each consisting of one
share of the Company’s common stock and a five-year warrant to purchase one share of common stock (see Note 13).

During the three months ended March 31, 2018, 9,773.7252 shares of Series 3 Preferred were converted into 103,976 shares of the Company’s common stock.

During the three months ended March 31, 2018, the Company issued 243 shares of common stock for fractional shares due to the reverse stock split effective February 6, 2018.

During the three months ended June 30, 2018, 411.25 shares of Series 3 Preferred were converted into 4,375 shares of the Company’s common stock.

During the three months ended June 30, 2018, 7,796.7067 shares of Series 4 Preferred were converted into 718,452 shares of the Company’s common stock.

During the three months ended September 30, 2018, 2,311.2933 shares of Series 4 Preferred were converted into 324,803 shares of the Company’s common stock.

On October 8, 2018, the Company issued 142,282 shares of the Company’s common stock at an effective price per share of $10.80 to pay $1,536,649 towards the balance of the November
Note (see Note 12).

During the three months ended December 31, 2018, 6 shares of Series 4 Preferred were converted into 843 shares of the Company’s common stock.

During the three months ended December 31, 2018, the Company issued 37,500 shares of common stock for services, which were fully vested upon the date of issuance. The Company
recorded an expense of approximately $465,000 for the fair value of those shares.

F-34

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 14 - Common Stock (continued)

During the three months ended December 31, 2018, the Company issued 27,653 shares of common stock for fractional shares due to the reverse stock split effective November 2, 2018.

During the three months ended December 31, 2018, the Company issued 92,489 shares of common stock in connection with the exercise of 92,489 warrants at $10.80 a share. 

Note 15 - Preferred Stock

The Company is authorized to issue up to 5,000,000 shares of preferred stock with a par value of $0.001 per share with rights, preferences, privileges and restrictions as to be determined by
the Company’s Board of Directors.

Convertible Series 1 Preferred Stock

On August 9, 2016, the Company entered into a Securities Purchase Agreement pursuant to which it issued and sold (i) an 8% Original Issue Discount Senior Convertible Debenture in an
aggregate  principal  amount  of  $5,700,000  and  (ii)  2,250  shares  of  newly  created  Series  1  Convertible  Preferred  Stock  for  an  aggregate  purchase  price  of  $5,000,000.  The  Company
allocated the fair value of the debt and preferred stock under a relative fair value methodology.

The  Series  1  Convertible  Preferred  Stock  authorized  has  a  stated  price  of  $1,000  per  share,  par  value  of  $0.001.  The  Series  1  Convertible  Preferred  Stock  is  not  cumulative,  has  no
redemption features outside the control of the Company and has a liquidation preference of $2,250,000 and is subject to certain typical anti-dilution provisions, such as stock dividend or
stock splits.

The Series 1 Convertible Preferred Stock is convertible at any time by the shareholder. The number of shares of common stock to be issued is computed by dividing the Stated Value of the
share of Preferred Stock, defined as $15,000, by the Conversion Price, defined as $675.00. In addition under the terms of the agreement if, at any time following the six month anniversary
of the original issue date or, in the event the Company sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues any shares of common
stock or common stock equivalents at an effective price per share that is lower than the conversion price, then the conversion price is reduced to equal the lower price. The holders of the
Company’s  Series  1  Convertible  Preferred  Stock  have  no  voting  rights.  Because  the  conversion  option  associated  with  the  Series  1  Convertible  Preferred  Stock  is  clearly  and  closely
related to the host instrument, the conversion option does not require bifurcation and classification as a derivative liability. During the year ended December 31, 2017, the Company issued
83 shares of common stock for the conversion of the Series 1 convertible preferred stock. There were 0 shares of Series 1 Preferred Stock issued and outstanding as of December 31, 2018
and 2017, respectively.

Series 2 Convertible Preferred Stock

On June 29, 2017, Inpixon filed with the Secretary of State of the State of Nevada the Certificate of Designation that created the Series 2 Convertible Preferred Stock, par value $0.001 per
share (“Series 2 Preferred”), authorized 4,669 shares of Series 2 Preferred and designated the preferences, rights and limitations of the Series 2 Preferred. The Series 2 Preferred is non-
voting (except to the extent required by law). The Series 2 Preferred was convertible into the number of shares of the Company’s common stock, par value $0.001 per share, determined by
dividing the aggregate stated value of the Series 2 Preferred of $1,000 per share to be converted by $1,260.00.

On June 30, 2017, the Company completed a registered underwritten public offering and sold 4,060 Class B Units with each Class B Unit consisting of one share of Series 2 Preferred and
one warrant to purchase the number of shares of common stock equal to the number of shares of common stock underlying the Series 2 Preferred (See Note 13). During the three months
ended September 30, 2017, the 4,060 shares of Series 2 Preferred Stock were converted to 6,426 shares of common stock (see Note 14). There were 0 shares of Series 2 Preferred issued
and outstanding as of December 31, 2018 and 2017, respectively.

F-35

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 15 - Preferred Stock (continued)

Series 2 Convertible Preferred Stock (continued)

On August 14, 2017, the Company entered into an exchange right agreement with Hillair, pursuant to which the Company granted Hillair the right to exchange 1,850 of the Company’ s
Series 2 Convertible Preferred Stock (the “Preferred Shares”) for up to an aggregate of 4,672 shares of the Company’ s common stock. Pursuant to the exchange right agreement, for so
long  as  the  Preferred  Shares  remained  outstanding,  each  outstanding  Preferred  Share  may  have  been  exchanged  for  the  number  of  Exchange  Shares  equal  to  the  quotient  obtained  by
dividing $1,000 by $396.00. The exchange of the Preferred Shares would not be effected if, after giving effect to the exchange Hillair, together with its affiliates, would beneficially own in
excess of 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of the Exchange Shares. Upon not less than 61 days’
prior notice to the Company, Hillair may have increased or decreased the ownership limitation, provided that the ownership limitation in no event exceeded 9.99% of the number of shares
of the Company’s common stock outstanding immediately after giving effect to the issuance of the Exchange Shares. The 1,850 shares of Preferred Shares were converted to common stock
during the year ended December 31, 2017. The Company recorded a $756,000 deemed dividend as shown on the statement of operations for the year ended December 31, 2017 for the
excess of the fair value of the common stock issued over the carrying value of the preferred stock that was exchanged.

Series 3 Convertible Preferred Stock

On February 15, 2018, the Company filed with the Secretary of State of the State of Nevada the Certificate of Designation that created the Series 3 Convertible Preferred Stock (“Series 3
Preferred”),  authorized  10,184.9752  shares  of  Series  3  Preferred  and  designated  the  preferences,  rights  and  limitations  of  the  Series  3  Preferred.  The  Series  3  Preferred  is  non-voting
(except to the extent required by law). The Series 3 Preferred was convertible into the number of shares of Common Stock, determined by dividing the aggregate stated value of the Series
3 Preferred of $1,000 per share to be converted by $94.00.

On February 20, 2018, the Company completed a public offering including an aggregate of 10,184.9752 Class B units, at a price to the public of $1,000 per Class B unit, each consisting of
one share of the Series 3 Preferred with a stated value of $1,000 and initially convertible into approximately 11 shares of our common stock at a conversion price of $94.00 per share (see
Note 13).

During the three months ended March 31, 2018, 9773.7252 shares of Series 3 Preferred were converted into 103,976 shares of the Company’s common stock. During the three months
ended June 30, 2018, 411.25 shares of Series 3 Preferred were converted into 4,375 shares of the Company’s common stock. As of December 31, 2018, there are no Series 3 Preferred
shares outstanding.

Series 4 Convertible Preferred Stock

On April 20, 2018, the Company filed with the Secretary of State of the State of Nevada the Certificate of Designation that created the Series 4 Convertible Preferred Stock (“Series 4
Preferred”), authorized 10,415 shares of Series 4 Preferred and designated the preferences, rights and limitations of the Series 4 Preferred. The Series 4 Preferred is non-voting (except to
the extent required by law) and was convertible into the number of shares of common stock, determined by dividing the aggregate stated value of the Series 4 Preferred of $1,000 per share
to be converted by $18.40 (the “Conversion Price”).

On April 24, 2018, the Company completed a public offering consisting of 10,115 units at a price to the public of $1,000 per unit, each consisting of (i) one share of our newly designated
Series 4 Preferred and (ii) one warrant to purchase such number of shares of common stock as each share of Series 4 Preferred is convertible into (see Note 13).

On June 25, 2018, in accordance with the terms of the price reset provisions described in the Certificate of Designations the Conversion Price of the Series 4 Preferred was adjusted to
$7.12. On January 15, 2019, following the rights offering described below (See Note 25), the Conversion Price of the Series 4 Preferred was reduced to the floor price of $4.96.

F-36

 
 
 
 
 
 
 
 
  
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 15 - Preferred Stock (continued)

Series 4 Convertible Preferred Stock (continued)

During the three months ended June 30, 2018, 7,796.7067 shares of Series 4 Preferred were converted into 718,452 shares of the Company’s common stock. During the three months ended
September 30, 2018, 2,311.2933 shares of Series 4 Preferred were converted into 324,803 shares of the Company’s common stock. During the three months ended December 31, 2018, 6
shares of Series 4 Preferred were converted into 843 shares of the Company’s common stock. As of December 31, 2018, there was 1 share of Series 4 Preferred outstanding.

Note 16 - Authorized Share Increase and Reverse Stock Split

On February 27, 2017, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to effect a 1-for-15 reverse stock
split of the Company’s issued and outstanding shares of common stock, effective as of March 1, 2017.

On February 2, 2018, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to increase the total number of
authorized shares of common stock from 50,000,000 to 250,000,000, as approved by the Company’s stockholders at a special meeting held on February 2, 2018.

On February 2, 2018, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to effect a 1-for-30 reverse stock split
of the Company’s issued and outstanding shares of common stock, effective as of February 6, 2018.

On October 31, 2018, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to effect a 1-for-40 reverse stock
split of the Company’s issued and outstanding shares of common stock, effective as of November 2, 2018.

The consolidated financial statements and accompanying notes give effect to the 1-for-15, 1-for-30 and 1-for-40 reverse stock splits and increase in authorized shares as if they occurred at
the first period presented. 

Note 17 - Stock Options

In September 2011, the Company adopted the 2011 Employee Stock Incentive Plan (the “2011 Plan”) which provides for the granting of incentive and non-statutory common stock options
and stock based incentive awards to employees, non-employee directors, consultants and independent contractors. The plan was amended and restated in May 2014. Unless terminated
sooner by the Board of Directors, this plan will terminate on August 31, 2021.

In February 2018, the Company adopted the 2018 Employee Stock Incentive Plan (the “2018 Plan” and together with the 2011 Plan, the “Option Plans”), which will be utilized with the
2011 Plan for employees, corporate officers, directors, consultants and other key persons employed. The 2018 Plan will provide for the granting of incentive stock options, NQSOs, stock
grants and other stock-based awards, including Restricted Stock and Restricted Stock Units (as defined in the 2018 Plan).

Incentive stock options granted under the Option Plans are granted at exercise prices not less than 100% of the estimated fair market value of the underlying common stock at date of grant.
The  exercise  price  per  share  for  incentive  stock  options  may  not  be  less  than  110%  of  the  estimated  fair  value  of  the  underlying  common  stock  on  the  grant  date  for  any  individual
possessing more that 10% of the total outstanding common stock of the Company. Options granted under the Option Plans vest over periods ranging from immediately to four years and are
exercisable over periods not exceeding ten years.

The aggregate number of shares that may be awarded under the 2011 Plan as of December 31, 2018 is 2,640 and awarded under the 2018 Plan as of December 31, 2018 is 5,000,000. As of
December 31, 2018, 73,043 of options were granted to employees, directors and consultants of the Company (including 39 shares outside of our Options Plans) and 4,929,636 options were
available for future grant under the Option Plans.

F-37

 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 17 - Stock Options (continued)

During the year ended December 31, 2017, the Company granted options for the purchase of 29 shares of common stock to employees and directors of the Company. These options vest
pro-rata over 48 months and have a life of ten years and an exercise price of $4,179.00 per share. The Company valued the stock options using the Black-Scholes option valuation model
and the fair value of the awards was determined to be $51,000. The fair value of the common stock as of the grant date was determined to be $4,179.00 per share.

During the year ended December 31, 2018, the Company granted options under the 2018 Plan for the purchase of 76,009 shares of common stock to employees and consultants of the
Company. These options are 100% vested or vest pro-rata over 48 months, have a life of ten years and an exercise price between $6.42 and $12.68 per share. The Company valued the
stock options using the Black-Scholes option valuation model and the fair value of the awards was determined to be $428,000. The fair value of the common stock as of the grant date was
determined to be between $6.42 and $12.68 per share.

During the year ended December 31, 2018 and 2017, the Company recorded a charge of $1,494,000 and $1,533,000, respectively, for the amortization of employee stock options.

As of December 31, 2018, the fair value of non-vested options totaled $196,411, which will be amortized to expense over the weighted average remaining term of 0.64 years.

The fair value of each employee option grant is estimated on the date of the grant using the Black-Scholes option-pricing model. Key weighted-average assumptions used to apply this
pricing model during the years ended December 31, 2018 and 2017 were as follows:

Risk-free interest rate
Expected life of option grants
Expected volatility of underlying stock
Dividends assumption

For the Years Ended
December 31,

2018
2.79-3.01%
5-6 years

45.64-46.18%  

$   --

2017
2.27%
7 years
47.34%
$   --

The expected stock price volatility for the Company’s stock options was determined by the historical volatilities for industry peers and used an average of those volatilities. The Company
attributes the value of stock-based compensation to operations on the straight-line single option method. Risk free interest rates were obtained from U.S. Treasury rates for the applicable
periods. The dividends assumptions was $0 as the Company historically has not declared any dividends and does not expect to.

F-38

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 17 - Stock Options (continued)

The following table summarizes the changes in options outstanding during the years ended December 31, 2017 and 2018:

Outstanding at January 1, 2017

Granted
Exercised
Expired
Forfeitures

Outstanding at December 31, 2017

Granted
Exercised
Expired
Forfeitures

Outstanding at December 31, 2018

Exercisable at December 31, 2017

Exercisable at December 31, 2018

Note 18 - Warrants

Number
of
Options

Weighted
Average
Exercise
Price

Aggregate
Intrinsic
Value
(in thousands)

574    $
29     
--     
(75)    
(167)    
361    $
76,009     
--     
(2,614)    
(713)    
73,043    $

26,184.45    $
4,178.57     
--     
30,321.43     
18,350.30     
27,181.28    $
12.55     
--     
594.45     
1,017.33     
116.20    $

176    $

33,727.36    $

67,363    $

104.57    $

-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 
-- 

-- 

-- 

On June 30, 2017, the Company granted warrants for the purchase of 4,771 shares of stock in connection with a public offering and is more fully described in Note 13. The warrants are
exercisable for 5 years at an exercise price equal to $360.00 per share.

On August 9, 2017, the Company granted warrants for the purchase of 917 shares of common stock in connection with an agreement with warrant holders and is more fully described in
Note 13. The warrants are exercisable for 5 years at an exercise price equal to $660.00 per share.

During the three months ended September 30, 2017, 2,747 warrants were exercised in exchange for 2,747 of the Company’s common stock at $360.00 a share. The Company received
approximately $989,000 in proceeds from the warrants exercised.

During the three months ended December 31, 2017, 1,288 warrants were exercised in exchange for 1,288 of the Company’s common stock at $360.00 a share. The Company received
approximately $464,000 in proceeds from the warrants exercised.

During the three months ended December 31, 2018, the Company issued 92,489 shares of common stock in connection with the exercise of 92,489 warrants at $0.27 a share. 

F-39

 
 
 
 
 
 
 
   
   
 
   
   
   
   
   
   
   
   
   
   
   
 
   
      
      
  
   
 
   
      
      
  
   
 
 
 
 
 
 
  
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 18 - Warrants (continued)

The following table summarizes the changes in warrants outstanding during the years ended December 31, 2017 and 2018:

Outstanding at January 1, 2017
Granted
Exercised
Expired
Cancelled
Outstanding at December 31, 2017

Granted
Exercised
Expired
Cancelled
Outstanding at December 31, 2018

Exercisable at December 31, 2017

Exercisable at December 31, 2018

Note 19 - Income Taxes

Number
of
Options

Weighted
Average
Exercise
Price

Aggregate 
Intrinsic
Value
(in thousands)

240    $
5,698     
(4,035)    
(15)    
(805)    
1,083    $

2,459,840    $ 
(92,489)    
(3)    
--     
2,368,431    $

11,616.00    $
408.00     
360.00     
5,616.00     
422.00     
387.20    $

17.86     
0.27     
18,000.00     
--     
19.26    $

1,083    $ 

387.20     

2,368,431    $

19.26     

-- 
-- 
-- 
-- 
-- 
-- 

-- 
-- 
-- 
-- 
-- 

-- 

-- 

The domestic and foreign components of income (loss) before income taxes from continuing operations for the years ended December 31, 2018 and 2017 are as follows (in thousands):

Domestic
Foreign

Loss from Continuing Operations before Provision for Income Taxes

F-40

2018

2017

(18,336)   $
(1,447)  

(16,260)
(1,821)

(19,783)   $

(18,081)

  $

  $

 
 
 
 
  
 
 
   
   
 
   
   
   
   
   
   
    
      
      
 
   
   
   
   
   
    
      
      
  
   
    
      
      
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
     
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 19 - Income Taxes (continued)

The income tax provision (benefit) for the years ended December 31, 2018 and 2017 consists of the following (in thousands):

Foreign
Current
Deferred
U.S. federal
Current
Deferred
State and local
Current
Deferred

Change in valuation allowance

Income Tax Provision

  $

2018

2017

  $

17 
(142)  
-- 
-- 
734 
-- 
7 
391 
1,007 
(1,007)  

-- 
(454)
-- 
-- 
9,422 
-- 
18 
1,844 
10,830 
(10,830)

  $

-- 

  $

-- 

The reconciliation between the U.S. statutory federal income tax rate and the Company’s effective rate for the years ended December 31, 2018 and 2017 is as follows:

U.S. federal statutory rate
State income taxes, net of federal benefit
Impairment of goodwill
Impairment of net operating loss
Incentive stock options
Additional Beneficial Conversion Feature
Federal and state rate change and other
US-Foreign income tax rate difference
Other permanent items
Change in valuation allowance
Effective Rate

F-41

2018

2017

21.0%   
(0.2)    
(0.7)    
(4.5)    
(0.5)    
(0.5)    
0.8 
0.4 
(0.5)    
(15.3)    
0.0%   

34.0%
(3.6)
(5.0)
(45.1)
(0.4)
0.0 
(8.4)
(0.4)
(2.1)
31.0 
0.0%

 
  
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
   
 
 
 
 
 
 
     
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 19 - Income Taxes (continued)

As of December 31, 2018 and 2017, the Company’s deferred tax assets consisted of the effects of temporary differences attributable to the following:

(in 000s)
Deferred Tax Asset
Net operating loss carryovers
Deferred revenue
Stock based compensation
Debt debenture
Research credits
Accrued compensation
Reserves
Intangibles
Other

Total Deferred Tax Asset
Less: valuation allowance

Deferred Tax Asset, Net of Valuation Allowance

Deferred Tax Liabilities
Intangible assets
Fixed assets
Other
Prepaid maintenance
Capitalized research
Total deferred tax liabilities

Net Deferred Tax Asset (Liability)

2018

2017

  $

4,892 
-- 
646 
-- 
133 
55 
191 
1,741 
470 

8,128 
(7,677)  

451 

  $

2018

2017

  $

-- 
-- 
(36)  
-- 
(415)  
(451)  

-- 

  $

5,458 
1,486 
490 
412 
139 
98 
512 
-- 
976 

9,571 
(8,660)

911 

(463)
-- 
-- 
(1)
(447)
(911)

-- 

  $

  $

  $

  $

In accordance with applicable U.S. tax laws, the Spin-off as more fully described in Note 9 was determined to result in a taxable gain to the Company. The Company expects to make an
election pursuant to section 336(e) to treat the distribution of all the shares of common stock of our wholly-owned subsidiary, Sysorex, as a sale of assets. Net operating losses were utilized
to offset any taxable gain resulting from the Spin-off of assets and liabilities. Accordingly, the tax effects, as offset by a valuation allowance, have been recognized in equity.

On  December  22,  2017,  the  President  of  the  United  States  signed  into  law  the  Tax  Cuts  and  Jobs Act  tax  reform  legislation.  This  legislation  made  significant  changes  in  U.S.  tax  law
including a reduction in the corporate tax rates, changes to net operating loss carryovers and carrybacks, and a repeal of the corporate alternative minimum tax. The legislation reduced the
U.S. corporate tax rate from the current rate of 34% to 21%. As a result of the enacted law, the Company was required to revalue deferred tax assets and liabilities at the enacted rate. In
2017, this revaluation resulted in a provision of $3.0 million to income tax expense in continuing operations and a corresponding reduction in the deferred tax assets, which was offset by an
equivalent adjustment to the valuation allowance. The new legislation required the Company to pay tax on the unremitted earnings of its foreign subsidiaries through December 31, 2017.
The Company completed its accounting with respect to changes required by the Tax Cuts and Jobs Act, which did not have a material impact on the consolidated financial statements.

The  transition  tax  is  based  on  total  post-1986  earnings  and  profits  which  were  previously  deferred  from  U.S.  income  taxes. At  December  31,  2018,  the  Company  did  not  have  any
undistributed earnings of our foreign subsidiaries. As a result, no additional income or withholding taxes have been provided for. The Company does not anticipate any impacts of the
global intangible low taxed income (“GILTI”) and base erosion anti-abuse tax (“BEAT) and as such, the Company has not recorded any impact associated with either GILTI or BEAT. 

As  of  December  31,  2018  and  2017,  the  Company  had  approximately  $55.1  million  and  $57.4  million,  respectively,  of  U.S.  federal  and  state  net  operating  loss  (“NOL”)  carryovers
available to offset future taxable income. These NOLs, if not utilized, begin expiring in the year ended December 31, 2023.  

In accordance with Section 382 of the Internal Revenue Code, deductibility of the Company’s NOL carryover is subject to an annual limitation in the event of a change of control, as
defined  by  the  regulations.  The  Company  performed  an  analysis  to  determine  the  annual  limitation  as  a  result  of  the  changes  in  ownership  that  occurred  during  2018.  Based  on  the
Company’s analysis, the NOL available to offset future taxable income is approximately $6.2 million. 

F-42

 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
   
  
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 19 - Income Taxes (continued)

As of December 31, 2018 and 2017, Inpixon Canada, which was acquired on April 18, 2014 as part of the AirPatrol Merger Agreement, had approximately $10.2 million and $9.2 million,
respectively, of Canadian NOL carryovers available to offset future taxable income. These NOLs, if not utilized, begin expiring in the year 2026.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for
income tax purposes. In assessing the realization of deferred tax assets, management considers, whether it is “more likely than not”, that some portion or all of the deferred tax assets will
not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net
future deductible amounts become deductible.

ASC 740, “Income Taxes” requires that a valuation allowance be established when it is “more likely than not” that all, or a portion of, deferred tax assets will not be realized. A review of
all available positive and negative evidence needs to be considered, including the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies.
After consideration of all the information available, management believes that uncertainty exists with respect to future realization of its deferred tax assets and has, therefore, established a
full valuation allowance as of December 31, 2018 and 2017. As of December 31, 2018 and December 31, 2017, the change in valuation allowance was $(1.0) million and $(10.8) million,
respectively.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for
financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not  to  be  sustained  upon  examination  by  taxing  authorities.   ASC  740  also  provides  guidance  on  de-recognition,  classification,  interest  and  penalties,  accounting  in  interim  periods,
disclosure and transition.  The Company is required to file income tax returns in the United States (federal), Canada, India, and in various state jurisdictions in the United States. Based on
the Company’s evaluation, it has been concluded that there are no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements for the years
ended December 31, 2018 and 2017.

The Company’s policy for recording interest and penalties associated with unrecognized tax benefits is to record such interest and penalties as interest expense and as a component of
selling, general and administrative expense, respectively.  There were no amounts accrued for interest or penalties for the years ended December 31, 2018 and 2017.  Management does not
expect any material changes in its unrecognized tax benefits in the next year.

The Company operates in multiple tax jurisdictions and, in the normal course of business, its tax returns are subject to examination by various taxing authorities. Such examinations may
result in future assessments by these taxing authorities. The Company is subject to examination by U.S. tax authorities beginning with the year ended December 31, 2015. In general, the
Canadian Revenue Authority may reassess taxes four years from the date the original notice of assessment was issued. The tax years that remain open and subject to Canadian reassessment
are 2014 – 2018. The Company is also subject to examination in India for five years following the filing of the income tax return.

F-43

 
 
 
 
 
 
 
 
  
  
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 20 - Fair Value

The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”) which defines fair
value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset
or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of
observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices available in active markets for identical assets or liabilities trading in active markets.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quotable prices for similar assets and liabilities in active markets; quoted prices for identical or similar
assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models,
discounted cash flow methodologies and similar valuation techniques that use significant unobservable inputs.

Financial instruments, including accounts receivable and accounts payable are carried at cost, which management believes approximates fair value due to the short-term nature of these
instruments. The Company’s other financial instruments include debt payable, the carrying value of which approximates fair value, as the notes bear terms and conditions comparable to
market for obligations with similar terms and maturities, as well as warrant and embedded conversion liabilities that are accounted for at fair value on a recurring basis as of December 31,
2017, by level within the fair value hierarchy (in thousands): 

Warrant liability
Derivative liability – December 31, 2017

Quoted
Prices in
Active
Markets
for
Identical
Assets or
Liabilities
(Level 1)

  $

Significant Other
Observable Inputs
(Level 2)

-       
-      $

-       
-      $

Significant
Unobservable
Inputs
(Level 3)

48     
48    $

Total

48 
48 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant
model assumption or input is unobservable. The Company’s level 3 liabilities shown in the above table consist of warrants that contain a cashless exercise feature that provides for their net
share settlement at the option of the holder. Settlement at fair value upon the occurrence of a fundamental transaction would be computed using the Black Scholes Option Pricing Model.
The Company’s CEO and CFO are responsible for the fair valuations.

Assumptions utilized in the valuation of Level 3 liabilities are described as follows:

Risk-free interest rate
Expected life of option grants
Expected volatility of underlying stock
Dividends assumption

For the Years Ended
December 31,

2018
2.37%
5 years

45.53-46.34%  

  $

--

  $

2017
2.2%
5 years
51.08%
--

The  expected  stock  price  volatility  for  the  Company’s  stock  options  was  determined  by  the  historical  volatilities  for  industry  peers  and  used  an  average  of  those  volatilities.  Risk  free
interest rates were obtained from U.S. Treasury rates for the applicable periods. The expected term used is the contractual life of the instrument being valued. The dividends assumptions
were $0 as the Company historically has not declared any dividends and does not expect to.

F-44

 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 20 - Fair Value (continued)

The following table presents the fair value reconciliation of Level 3 liabilities measured at fair value during the year ended December 31, 2018 and 2017 (in thousands):

  Warrant Liability 

Embedded
Conversion
Feature

Total Derivative
Liabilities

Balance at January 1, 2017
Fair value of warrants issued
Reclassification of warrants to derivative liabilities
Reclassification of warrants from derivative liabilities to equity
Change in fair value of derivative
Balance at January 1, 2018
Change in fair value of derivative
Balance at December 31, 2018

Note 21 - Credit Risk and Concentrations

  $

  $

  $

  $

209 
393 
3,773 
(3,773)  
(554)  
48 
(48)  
-- 

  $

  $

  $

          1 
-- 
-- 
-- 
(1)    
-- 
  $
-- 
-- 

  $

210 
393 
3,773 
(3,773)
(555)
48 
(48)
-- 

Financial  instruments  that  subject  the  Company  to  credit  risk  consist  principally  of  trade  accounts  receivable  and  cash  and  cash  equivalents.  The  Company  performs  certain  credit
evaluation  procedures  and  does  not  require  collateral  for  financial  instruments  subject  to  credit  risk.  The  Company  believes  that  credit  risk  is  limited  because  the  Company  routinely
assesses the financial strength of its customers and, based upon factors surrounding the credit risk of its customers, establishes an allowance for uncollectible accounts and, consequently,
believes that its accounts receivable credit risk exposure beyond such allowances is limited.

The Company maintains cash deposits with financial institutions, which, from time to time, may exceed federally insured limits. Cash is also maintained at foreign financial institutions for
its  Canadian  subsidiary  and  its  majority-owned  India  subsidiary.  Cash  in  foreign  financial  institutions  as  of  December  31,  2018  and  2017  was  immaterial.  The  Company  has  not
experienced any losses and believes it is not exposed to any significant credit risk from cash.

The following table sets forth the percentages of revenue derived by the Company from those customers, which accounted for at least 10% of revenues during the years ended December
31, 2018 and 2017 (in thousands):

Customer A
Customer B

For the Year Ended 
December 31,
2018

$
1,238
--

%
33%
--

For the Year Ended 
December 31,
2017

$
--
6,700

%
--
15%

As of December 31, 2018, Customer C represented approximately 30%, Customer D represented approximately 26%, Customer E represented approximately 13%, Customer F represented
approximately  10%  and  Customer  G  represented  approximately  10%  of  total  accounts  receivable. As  of  December  31,  2017,  Customer  H  represented  approximately  15%,  Customer  I
represented approximately 13% and Customer J represented approximately 11% of total accounts receivable.

As  of  December  31,  2018,  one  vendor  represented  approximately  49%  of  total  gross  accounts  payable.  Purchases  from  this  vendor  during  the  year  ended  December  31,  2018  was  $0
million.  As of December 31, 2017, two vendors represented approximately 28% and 14% of total gross accounts payable. Purchases from these vendors during the year ended December
31, 2017 were $6.5 million and $2.8 million.

For the year ended December 31, 2018, one vendor represented approximately 97% of total purchases. For the year ended December 31, 2017, two vendors represented approximately 28%
and 12% of total purchases.

F-45

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
   
 
 
 
   
 
 
 
 
 
 
   
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
     
 
 
 
  
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 22 - Foreign Operations

The Company’s operations are located primarily in the United States, Canada, India and, prior to the sale of Sysorex Arabia, in Saudi Arabia. Revenues by geographic area are attributed by
country of domicile of our subsidiaries. The financial data by geographic area are as follows (in thousands):

For the Year Ended December 31, 2018:
Revenues by geographic area
Operating income (loss) by geographic area
Net income (loss) by geographic area

For the Year Ended December 31, 2017:
Revenues by geographic area
Operating loss by geographic area
Net loss by geographic area

As of December 31, 2018:
Identifiable assets by geographic area
Long lived assets by geographic area

As of December 31, 2017:
Identifiable assets by geographic area
Long lived assets by geographic area

Note 23 - Related Party Transactions

United
States

Canada

Saudi
Arabia

India

    Eliminations    

Total

3,737 
  $
(16,956)   $
(23,111)   $

19 
  $
(1,509)   $
(1,513)   $

3,795 
  $
(13,210)   $
(33,174)   $

140 
  $
(1,820)   $
(1,821)   $

--    $
--    $
--    $

--    $
--    $
(35)   $

301    $
63    $
63    $

(301)   $
--    $
--    $

3,756 
(18,402)
(24,561)

--    $
--    $
--    $

--    $
--    $
--    $

3,935 
(15,030)
(35,030)

11,872 
6,233 

  $
  $

187 
140 

  $
  $

--    $
--    $

119    $
28    $

--    $
--    $

12,178  
6,401 

27,189 
9,599 

  $
  $

432 
318 

  $
  $

23    $
--    $

47    $
14    $

--    $
--    $

27,691 
9,931 

  $
  $
  $

  $
  $
  $

  $
  $

  $
  $

Nadir Ali is the CEO of Inpixon as well as the Chairman of the Board of Sysorex.

Pursuant  to  the  terms  of  those  certain  employee  transition  agreements  entered  into  between  the  Company  and  Sysorex,  effective  as  of August  31,  2018  (collectively,  the  “Transition
Agreements”), Sysorex agreed to furnish to the Company, on a transitional basis, the services of certain of its employees and keep such employees’ on its payroll and benefits plans from
August 31, 2018 through and including December 31, 2018 (the “Transitional Period”).  The Company agreed to reimburse Sysorex for all costs and expenses incurred by Sysorex with
respect to such employees’ employment during the Transitional Period.  Sysorex agreed to invoice the Company upon the calculation of amounts owed for the foregoing costs, and the
Company agreed to reimburse Sysorex for all such costs within 3 days of its receipt of each such invoice, plus an administrative service fee of 2% of the gross amount of each respective
invoice; provided, however, that Sysorex agreed waive such fee for so long as any Company employees are providing any necessary administrative services on behalf of and for the benefit
of Sysorex, including any employees that are furnished to the Company in accordance with the Transition Agreements.

F-46

 
 
 
 
 
 
 
 
 
 
 
 
   
 
     
   
 
 
 
 
 
 
 
 
   
 
 
  
 
  
 
    
    
    
  
 
 
 
  
 
 
  
 
 
      
      
      
  
 
 
  
 
 
  
 
 
      
      
      
  
 
 
 
  
 
 
  
 
 
      
      
      
  
 
 
  
 
 
  
 
 
      
      
      
  
 
 
 
  
 
 
  
 
 
      
      
      
  
 
 
  
 
 
  
 
 
      
      
      
  
 
 
 
  
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 23 - Related Party Transactions (continued)

Note Purchase Agreement

On December 31, 2018, the Company and Sysorex entered into a note purchase agreement (the “Note Purchase Agreement”) pursuant to which the Company agreed to purchase from
Sysorex at a purchase price equal to the Loan Amount (as defined below), a secured promissory note (the “Secured Note”) for up to an aggregate principal amount of 3,000,000.00 (the
“Principal Amount”), including any amounts advanced through the date of the Secured Note (the “Prior Advances”), to be borrowed and disbursed in increments (such borrowed amount,
together with the Prior Advances, collectively referred to as the “Loan Amount”), with interest to accrue at a rate of 10% percent per annum on all such Loan Amounts, beginning as of the
date of disbursement with respect to any portion of such Loan Amount. In addition, Sysorex agreed to pay $20,000 to the Company to cover the Company’s legal fees, accounting costs,
due diligence, monitoring and other transaction costs incurred in connection with the purchase and sale of the Secured Note (the “Transaction Expense Amount”), all of which amount is
included in the Principal Amount. Sysorex may borrow repay and borrow under the Secured Note, as needed, for a total outstanding balance, exclusive of any unpaid accrued interest, not
to exceed the Principal Amount at any one time.

All  sums  advanced  by  the  Company  to  the  Maturity  Date  (as  defined  below)  pursuant  to  the  terms  of  the  Note  Purchase Agreement  will  become  part  of  the  aggregate  Loan Amount
underlying the Secured Note. All outstanding principal amounts and accrued unpaid interest owing under the Secured Note shall become immediately due and payable on the earlier to
occur of (i) 24 month anniversary of the date the Secured Note is issued (the “Maturity Date”), (ii) at such date when declared due and payable by the Company upon the occurrence of an
Event of Default (as defined in the Secured Note), or (iii) at any such earlier date as set forth in the Secured Note. All accrued unpaid interest shall be payable in cash. The amount owed by
Sysorex to the Company as of December 31, 2018 was $2.2 million. On February 4, 2019, the Related Party Note was amended to increase the maximum principal amount that may be
outstanding at any time under the Related Party Note from $3,000,000 to $5,000,000.

Note 24 - Commitments and Contingencies

Operating Leases 

The Company leases facilities located in California and Canada for its office space under non-cancelable operating leases that expire at various times through 2021. The total amount of
rent  expense  under  the  leases  is  recognized  on  a  straight-line  basis  over  the  term  of  the  leases. As  of  December  31,  2018  and  2017,  deferred  rent  payable  was  $42,000  and  $61,000,
respectively. Rent expense under the operating leases for the years ended December 31, 2018 and 2017 was $0.6 million and $1.6 million, respectively.

Future minimum lease payments under the above operating lease commitments at December 31, 2018 are as follows (in thousands):

For the Years Ending December 31,
2019
2020
2021
Total

F-47

Operating
Lease
Amounts

  $

  $

223 
210 
309 
742 

 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
  
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 24 - Commitments and Contingencies (continued)

Litigation

Certain conditions may exist as of the date the consolidated financial statements are issued which may result in a loss to the Company, but which will only be resolved when one or more
future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies
related  to  legal  proceedings  that  are  pending  against  the  Company,  or  unasserted  claims  that  may  result  in  such  proceedings,  the  Company  evaluates  the  perceived  merits  of  any  legal
proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be
accrued  in  the  Company’s  consolidated  financial  statements.  If  the  assessment  indicates  that  a  potentially  material  loss  contingency  is  not  probable,  but  is  reasonably  possible,  or  is
probable but cannot be estimated, then the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed. 

Loss contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed. There can be no assurance that such
matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. 

On January 22, 2018, Deque Systems, Inc. filed a motion for entry of default judgment (the “Motion”) against SGS in the Circuit Court of Fairfax County, Virginia. The Motion alleged
that SGS failed to respond to a complaint served on November 22, 2017. The Motion requested a default judgment in the amount of $336,000. On August 10, 2018, the parties agreed to a
settlement payment schedule. In connection with the Spin-off, Sysorex agreed to indemnify, defend and hold harmless the Company from and against any damages in connection with
Sysorex liabilities, including this matter.

On April 6, 2018, AVT Technology Solutions, LLC, filed a complaint in the United States District Court Middle District of Florida Tamp Division against Inpixon and Sysorex, formerly
Inpixon USA, alleging breach of contract, breach of corporate guaranty and unjust enrichment in connection with non-payment for goods received and requesting a judgment in an amount
of not less than $9,152,699. On August 15, 2018, the parties entered into a settlement agreement pursuant to which Sysorex agreed to a settlement payment schedule in connection with this
matter. Pursuant to the terms of the settlement agreement, the Company is not liable for any payments to be made by Sysorex or any damages that may arise under such agreement.

On March 19, 2018, the Company was notified by a consultant for advisory services (the “Consultant”) that it believed the Company is required to pay a minimum project fee in an amount
equal to $1 million less certain amounts previously paid as a result of the Company’s completion of certain financing transactions. On April 18, 2018, the Consultant filed a demand for
arbitration with the American Arbitration Association. The Consultant was awarded approximately $1.1 million under arbitration. (See Note 25)

F-48

 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 24 - Commitments and Contingencies (continued)

Compliance with Nasdaq Continued Listing Requirement

On  May  19,  2017,  the  Company  received  written  notice  from  the  Listing  Qualifications  Staff  of  the  Nasdaq  Stock  Market  LLC  (“Nasdaq”)  notifying  the  Company  that  it  no  longer
complied with Nasdaq Listing Rule 5550(b)(1) due to our failure to maintain a minimum of $2,500,000 in stockholders’ equity (the “Minimum Stockholders’ Equity Requirement”) or to
demonstrate compliance with any alternative to such requirement. On October 24, 2017, the Company received notification from Nasdaq that the Company had not regained compliance
with the Minimum Stockholders’ Equity Requirement. The Company appealed the Staff Delisting Determination and requested a hearing that was held on December 7, 2017. As a result,
the  suspension  and  delisting  was  stayed  pending  the  issuance  of  a  written  decision  by  the  Nasdaq  Hearings  Panel.  By  the  decision  dated  December  14,  2017,  the  Panel  granted  the
Company’s  request  for  a  further  extension,  through April  23,  2018,  to  evidence  compliance  with  the  $2,500,000  stockholders’  equity  requirement.  Following  the  closing  of  a  public
offering on April 24, 2018, on May 2, 2018, the Company received a letter from Nasdaq notifying the Company that it had regained compliance with the Minimum Stockholders’ Equity
Requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(1).

On May 17, 2018, the Company received written notice from the Listing Qualifications Staff of Nasdaq indicating that, based upon the closing bid price of the Company’s common stock
for the last 30 consecutive business days beginning on April 5, 2018 and ending on May 16, 2018, the Company no longer met the requirement to maintain a minimum bid price of $1 per
share, as set forth in Nasdaq Listing Rule 5550(a)(2).

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided a period of 180 calendar days, or until November 13, 2018, in which to regain compliance. In order to
regain  compliance  with  the  minimum  bid  price  requirement,  the  closing  bid  price  of  the  Company’s  common  stock  must  have  been  at  least  $1.00  per  share  for  a  minimum  of  ten
consecutive business days, but generally no more than twenty consecutive business days during such 180-day period.

On  October  31,  2018,  the  Company  received  stockholder  approval  for  a  reverse  stock  split  at  its  2018  annual  meeting  of  stockholders  and  implemented  a  1-for-40  reverse  stock  split,
effective as of November 2, 2018. Thereafter, the Company complied with the minimum bid price requirement. On November 28, 2018, the Company received written notice from Nasdaq
notifying the Company that it had regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule
5550(a)(2).

F-49

 
 
 
  
 
  
 
  
  
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 25 - Subsequent Events

During the three months ended March 31, 2019, the Company issued 13,761 shares of common stock in connection with the exercise of 13,761 warrants at $3.33 per share.

During the three months ended March 31, 2019, the Company issued 1,248,324 shares of common stock in connection with the exercise of 2,080,539 warrants as a cashless exercise.

During the three months ended March 31, 2019, 10,014 shares of Series 5 Preferred were converted into 3,007,248 shares of the Company’s common stock.

During the three months ended March 31, 2019, the Company issued 200,000 shares of common stock for services, which were fully vested upon grant. The Company recorded an expense
of approximately $242,000.

Series 5 Preferred

On January 14, 2019, the Company filed with the Secretary of State of the State of Nevada the Certificate of Designation that created the Series 5 Convertible Preferred Stock, authorized
12,000 shares of Series 5 Convertible Preferred Stock and designated the preferences, rights and limitations of the Series 5 Convertible Preferred Stock. The Series 5 Convertible Preferred
Stock is non-voting (except to the extent required by law). The Series 5 Convertible Preferred Stock is convertible into the number of shares of Common Stock, determined by dividing the
aggregate stated value of the Series 5 Convertible Preferred Stock of $1,000 per share to be converted by $3.33. 

January 2019 Capital Raise

On  January  15,  2019,  the  Company  closed  a  rights  offering  whereby  it  agreed  to  sell  an  aggregate  of  12,000  units  consisting  of  an  aggregate  of  12,000  shares  of  Series  5  Convertible
Preferred Stock and 3,600,000 warrants to purchase common stock exercisable for one share of common stock at an exercise price of $3.33 per share in accordance with the terms and
conditions of a warrant agency agreement (the “Warrant Agency Agreement”), resulting in gross proceeds to the Company of approximately $12 million, and net proceeds of approximately
$10.77 million after deducting expenses relating to dealer-manager fees and expenses, and excluding any proceeds received upon exercise of any warrants.

Following the rights offering, the conversion price of the Series 4 Preferred was reduced to the floor price of $4.96, the exercise price of the warrants issued in the April offering were also
reduced to the floor price of $4.96 and the number of shares issuable upon exercise of such warrants was increased to 2,769,000 shares of common stock.

Exchange Agreement

On January 29, 2019, the Company and the November Noteholder of that certain outstanding convertible promissory note, issued on November 17, 2017 (as amended, supplemented or
otherwise  modified,  the  “Original  Note”),  with  an  outstanding  balance  of  $383,768.07  (the  “Remaining  Balance”),  entered  into  an  exchange  agreement  (the  “Exchange Agreement”),
pursuant to which the Company and the Note Holder agreed to (i) partition a new convertible promissory note in the form of the Original Note (the “Partitioned Note”) in the original
principal  amount  equal  to  the  Remaining  Balance  (the  “Exchange Amount”)  and  then  cause  the  Remaining  Balance  to  be  reduced  by  the  Exchange Amount;  and  (ii)  exchange  the
Partitioned Note for the delivery of 172,869 shares of the Company’s common stock at an effective price share equal to $2.22. Following such partition of the Original Note, the Original
Note was deemed paid in full, was automatically deemed canceled, and shall not be reissued.

Amendment to Sysorex Loan Documents

On  February  4,  2019,  the  Company  and  Sysorex  entered  into  a  first  amendment  agreement  (the  “First Amendment Agreement”)  to  that  certain  Note  Purchase Agreement,  dated  as  of
December 31, 2018, between the Company and Sysorex (the “NPA”), and that certain Secured Promissory Note issued to the Company by Sysorex on December 31, 2018 (the “Note,”
together with the NPA, the “Sysorex Loan Documents”). Pursuant to the terms of the First Amendment Agreement, the Sysorex Loan Documents were amended to increase the maximum
principal amount that may be outstanding at any time under the Note from $3,000,000.00 to $5,000,000.00.

F-50

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
INPIXON AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017

Note 25 - Subsequent Events (continued)

Atlas Settlement

On February 20, 2019, in connection with the satisfaction of an award in an aggregate amount of $1,156,840 plus pre-judgment interest equal to an aggregate of $59,955 (the “Award”)
granted to Atlas Technology Group, LLC (“Atlas”) following arbitration proceedings arising out of an engagement agreement, dated September 8, 2016, by and between Atlas and the
Company (including its subsidiaries) (the “Engagement Agreement”), the Company, Sysorex and Atlas entered into a settlement agreement (the “Settlement Agreement”) pursuant to which
Atlas agreed to (a) reduce the Award by $275,000 resulting in a “Net Award” of $941,796 and (b) accept an aggregate of 749,440 shares of freely-tradable common stock of the Company
(the “Settlement Shares”) in satisfaction of the Award which was determined by dividing 120% of the Net Award by $1.508, which was the “minimum price,” as defined under Nasdaq
Listing Rule 5635(d).

Pursuant to the Settlement Agreement, after the Company issued and delivered the Settlement Shares to Atlas, the Award was deemed satisfied in full and the parties were deemed to have
released each other from any claims arising out of the Engagement Agreement. The Settlement Shares were issued to Atlas pursuant to the Company’s registration statement on Form S-3,
as amended (SEC File No. 333-223960), which was declared effective by the Securities and Exchange Commission on June 5, 2018.

In connection with Spin-off of Sysorex, the Company and Sysorex each agreed pursuant to the terms and conditions of that certain Separation and Distribution Agreement, dated August 7,
2018, as amended, that 50% of the costs and liabilities related to the arbitration action arising from the Engagement Agreement would be shared by each party following the Spin-off.  As a
result, Sysorex indemnified the Company for half of the total amount paid by the Company to satisfy the Award.

F-51

 
 
 
 
 
 
 
 
 
 
 ITEM 9: CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Not applicable.

 ITEM 9A: CONTROLS AND PROCEDURES

Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that
it  files  or  submits  under  the  Exchange Act  is  accumulated  and  communicated  to  the  issuer’s  management,  including  its  principal  executive  and  principal  financial  officers,  or  persons
performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer (our principal executive officer) and our
VP of Finance (our principal financial and accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered
by this report. The evaluation was undertaken in consultation with our accounting personnel. Based on that evaluation, our chief executive officer and our VP of Finance concluded that as
of  December  31,  2018,  our  disclosure  controls  and  procedures  are  effective  to  ensure  that  information  required  to  be  disclosed  by  us  in  the  reports  that  we  file  or  submit  under  the
Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) and
15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our Board,
management  and  other  personnel,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for  external  purposes  in
accordance with generally accepted accounting principles and includes those policies and procedures that:

●

●

●

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

provide reasonable  assurance  that  transactions  are  recorded  as  necessary  to  permit  preparation  of  financial  statements  in  accordance with  generally  accepted  accounting
principles, and that our receipts and expenditures are being made only in accordance with authorizations of management and our directors; and

provide reasonable  assurance  regarding  prevention  or  timely  detection  of  unauthorized  acquisition,  use  or  disposition  of  our  assets that  could  have  a  material  effect  on  the
financial statements.

Because of its inherent limitations, our internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective
can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk
that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our principal executive officer and our principal financial officer assessed the effectiveness of our internal control over financial reporting as of December 31, 2018. In making
this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework
issued in 2013.

Based on the assessment, our principal executive officer and our principal financial officer determined that, as of December 31, 2018, our internal control over financial reporting

is effective.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15 (f) under the Exchange Act) during the fourth

quarter of the last fiscal year that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 ITEM 9B: OTHER INFORMATION

Not applicable.

54

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 ITEM 10: DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 PART III

The following table sets forth the names and ages of all of our current directors and executive officers. Our officers are appointed by, and serve at the pleasure of, the Company’s

Board of Directors (referred to herein as the “Board”) and/or our Chief Executive Officer.

Name
Nadir Ali
Soumya Das
Wendy Loundermon
Leonard Oppenheim
Kareem Irfan
Tanveer Khader

Nadir Ali

Age
50
46
48
72
58
50

  Chief Executive Officer and Director
  Chief Marketing Officer and Chief Operating Officer
  Principal Financial and Accounting Officer, Vice President of Finance and Secretary of Inpixon and Secretary of Inpixon Canada, Inc.
  Director
  Director
  Director

Position

Mr. Ali has served as our Chief Executive Officer and as a member of our Board since September 2011. Mr. Ali has also served as the chairman of Sysorex (OTCQB: SYSX)
since August 2018 and as a member of its board of directors since March 2013. Mr. Ali has also served as the sole member of the board of directors of SGS since August 2002. From
November 2015 until the completion of the Spin-off in August 2018, Mr. Ali served as the Chief Executive Officer of Sysorex. From July 2011 until August 2011, he served as President of
Sysorex Consulting Inc. and its subsidiaries. As the Chief Executive Officer of the Company, Mr. Ali is responsible for establishing the vision, strategic intent, and the operational aspects
of  Inpixon.  Mr. Ali  works  with  the  Inpixon  executive  team  to  deliver  both  operational  and  strategic  leadership  and  has  over  15  years  of  experience  in  the  consulting  and  high  tech
industries. 

From  1998  to  2001,  Mr. Ali  was  the  co-founder  and  Managing  Director  of  Tira  Capital,  an  early  stage  technology  fund.  Immediately  prior  thereto,  Mr. Ali  served  as  Vice
President of Strategic Planning for Isadra, Inc., an e-commerce software start-up, which was acquired by VerticalNet. From 1995 through 1998, Mr. Ali was Vice President of Strategic
Programs at Sysorex Information Systems, a computer systems integrator, which was acquired by Vanstar Government Systems in 1997. Mr. Ali’s valuable entrepreneurial, management,
mergers and acquisitions and technology experience together with his in-depth knowledge of the business of Sysorex led us to the conclusion that he should serve as a member of our
Board.  Mr. Ali  received  a  Bachelor  of Arts  degree  in  Economics  from  the  University  of  California  at  Berkeley  in  1989.  Mr. Ali’s  valuable  entrepreneurial,  management,  M&A  and
technology experience together with his in-depth knowledge of the Company provide him with the qualifications and skills to serve as a director of our Company.

Soumya Das

Mr. Das has served as our Chief Marketing Officer since November 2016 and as our Chief Operating Officer since February 2018. Prior to joining Inpixon, from November 2013
until January 2016, Mr. Das was the Chief Marketing Officer of Indetiv, a security technology company. From January 2012 until October 2013, Mr. Das was the Chief Marketing Officer
of SecureAuth, a provider of multi-factor authentication, single sign-on, adaptive authentication and self-services tools for different applications. Prior to joining SecureAuth, Mr. Das was
the Vice President, Marketing and Strategy of CrownPeak, a provider of web content management solutions, from April 2010 until January 2012. Mr. Das earned an MBA from Richmond
College, London, United Kingdom, a post-graduate diploma in Export/Import Management and Bachelor of Business Management from Andhra University in India.

Wendy Loundermon

Ms. Loundermon, who was appointed our Principal Financial and Accounting Officer on July 19, 2017, has overseen all of Inpixon’s finance, accounting and HR activities from
2002 until October 2014 at which time she became the Vice President of Finance until December 2014. From January 2015 and October 2015, she was appointed Interim CFO of the
Company. Thereafter, she continued with the Company as Vice President of Finance. Ms. Loundermon has over 20 years of finance and accounting experience. She is currently responsible
for the preparation and filing of financial statements and reports for all companies, tax return filings, and managing the accounting staff. Ms. Loundermon received a Bachelor of Science
degree in Accounting and a Master of Science degree in Taxation from George Mason University.

55

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Leonard A. Oppenheim

Mr. Oppenheim has served as a member of our Board since July 2011. Mr. Oppenheim retired from business in 2001 and has since been active as a private investor. From 1999 to
2001,  he  was  a  partner  in  Faxon  Research,  a  company  offering  independent  research  to  professional  investors.  From  1983  to  1999,  Mr.  Oppenheim  was  a  principal  in  the  Investment
Banking and Institutional Sales division of Montgomery Securities. Prior to that, he was a practicing attorney. Mr. Oppenheim is a graduate of New York University Law School. Mr.
Oppenheim served on the Board of Apricus Biosciences, Inc. (Nasdaq: APRI), a publicly held bioscience company, from June 2005 to May 2014. Mr. Oppenheim’s public company board
experience is essential to the Company. Mr. Oppenheim also meets the Audit Committee Member requirements as a financial expert. Mr. Oppenheim’s public company board experience
and financial knowledge provide him with the qualifications and skills to serve as a director of our Company.

Kareem M. Irfan

Mr.  Irfan  has  served  as  a  member  of  our  Board  since  July  2014.  Since  2014,  Mr.  Irfan  has  been  the  CEO  (Global  Businesses)  of  Cranes  Software  International  (Cranes),  a
business group offering business intelligence, data analytics and engineering software solutions and services. Previously, Mr. Irfan was Chief Strategy Officer at Cranes starting in 2011.
From  2005  until  2011,  he  was  General  Counsel  at  Schneider  Electric,  a  Paris-based  global  company  that  specializes  in  electricity  distribution,  automation  and  energy  management
solutions. Mr. Irfan served earlier as Chief IP & IT Counsel at Square D Co., a US-based electrical distribution and automation business, and also practiced law at two international IP law
firms in Chicago. Mr. Irfan is a graduate of DePaul University College of Law, holds a MS in Computer Engineering from the University of Illinois, and a BS in Electronics Engineering
from Bangalore University. Mr. Irfan’s extensive experience in advising information technology companies, managing corporate governance and regulatory management policies, and over
fifteen years of executive management leadership give him strong qualifications and skills to serve as a director of our Company.

Tanveer A. Khader

Mr. Khader has served as a member of our Board since July 2014. Since 2010, Mr. Khader has been the Executive Vice President of Systat Software Inc., a company offering
scientific software products for statisticians and researchers. Prior thereto he was Senior Vice President from 2008-2010, Vice President from 2004-2008, and General Manager from 2002-
2004. Mr. Khader holds a BE in Engineering from Bangalore University and a degree in Business Administration from St. Joseph’s Commerce College. Mr. Khader’s extensive experience
with software development, data analytics and strategic planning give him the qualifications and skills to serve as director of our Company.

56

 
 
 
 
 
 
 
 
Board of Directors

Our Board may establish the authorized number of directors from time to time by resolution. The current authorized number of directors is seven. Our current directors, if elected,
will continue to serve as directors until the next annual meeting of stockholders and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, or
removal.

We continue to review our corporate governance policies and practices by comparing our policies and practices with those suggested by various groups or authorities active in
evaluating or setting best practices for corporate governance of public companies. Based on this review, we have adopted, and will continue to adopt, changes that the Board believes are the
appropriate corporate governance policies and practices for our Company.

Our Board held 7 meetings during 2018 and acted through 13 written consents. Except for Tanveer Khader, no member of our Board attended fewer than 75% of the aggregate of
(i) the total number of meetings of the Board (held during the period for which he or she was a director) and (ii) the total number of meetings held by all committees of the Board on which
such director served (held during the period that such director served). Members of our Board are invited and encouraged to attend our annual meeting of stockholders.

Independence of Directors

In determining the independence of our directors, we apply the definition of “independent director” provided under the listing rules of Nasdaq. Pursuant to these rules, the Board
has determined that all of the directors currently serving on the Board are independent within the meaning of Nasdaq Listing Rule 5605 with the exception of Nadir Ali, who is an executive
officer.

Committees of our Board

The Board has three standing committees: the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee.

Audit Committee

The Audit Committee consists of Leonard Oppenheim, Tanveer Khader, and Kareem Irfan, all of whom are “independent” as defined under section 5605(a)(2) of the Nasdaq
Listing Rules. Mr. Oppenheim is the Chairman of the Audit Committee. In addition, the Board has determined that Leonard Oppenheim qualifies as an “audit committee financial expert”
as defined in the rules of the SEC. The Audit Committee operates pursuant to a charter, which can be viewed on our website at http://www.inpixon.com (under “Investors”). The Audit
Committee met 5 times during 2018. All members attended more than 75% of such committee meetings. The role of the Audit Committee is to:

●

●

●

●

●

●

●

oversee management’s preparation of our financial statements and management’s conduct of the accounting and financial reporting processes;

oversee management’s maintenance of internal controls and procedures for financial reporting;

oversee our compliance with applicable legal and regulatory requirements, including without limitation, those requirements relating to financial controls and reporting;

oversee the independent auditor’s qualifications and independence;

oversee the performance of the independent auditors, including the annual independent audit of our financial statements;

prepare the report required by the rules of the SEC to be included in our Proxy Statement; and

discharge such duties and responsibilities as may be required of the Committee by the provisions of applicable law, rule or regulation.

57

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compensation Committee

The Compensation Committee consists of Kareem Irfan, Leonard Oppenheim and Tanveer Khader, all of whom are “independent” as defined in section 5605(a)(2) of the Nasdaq
Listing Rules. Mr. Irfan is the Chairman of the Compensation Committee. The Compensation Committee met 4 times during 2018. All members attended 75% or more of such committee
meetings. The role of the Compensation Committee is to:

●

●

●

●

develop and  recommend  to  the  independent  directors  of  the  Board  the  annual  compensation  (base  salary,  bonus,  stock  options  and  other benefits)  for  our  President/Chief
Executive Officer;

review, approve and recommend to the independent directors of the Board the annual compensation (base salary, bonus and other benefits) for all of our Executive Officers (as
used in Section 16 of the Securities Exchange Act of 1934 and defined in Rule 16a-1 thereunder);

review, approve and recommend to the Board the aggregate number of equity grants to be granted to all other employees; and

ensure that a significant portion of executive compensation is reasonably related to the long-term interest of our stockholders.

A copy of the charter of the Compensation Committee is available on our website at http://www.inpixon.com (under “Investors”).

The  Compensation  Committee  may  form  and  delegate  a  subcommittee  consisting  of  one  or  more  members  to  perform  the  functions  of  the  Compensation  Committee.  The
Compensation Committee may engage outside advisers, including outside auditors, attorneys and consultants, as it deems necessary to discharge its responsibilities. The Compensation
Committee has sole authority to retain and terminate any compensation expert or consultant to be used to provide advice on compensation levels or assist in the evaluation of director,
President/Chief Executive Officer  or  senior  executive  compensation,  including  sole  authority  to  approve  the  fees  of  any  expert  or  consultant  and  other  retention  terms.  In  addition,  the
Compensation Committee considers, but is not bound by, the recommendations of our Chief Executive Officer with respect to the compensation packages of our other executive officers.

Nominating and Corporate Governance Committee

The Nominating and Corporate Governance Committee, or the “Governance Committee,” consists of Tanveer Khader, Leonard Oppenheim and Kareem Irfan, all of whom are
“independent”  as  defined  in  section  5605(a)(2)  of  the  Nasdaq  Listing  Rules.  Mr.  Khader  is  the  Chairman  of  the  Governance  Committee.  The  Nominating  and  Corporate  Governance
Committee met 1 time during 2018. Except for Kareem Irfan who missed the meeting, all members attended the meeting. The role of the Governance Committee is to:

●

●

●

●

●

evaluate from time to time the appropriate size (number of members) of the Board and recommend any increase or decrease;

determine the desired skills and attributes of members of the Board, taking into account the needs of the business and listing standards;

establish criteria  for  prospective  members,  conduct  candidate  searches,  interview  prospective  candidates,  and  oversee  programs  to  introduce the  candidate  to  us,  our
management, and operations;

annually recommend to the Board persons to be nominated for election as directors;

recommend to the Board the members of all standing Committees;

58

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
●

●

●

periodically review the “independence” of each director;

adopt or develop for Board consideration corporate governance principles and policies; and

provide oversight to the strategic planning process conducted annually by our management.

A copy of the charter of the Governance Committee is available on our website at http://www.inpixon.com (under “Investors”). 

Stockholder Communications

Stockholders may communicate with the members of the Board, either individually or collectively, by writing to the Board at 2479 E. Bayshore Road, Suite 195, Palo Alto, CA
94303.  These  communications  will  be  reviewed  by  the  Secretary  as  agent  for  the  non-employee  directors  in  facilitating  direct  communication  to  the  Board.  The  Secretary  will  treat
communications  containing  complaints  relating  to  accounting,  internal  accounting  controls,  or  auditing  matters  as  reports  under  our  Whistleblower  Policy.  Further,  the  Secretary  will
disregard communications that are bulk mail, solicitations to purchase products or services not directly related either to us or the non-employee directors’ roles as members of the Board,
sent other than by stockholders in their capacities as such or from particular authors or regarding particular subjects that the non-employee directors may specify from time to time, and all
other communications which do not meet the applicable requirements or criteria described below, consistent with the instructions of the non-employee directors.

General Communications. The Secretary will summarize all stockholder communications directly relating to our business operations, the Board, our officers, our activities or other

matters and opportunities closely related to us. This summary and copies of the actual stockholder communications will then be circulated to the Chairman of the Governance Committee.

Stockholder  Proposals  and  Director  Nominations  and  Recommendations.  Stockholder  proposals  are  reviewed  by  the  Secretary  for  compliance  with  the  requirements  for  such
proposals set forth in our Bylaws and in Regulation 14a-8 promulgated under the Exchange Act. Stockholder proposals that meet these requirements will be summarized by the Secretary.
Summaries and copies of the stockholder proposals are circulated to the Chairman of the Governance Committee.

Stockholder nominations for directors are reviewed by the Secretary for compliance with the requirements for director nominations that are set forth in our Bylaws. Stockholder
nominations for directors that meet these requirements are summarized by the Secretary. Summaries and copies of the nominations or recommendations are then circulated to the Chairman
of the Governance Committee.

The Governance Committee will consider director candidates recommended by stockholders. If a director candidate is recommended by a stockholder, the Governance Committee
expects to evaluate such candidate in the same manner it evaluates director candidates it identifies. Stockholders desiring to make a recommendation to the Governance Committee should
follow the procedures set forth above regarding stockholder nominations for directors.

Retention of Stockholder Communications. Any stockholder communications which are not circulated to the Chairman of the Governance Committee because they do not meet
the  applicable  requirements  or  criteria  described  above  will  be  retained  by  the  Secretary  for  at  least  ninety  calendar  days  from  the  date  on  which  they  are  received,  so  that  these
communications may be reviewed by the directors generally if such information relates to the Board as a whole, or by any individual to whom the communication was addressed, should
any director elect to do so.

Distribution of Stockholder Communications. Except as otherwise required by law or upon the request of a non-employee director, the Chairman of the Governance Committee

will determine when and whether a stockholder communication should be circulated among one or more members of the Board and/or Company management.

59

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Director Qualifications and Diversity

The  Board  seeks  independent  directors  who  represent  a  diversity  of  backgrounds  and  experiences  that  will  enhance  the  quality  of  the  Board’s  deliberations  and  decisions.
Candidates  should  have  substantial  experience  with  one  or  more  publicly  traded  companies  or  should  have  achieved  a  high  level  of  distinction  in  their  chosen  fields.  The  Board  is
particularly interested in maintaining a mix that includes individuals who are active or retired executive officers and senior executives, particularly those with experience in technology;
research and development; finance, accounting and banking; or marketing and sales.

There is no difference in the manner in which the Governance Committee evaluates nominees for director based on whether the nominee is recommended by a stockholder. In
evaluating nominations to the Board, the Governance Committee also looks for depth and breadth of experience within the Company’s industry and otherwise, outside time commitments,
special  areas  of  expertise,  accounting  and  finance  knowledge,  business  judgment,  leadership  ability,  experience  in  developing  and  assessing  business  strategies,  corporate  governance
expertise, and for incumbent members of the Board, the past performance of the incumbent director. Each of the candidates nominated for election to our Board at our last annual meeting
of stockholders was recommended by the Governance Committee.

Code of Business Conduct and Ethics

The Board has adopted a code of business conduct and ethics (the “Code”) designed, in part, to deter wrongdoing and to promote honest and ethical conduct, including the ethical
handling of actual or apparent conflicts of interest between personal and professional relationships, full, fair, accurate, timely and understandable disclosure in reports and documents that
the  Company  files  with  or  submits  to  the  SEC  and  in  the  Company’s  other  public  communications,  compliance  with  applicable  governmental  laws,  rules  and  regulations,  the  prompt
internal reporting of Code violations to an appropriate person or persons, as identified in the Code and accountability for adherence to the Code. The Code applies to all directors, executive
officers and employees of the Company. The Code is periodically reviewed by the Board. In the event we determine to amend or waive certain provisions of the Code, we intend to disclose
such  amendments  or  waivers  on  our  website  at  http://www.inpixon.com  under  the  heading  “Investors”  within  four  business  days  following  such  amendment  or  waiver  or  as  otherwise
required by the Nasdaq Listing Rules.

Risk Oversight

Our Board provides risk oversight for our entire company by receiving management presentations, including risk assessments, and discussing these assessments with management.
The Board’s overall risk oversight, which focuses primarily on risks and exposures associated with current matters that may present material risk to our operations, plans, prospects or
reputation,  is  supplemented  by  the  various  committees.  The Audit  Committee  discusses  with  management  and  our  independent  registered  public  accounting  firm  our  risk  management
guidelines  and  policies,  our  major  financial  risk  exposures  and  the  steps  taken  to  monitor  and  control  such  exposures.  Our  Compensation  Committee  oversees  risks  related  to  our
compensation programs and discusses with management its annual assessment of our employee compensation policies and programs. Our Nomination and Governance Committee oversees
risks related to corporate governance and management and director succession planning.

Board Leadership Structure

The Chairman of the Board presides at all meetings of the Board, unless such position is vacant, in which case, the Chief Executive Officer of the Company presides. The office of

Chairman of the Board has been vacant since the resignation of Abdus Salam Qureishi in September 2016.

The Company has no fixed policy with respect to the separation of the offices of the Chairman of the Board and Chief Executive Officer. The Board believes that the separation of

the offices of the Chairman of the Board and Chief Executive Officer is in the best interests of the Company and will review this determination from time to time.

Compliance with Section 16 of the Exchange Act

Based  solely  upon  a  review  of  Forms  3  and  4  and  amendments  thereto  furnished  to  us  under  Rule  16a-3(e)  during  the  year  ended  December  31,  2018,  Forms  5  and  any
amendments thereto furnished to us with respect to the year ended December 31, 2018, and the representations made by the reporting persons to us, we do not believe that that any person
who,  at  any  time  during  such  fiscal  year  was  a  director,  officer  or  beneficial  owner  of  more  than  10%  of  the  Company’s  common  stock,  failed  to  comply  with  all  Section  16(a)  filing
requirements during the fiscal year.

60

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 ITEM 11: EXECUTIVE COMPENSATION

The table below sets forth, for the last two fiscal years, the compensation earned by (i) each individual who served as our principal executive officer, (ii) our two other most highly
compensated  executive  officers,  other  than  our  principal  executive  officer,  who  were  serving  as  an  executive  officer  at  the  end  of  the  last  fiscal  year,  and  (iii)  up  to  two  additional
individuals  for  whom  disclosure  would  have  been  provided  pursuant  to  the  preceding  paragraph  (ii)  but  for  the  fact  that  the  individual  was  not  serving  as  an  executive  officer  of  the
Company at the end of the last completed fiscal year. Together, these three individuals are sometimes referred to as the “Named Executive Officers.”

Name and Principal Position

Nadir Ali,
Chief Executive Officer

Souma Das
Chief Marketing Officer

Wendy Loundermon
VP of Finance

Salary
($)

Bonus
($)

Option Awards
($)(1)

All Other
Compensation
($)

Total
($)

  $
  $

  $
  $

  $
  $

279,400 
252,400 

  $
  $

265,625 
250,000 

  $
  $

255,938 
221,145 

  $
  $

140,000    $
40,000    $

83,000    $
48,000    $

50,000    $
96,250    $

79,022    $
--    $

47,415    $
19,950    $

55,317    $
--    $

225,295(2)  $
158,000(3)  $

21,127(4)  $
  $
-- 

24,038(5)  $
  $
-- 

723,717 
450,400 

417,167 
317,950 

385,293 
317,395 

Year

2018
2017

2018
2017

2018
2017

(1) The fair  value  of  employee  option  grants  are  estimated  on  the  date  of  grant  using  the  Black-Scholes  option  pricing  model  with key  weighted  average  assumptions,  expected  stock

volatility and risk free interest rates based on US Treasury rates from the applicable periods.

(2) Accrued vacation paid as compensation, automobile allowance and housing allowance.
(3) Represents fringe benefits and auto allowance.
(4) Represents commission and automobile allowance.
(5) Accrued vacation paid as compensation.

61

 
  
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
  
 
    
    
  
 
  
 
 
 
 
 
 
 
  
 
 
      
      
  
   
  
 
 
 
 
 
 
 
  
 
 
      
      
  
   
  
 
 
 
 
Outstanding Equity Awards at Fiscal Year-End

Other than as set forth below, there were no outstanding unexercised options, unvested stock, and/or equity incentive plan awards issued to our Named Executive Officers as of December
31, 2018.

Option Awards

Stock Awards

Equity
incentive
plan
awards:
number of
securities
underlying
unexercised
unearned
options
(#)

-0-     
-0-     
-0-     
-0-     

-0-     
-0-     

-0-     
-0-     
-0-     
-0-     
-0-     
-0-     
-0-     
-0-     

Number of
securities
underlying
unexercised
options (#)
exercisable

8(1)   
39(1)   
31(2)   
14,001(1)   

5(2)   
8,401(1)   

6(1)   
5(1)   
8(1)   
2(1)   
6(2)   
1(1)   
1(2)   
9,801(1)   

Number of
securities
underlying
unexercised
options (#)
unexercisable  
-0- 
-0- 

1(2)   

-0- 

5(2)   

-0- 

-0- 
-0- 
-0- 
-0- 

1(2)   

-0- 

2(2)   

-0- 

Option
exercise price
($)
5,014.29     
43,392.86     
37,285.72     
12.68     

Option
expiration
date
12/21/2022     
08/14/2023     
04/17/2025     
05/17/2028     

4,178.57     
12.68     

02/03/2027     
05/17/2028     

22,500.00     
5,014.29     
41,142.86     
77,946.43     
28,125.00     
8,357.14     
7,553.57     
12.68     

12/05/2021     
12/21/2022     
11/18/2023     
05/09/2024     
08/05/2025     
02/25/2026     
07/20/2026     
05/17/2028     

Name
Nadir Ali

  Grant Date
12/21/2012
08/14/2013
04/17/2015
05/17/2018

Soumya Das 

02/03/2017
05/17/2018

Wendy
Loundermon 

12/05/2011
12/21/2012
11/18/2013
05/09/2014
08/05/2015
02/25/2016
07/20/2016
05/17/2018

(1) This option is 100% vested.
(2) This option vests 1/48th per month at the end of each month starting on the grant date. 

62

Equity
incentive
plan
awards:
market
or
payout
value of
unearned
shares,
units
or other
rights
that
have not
vested
($)

Equity
incentive
plan
awards:
number
of
unearned
shares,
units or
other
rights
that have
not
vested
(#)

-0-     
-0-     
-0-     
-0-     

-0-     
-0-     

-0-     
-0-     
-0-     
-0-     
-0-     
-0-     
-0-     
-0-     

-0-   
-0-   
-0-   
-0-   

-0-   
-0-   

-0-   
-0-   
-0-   
-0-   
-0-   
-0-   
-0-   
-0-   

-0- 
-0- 
-0- 
-0- 

-0- 
-0- 

-0- 
-0- 
-0- 
-0- 
-0- 
-0- 
-0- 
-0- 

Number
of
shares
or units
of stock
that
have
not
vested
#

Market
value
of
shares
of units
of
stock
that
have
not
vested
($)

-0-     
-0-     
-0-     
-0-     

-0-     
-0-     

-0-     
-0-     
-0-     
-0-     
-0-     
-0-     
-0-     
-0-     

 
 
 
 
 
 
 
 
   
 
 
 
 
 
   
   
   
   
   
  
 
 
   
   
 
 
   
   
 
 
   
 
 
   
   
 
   
   
  
   
  
   
      
      
      
      
      
    
  
   
 
 
   
   
 
   
   
  
   
  
   
      
      
      
      
      
    
  
   
   
 
 
   
   
 
 
   
   
 
 
   
   
 
 
   
 
 
   
   
 
 
   
 
 
   
   
 
 
Employment Agreements and Arrangements

Nadir Ali

On July 1, 2010, Nadir Ali entered into an at-will Employment and Non-Compete Agreement, as subsequently amended, with Inpixon Federal, Inc., Inpixon Government Services
and Inpixon Consulting prior to their acquisition by the Company. Under the terms of the Employment Agreement Mr. Ali serves as President. The employment agreement was assumed by
the Company and Mr. Ali became CEO in September 2011. Mr. Ali’s salary under the agreement was initially $240,000 per annum plus other benefits including a bonus plan, a housing
allowance, health insurance, life insurance and other standard Inpixon employee benefits. If Mr. Ali’s employment is terminated without Cause (as defined), he will receive his base salary
for 12 months from the date of termination. Mr. Ali’s employment agreement provides that he will not compete with the Company and will be subject to non-solicitation provisions relating
to employees, consultants and customers, distributors, partners, joint ventures or suppliers of the Company during the term of his employment or consulting relationship with the Company.
On April  17,  2015,  the  compensation  committee  approved  the  increase  of  Mr. Ali’s  annual  salary  to  $252,400,  effective  January  1,  2015.  Effective  May  16,  2018  the  compensation
committee approved an increase in Mr. Ali’s annual salary to $280,000 and an auto allowance of $1,000 a month.

Soumya Das

On November 4, 2016, and effective as of November 7, 2016, Mr. Das entered into an employment agreement to serve as Chief Marketing Officer of the Company. On February
2, 2018, he was promoted to Chief Operating Officer. In accordance with the terms of the agreement, Mr. Das will receive a base salary of $250,000 per annum. In addition, Mr. Das will
receive a bonus up to $75,000 annually, provided that he completes the required tasks before their deadlines, and the tasks, their deadlines and the amount of corresponding bonuses shall
be determined by the Company and the CEO. The agreement was effective for an initial term of twenty-four (24) months and was automatically renewed for one additional twelve (12)
month period. The Company may terminate the services of Mr. Das with or without “just cause,” (as defined). If the Company terminates Mr. Das’ employment without just cause, or if Mr.
Das resigns within twenty-four (24) months following a change of control (as defined) and as a result of a material diminution of his position or compensation, Mr. Das will receive (1) his
base salary at the then current rate and levels for one (1) month if Mr. Das has been employed by the Company for at least six (6) months but not more than twelve (12) months as of the
date of termination or resignation, for three (3) months if Mr. Das has been employed by the Company more than twelve (12) but not more than twenty-four (24) months as of the date of
termination or resignation, or for six (6) months if Mr. Das has been employed by the Company for more than twenty-four (24) months as of the date of resignation or termination; (2) 50%
of  the  value  of  any  accrued  but  unpaid  bonus  that  Mr.  Das  otherwise  would  have  received;  (3)  the  value  of  any  accrued  but  unpaid  vacation  time;  and  (4)  any  unreimbursed  business
expenses and travel expenses that are reimbursable under the agreement. If the Company terminates Mr. Das’ employment with just cause, Mr. Das will receive only the portion of his base
salary and accrued but unused vacation pay that has been earned through the date of termination. On August 31, 2018, the Company amended Mr. Das’ employment agreement to make the
following changes to his compensation effective May 14, 2018: (1) increase in base salary to $275,000 per year, (2) have up to $50,000 in MBO’s annually, (3) commissions equal to 2% of
recognized  revenue  associated  with  the  IPA  product  line  paid  quarterly  and  subject  to  the  Company  policies  in  connection  with  commissions  payable  and  (4)  provide  a  transportation
allowance of $1,000 per month.

Wendy Loundermon

On October 21, 2014, and effective as of October 1, 2014, the Company entered into an at-will employment agreement with Wendy Loundermon. Ms. Loundermon currently
serves as Vice President of Finance and Secretary of the Company and Secretary of Inpixon Canada, Inc. Pursuant to the agreement, Ms. Loundermon was compensated at an annual rate of
$200,000  and  is  entitled  to  benefits  customarily  provided  to  senior  management  including  equity  awards  and  cash  bonuses  subject  to  the  satisfaction  of  certain  performance  goals
determined by the Company. The standards and goals and the bonus targets is set by the compensation committee, in its sole discretion. The Company may terminate the services of Ms.
Loundermon with or without “cause” (as defined). If the Company terminates Ms. Loundermon’s employment without cause or in connection with a change of control (as defined), Ms.
Loundermon will receive (1) severance consisting of her base salary at the then current rate for twelve (12) months from the date of termination, and (2) her accrued but unpaid salary. If
Ms. Loundermon’s employment is terminated under any circumstances other than the above, Ms. Loundermon will receive her accrued but unpaid salary. Ms. Loundermon’s salary was
increased to $228,500 effective April 1, 2017 and to $250,000 effective March 1, 2018.

63

 
 
 
 
 
 
 
 
 
Employee Stock Incentive Plans

2018 Employee Stock Incentive Plan

The following is a summary of the material terms of our 2018 Employee Stock Incentive Plan, as amended to date (the “2018 Plan”). This description is not complete. For more

information, we refer you to the full text of the 2018 Plan.

The 2018 Plan is an important part of our compensation program. It promotes financial saving for the future by our employees, fosters good employee relations, and encourages
employees to acquire shares of our common stock, thereby better aligning their interests with those of the other stockholders. Therefore, the Board believes it is essential to our ability to
attract, retain, and motivate highly qualified employees in an extremely competitive environment both in the United States and internationally.

Amount of Shares of Common Stock. The number of shares of our common stock initially reserved for issuance under the 2018 Plan was 2,000,000, which number is automatically
increased on the first day of each quarter, beginning on April 1, 2018 and for each quarter thereafter through October 1, 2028, by a number of shares of common stock equal to the least of
(i) 1,000,000 shares, (ii) twenty percent (20%) of the outstanding shares of common stock on the last day of the immediately preceding calendar quarter, or (iii) such number of shares that
may be determined by the Board. The amount of shares available for issuance is not adjusted in connection with a change in the outstanding shares of common stock by reason of stock
dividends, stock splits, reverse stock splits, recapitalizations, mergers, consolidations, combinations or exchanges of shares, separations, reorganizations or liquidations; provided; however,
that in no event will the Company issue more than 42,000,000 shares of common stock under the 2018 Plan, including the maximum amount of shares of common stock that may be added
to the 2018 Plan in accordance with the automatic quarterly increases.

Types  of  Awards .  The  2018  Plan  provides  for  the  granting  of  incentive  stock  options,  non-qualified  stock  options  (“NQSOs”),  stock  grants  and  other  stock-based  awards,

including Restricted Stock and Restricted Stock Units (as defined in the 2018 Plan).

●

●

●

Incentive and Nonqualified Stock Options. The plan administrator determines the exercise price of each stock option. The exercise price of an NQSO may not be less than the fair
market value of our common stock on the date of grant. The exercise price of an incentive stock option may not be less than the fair market value of our common stock on the date
of grant if the recipient holds 10% or less of the combined voting power of our securities, or 110% of the fair market value of a share of our common stock on the date of grant
otherwise.

Stock Grants. The plan administrator may grant or sell stock, including restricted stock, to any participant, which purchase price, if any, may not be less than the par value of shares
of our common stock. The stock grant will be subject to the conditions and restrictions determined by the administrator. The recipient of a stock grant shall have the rights of  a
stockholder with respect to the shares of stock issued to the holder under the 2018 Plan.

Stock-Based Awards. The plan administrator of the 2018 Plan may grant other stock-based awards, including stock appreciation rights, restricted stock and restricted stock units,
with  terms  approved by the administrator, including restrictions related to the awards. The holder of a stock-based award shall not have the rights of a stockholder except to the
extent permitted in the applicable agreement.

Plan Administration. Our Board is the administrator of the 2018 Plan, except to the extent it delegates its authority to a committee, in which case the committee shall be the
administrator. Our Board has delegated this authority to our compensation committee. The administrator has the authority to determine the terms of awards, including exercise and purchase
price,  the  number  of  shares  subject  to  awards,  the  value  of  our  common  stock,  the  vesting  schedule  applicable  to  awards,  the  form  of  consideration,  if  any,  payable  upon  exercise  or
settlement of an award and the terms of award agreements for use under the 2018 Plan.

64

 
 
 
 
 
 
 
 
 
 
 
 
Eligibility. The plan administrator will determine the participants in the 2018 Plan from among our employees, directors and consultants. A grant may be approved in advance

with the effectiveness of the grant contingent and effective upon such person’s commencement of service within a specified period.

Termination of Service. Unless otherwise provided by the administrator or in an award agreement, upon a termination of a participant’s service, all unvested options then held by

the participant will terminate and all other unvested awards will be forfeited.

Transferability. Awards under the 2018 Plan may not be transferred except by will or by the laws of descent and distribution, unless otherwise provided by the plan administrator

in its discretion and set forth in the applicable agreement, provided that no award may be transferred for value.

Adjustment.  In  the  event  of  a  stock  dividend,  stock  split,  recapitalization  or  reorganization  or  other  change  in  change  in  capital  structure,  the  plan  administrator  will  make

appropriate adjustments to the number and kind of shares of stock or securities subject to awards.

Corporate Transaction.  If  we  are  acquired,  the  plan  administrator  will:  (i)  arrange  for  the  surviving  entity  or  acquiring  entity  (or  the  surviving  or  acquiring  entity’s  parent
company) to assume or continue the award or to substitute a similar award for the award; (ii) cancel or arrange for cancellation of the award, to the extent not vested or not exercised prior to
the effective time of the transaction, in exchange for such cash consideration, if any, as the plan administrator in its sole discretion, may consider appropriate; or (iii) make a payment, in
such form as may be determined by the plan administrator equal to the excess, if any, of (A) the value of the property the holder would have received upon the exercise of the award
immediately  prior  to  the  effective  time  of  the  transaction,  over  (B)  any  exercise  price  payable  by  such  holder  in  connection  with  such  exercise.  In  addition  in  connection  with  such
transaction, the plan administrator may accelerate the vesting, in whole or in part, of the award (and, if applicable, the time at which the award may be exercised) to a date prior to the
effective time of such transaction and may arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us with respect to an award.

Amendment and Termination. The 2018 Plan will terminate on January 4, 2028 or at an earlier date by vote of our Board; provided, however, that any such earlier termination
shall not affect any awards granted under the 2018 Plan prior to the date of such termination. The 2018 Plan may be amended by our Board, except that our Board may not alter the terms of
the 2018 Plan if it would adversely affect a participant’s rights under an outstanding stock right without the participant’s consent.

The  Board  may  at  any  time  amend  or  terminate  the  2018  Plan;  provided  that  no  amendment  may  be  made  without  the  approval  of  the  stockholder  if  such  amendment  would
increase either the maximum number of shares which may be granted under the 2018 Plan or any specified limit on any particular type or types of award, or change the class of employees
to whom an award may be granted, or withdraw the authority to administer the 2018 Plan from a committee whose members satisfy the independence and other requirements of Section
162(m) and applicable SEC and Nasdaq requirements. Pursuant to the listing standards of the Nasdaq Stock Market, certain other material revisions to the 2018 Plan may also require
stockholder approval.

Federal  Income  Tax  Consequences  of  the  2018  Plan. The federal income tax consequences of grants under the 2018 Plan will depend on the type of grant. The following is a
general summary of the principal United States federal income taxation consequences to participants and us under current law with respect to participation in the 2018 Plan. This summary
is not intended to be exhaustive and does not discuss the income tax laws of any city, state or foreign jurisdiction in which a participant may reside or the rules applicable to deferred
compensation  under  Section  409A  of  the  Code.  Our  ability  to  realize  the  benefit  of  any  tax  deductions  described  below  depends  on  our  generation  of  taxable  income  as  well  as  the
requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of our tax reporting obligations.

65

 
 
 
 
 
 
 
 
 
 
From the grantees’ standpoint, as a general rule, ordinary income will be recognized at the time of delivery of shares of our common stock or payment of cash under the 2018
Plan. Future appreciation on shares of our common stock held beyond the ordinary income recognition event will be taxable as capital gain when the shares of our common stock are sold.
The tax rate applicable to capital gain will depend upon how long the grantee holds the shares. We, as a general rule, will be entitled to a tax deduction that corresponds in time and amount
to the ordinary income recognized by the grantee, and we will not be entitled to any tax deduction with respect to capital gain income recognized by the grantee.

Exceptions to these general rules arise under the following circumstances:

●

●

If shares  of  our  common  stock,  when  delivered,  are  subject  to  a  substantial  risk  of  forfeiture by  reason  of  any  employment  or  performance-related  condition,  ordinary  income
taxation and our tax deduction will be delayed until the risk of forfeiture lapses, unless the grantee makes a special election to accelerate taxation under section 83(b) of the Code.

If an employee exercises a stock option that qualifies as an ISO, no ordinary income will be recognized, and we will not be entitled to any tax deduction, if shares of our common
stock acquired upon exercise of the stock option are held until the later of (A) one year from the date of exercise and (B) two years from the date of grant. However, if the employee
disposes  of  the  shares  acquired  upon  exercise  of  an  ISO  before  satisfying both  holding  period  requirements,  the  employee  will  recognize  ordinary  income  at  the time  of  the
disposition equal to the difference between the fair market value of the shares on the date of exercise (or the amount realized on the disposition, if less) and the exercise price, and we
will be entitled to a tax deduction in that amount. The gain, if any, in excess of the amount recognized as ordinary income will be long-term or short-term capital gain, depending
upon the length of time the employee held the shares before the disposition.

● A grant may be subject to a 20% tax, in addition to ordinary income tax, at the time the grant becomes vested, plus interest, if the grant constitutes deferred compensation under

section 409A of the Code and the requirements of section 409A of the Code are not satisfied.

Section 162(m) of the Code generally disallows a publicly held corporation’s tax deduction for compensation paid to its chief executive officer or certain other officers in excess
of $1 million in any year. Qualified performance-based compensation is excluded from the $1 million deductibility limit, and therefore remains fully deductible by the corporation that pays
it. We intend that options and SARs granted under the 2018 Plan will be qualified performance-based compensation. Stock units, stock awards, dividend equivalents, and other stock-based
awards granted under the 2018 Plan may be designated as qualified performance-based compensation if the Committee conditions such grants on the achievement of specific performance
goals in accordance with the requirements of section 162(m) of the Code.

We have the right to require that grantees pay to us an amount necessary for us to satisfy our federal, state or local tax withholding obligations with respect to grants. We may
withhold from other amounts payable to a grantee an amount necessary to satisfy these obligations. The Committee may permit a grantee to satisfy our withholding obligation with respect
to  grants  paid  in  shares  of  our  common  stock  by  having  shares  withheld,  at  the  time  the  grants  become  taxable,  provided  that  the  number  of  shares  withheld  does  not  exceed  the
individual’s minimum applicable withholding tax rate for federal, state and local tax liabilities.

2011 Employee Stock Incentive Plan

Except as set forth below, the material terms of our 2011 Employee Stock Incentive Plan, as amended to date (the “2011 Plan”) are substantially similar to the material terms of

the 2018 Plan. However, this description is not complete. For more information, we refer you to the full text of the 2011 Plan.

The 2011 Plan is intended to encourage ownership of common stock by our employees and directors and certain of our consultants in order to attract and retain such people, to

induce them to work for the benefit of us and to provide additional incentive for them to promote our success. The number of shares of our common stock available for issuance under the
2011 Plan is 2,640 as of December 31, 2018, which number is automatically increased on January 1 of each of year by 10% of the aggregate number of shares of common stock issued by
the Company in the prior calendar year.

66

 
 
 
 
 
 
 
 
 
 
 
 
Securities Authorized for Issuance under Equity Compensation Plans

The following table provides information as of December 31, 2018 regarding the shares of our common stock to be issued upon exercise of outstanding options or available for

issuance under equity compensation plans and other compensation arrangements that were (i) adopted by our security holders and (ii) were not approved by our security holders.

Plan Category
Equity compensation plans approved by security holders
Equity compensation plans not approved by security holders
Total

Number of
securities to be
issued upon
exercise of
outstanding
options
(a)

Weighted-
average exercise 
price of
outstanding
(b)

73,004(1)  $
39(3)  $
  $

73,043 

93.08     
43,392.86     
116.20     

Number of
securities
remaining
available for
future issuance
under equity
compensation
plans (excluding
securities
reflected in
column a) 
(c)
4,929,636(2)

0 
4,929,636 

(1) Represents 215 shares of common stock that may be issued pursuant to outstanding stock options granted under the 2011 Plan and 72,789 shares of common stock that may be issued

pursuant to outstanding stock options granted under the 2018 Plan.

(2) Represents 2,425 shares of common stock available for future issuance in connection with equity award grants under the 2011 Plan and 4,927,211 shares of common stock available for

future issuance in connection with equity award grants under the 2018 Plan.

(3) Represents shares of common stock issuable upon the exercise of stock options granted to Nadir Ali on August 14, 2013 outside of the 2011 Plan and the 2018 Plan.

Director Compensation

The following table provides certain summary information concerning compensation awarded to, earned by or paid to our Directors in the year ended December 31, 2018 except

Nadir Ali, whose aggregate compensation information has been disclosed above.

Fees Earned or
paid in cash
($)

Stock
awards
($)

Option awards
($)

Non-equity Incentive
plan compensation ($)    

Nonqualified deferred
compensation
earnings
($)

All other compensation
($)

Total
($)

55,000     
52,000     
45,500     

—     
—     
—     

—     
—     
—     

    —     
—     
—     

    —    $
—    $
—    $

    —    $
—    $
—    $

55,000 
52,000 
45,500 

Name
Leonard Oppenheim  $
  $
Kareem Irfan
  $
Tanveer Khader

Directors are entitled to reimbursement of ordinary and reasonable expenses incurred in exercising their responsibilities and duties as a director.

Effective  July  1,  2015,  the  Board  approved  the  following  compensation  plan  for  the  independent  directors  payable  in  accordance  with  each  independent  director’s  services
agreement: $30,000 per year for their services rendered on the Board, $15,000 per year for service as the audit committee chair, $10,000 per year for service as the compensation committee
chair, $6,000 per year for service on the audit committee, $4,000 per year for service on the compensation committee, $2,500 per year for service on the nominating committee, a one-time
non-qualified stock option grant to purchase 20,000 shares (on a pre-Reverse Splits basis) of the Company’s common stock under the 2011 Plan and restricted stock awards of 20,000
shares (on a pre-Reverse Splits basis) of common stock under the 2011 Plan, which are granted in four equal installments on a quarterly basis and are each 100% vested upon grant.

67

 
 
 
 
 
 
 
   
 
   
   
   
 
  
 
 
 
   
   
   
   
   
 
  
 
 
During the year ended December 31, 2018, the independent directors did not receive any non-qualified stock options or restricted stock awards.

On January 25, 2019, each independent director entered into an amendment to his respective director services agreement pursuant to which the Company agreed to grant each
independent director, so long as such director continues to fulfill his duties and provide services pursuant to their services agreement, an annual non-qualified stock option to purchase up to
20,000 shares of common stock in lieu of the above-mentioned equity awards. Each stock option grant will be subject to the approval of the Board, which shall determine the appropriate
vesting schedule, if any, and the exercise price. 

 ITEM 12: SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth certain information as of March 20, 2019, regarding the beneficial ownership of our common stock by the following persons:

●

●

●

●

our Named Executive Officers;

each director;

all of our executive officers and directors as a group; and

each person or entity who, to our knowledge, owns more than 5% of our common stock.

Except as indicated in the footnotes to the following table, subject to applicable community property laws, each stockholder named in the table has sole voting and investment
power. Unless otherwise indicated, the address for each stockholder listed is c/o Inpixon, 2479 E. Bayshore Road, Suite 195, Palo Alto, California 94303. Shares of common stock subject
to options, warrants, or other rights currently exercisable or exercisable within 60 days of March 20, 2019, are deemed to be beneficially owned and outstanding for computing the share
ownership  and  percentage  of  the  stockholder  holding  the  options,  warrants  or  other  rights,  but  are  not  deemed  outstanding  for  computing  the  percentage  of  any  other  stockholder. The
information provided in the following table is based on our records, information filed with the SEC, and information furnished by our stockholders.

Name of Beneficial Owner
Named Executive Officers and Directors
Nadir Ali
Leonard Oppenheim
Kareem Irfan
Tanveer Khader
Soumya Das
Wendy Loundermon
All executive officers and directors as a group (6 persons)
More than 5% Beneficial Owner
Hudson Bay Master Fund Ltd. (9)

*

Represents beneficial ownership of less than 1%.

(1) Based on 6,973,522 shares outstanding on March 20, 2019.

68

Amount and
nature of
beneficial
ownership

Percent of
Class(1)

139,162(2)    
20,009(3)    
20,006(4)    
20,126(5)    
83,410(6)    
97,330(7)    
380,044(8)    

* 
* 
* 
* 
* 
* 
* 

599,021(10)   

7.9%

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
   
   
   
   
   
   
   
   
  
   
  
   
 
 
 
(2)

(3)

(4)

(5)

(6)

(7)

(8)

Includes (i) 32 shares of common stock held of record by Nadir Ali, (ii) 139,078 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20,
2019, (iii) 3 shares of common stock held of record by Lubna Qureishi, Mr. Ali’s wife, (iv) 3 shares of common stock held of record by Naheed Qureishi, Mr. Ali’s mother-in-law, (v)
15  shares  of  common  stock  held  of  record  by  the  Qureishi  Ali  Grandchildren  Trust,  of  which  Mr.  Ali  is  the  joint-trustee  (with  his  wife  Lubna  Qureishi)  of  the  Qureishi  Ali
Grandchildren Trust and has shared voting and investment control over the shares held, and (vi) 31 shares of common stock held of record by the Qureishi 1998 Family Trust, of which
Mr. Ali’s father-in-law, A. Salam Qureishi, is the sole trustee and has voting and investment control over the shares held.
Includes  (i)  6  shares  of  common  stock  held  of  record  by  Mr. Oppenheim,  and  (ii)  20,003  shares  of  common  stock  issuable  upon  exercise  of  options  exercisable  within  60  days  of
March 20, 2019.
Includes (i) 3 shares of common stock held of record by Mr. Irfan and (ii) 20,003 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20,
2019.
Includes (i) 120 shares of common stock owned directly by SyHolding Corp., (ii) 3 shares of common stock held of record by Mr. Khader and (iii) 20,003 shares of common stock
issuable upon exercise of options exercisable within 60 days of March 20, 2019. Tanveer Khader holds the power to vote and dispose of the SyHolding Corp. shares.
Includes (i) 4 shares of common stock held of record by Mr. Das and (ii) 83,406 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20,
2019.
Includes (i) 1 shares of common stock held of record by Ms. Loundermon and (ii) 97,329 shares of common stock issuable upon exercise of options exercisable within 60 days of
March 20, 2019.
Includes (i) 56 shares of common stock held directly, or by spouse or relative, (ii) 166 shares of common stock held of record by entities, and (iii) 379,822 shares of common stock
issuable upon exercise of options exercisable within 60 days of March 20, 2019.

(9) Hudson Bay Capital Management LP, the investment manager of Hudson Bay Master Fund Ltd., has voting and investment power over these securities. Sander Gerber is the managing
member of Hudson Bay Capital GP LLC, which is the general partner of Hudson Bay Capital Management, L.P. Each of Hudson Bay Master Fund Ltd. and Sander Gerber disclaims
beneficial ownership over these securities. The mailing address of this beneficial holder is 777 Third Avenue, 30th Floor, New York, New York 10017.
Includes (i) 2,355 shares of common stock issuable upon exercise of a warrant to purchase common stock, dated January 8, 2018, exercisable within 60 days of March 20, 2019, (ii)
234,622 shares of common stock issuable upon exercise of a warrant to purchase common stock, dated February 20, 2018, exercisable within 60 days of March 20, 2019, (iii) 361,842
shares of common stock issuable upon exercise of a warrant to purchase common stock, dated April 24, 2018, exercisable within 60 days of March 20, 2019, and (iv) 202 shares of
common stock issuable upon conversion of 1 share of Series 4 Convertible Preferred Stock convertible within 60 days of March 20, 2019.

(10)

 ITEM 13: CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Review, Approval or Ratification of Transactions with Related Persons.

The Board reviews issues involving potential conflicts of interest, and reviews and approves all related party transactions, including those required to be disclosed as a “related
party” transaction under applicable federal securities laws. The Board has not adopted any specific procedures for conducting reviews of potential conflicts of interest and considers each
transaction in light of the specific facts and circumstances presented. However, to the extent a potential related party transaction is presented to the Board, the Company expects that the
Board would become fully informed regarding the potential transaction and the interests of the related party, and would have the opportunity to deliberate outside of the presence of the
related party. The Company expects that the Board would only approve a related party transaction that was in the best interests of the Company, and further would seek to ensure that any
completed related party transaction was on terms no less favorable to the Company than could be obtained in a transaction with an unaffiliated third party. Other than as described below,
no transaction requiring disclosure under applicable federal securities laws occurred during fiscal year 2018 that was submitted to the Board for approval as a “related party” transaction.

Related Party Transactions

SEC regulations define the related person transactions that require disclosure to include any transaction, arrangement or relationship in which the amount involved exceeds the
lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed fiscal years in which we were or are to be a participant and in which a related
person  had  or  will  have  a  direct  or  indirect  material  interest. A  related  person  is:  (i)  an  executive  officer,  director  or  director  nominee,  (ii)  a  beneficial  owner  of  more  than  5%  of  our
common stock, (iii) an immediate family member of an executive officer, director or director nominee or beneficial owner of more than 5% of our common stock, or (iv) any entity that is
owned or controlled by any of the foregoing persons or in which any of the foregoing persons has a substantial ownership interest or control.

For the period from January 1, 2017, through the date of this report (the “Reporting Period”), described below are certain transactions or series of transactions between us and

certain related persons.

69

 
 
 
 
 
 
 
 
 
Sysorex Consulting, Inc. Transactions

The Company has borrowed funds from Sysorex Consulting, Inc.(“SCI”), which was a stockholder of the Company and for which Abdus Salam Qureishi, the former Chairman of
the Board, is the majority stockholder, pursuant to an oral agreement with no stated interest rate and which is payable upon demand. Mr. Qureishi is also our Chief Executive Officer’s
father-in-law and a member of his household. These advances were made to fund operations of SCI and recorded as intercompany accounts without any written agreement. The largest
aggregate amount of principal outstanding during the year ended December 31, 2017 was $665,554. Non-interest bearing amounts due on demand from SCI to Sysorex Arabia was $0 as of
December 31, 2017 as on that date the Company received 82.5% of Sysorex India from SCI in exchange for the amount owed under this receivable by SCI and accordingly the balance of
this receivable was $0.

Effective  as  of  December  31,  2017,  the  Company  acquired  approximately  82.5%  of  the  outstanding  equity  securities  of  Sysorex  India  Limited  (“Sysorex  India”)  from  SCI
pursuant to that certain Stock Purchase Agreement dated as of December 31, 2017 by and among the Company, SCI and Sysorex India, for aggregate consideration for the assignment by
the Company of $666,000 of outstanding receivables.

On January 18, 2018, the Company sold its 50.2% interest in Sysorex Arabia to SCI in consideration for SCI’s assumption of 50.2% of the assets and liabilities of Sysorex Arabia,

totaling approximately $11,400 and $1,031,000, respectively.

Agreements with Duroob Technology, Inc.

During 2015, the Company borrowed funds for working capital from Duroob Technology, Inc., a Saudi Arabian limited liability company (“Duroob”), a related party as Duroob’s
CEO owns a minority interest in Sysorex Arabia LLC, pursuant to an oral agreement with no stated interest rate and which is payable upon demand. As of December 31, 2018 and 2017,
Duroob was owed $0 and $4,802, respectively. The largest aggregate amount of principal outstanding during the years ended December 31, 2018 and 2017 was $4,802, and there were no
interest payments paid during such years. Sysorex Arabia LLC is 50.2% owned by the Company and 49.8% owned by Abdul Aziz Salloum (“Salloum”), its general manager. Salloum is
also the CEO and principal stockholder of Duroob. As disclosed above, on January 18, 2018, the Company sold its 50.2% interest in Sysorex Arabia to SCI in consideration for SCI’s
assumption of 50.2% of the assets and liabilities of Sysorex Arabia.

Consulting Agreement

Kevin Harris, our former Chief Financial Officer, resigned as of July 14, 2017. Mr. Harris served as a senior financial advisor to the Company’s Chief Executive Officer until
August 31, 2017. In that new role, Mr. Harris was an at-will employee with monthly compensation of $10,000. Pursuant to the terms of the Harris Employment Agreement, Mr. Harris was
entitled  to  a  cash  bonus  of  approximately  $53,000  as  of  the  date  of  his  resignation.  The  Company  agreed  to  pay  such  bonus  as  soon  as  possible  but  no  later  than  over  3  pay  periods,
beginning with the pay period ending July 31, 2017. This arrangement terminated on August 31, 2017.

Sysorex Transactions

Nadir Ali, Chief Executive Officer and member of the Board, is also the Chairman of Sysorex.

Employee Transition Agreements

Pursuant  to  the  terms  of  those  certain  employee  transition  agreements  entered  into  between  the  Company  and  Sysorex,  effective  as  of  August  31,  2018  (collectively,  the
“Transition Agreements”), Sysorex agreed to furnish to the Company, on a transitional basis, the services of certain of its employees and keep such employees’ on its payroll and benefits
plans from August 31, 2018 through and including December 31, 2018 (the “Transitional Period”).  The Company agreed to reimburse Sysorex for all costs and expenses incurred by
Sysorex with respect to such employees’ employment during the Transitional Period.  Sysorex agreed to invoice the Company upon the calculation of amounts owed for the foregoing costs,
and the Company agreed to reimburse Sysorex for all such costs within 3 days of its receipt of each such invoice, plus an administrative service fee of 2% of the gross amount of each
respective invoice; provided, however, that Sysorex agreed waive such fee for so long as any Company employees are providing any necessary administrative services on behalf of and for
the benefit of Sysorex, including any employees that are furnished to the Company in accordance with the Transition Agreements.

70

 
 
 
 
 
  
 
 
 
 
 
 
 
 
Sysorex Revolving Loan

On December 31, 2018, the Company and Sysorex entered into a note purchase agreement (the “Note Purchase Agreement”) pursuant to which the Company agreed to purchase
from Sysorex at a purchase price equal to the Loan Amount (as defined below), a secured promissory note (the “Secured Note”) for up to an aggregate principal amount of 3,000,000.00
(the  “Principal Amount”),  including  any  amounts  advanced  through  the  date  of  the  Secured  Note  (the  “Prior Advances”),  to  be  borrowed  and  disbursed  in  increments  (such  borrowed
amount, together with the Prior Advances, collectively referred to as the “Loan Amount”), with interest to accrue at a rate of 10% percent per annum on all such Loan Amounts, beginning
as of the date of disbursement with respect to any portion of such Loan Amount. In addition, Sysorex agreed to pay $20,000 to the Company to cover the Company’s legal fees, accounting
costs, due diligence, monitoring and other transaction costs incurred in connection with the purchase and sale of the Secured Note (the “Transaction Expense Amount”), all of which amount
is included in the Principal Amount. Sysorex may borrow repay and borrow under the Secured Note, as needed, for a total outstanding balance, exclusive of any unpaid accrued interest, not
to exceed the Principal Amount at any one time.

All  sums  advanced  by  the  Company  to  the  Maturity  Date  (as  defined  below)  pursuant  to  the  terms  of  the  Note  Purchase Agreement  will  become  part  of  the  aggregate  Loan
Amount underlying the  Secured  Note. All  outstanding  principal  amounts  and  accrued  unpaid  interest  owing  under  the  Secured  Note  shall  become  immediately  due  and  payable  on  the
earlier  to  occur  of  (i)  24  month  anniversary  of  the  date  the  Secured  Note  is  issued  (the  “Maturity  Date”),  (ii)  at  such  date  when  declared  due  and  payable  by  the  Company  upon  the
occurrence of an Event of Default (as defined in the Secured Note), or (iii) at any such earlier date as set forth in the Secured Note. All accrued unpaid interest shall be payable in cash. On
February 4, 2019, the Secured Note was amended to increase the maximum principal amount that may be outstanding at any time under the Secured Note from $3,000,000 to $5,000,000.
The amount owed by Sysorex to the Company as of December 31, 2018 was $2.2 million. The largest aggregate principal amount owed by Sysorex to the Company during the Reporting
Period is $2.6 million, the amount of principal paid during the Reporting Period was $956,000 and the interest paid during the Reporting Period was $53,000. Since the end of the period
covered by this report, the maximum loan amount has been fully extended to Sysorex.

 ITEM 14: PRINCIPAL ACCOUNTANT FEES AND SERVICES

Set forth below are approximate fees for services rendered by Marcum LLP, our independent registered public accounting firm, for the fiscal years ended December 31, 2018 and

2017.

Audit Fees(1)
Audit Related Fees
Tax Fees
All Other Fees

2018

2017

499,850 
-- 
-- 
-- 

  $
  $
  $
  $

453,894 
2,163 
-- 
-- 

  $
  $
  $
  $

(1) Audit fees represent fees for professional services provided in connection with the audit of our financial statements and review of our quarterly financial statements and audit services

provided in connection with other statutory or regulatory filings.

Audit Fees. The “Audit Fees” are the aggregate fees of Marcum attributable to professional services rendered in 2018 and 2017 for the audit of our annual financial statements, for review
of  financial  statements  included  in  our  quarterly  reports  on  Form  10-Q  or  for  services  that  are  normally  provided  by  Marcum  in  connection  with  statutory  and  regulatory  filings  or
engagements for that fiscal year. These fees include fees billed for professional services rendered by Marcum for the review of registration statements or services that are normally provided
in connection with statutory and regulatory filings or engagements for those fiscal years.

Audit-Related Fees. Marcum billed us for professional services that were reasonably related to the performance of the audit or review of financial statements in 2018 and 2017, which are
not included under Audit Fees above including the filing of our registration statements, including our Registration Statement on Form S-3. This amount also includes audit fees related to
acquisitions.

Tax Fees. Marcum did not perform any tax advice or planning services in 2018 or 2017.

All Other Fees. Marcum did not perform any services for us or charge any fees other than the services described above in 2018 and 2017.

Pre-approval Policies and Procedures

The Audit Committee is required to review and approve in advance the retention of the independent auditors for the performance of all audit and lawfully permitted non-audit
services and the fees for such services. The Audit Committee may delegate to one or more of its members the authority to grant pre-approvals for the performance of non-audit services, and
any such Audit Committee member who pre-approves a non-audit service must report the pre-approval to the full Audit Committee at its next scheduled meeting. The Audit Committee is
required to periodically notify the Board of their approvals. The required pre-approval policies and procedures were complied with during 2018.

71

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

15(a)(1) Financial Statements

 PART IV

The financial statements filed as part of this report are listed and indexed in the table of contents. Financial statement schedules have been omitted because they are not applicable

or the required information has been included elsewhere in this report.

15(a)(2) Financial Statement Schedules

Not applicable.

15(a)(3) Exhibits

The exhibits filed as part of this Annual Report on Form 10-K are listed in the Exhibit Index immediately preceding the exhibits. The Company has identified in the Exhibit Index

each management contract and compensation plan filed as an exhibit to this Annual Report on Form 10-K in response to Item 15(a)(3) of Form 10-K.

 ITEM 16. FORM 10-K SUMMARY.

Not applicable.

72

 
 
 
 
 
 
 
 
 
  
 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,

 SIGNATURES

thereunto duly authorized.

Date: March 28, 2019

INPIXON

By:

/s/ Nadir Ali
Nadir Ali
Chief Executive Officer

Each person whose signature appears below constitutes and appoints Nadir Ali and Wendy Loundermon, and each of them, as his or her true and lawful attorney-in-fact and agent,
with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on
Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and
purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes, may lawfully do or
cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities

and on the dates indicated:

/s/ Nadir Ali
Nadir Ali

/s/ Wendy Loundermon
Wendy Loundermon

/s/ Leonard A. Oppenheim
Leonard A. Oppenheim

/s/ Kareem Irfan
Kareem Irfan

/s/ Tanveer Khader
Tanveer Khader

Signature

Title

  Chief Executive Officer and Director
  (Principal Executive Officer)

  Vice President of Finance
  (Principal Financial and Accounting Officer)

  Director

  Director

  Director

73

Date

March 28, 2019

March 28, 2019

March 28, 2018

March 28, 2019

March 28, 2019

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
 
 
 
   
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
Exhibit
Number

2.1†

2.2

2.3

2.4

2.5

2.6

2.7†

2.8

2.9†

2.10

EXHIBIT INDEX

Exhibit Description

Form

File No.

  Exhibit

Filing Date

Filed
Herewith

Incorporated by Reference

  Asset Purchase and Merger Agreement dated March 1, 2013 by and among Sysorex
Global Holdings Corp., Lilien, LLC and Lilien Systems.

  Agreement and Plan of Merger dated August 31, 2013 by and among Sysorex Global
Holdings Corp., Sysorex Merger Sub, Inc., Shoom, Inc. and the Shareholder
Representative.

S-1

S-1

333-190574

2.1

  August 12, 2013  

333-191648

2.4

  October 9, 2013  

  Agreement and Plan of Merger dated as of December 20, 2013, by and among
Sysorex Global Holdings Corp., AirPatrol Corporation, AirPatrol Acquisition Corp.
I, AirPatrol Acquisition Corp. II, and Shareholders Representative Services LLC.

S-1/A

333-191648

2.6

  January 21, 2014  

  Amendment No. 1 to Agreement and Plan of Merger dated February 28, 2014 with
AirPatrol Corporation.

S-1/A

333-191648

2.7

  March 13, 2014  

  Amendment No. 2 to Agreement and Plan of Merger dated April 18, 2014 with
AirPatrol Corporation.

  Waiver and Amendment No. 3 to Agreement and Plan of Merger dated May 30, 2014
with AirPatrol Corporation.

  Asset Purchase Agreement, dated as of April 24, 2015, between Sysorex Global
Holdings Corp., LightMiner Systems, Inc. and Chris Baskett.

  Agreement and Plan of Merger, dated as of December 14, 2015, between Sysorex
Global Holdings Corp. and Sysorex Global.

  Asset Purchase Agreement, dated November 14, 2016, among Integrio Technologies,
LLC, Emtec Federal, LLC, Sysorex Government Services, Inc. and Sysorex Global.

  Amendment No. 1 to Asset Purchase Agreement, dated as of November 21, 2016, by
and among Sysorex Global, Sysorex Government Services, Inc., Integrio
Technologies, LLC and Emtec Federal, LLC.

8-K

S-1

8-K

8-K

8-K

8-K

001-36404

2.8

  April 24, 2014

333-198502

12.9

  August 29, 2014  

001-36404

2.1

  April 30, 2015

001-36404

10.3

  December 18,

2015

001-36404

2.1

  November 18,

2016

001-36404

2.2

  November 28,

2016

74

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Exhibit
Number
2.11

  Agreement and Plan of Merger, dated as of February 27, 2017, between Sysorex
Global and Inpixon.

Exhibit Description

Form
8-K

File No.
001-36404

  Exhibit

Filing Date

2.1

  March 1, 2017

Filed
Herewith

  Agreement and Plan of Merger, dated as of July 25, 2018, between Inpixon USA and
Sysorex, Inc.

8-K

001-36404

2.1

July 31, 2018

  Separation and Distribution Agreement, dated August 7, 2018 between Inpixon and
Sysorex, Inc.

10-Q

001-36404

2.1

  August 13, 2018  

2.12

2.13

2.14

3.1

3.2

3.3

3.4

3.5

3.6

3.7

3.8

3.9

  Amendment No. 1 to Separation and Distribution Agreement dated August 31, 2018
between Inpixon and Sysorex, Inc.

  Restated Articles of Incorporation.

  Certificate of Amendment to Articles of Incorporation (Increase Authorized Shares).

  Certificate of Amendment to Articles of Incorporation (Reverse Split).

  Articles of Merger (renamed Sysorex Global).

  Articles of Merger (renamed Inpixon).

  Certificate of Amendment to Articles of Incorporation (Reverse Split).

  Certificate of Amendment to Articles of Incorporation (authorized share increase).

  Certificate of Amendment to Articles of Incorporation (Reverse Split).

  Certificate of Amendment to Articles of Incorporation (Reverse Split).

3.10

  Bylaws, as amended.

4.1

4.2

4.3

4.4

4.5

4.6

4.7

  Specimen Stock Certificate of the Company.

  Form of Certificate of Designation of Preferences, Rights and Limitations of Series 4
Convertible Preferred Stock.

  Certificate of Designation of Series 5 Convertible Preferred Stock, dated as of
January 14, 2019.

  Promissory Note, dated as of October 12, 2018.

  Promissory Note, dated as of December 21, 2018.

  Warrant to purchase common stock dated March 20, 2013 held by Bridge Bank N.A.

  Warrant to purchase common stock dated August 29, 2013 held by Bridge Bank
N.A.

8-K

S-1

S-1

8-K

8-K

8-K

8-K

8-K

8-K

8-K

S-1

S-1

8-K

8-K

8-K

8-K

S-1

S-1

001-36404

10.5

  September 4, 2018  

333-190574

333-218173

001-36404

001-36404

001-36404

001-36404

001-36404

001-36404

001-36404

333-190574

333-190574

001-36404

3.1

3.2

3.1

3.1

3.1

3.2

3.1

3.1

3.1

3.2

4.1

3.1

  August 12, 2013  

  May 22, 2017

  April 10, 2014

  December 18, 2015  

  March 1, 2017

  March 1, 2017

  February 5, 2018  

  February 6, 2018  

  November 1, 2018  

  August 12, 2013  

  August 12, 2013  

  April 24, 2018

001-36404

3.1

  January 15, 2019  

001-36404

001-36404

333-190574

333-191648

4.1

4.1

4.3

4.5

4.7

  October 18, 2018  

  December 31, 2018  

  August 12, 2013  

  October 9, 2013  

June 23, 2017

4.8

  Form of Warrant Agency Agreement.

S-1/A

333-218173

75

 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Filed
Herewith

X

X

X

Exhibit
Number
4.9

4.10

4.11

4.12

4.13

4.14

  Form of Additional Warrant.

Exhibit Description

  Form of Warrant.

  Form of Warrant.

  Form of Warrant.

  Form of Warrant.

  Form of Warrant Agency Agreement.

10.1+

  Amended and Restated 2011 Employee Stock Incentive Plan.

10.2+

  Form of Incentive Stock Option Agreement.

10.3+

  Form of Non-Qualified Stock Option Agreement.

10.4+

  Form of Restricted Stock Award Agreement.

10.5+

  2018 Employee Stock Incentive Plan.

10.6+

  2018 Employee Stock Incentive Plan Form of Incentive Stock Option Agreement.

10.7+

  2018 Employee Stock Incentive Plan Form of Non-Qualified Stock Option
Agreement.

10.8+

  Director Services Agreement with Leonard A. Oppenheim dated October 21, 2014.

10.9+

  Waiver and Amendment No. 1 to Board of Directors Services Agreement with
Leonard A. Oppenheim dated February 4, 2019.

Form
8-K

8-K

8-K

8-K

8-K

8-K

S-8

8-K

8-K

8-K

S-8

8-K

8-K

8-K

File No.
001-36404

001-36404

001-36404

001-36404

001-36404

001-36404

  Exhibit

4.1

4.1

4.1

4.1

4.1

4.2

Filing Date
  August 9, 2017  

January 9, 2018  

  February 16, 2018  

  April 24, 2018

  January 15, 2019  

  January 15, 2019  

333-195655

10.22

  May 2, 2014

001-36404

001-36404

001-36404

333-229374

001-36404

001-36404

10.9

10.5

10.6

99.1

10.1

10.2

  October 27, 2014  

  October 27, 2014  

  October 27, 2014  

  January 25, 2019  

  May 18, 2018

  May 18, 2018

001-36404

10.1

  October 27, 2014  

10.10+

  Director Services Agreement with Kareem M. Irfan dated October 21, 2014.

8-K

001-36404

10.3

  October 27, 2014  

10.11+

  Waiver and Amendment No. 1 to Board of Directors Services Agreement with
Kareem M. Irfan dated February 4, 2019.

10.12+

  Director Services Agreement with Tanveer A. Khader dated October 21, 2014.

8-K

001-36404

10.4

  October 27, 2014  

10.13+

10.14+

10.15+

10.16+

10.17+

  Waiver and Amendment No. 1 to Board of Directors Services Agreement with
Tanveer A. Khader dated February 4, 2019.

  Employment Agreement dated July 1, 2010, by and between the Company and Nadir
Ali, as amended.

S-1

333-191648

10.7

  October 9, 2013  

  Amended and Restated Employment Agreement by and between the Company and
Nadir Ali

10-Q

001-36404

10.14

  May 15, 2018

  Employment Agreement, effective as of October 1, 2014, between Wendy
Loundermon and the Company.

8-K

001-36404

10.8

  October 27, 2014  

  Employment Agreement dated November 4, 2016, by and between Sysorex USA and
Soumya Das.

10-K

 001-36404

10.51

  April 17, 2017

10.18+

  Amended Compensation Terms for Soumya Das

10.19+

  Amendment to Employment Agreement dated August 31, 2018 among Inpixon,
Sysorex, Inc. and Soumya Das

10.20+

  Offer Letter dated June 20, 2014, by and between Lilien Systems and Craig Harper.

10.21+

  Services Arrangement, effective July 14, 2017, between Kevin Harris and the

Company.

10-Q

8-K

10-K

8-K

001-36404

001-36404

10.9

10.8

  August 13, 2018  

  September 4, 2018  

001-36404

10.58

 April 17, 2017  

001-36404

10.2

July 20, 2017

76

 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit Description

  Lease Agreement dated August 21, 2014, by and between ECI Two Bayshore LLC
and Sysorex Global Holdings Corp.

Form

10-K

File No.

  Exhibit

Filing Date

Filed
Herewith

001-36404

10.57

  April 17, 2017

  Commercial Lease Amendment dated September 19, 2016, by and between 424116
B.C. Ltd. and Sysorex Canada Corp.

10-K

001-36404

10.53

  April 17, 2017

  Amended and Restated GemCap Loan and Security Agreement: Payplant Loan and
Security Agreement, by and among GemCap Lending, LLC, Inpixon, Inpixon USA,
Inpixon Federal, Inc. and Payplant LLC, as agent for Payplant Alternatives Fund
LLC.

  Payplant Client Agreement by and among Inpixon, Inpixon USA, Inpixon Federal,
Inc. and Payplant LLC.

  Amendment 1 to Payplant Client Agreement dated August 31, 2018 between
Inpixon, Sysorex, Inc., Sysorex Government Services, Inc. and Payplant LLC.

  Securities Purchase Agreement by and between Inpixon and Chicago Venture
Partners, L.P. dated November 17, 2017.

8-K

001-36404

10.1

  August 18, 2017  

8-K

8-K

001-36404

10.2

  August 18, 2017  

001-36404

10.7

  September 4, 2018  

10-Q

001-36404

10.12

  November 20, 2017  

  Convertible Promissory Note by and between Inpixon and Chicago Venture Partners,
L.P. dated November 17, 2017.

10-Q

001-36404

10.13

  November 20, 2017  

Exhibit
Number

10.22

10.23

10.24

10.25

10.26

10.27

10.28

10.29

  Waiver and First Amendment Agreement, dated January 5, 2018, by and between
Inpixon and certain note holder.

10.30

  Standstill Agreement.

10.31

  Standstill Agreement between Inpixon and Chicago Venture Partners, L.P.

10.32

  Exchange Agreement, dated as of October 5, 2018.

10.33

  Standstill Agreement, dated November 26, 2018.

10.34

  Exchange Agreement, dated as of January 29, 2019.

10.35

  Form of Securities Purchase Agreement, dated January 5, 2018.

10.36

  Placement Agency Agreement, dated January 5, 2018, by and between Inpixon and
ROTH Capital Partners, LLC.

10.37

  Form of Lead-out Agreement, dated January 5, 2018.

10.38

  Placement Agency Agreement, dated February 14, 2018, by and between Inpixon
and ROTH Capital Partners, LLC.

77

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

001-36404

10.4

January 9, 2018

001-36404

10.1

  May 25, 2018

001-36404

10.7

  September 4, 2018  

001-36404

10.1

  October 5, 2018

001-36404

10.1

  November 27, 2018  

001-36404

10.1

  January 29, 2019  

001-36404

001-36404

10.1

10.2

January 9, 2018

January 9, 2018

001-36404

10.5

January 9, 2018

001-36404

10.1

  February 16, 2018  

 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit
Number

Exhibit Description

Form

File No.

  Exhibit

Filing Date

Filed
Herewith

10.39

  Form of Securities Purchase Agreement.

10.40

  Form of Leak-Out Agreement

10.41

  Form of Lock-Up Agreement.

10.42

  Form of Securities Purchase Agreement.

10.43

  Disclosure Schedules to Form of Securities Purchase Agreement.

10.44

Placement Agency Agreement, dated April 20, 2018, by and between Inpixon and
ROTH Capital Partners, LLC.

10.45

  Form of Lock-Up Agreement.

10.46

Transition Services Agreement dated August 31, 2018 between Inpixon and
Sysorex, Inc.

10.47

  Tax Matters Agreement dated August 31, 2018 between Inpixon and Sysorex, Inc.

10.48

10.49

Employee Matters Agreement dated August 31, 2018 between Inpixon and Sysorex,
Inc.

Assignment and Assumption Agreement dated August 31, 2018 between members of
the Inpixon Group and members of the Sysorex Group

10.50

  Note Purchase Agreement, dated as of October 12, 2018.

10.51

  Note Purchase Agreement, dated as of December 21, 2018.

10.52

  Global Amendment, dated February 8, 2019.

10.53

  Form of Non-Transferable Subscription Rights Certificate.

10.54

10.55

10.56

10.57

10.58

Dealer-Manager Agreement, dated December 7, 2018, between Maxim Group LLC
and Inpixon.

Amendment to Dealer-Manager Agreement, dated January 14, 2019, between Maxim
Group LLC and Inpixon.

Note Purchase Agreement, dated as of December 31, 2018, by and between Inpixon
and Sysorex, Inc.

  Sysorex Secured Promissory Note, dated as of December 31, 2018.

First Amendment Agreement, dated as of February 4, 2019, between Inpixon and
Sysorex, Inc.

78

8-K

8-K

001-36404

001-36404

10.2

10.3

  February 16, 2018  

  February 16, 2018  

S-1/A

333-222125

10.63

  February 7, 2018  

8-K

10-Q

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

001-36404

10.1

  April 24, 2018  

001-36404

10.11

  May 15, 2018

001-36404

10.2

  April 24, 2018

001-36404

001-36404

001-36404

001-36404

10.3

10.1

10.2

10.3

  April 24, 2018  

  September 4, 2018

  September 4, 2018 

  September 4, 2018

001-36404

10.4

  September 4, 2018

001-36404

001-36404

10.1

10.1

  October 18, 2018  

  December 31,

2018

001-36404

10.1

  February 8, 2019  

001-36404

4.2

January 8, 2019  

001-36404

10.1

  December 7, 2018

001-36404

1.1

  January 15, 2019

001-36404

10.2

  December 31,

2018

001-36404

10.3

  December 31,

2018

001-36404

10.2

  February 8, 2019

 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit
Number
21

  List of Subsidiaries of the Company.

Exhibit Description

Form

File No.

  Exhibit

Filing Date

Filed
Herewith
X 

23.1

  Consent of Marcum LLP.

24.1

  Power of Attorney (included on the signature page).

31.1

31.2

32.1

Certification of the Company’s Principal Executive Officer pursuant to Section 302
of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on
Form 10-K for the year ended December 31, 2018.

Certification of the Company’s Principal Financial Officer pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on
Form 10-K for the year ended December 31, 2018.

Certification of the Company’s Principal Executive Officer and Principal Financial
Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

101.INS

XBRL Instant Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

X

X

X

X

X

X

X

X

X

X

X

+
†

Indicates a management contract or compensatory plan.
Exhibits and schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K and the registrant undertakes to furnish supplemental copies of any of the omitted exhibits and
schedules upon request by the Commission.

79

 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Waiver and Amendment No. 1
to
Board of Directors Services Agreement

Exhibit 10.9

This  Waiver  and Amendment  No.  1  to  Board  of  Directors  Services Agreement  (this  “Amendment”)  is  entered  into  as  of  February  4,  2019,  between  Inpixon, f/k/a

Sysorex Global Holdings Corp., a Nevada corporation (the “Company”), and Leonard A. Oppenheim, an individual (“Director”).

WHEREAS, the Company and Director entered into that certain Board of Directors Services Agreement, dated October 21, 2014 (the “Original Agreement”);

WHEREAS,  Section  2(d)  of  the  Original Agreement  provided  that  Director  shall  be  entitled  to  a  restricted  stock  award  equal  to  5,000  shares  per  quarter  (each,  a
“Quarterly  Stock Award”  and  collectively,  the  “Quarterly  Stock Awards”)  so  long  as  Director  continues  to  fulfill  Director’s  duties  and  provides  services  pursuant  to  the
Original Agreement;

WHEREAS,  the  Quarterly  Stock Awards  have  not  been  granted  to  Director  from  July  1,  2017  to  the  date  of  this Amendment  (the  “Unissued  Quarterly  Stock

Awards”);

WHEREAS,  Director  has  agreed  to  (i)  waive  any  such  Quarterly  Stock Awards  and  (ii)  amend  the  Original Agreement  to  remove  the  requirement  to  grant  future

Quarterly Stock Awards; and

WHEREAS, the Company and Director desire to amend the Original Agreement to provide for an annual grant of stock options to purchase up to 20,000 shares of the
Company’s  common  stock  in  accordance  with  this  Amendment  so  long  as  Director  continues  to  fulfill  Director’s  duties  and  provide  services  pursuant  to  the  Original
Agreement.

NOW THEREFORE, for consideration and as set forth herein, the parties hereto agree as follows:

1. Waiver. Director hereby waives any right under the Original Agreement to receive any Unissued Quarterly Stock Awards. Director acknowledges that by signing

this Amendment, the Company is released from any obligation to issue the Unissued Quarterly Stock Awards to Director.

2. Amendments to Original Agreement.

2.1 Section 2(c) of the Original Agreement is deleted and replaced in its entirety with the following:

“(c) Options. In addition to the above-mentioned compensation, Director shall also be entitled to non-qualified stock options to purchase up to 20,000 shares of
the Company’s common stock every calendar year so long as Director continues to fulfill Director’s duties and provide services pursuant to this Agreement,
issued under the Company’s equity incentive plan(s) (individually or collectively, the “Plan”), in accordance with the terms of the Plan and the standard non-
qualified stock option agreement under such plan (an “Annual Option Grant”). Each Annual Option Grant shall be subject to the approval of the Company’s
Board of Directors, which shall determine the appropriate vesting schedule, if any, and the exercise price in accordance with the terms and conditions of the
Plan.  In  the  event  of  a  change  in  the  outstanding  shares  of  common  stock  of  the  Company  by  reason  of  stock  dividends,  stock  splits,  reverse  stock  splits,
recapitalizations, mergers, consolidations, combinations or exchanges of shares, separations, reorganizations or liquidations, the number of shares of common
stock under an outstanding Annual Option Grant granted in accordance with this Section 2(c) shall be correspondingly adjusted, provided, that there shall be no
adjustment to the number of shares of common stock underlying the Annual Option Grant to be granted in accordance with this Section 2(c) subsequent to such
change.”

 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2. Section 2(d) of the Original Agreement is deleted in its entirety and replaced with the following:

“(d) Intentionally deleted.”

3. All references to the term “Agreement” in the Original Agreement shall be deemed to refer to the Original Agreement, as modified by this Amendment.

4. Except as otherwise provided in this Amendment, all of the terms, covenants and conditions of the Original Agreement shall remain in full force and effect.

[SIGNATURE PAGE FOLLOWS]

2

 
 
 
 
 
 
 
IN WITNESS WHEREOF, the parties hereto enter into this Amendment as of the date first set forth above.

THE COMPANY:

Inpixon

/s/ Nadir Ali

By:
Name:  Nadir Ali
Title:

Chief Executive Officer

DIRECTOR:

/s/ Leonard A. Oppenheim
Leonard A. Oppenheim

3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Waiver and Amendment No. 1
to
Board of Directors Services Agreement

Exhibit 10.11

This  Waiver  and Amendment  No.  1  to  Board  of  Directors  Services Agreement  (this  “Amendment”)  is  entered  into  as  of  February  4,  2019,  between  Inpixon, f/k/a

Sysorex Global Holdings Corp., a Nevada corporation (the “Company”), and Kareem M. Irfan, an individual (“Director”).

WHEREAS, the Company and Director entered into that certain Board of Directors Services Agreement, dated October 21, 2014 (the “Original Agreement”);

WHEREAS,  Section  2(d)  of  the  Original Agreement  provided  that  Director  shall  be  entitled  to  a  restricted  stock  award  equal  to  5,000  shares  per  quarter  (each,  a
“Quarterly  Stock Award”  and  collectively,  the  “Quarterly  Stock Awards”)  so  long  as  Director  continues  to  fulfill  Director’s  duties  and  provides  services  pursuant  to  the
Original Agreement;

WHEREAS,  the  Quarterly  Stock Awards  have  not  been  granted  to  Director  from  July  1,  2017  to  the  date  of  this Amendment  (the  “Unissued  Quarterly  Stock

Awards”);

WHEREAS,  Director  has  agreed  to  (i)  waive  any  such  Quarterly  Stock Awards  and  (ii)  amend  the  Original Agreement  to  remove  the  requirement  to  grant  future

Quarterly Stock Awards; and

WHEREAS, the Company and Director desire to amend the Original Agreement to provide for an annual grant of stock options to purchase up to 20,000 shares of the
Company’s  common  stock  in  accordance  with  this  Amendment  so  long  as  Director  continues  to  fulfill  Director’s  duties  and  provide  services  pursuant  to  the  Original
Agreement.

NOW THEREFORE, for consideration and as set forth herein, the parties hereto agree as follows:

1. Waiver. Director hereby waives any right under the Original Agreement to receive any Unissued Quarterly Stock Awards. Director acknowledges that by signing

this Amendment, the Company is released from any obligation to issue the Unissued Quarterly Stock Awards to Director.

2. Amendments to Original Agreement.

2.1 Section 2(c) of the Original Agreement is deleted and replaced in its entirety with the following:

“(c) Options.  In  addition  to  the  above-mentioned  compensation,  Director  shall  also  be  entitled  to  non-qualified  stock  options  to  purchase  up  to  20,000  shares  of  the
Company’s common stock every calendar year so long as Director continues to fulfill Director’s duties and provide services pursuant to this Agreement, issued under the
Company’s  equity  incentive  plan(s)  (individually  or  collectively,  the  “Plan”),  in  accordance  with  the  terms  of  the  Plan  and  the  standard  non-qualified  stock  option
agreement under such plan (an “Annual Option Grant”). Each Annual Option Grant shall be subject to the approval of the Company’s Board of Directors, which shall
determine  the  appropriate  vesting  schedule,  if  any,  and  the  exercise  price  in  accordance  with  the  terms  and  conditions  of  the  Plan.  In  the  event  of  a  change  in  the
outstanding  shares  of  common  stock  of  the  Company  by  reason  of  stock  dividends,  stock  splits,  reverse  stock  splits,  recapitalizations,  mergers,  consolidations,
combinations or exchanges of shares, separations, reorganizations or liquidations, the number of shares of common stock under an outstanding Annual Option Grant
granted in accordance with this Section 2(c) shall be correspondingly adjusted, provided, that there shall be no adjustment to the number of shares of common stock
underlying the Annual Option Grant to be granted in accordance with this Section 2(c) subsequent to such change.”

 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2. Section 2(d) of the Original Agreement is deleted in its entirety and replaced with the following:

“(d) Intentionally deleted.”

3. All references to the term “Agreement” in the Original Agreement shall be deemed to refer to the Original Agreement, as modified by this Amendment.

4. Except as otherwise provided in this Amendment, all of the terms, covenants and conditions of the Original Agreement shall remain in full force and effect.

[SIGNATURE PAGE FOLLOWS]

2

 
 
 
 
 
 
 
IN WITNESS WHEREOF, the parties hereto enter into this Amendment as of the date first set forth above.

THE COMPANY:

Inpixon

/s/ Nadir Ali

By:
Name:  Nadir Ali
Title:

Chief Executive Officer

DIRECTOR:

/s/ Kareem M. Irfan
Kareem M. Irfan

3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Waiver and Amendment No. 1
to
Board of Directors Services Agreement

Exhibit 10.13

This  Waiver  and Amendment  No.  1  to  Board  of  Directors  Services Agreement  (this  “Amendment”)  is  entered  into  as  of  February  4,  2019,  between  Inpixon, f/k/a

Sysorex Global Holdings Corp., a Nevada corporation (the “Company”), and Tanveer A. Khader, an individual (“Director”).

WHEREAS, the Company and Director entered into that certain Board of Directors Services Agreement, dated October 21, 2014 (the “Original Agreement”);

WHEREAS,  Section  2(d)  of  the  Original Agreement  provided  that  Director  shall  be  entitled  to  a  restricted  stock  award  equal  to  5,000  shares  per  quarter  (each,  a
“Quarterly  Stock Award”  and  collectively,  the  “Quarterly  Stock Awards”)  so  long  as  Director  continues  to  fulfill  Director’s  duties  and  provides  services  pursuant  to  the
Original Agreement;

WHEREAS,  the  Quarterly  Stock Awards  have  not  been  granted  to  Director  from  July  1,  2017  to  the  date  of  this Amendment  (the  “Unissued  Quarterly  Stock

Awards”);

WHEREAS,  Director  has  agreed  to  (i)  waive  any  such  Quarterly  Stock Awards  and  (ii)  amend  the  Original Agreement  to  remove  the  requirement  to  grant  future

Quarterly Stock Awards; and

WHEREAS, the Company and Director desire to amend the Original Agreement to provide for an annual grant of stock options to purchase up to 20,000 shares of the
Company’s  common  stock  in  accordance  with  this  Amendment  so  long  as  Director  continues  to  fulfill  Director’s  duties  and  provide  services  pursuant  to  the  Original
Agreement.

NOW THEREFORE, for consideration and as set forth herein, the parties hereto agree as follows:

1. Waiver. Director hereby waives any right under the Original Agreement to receive any Unissued Quarterly Stock Awards. Director acknowledges that by signing

this Amendment, the Company is released from any obligation to issue the Unissued Quarterly Stock Awards to Director.

2. Amendments to Original Agreement.

2.1 Section 2(c) of the Original Agreement is deleted and replaced in its entirety with the following:

“(c) Options. In addition to the above-mentioned compensation, Director shall also be entitled to non-qualified stock options to purchase up to 20,000 shares of
the Company’s common stock every calendar year so long as Director continues to fulfill Director’s duties and provide services pursuant to this Agreement,
issued under the Company’s equity incentive plan(s) (individually or collectively, the “Plan”), in accordance with the terms of the Plan and the standard non-
qualified stock option agreement under such plan (an “Annual Option Grant”). Each Annual Option Grant shall be subject to the approval of the Company’s
Board of Directors, which shall determine the appropriate vesting schedule, if any, and the exercise price in accordance with the terms and conditions of the
Plan.  In  the  event  of  a  change  in  the  outstanding  shares  of  common  stock  of  the  Company  by  reason  of  stock  dividends,  stock  splits,  reverse  stock  splits,
recapitalizations, mergers, consolidations, combinations or exchanges of shares, separations, reorganizations or liquidations, the number of shares of common
stock under an outstanding Annual Option Grant granted in accordance with this Section 2(c) shall be correspondingly adjusted, provided, that there shall be no
adjustment to the number of shares of common stock underlying the Annual Option Grant to be granted in accordance with this Section 2(c) subsequent to such
change.”

 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2. Section 2(d) of the Original Agreement is deleted in its entirety and replaced with the following:

“(d) Intentionally deleted.”

3. All references to the term “Agreement” in the Original Agreement shall be deemed to refer to the Original Agreement, as modified by this Amendment.

4. Except as otherwise provided in this Amendment, all of the terms, covenants and conditions of the Original Agreement shall remain in full force and effect.

[SIGNATURE PAGE FOLLOWS]

2

 
 
 
 
 
 
 
IN WITNESS WHEREOF, the parties hereto enter into this Amendment as of the date first set forth above.

THE COMPANY:

Inpixon

/s/ Nadir Ali

By:
Name:  Nadir Ali
Title:

Chief Executive Officer

DIRECTOR:

/s/ Tanveer A. Khader
Tanveer A. Khader

3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INPIXON

List of Subsidiaries

Name of Subsidiary

  State of Jurisdiction of Incorporation 

Fictitious Name (if any)

Inpixon Canada, Inc.

Sysorex India Limited

Canada

India

None

None

Exhibit 21.1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

We consent to the incorporation by reference in the Registration Statement of Inpixon and Subsidiaries on Form S-3 [File No. 333-223960]; Forms S-8 [File No. 333-229374];
[File No. 333-224506]; [File No. 333-216295] and [File No. 333-195655] of our report, which includes an explanatory paragraph as to the Company’s ability to continue as a
going concern, dated March 28, 2019, with respect to our audits of the consolidated financial statements of Inpixon and Subsidiaries as of December 31, 2018 and 2017 and for
the years ended December 31, 2018 and 2017, which report is included in this Annual Report on Form 10-K of Inpixon for the year ended December 31, 2018.

Exhibit 23.1

/s/ Marcum llp

Marcum llp
New York, NY
March 28, 2019

 
 
 
 
CERTIFICATION

Exhibit 31.1

I, Nadir Ali, certify that:

1.

I have reviewed this Annual Report on Form 10-K of Inpixon;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results

of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-

15(e) and 15-d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed  such  disclosure  controls  and  procedures,  or  caused  such  disclosure  controls  and  procedures  to  be  designed  under  our  supervision,  to  ensure  that  material
information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared; and

b) Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our  supervision,  to  provide
reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for  external  purposes  in  accordance  with  generally
accepted accounting principles; and

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure

controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed  in  this  report  any  change  in  the  registrant’s  internal  control  over  financial  reporting  that  occurred  during  the  registrant’s  most  recent  fiscal  quarter  (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors
and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect

the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 28, 2019

/s/ Nadir Ali
Nadir Ali
Chief Executive Officer
(Principal Executive Officer)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION

Exhibit 31.2

I, Wendy F. Loundermon, certify that:

1.

I have reviewed this Annual Report on Form 10-K of Inpixon;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results

of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-

15(e) and 15-d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed  such  disclosure  controls  and  procedures,  or  caused  such  disclosure  controls  and  procedures  to  be  designed  under  our  supervision,  to  ensure  that  material
information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared; and

b) Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our  supervision,  to  provide
reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for  external  purposes  in  accordance  with  generally
accepted accounting principles; and

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure

controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed  in  this  report  any  change  in  the  registrant’s  internal  control  over  financial  reporting  that  occurred  during  the  registrant’s  most  recent  fiscal  quarter  (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors

and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect

the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 28, 2019

/s/ Wendy F. Loundermon
Wendy F. Loundermon
VP of Finance 
(Principal Financial and Accounting Officer)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION

Exhibit 32.1

In connection with the Annual Report of Inpixon (the “Company”) on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange
Commission  (the  “Report”),  we,  Nadir  Ali,  Chief  Executive  Officer  (Principal  Executive  Officer)  and  Wendy  F.  Loundermon,  VP  of  Finance  (Principal  Financial  and
Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of
our knowledge: 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for

the periods indicated.

Date: March 28, 2019

/s/ Nadir Ali
Nadir Ali
Chief Executive Officer 
(Principal Executive Officer)

/s/ Wendy F. Loundermon
Wendy F. Loundermon
VP of Finance 
(Principal Financial and Accounting Officer)